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Abstract 
Marine sponges are a rich source of bioactive natural products with potent 
anticancer activities. Currently, the limited availability of most of these substances 
prohibits further drug development (Proksch et al., 2002). Highly complex consortia 
of bacterial symbionts associated with sponges have been frequently proposed to 
be the true producers of many secondary metabolites (Piel, 2004). However, the 
majority of these complex microbial assemblages are not amenable to cultivation 
(Amann et al., 1995; Hugenholtz et al., 1998; Friedrich et al., 2001; Webster & Hill, 
2001),  thereby hampering efforts to prove the symbiont hypothesis as well as to 
access their biosynthetic potential. Using metagenomic-based approaches, Piel and 
colleagues have previously provided the first genetic evidence for the bacterial origin 
of invertebrate-derived natural products by cloning the entire gene cluster for 
onnamide/theopederin from the Japanese sponge Theonella swinhoei (Piel et al., 
2004a, 2004b). 
 
 
 
 
 
 
 
 
 
 
 
In this work, we investigated further natural product biosynthetic pathways from 
uncultivated symbiotic bacteria using Japanese T. swinhoei as a symbiotic 
assemblage model. The reasons for selecting this sponge are the wide variety of 
pharmaceutically important secondary metabolites isolated from this sponge as well 
as the high complexity of the associated bacteria (Fusetani & Matsunaga, 1993; 
Henstchel et al., 2002), which might play an important role in metabolite 
biosynthesis. Metagenome mining strategies that we applied and developed in this 
work have led to the cloning of two new biosynthetic pathways from this complex 
symbiosis model. Our bioinformatic analysis predicted that one pathway is 
responsible for the biosynthesis of misakinolide A, and another one for keramamide 
H. Interestingly, we found that the first pathway contains additional components that 
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match structures of swinholide A and hurghadolide A, potent actin polymerization 
inhibitors isolated from other sponges (Carmely & Kashman, 1985; Kitagawa et al., 
1990; Doi et al. 1991; Youssef & Mooberry, 2006). 
 
 
 
 
 
 
 
 
 
 
Both biosynthetic pathways were encoded on two different gene clusters that 
exhibited typical bacterial gene features, strongly indicating that the producer of 
misakinolide A and keramamide H is a symbiotic bacterium. Since the screening 
system used to clone the gene clusters was based on the filamentous fraction 
dominated by “Candidatus Entotheonella sp.”, a heterothropic delta-proteobacterium 
associated with T. swinhoei, we assumed that misakinolide A and keramamide H 
are produced by “Entotheonella sp.” To confirm the taxonomic status of the bacterial 
producer, further analysis either by single cell studies or its combination with 
complete genome is currently underway. 
 
Subsequent genome sequencing of another member of this as-yet uncultivable 
candidate genus from a different chemotype of T. swinhoei led to the identification of 
genes for the biosynthesis of orbiculamide-like structure, which is structurally related 
to keramamides. Therefore, the results in this work provide not only convincing proof 
for the microbial origin of marine natural products but also specific taxonomic 
information as well as the potential to sustainable supply of pharmacologically 
potential compounds.  
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Chapter I 
Introduction 
Oceans account for over 70% of the earth`s surface area. The majority of these 
waters are at great depth, in which about 95% are more than 1000 m deep 
(Skropeta, 2008) or 60% are more than 2000 m deep (Bull et al., 2000).  Fourteen of 
35 animal phyla found in the sea are exclusively marine, whereas only 11 are 
terrestrial (Briggs, 1994; Ray, 1997; Sala and Knowlton, 2006). So far approximately 
300,000 marine species have been described (Bouchet, 2006; Sala & Knowlton, 
2006; Douvere and Laffoley, 2010), and the total number of eukaryote species in the 
world`s oceans is estimated at 2.21 million (Mora et al., 2001). The highest 
biodiversity in the ocean is found in coral reefs, where the number of species per 
unit area is extremely high and predicted to exceed that of tropical rainforests 
(Haefner, 2003; Sogin et al., 2006). Around 600,000 to more than 9 million species 
have been estimated in the coral reefs worldwide (Plaisance et al., 2011). The deep 
sea, on the other hand, is considered as high biodiversity repository due to the 
enormous surface area (Sala and Knowlton, 2006). Over 500 eukaryote species, 
encompassing 12 animal phyla and more than 150 new genera, have been 
described from deep vent sites in the last three decades (Thornburg et al., 2010). 
However, the marine biodiversity estimates assessed so far almost exclusively 
accounts for multicellular eukaryotes, mainly large- and well-studied macrofauna 
(Belwood and Hughes, 2001; Mellin et al., 2011; Plaisance et al., 2011). It does not 
account for single-cell eukaryotes, bacteria, archaea, and viruses (Sala & Knowlton, 
2006), suggesting that the marine species diversity is much higher than previously 
thought (www.coml.org; Grassle and Maciolek, 1992; Committee on Biological 
Diversity in Marine Systems of the U.S. NRC, 1995). 
 
Pioneering work by ZoBell and colleagues in the 1940s and 1950s showed the 
enormous number and diversity of true marine bacteria from the deep sea (up to 10 
km deep). They described the multiplication, morphology, and physiological 
activities of deep sea bacteria able to grow both at normal pressures as well as 
those that prefer high hydrostatic pressures (up to 600 atmospheres) (ZoBell & 
Johnson, 1949; ZoBell and Oppenheimer, 1950; ZoBell and Morita, 1957). Recent 
genome shotgun sequencing conducted by Venter and coworkers showed the 
presence of at least 1800 new different genomic species of bacteria, including 148 
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previously unknown bacterial phylotypes, in just 1500 liters of seawater from the 
Sargasso Sea near Bermuda (Venter et al., 2004). A more recent ocean exploration 
(between 2000 to 2010) by the Census of Marine Life program involving 2,700 
scientists from 80 nations revealed that the estimated number of species in the 
oceans are more than 1 million (excluding microbes). The diversity of marine 
microbes is estimated as high as 1 billion, with ~38,000 species and 5,000-9,000 
species of microbial bacteria in a liter of seawater and a gram of sand, respectively 
(www.coml.org; Costello et al., 2010).  
 
Fluorescent in situ hybridization studies by DeLong, Karners and colleagues showed 
that the global oceans harbor approximately 1.3 x 1028 archaeal cells, and 3.1 x 1028 
bacterial cells. The pelagic archaea belonging to crenarchaeota accounts for 
approximately 20% of the global picoplankton cells, representing one of the most 
abundant cell types in the oceans (DeLong et al., 1999; Karner et al., 2001). The 
microbial biomass in the oceans is estimated at 3,6 x 1029 microbial cells with a total 
cellular carbon content of 3 x 1017 grams (Sogin et al., 2006). The deep-ocean 
sediments (0-10 m) contain approximately 6.6 x 1029 marine prokaryotic (archaeal 
and bacterial) cells (Whitman et al., 1998). Recent molecular studies on symbiotic 
bacteria showed that the microbial consortia in many sponges can account for up to 
60% of the total biomass and consist of hundreds to thousands of species with at 
least 18 bacterial and archaeal phyla identified from these hosts (Taylor et al., 
2007). Some well-studied sponge specimens harbor bacterial cells in the density 
range of 6.4 x 108 to 1.5 x 109 bacterial cells per ml of sponge extract, which 
exceeds at of seawater by two to four orders of magnitude (Scheuermayer et al., 
2006). It is therefore not surprising that marine microorganisms account for most of 
the oceanic biomass (Azam & Worden, 2004).  
 
Due to the enourmous diversity and abundance of marine microorganisms, there 
has been an emerging interest among scientists to understand their bio-ecological 
roles. Significant roles have been attributed to marine microorganisms including 
their involvement in nearly all primary and secondary production as well as in all 
biogeochemical cycles in the oceans (Staley, 1985; Storm, 2008). In the deep-sea 
hydrothermal vents, extremophiles have the ability to adapt in extreme conditions 
such as high pressure, high temperature, low pH, low oxygen, toxic metals, and
no sunlight (Skropeta, 2008). They play important roles in primary production in the 
vent communities via chemosynthesis (Thornburg et al., 2009). Recent genomic and 
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proteomic studies have revealed the remarkable diversity of metabolic pathways 
used by these chemosynthetic bacteria to obtain energy from their environments 
and feed their hosts (Dubilier et al., 2008). Symbiotic bacteria associated with 
marine animals have recently been shown to contribute to the survival and health of 
the host macro-organisms, including nutrition, chemical protection, localization cues, 
and developmental signals (Flachshaar & Piel, 2008, Woyke et al., 2006).  
 
A unique symbiotic role is exemplified by the luminescent symbionts of the 
Vibrionaceae group living in the light organs of squid of the genera Uroteuthis, 
Loliolus and Euprymna. These symbionts produce light to provide their host squid 
with a mechanism allowing them to evade predators by camouflage (Guerrero-
Ferreira & Nishiguchi, 2007). Other unique symbiosis was observed between the 
organic compound-degrading Oceanospirillales and the marine worms of genus 
Osedax living on the carcasse of a grey whale at the depth of 2891 m in Monterey 
Canyon, off the coast of California (Goffredi et al., 2005). Recent shotgun 
sequencing by Dubilier and colleagues has revealed that two symbionts identified as 
Olavius algarvensis play roles in providing the worms with multiple sources of 
nutrition by fixating carbon into organic carbon via autotrophy as well as by 
synthesizing almost all amino acids and various vitamins (Woyke et al., 2005). It 
was found that these symbionts are also able to uptake and recycle the waste 
products of the worm, such as dicarboxylate, succinate, monocarboxylates acetate 
and propionate, explaining how the host lives without excretory system (Woyke et 
al., 2005). Further metaproteomic and metabolomic studies revealed unsual 
pathways possessed by the symbionts of O. algarvensis to cope with energy and 
nutrient limitation, such as the potential use of carbon mononoxide as an energy 
source and as yet undescribed energy-efficient steps in CO2 fixation and SO4
2- 
reduction (Kleiner et al., 2011). Interestingly, symbiotic microorganisms have been 
proposed to provide chemical protection or defense to most sessile marine 
invertebrates that lack mobility, such as sponges, bryozoans, and tunicates (Amsler 
et al., 2001). To be able to accomplish all these bio-ecological roles as mentioned 
above, marine microorganisms appear to contain highly diverse and unique 
metabolic pathways, which can be explored for production of specific natural 
products that are useful for food, pharmaceutical, fuel and cosmetic industries. 
Therefore, biotechnological exploration of marine microorganisms undoubtedly 
offers exciting opportunities and challenges in discovery of intriguing biosynthetic 
pathways responsible for making compounds with promising pharmacological 
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activities. Further genetic manipulation of the biosynthetic pathways of interest could 
lead to the generation of structurally novel “unnatural” natural products with 
improved properties.  
1.1. Pharmacological Potential of Marine Bacteria 
Until 2009, approximately 569 compounds from marine bacteria have been reported 
(William et al., 2009), in which at least 15 marine bacterial natural products are 
currently being evaluated in clinical trials, especially as anticancer drugs (Gerwick et 
al., 2008). Approximately 390 novel natural products have been discovered from 
deep-sea (>50 m depth) organisms, including invertebrates, bacteria, archaea, and 
fungi (Skropeta, 2008).  Interestingly a number of new compounds have recently 
been reported from bacteria living in the deep-sea hydrothermal vents, which is 
exemplified by the apoptosis-inducing agents ammonificins A (1) and B (2) isolated 
from the thermophilic anaerobic ε-Proteobacterium, Thermovibrio ammonificans 
(Andrianasolo et al., 2009) (Fig. 1.1.1).  
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Figure 1.1.1 Examples of pharmacologically potential compounds discovered from marine 
bacteria: ammonificins A and B from Thermovibrio ammonificans (Andrianasolo et al., 2009), 
salinosporamide A from Salinospora tropica (Feling et al., 2003), and curacin A from Lyngbya 
majuscule (Gerwick et al., 1994). 
The majority of the wide diversity of marine bacteria cannot be cultivated under 
laboratory conditions (Staley & Konopka, 1985; Iverson et al., 2012). However, even 
the few genera that have been cultured (Fenical, 1993) have enabled access to 
intriguing chemistry and unique biosynthetic pathways. Pioneering work of Fenical, 
Jensen, and coworkers has led to the discovery of at least 13 new genera of unique 
marine actinomycete bacteria from deep-sea sediments (Jensen et al., 1991; 
Fenical et al., 1993; Mincer et al., 2002). All of the isolated actinomycetes were 
cultured in a seawater-based medium and have been shown to produce unique 
metabolites (Jensen et al., 1991; Jensen & Fenical, 1994). Further chemical 
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investigation has shown that the obligate marine genus Salinospora is a particularly 
rich source of unprecedented secondary metabolites (Fenical & Jensen, 2006). One 
notable example is salinosporamide A (3), a very potent proteasome inhibitor (IC50 = 
1.3 nM) (Feling et al., 2003; Fenical et al., 2009; Cragg et al., 2012). This potent 
cytotoxin is currently in phase I clinical trials and approaching phase II (Cragg et al., 
2009; Gerwick & Moore, 2012). By genome sequencing of S. tropica, B. Moore and 
colleagues identified at least 17 biosynthetic gene clusters (Udwary et al, 2007). 
Interestingly, only three of them are responsible for the biosynthesis of known 
natural products, including salinosporamides, suggesting the remarkable 
biosynthetic capacity of this marine actinomycete (Udwary et al, 2007). 
 
Marine cyanobacteria have attracted great attention as the producers of a large 
number of intriguing compounds with promising biological activities. These 
photosynthetic bacteria, also called blue green algae, are abundant under favorable 
environmental conditions in shallow tropical waters (Nunnery et al., 2010; Gerwick et 
al., 2008). Due to the profusive growth in nature, they can be collected in large 
enough quantities and cultivated under laboratory conditions (Gerwick et al., 2008). 
Starting with the pioneering work of R. E. Moore in the 1970s to the early 2000s, it 
was revealed that marine cyanobacteria are a significant source of pharmaceutically 
relevant secondary metabolites (Mynderse & Moore, 1978; Moore, 1996; Simmons 
et al., 2005; Gerwick et al., 2008; Cardellina II & Moore, 2010; Nunnery et al., 2010). 
Further investigation of marine cyanobacteria by Gerwick and coworkers has shown 
chemical structures, biosynthesis, and biological activities of these intriguing 
metabolites (Gerwick et al., 2008). Many of these cyanobacterial metabolites are 
structurally unique because they combine peptide and lipid features with additional 
functional modifications such halogen atoms to generate a wide variety of 
lipopeptides (Nunnery et al., 2010). A notable example, curacin A (4) from the truly 
marine cyanobacterium Lyngbya majuscula (Gerwick et al., 1994) is currently in 
preclinical trials as an anticancer agent (Newman & Crag, 2004; Simmons et al., 
2005). This compound was found to contain unusual structural features, such as 
thiazole ring, cyclopropyl ring, and a terminal alkene moiety (Gerwick et al., 1994). 
Using a gene cloning strategy, the curacin A gene cluster was identified, including a 
gene cassette responsible for cyclopropyl ring formation (Chang et al., 2004). 
Further biosynthetic studies have revealed that the terminal alkene formation occurs 
through a unique mechanism involving hydrolysis, decarboxylation, and sulfate 
elimination (Gu et al., 2009; Gehret et al., 2011).  
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Recently symbiotic bacteria associated with marine invertebrates have gained 
increasing attention from a medical perspective because they are suspected as the 
true producers of many rare bioactive secondary metabolites. Marine invertebrates 
such as sponges, bryozoans, and tunicates are well known chemically rich sources 
of pharmaceutically important and structurally unique compounds (Faulkner, 1994; 
Hay & Fenical, 1996). A frequently observed phenomenon supporting the symbiosis 
hypothesis is that invertebrate-derived metabolites are structurally related to typical 
bacterial compounds (Bewley and Faulkner, 1998; Moore 1999; Piel, 2004). In 
addition, numerous marine invertebrates harbor complex polyketide and structurally 
modified peptide families that are common in bacteria, but rare in other animals 
(Piel, 2006; Uria & Piel, 2009). Due to the limited amount of the metabolites in the 
animal tissues, exploitation of the biosynthetic pathways of symbiotic bacteria could 
provide a sustainable supply of marine compounds for drug development (Piel, 
2002). However, attempts to access these biosynthetic pathways have been 
hampered by the complexity of the microbial assemblages and the fact that they are 
not amenable to culture (Amann et al., Hugenholtz et al., 1998; Friedrich et al., 
2001). For example, a recent study of the Great Barrier Reef sponge Rhopaloeides 
odorabile showed that the culturable percentage of symbiotic bacteria accounts for 
only 0.1-0.23% of the total bacterial community (Webster & Hill, 2001). Despite 
improvements in cultivation techniques, the majority of sponge-associated bacteria 
cannot be cultured in the laboratory media (Hentschel et al., 2002). A potential 
problem is that laboratory cultivation may destroy any cell-to-cell communication 
between organisms in the natural habitats that might be crucial for growth. In nature, 
symbiotic bacteria likely coexist with a host and/or other bacteria to obtain essential 
nutrients and substrates that are not available with standard microbiological 
approaches (Joint et al., 2010). Even if cultivation conditions can be identified, the 
desired compound might not be produced due to the absence of required 
environmental signals (Uria & Piel, 2009). 
 
Recent advances in cultivation-independent techniques and DNA sequencing 
technology have enabled access to the biosynthetic pathways of pharmaceutically 
relevant natural products from complex microbial communities (Piel 2004; Schmidt 
2008). Using metagenomics-based approaches, Piel and colleagues have provided 
the first genetic evidence for the bacterial origin of marine invertebrate-derived 
natural products by cloning the gene cluster for onnamides/theopederins (5) from 
the sponge Theonella swinhoei (Piel et al., 2004b). Subsequently, Piel and 
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colleagues cloned the gene cluster for psymberin (6) from the sponge Psammocinia 
aff. bulbosa (Fisch et al., 2009). More recently, Piel and colleagues isolated 
biosynthetic genes for polytheonamides A (7) and B (8) from T. swinhoei 
metagenome (Freeman et al., 2012). These giant toxins function as unimolecular ion 
channels in cell membranes (Iwamoto et al., 2010) with near femtomolar activity 
(Freeman et al., 2012). These highly cytotoxic 48-residue polypeptides contain 13 
nonproteinogenic amino acids, and therefore, they were previously thought to have 
formed by a nonribosomal peptide synthetase (NRPS) (Fusetani & Matsunaga, 
1993; Hamada et al., 2010; Itoh et al., 2012). However, recent metagenomic studies 
by Freeman et al (2012) have revealed a ribosomal origin of these exceptionally 
potent natural products with only six candidate enzymes involved in 48 
posttranslational modifications (Freeman et al., 2012) (Fig. 1.1.2). 
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Figure 1.1.2 Pharmaceutically important natural products from marine sponges, in which 
their biosynthetic pathways have been characterized. These include onnamide A from 
the sponge Theonella swinhoei (Piel et al., 2004b), psymberin from the sponge 
Psammocinia aff. bulbosa (Fisch et al., 2009), and polytheonamides  from T. swinhoei 
(Freeman et al., 2012). Polytheonamides A and B differ in the configuration of the 
sulfoxide moiety in the unusual residue β,β-dimethylmethionine sulfoxide (red color). 
The biosynthetic pathways of a number of other natural products have been 
identified from the uncultivated bacterial symbionts of various other marine 
invertebrates, including the gene clusters coding for patellamides A (9) and C (10) 
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from a tunicate (Schmidt et al, 2005), bryostatin 0 (11) from a bryozoan, which is the 
common basis of the 20 known bryostatins including bryostatin 1 (12) (Sudek et al., 
2007), and ET-583 (13), an intermediate involved in the biosynthesis of the 
chemotherapeutic ET-743 (14) from a tunicate (Rath et al., 2011) (Fig. 1.1.3).  
 
Figure 1.1.3 Pharmaceutically important natural products from various marine invertebrates, 
in which their biosynthetic pathways have been characterized. These include patellamides A 
and C from the cyanobacterial symbiont of tunicate Lissoclinum patella (Schmidt et al, 
2005), bryostatin O that is a common basis of the 20 know bryostatins including bryostatin 1 
from the bryzoan Bugula neritina (Sudek et al., 2007), and ET-583 that is an intermediate in 
the biosynthesis of ET-743 from the tunicate Ecteinascidia turbinate (Rath et al., 2011). 
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Discovery of the biosynthetic pathways for these complex compounds not only 
provides convincing proof for the microbial origin but also facilitates the sustainable 
supply of rare marine drug candidates. Since among marine invertebrates, sponges 
(Porifera) are the leading sources of bioactive natural products in terms of the 
number of bioactive compounds discovered (Proksch, 1994; Faulkner, 2000; Leal et 
al., 2012), therefore the next sections will highlight recent progress in sponge-
symbiont studies and in exploring the biosynthetic potential of marine sponges for 
the sustainable supply of rare potent sponge-derived compounds. 
1.2 Microbial Associations with Marine Sponges 
Marine sponges (phylum Porifera) show a diverse range in structural, size, shape, 
and color, and are distributed in a wide range of marine habitats, including tropical, 
temperate, and antarctic oceans (Ruppert et al., 2004). Currently, there are 
approximately 11,000 sponge species described in the World Porifera Database 
(WPD) of which around 8,500 are considered valid (Van Soest et al., 2012a; Van 
Soest et al., 2012b). Their multicellular body plan is relatively simple and specifically 
designed for filter feeding. The simplest form is a hollow cylinder that is attached to 
the substratum and surrounded by many small pores called ostia with a larger upper 
opening called osculum. The body surface is covered by an outer layer 
(pinacoderm), and the hollow interior (atrium) is lined by a monolayer of flagellated 
collar cells (choanoderm). The connective tissue layer located between the 
pinacoderm and the choanoderm is called the mesohyl (Ruppert et al., 2004; Taylor 
et al., 2007; Eerkes-Medrano & Leys, 2006) (Fig. 1.2.1). Among many cells present 
in the mesohyl are archaeocytes, large amoeboid cells bearing a number of large 
lysosomes, which play a role in digestion and internal transport (Ruppert et al., 
2004). There are three cell types described in the pinacoderm, namely 
exopinacocytes that extend along the outer surfaces of the dermal membrane, ab-
endopinacocytes that line the inner wall of the osculum and the excurrent canals, 
and pros-endopinacocytes that cover the subdermal space and the inner surface of 
the dermal membrane (Mergner, 1964). The pinacoderm is a monolayer composed 
of flatted cells. The flattened shape of the endopinacocytes is especially intended for 
rapid diffusion between the water channels and the mesenchyme (Bagby, 1970) 
(Fig. 1.2.1).  As the name Porifera (pore bearers) implies, the sponge body is 
exceptionally porous which inhales seawater through the ostia throughout the body, 
then pass over the flagellated choanoderm to the atrium, and exits through the 
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osculum. This water circulatory system is called the aquiferous system (Ruppert et 
al., 2004). The water volume pumped by a sponge is equal to its body volume that 
flows through the aquiferous system once every 5 seconds (Ruppert et al., 2004) or 
up to 24,000 liters/kg its body in a single day (Vogel, 1977; Kennedy et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.1 The sponge`s body plan, showing various sponge cell types and symbiotic 
bacterial cell types. Modified from Ruppert et al (2004). 
The abundance and diversity of microbial communities in sponges were originally 
described by Wilkinson, Vacelet & Reisweg in the 1970s and 1980s (Reiswig, 1975; 
Wilkinson & Fay, 1979; Vacelet & Donadey, 1977). Based on electron microscopy 
and bacterial cultivation studies, they showed that the microbial biomass can 
account up to 40% of the total sponge volume. In particular the sponge specimens 
categorized as “bacteriosponges” are attributed to those with high numbers of 
bacteria (Vacelet and Donadey, 1977) with the densities of 108 to 1010 bacterial cells 
per gram of sponge body wet weight (Hentschel et al, 2006). It was found that 
sponge-specific microbial populations were particularly abundant in the sponge 
mesohyl (Wilkinson, 1978; Vacelet & Donadey, 1977). Recent developments in 
biomolecular techniques such as 16S rRNA gene analysis and denaturing gradient 
gel electrophoresis (DGGE) have enabled to obtain better insights into the diversity 
of symbionts in sponges. So far the diversity of microbes known in sponges 
encompass 14 recognized bacterial phyla, both major archaeal lineages, and 
assorted microbial eukaryotes. The most frequently isolated 16S rRNA gene 
sequences from sponges include those from Acidobacteria, Actinobacteria, and 
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Chloroflexi (Taylor et al., 2007). Hentschel and colleagues assessed the 
phylogenetic analysis of the mesohyl bacteria using fluorescence in situ 
hybridization (FISH) and showed that the vast majority of mesohyl bacteria belong to 
the domain with low GC content, which was mostly dominated by δ-proteobacteria, 
followed by γ-proteobacteria and representatives of the Bacteriodetes (Friedrich et 
al., 1999). In general, the internal mesohyl layer is primarily populated by 
heterotrophic and autotrophic bacteria. Whereas, the outer layer of the sponge 
exposed to sunlight is typically dominated by photosynthetic bacteria such as 
cyanobacteria (Kennedy et al., 2007) (Fig. 1.2.1). 
 
By pumping larger volumes of seawater, marine sponges remove living microscopic 
particles such as bacteria, microalgae or detritus from the seawater column 
(Hentschel et al., 2006). The acquired bacteria cells entering the aquiferous system 
are subsequently transferred to the mesohyl layer. In the mesohyl layer, bacterial 
cells can be digested as nutrients through extracellular lysis and subsequent 
phagocytosis by sponge cells called archaeocytes (Vacelet & Donadey, 1977; Ribes 
et al., 1999; Vacelet & Duport, 2004). However, some bacteria can live and become 
established as part of the sponge-specific symbionts (Vacelet & Donadey, 1977). 
This uptake process of bacterial symbionts by the host sponges from the seawater 
environment is known as horizontal transmission. Interestingly, during horizontal 
transmission, sponges have the ability to distinguish between bacterial symbionts 
and seawater bacteria through a specific mechanism for recognition and rejection of 
self-particulate matters in the epidermal cells (Wilkinson et al., 1984).  
 
The vertical transmission of symbionts from adult sponges to their offspring through 
reproductive stages was originally proposed by Lévi and Porte in the 1960s based 
on electron microscopy observation (Schmitt et al., 2008). This transmission is likely 
common and widespread among marine sponges in order to maintain stable 
symbiotic associations to each sponge generation (Schmitt et al., 2008; Lee et al., 
2009). Recent molecular studies by Schmitt, Hentschel and colleagues on five 
different Carribbean sponge species harboring high complex microbial consortia 
have provided the first comprehensive phylogenetic analysis showing the collective 
vertical transmission of a complex adult microbial community through reproductive 
stages in the sponges, Xestospongia muta, Ircina felix, and Corticium sp (Schmitt et 
al., 2008). Subsequently they proposed the following transmission model for 
symbiotic associations of high microbial abundance sponges based on a combined 
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electron and fluorescence observation and phylogenetic studies. At first, the 
microbial symbionts in the adult mesohyl are vertically transmitted to larvae. Since 
larvae are unable to feed during the transmission, it is assumed that there is no 
microbial exchange with the environment. This non-feeding period results in the 
symbiont separation in different sponges that would lead to cospeciation. 
Subsequently when the larvae become juveniles, a filter-feeding period begins 
indicated by the ability to uptake seawater microbes. This uptake process may result 
in the horizontal transmission of microbial symbionts between the host sponges and 
the environment (Schmitt et al., 2008). This vertical transmission of bacterial 
symbionts from adult to embryo was supported by the work of Lee et al (2009) who 
applied DGGE and clone library analysis to demonstrate that the bacterial 
communities associated with the adults of the Caribbean sponge Svenzea zeai were 
highly similar to the embryos of the same sponge species, but they were completely 
different from those in the surrounding seawater (Lee et al., 2009). 
 
There has been an emerging recognition about the mutualistic relationship between 
the bacterial symbionts and the host sponges themselves. In the surfaces or internal 
spaces of the sponge body, nutrients are much richer than in seawater and 
sediments, suggesting that the sponges offer nourishment and a safe habitat to their 
bacterial symbionts (Lee et al., 2001). The microbial symbionts contribute to the 
hosts by supporting the nutritional process through nitrogen fixation, nitrification and 
photosynthesis (Wilkinson & Fay, 1979; Hoffmann et al., 2009) and metabolic waste 
processing (Beer & Ilan, 1998). In particular, a nitrogen source is likely available in 
the form of ammonia as an endproduct of host metabolism (Scheuermayer et al., 
2006). Providing nutrition to the host through nitrogen fixation is exemplified by 
symbiotic cyanobacteria, which are autotrophic symbionts of a variety of sponges 
(Wilkinson and Fay, 1979). Many sponges contain photosynthetic symbionts, more 
commonly cyanobacteria, in their tissue and obtain nutritional benefit from the 
photosynthate. Further investigation showed that cyanobacteria transfer excess 
photosynthate in the form of glycerol and a small organic phosphate through a 
mechanism similar to the glycerol 3-phosphate shuttle functioning between 
chloroplasts and cytoplasm in plant cells (Arillo et al. 1993). The excess 
photosynthate is utilized by the sponges (Ruppert et al., 2004).  
 
Recently, Hentschel, Piel and coworkers have revealed the functional properties and 
lifestyle of a member of the possibly ancient symbiont phylum, “Candidatus 
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Poribacteria”. This symbiont was isolated as individual cells from the marine sponge, 
A. aerophoba by FACS. Whole genome amplification and sequencing indicated that 
the “Poribacteria” were mixotrophic bacteria with the capacities of autotrophic CO2 
fixation via the Wood-Ljungdahl pathway. Interestingly, two intermediate enzymes in 
the anaerobic respiratory chain, namely nitrite reductase and nitric oxide reductase 
were found. This suggests the ability of this symbiont to maintain a respiratory chain 
under oxygen-limiting conditions, such as during the sponge`s non-pumping periods 
in which the meshopyl turns anaerobic. In addition, several putative proteins in the 
sequenced genome might be involved in the sponge-microbe symbiosis, such as 
adhesins, adhesion-related proteins (ARP) and tetratricopeptide repeat domain-
encoding proteins (TPR) (Siegl et al., 2011).  
 
Another ecological role of microbial symbionts that have attracted special attention 
from a medical perspective is the ability to produce toxic metabolites (Faulkner et al, 
1994). There is growing evidence that symbiotic bacteria produce toxic compounds 
in order to provide the chemical defense system to the hosts, because sponges lack 
the complex immune system of higher animals (Kennedy et al., 2007; Lee et al., 
2001). In particular the toxic compounds released by the symbionts may help their 
sponge hosts to deter predators, keep competitors away, paralyze their prey, 
prevent settlement of other organisms on their body`s surfaces (biofouling), or 
compete for space with other organisms (Haefner, 2003). The substances playing a 
role as chemical defense have been the main focus of interest in recent years for 
being developed as clinically used medicines. Because these toxic substances are 
in general available in extremely limited amounts in the sponge tissue, efforts to 
study the involvement of bacterial symbionts in producing sponge-derived 
metabolites could lead to a sustainable supply of marine drug candidates. 
1.3 Sponge-derived Metabolites and Symbiosis Hypothesis 
One of the most interesting aspects of marine sponges is the presence of bioactive 
compounds in their tissue, which may play a role to chemically defend sponges 
against environmental pressure factors such as predation, overgrowth and 
settlement of other organisms, or competition for space (Proksch, 1994; Haefner, 
2003). Marine sponges have been an interesting target for extensive studies on 
pharmaceutically valuable compounds since the discovery of two cytotoxic 
nucleosides from the marine sponge Cryptotethia crypta by Bergmann and 
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coworkers in the late 1940s and the early 1950s (Bergmann & Feeney, 1950, 1951; 
Bergmann & Swift, 1951). These nucleosides, named spongothymidine (15) and 
spongouridine (16), subsequently provided the basis for the synthesis of the antiviral 
agent vidarabine (Ara-A) (17), the anticancer agent cytarabine (Ara-C) (18) (Proksch 
et al., 2002), and the antiviral agent zidovudine (AZT) (19) (Bowling et al., 2007) 
(Fig. 1.3.1). Ara-C (18) became the first marine-derived anticancer drug that is 
currently used in the routine treatment of patients with leukemia and lymphoma 
(Proksch et al., 2002).  
 
Figure 1.3.1 Sponge-derived natural products and their analogs that are approved by FDA 
and/or EMA as clinically used agents or in clinical trial. Spongothymidine and spongouridine 
inspired the development of the well-known medicines Ara-A, Ara-C, and AZT. Halichondrin 
B became a basis for the synthesis of the newly approved anticancer drug Halaven® 
(E7389). Hemiasterlin isolated from several marine sponge species inspired the synthesis of 
E7974, an anticancer drug candidate currently in human clinical trials. 
In more recent year, a synthetic analog of halicondrin B (20), termed Eribulin 
Mesylate (E7389, Halaven®) (21), has been approved as a new chemotherapy 
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agent for metastatic breast cancer patients by US Food and Drug Administration 
(Donoghue et al., 2012) as well as by the European Medicines Agency (Menis and 
Twelves, 2011; Gourmelon et al., 2012; Ortega & Cortés, 2012). It inhibits 
microtubule polymerization and aggregates soluble tubulin in nonreprodutive form 
(Gourmelon et al., 2012). Halichondrin B (20) is a large macrolide isolated from the 
Japanese sponge, Halicondria okadai (Uemura et al., 1985; Hirata et al., 1986). 
Total synthesis of this tubulin-binding agent was performed by Kishi and colleagues 
(Aicher et al., 1992). In addition, a synthetic analogue of the marine sponge natural 
product Hemiasterlin (22), termed E7974 (23) (Kowalczyk et al., 2005), is in current 
phase I clinical trial as an anticancer agent (Rocha-Lima et al., 2012; Gerwick & 
Moore, 2012). It acts through an antimitotic mechanism inhibiting microtubule 
polymerization (Kuznetsov et al., 2009). Hemiasterlin, a modified liniear tripeptide, 
was isolated from the marine sponges Hemiasterella minor (Talpir et al., 1994), 
Cymbastela sp. (Coleman et al., 1995), and Auletta sp. and Siphonochalina sp. 
(Gamble et al., 1999) (Fig. 1.3.1). 
 
Among marine sponges, the order Lithistida (Demospongiae) is a renowned source 
of a diverse array of structurally complex biologically active metabolites. Over 300 
natural products have been reported from these lithistid sponges and structurally 
include sterols, macrolides, acetogenins, alkaloids, and peptides (Fusetani & 
Matsunaga, 1993; Bewley & Faulkner, 1998; Wright et al., 2010). Within the 
Lithistida, the chemistry of Theonella and Disocdermia species has been studied 
extensively. Early work by Djerassi, Kashman, and coworkers on T. swinhoei and T. 
conica in the 1980s led to the isolation of the sterols, conicasterol and 
theonellasterol (Kho et al., 1981). Furher work by Carmely and Kashman on the Red 
Sea T. swinhoei led to the isolation of the polyketide swinholide A. This cytotoxic 
compound was first identified as a monomeric 22-membered macrolide (Carmely & 
Kashman, 1985). Misakinolide A was first identified from Theonella sp. as a 
monomeric macrolide structurally very similar to swinholide A, but lacked an 
additional double bond in the lactone ring (Sakai et al., 1986). Subsequently, two 
macrolides, bistheonellide A and B, were discovered from a Theonella sp. collected 
at Hachijo-Jima island, Japan. NMR data, spectroscopic and chemical studies led to 
the conclusion that bistheonellide A was identical to misakinolide A (24) and the 
chemical structure proposed for both was dimeric instead of monomeric (Kato et al., 
1987). This allowed the previous monomeric swinholide A (25) structure to be 
revised to be a symmetric cyclic 44-membered dimer using X-ray single crystal 
Chapter 1 Introduction 
__________________________________________________________________________________ 
16 
 
analysis, as reported for the Okinawan T. swinhoei (Kitagawa et al., 1990; Doi et al. 
1991) (Fig. 1.3.2). Recent studies by Youssef and Mooberry (2006) on the Red Sea 
T. swinhoei resulted in the isolation of hurghadolide A (26), an unprecedented 42-
membered dilactone moiety that is structurally related to swinholide A. It is 
asymmetric due to the absence of an olefin in the lactone ring of only in one of the 
monomeric lactone. Compounds closely related to compounds 24-26 have been 
reported from remarkably diverse sources, including luminaolide (27) from algae 
(Kitamura et al., 2009), scytophycin C (28) from the filamentous cyanobacterium 
Scytonema pseudohofmanni (Ishibashi et al., 1986), and lobophorolide (29) from 
seaweed (Kubanek et al., 2003) (Fig. 1.3.2). This suggests that misakinolide A and 
its analogs are produced by microorganisms associated with the sponges. This 
symbiont hypothesis was somewhat supported by scanning electron micrograms for 
the Okinawan T. swinhoei containing swinholide A (Kitigawa et al., 1990) and the T. 
swinhoei from Hachijo-jima Island, showing the abundant presence of filamentous 
bacteria in the sponge tissues (Fusetani & Matsunaga, 1993). 
 
Figure 1.3.2 Macrolides closely related to misakinolide A reported from diverse sources: 
swinholide A and hurghadolide A from the sponge T. swinhoei (Carmely & Kashman, 1985; 
Kitagawa et al., 1990; Doi et al. 1991; Youssef and Mooberry, 2006), luminaolide from the 
crustose coralline algae Hydrolithonreinboldii (Kitamura et al., 2009), lobophorolide from the 
seaweed Lobophora variegate (Kubanek et al., 2003), and scytophycin C from the 
filamentous cyanobacterium Scytonema pseudohofmanni (Ishibashi et al., 1986). 
Although all three compounds (swinholide A, misakinolide A, and hurghadolide A) 
are potent actin polymerization inhibitors (Carmely & Kashman, 1985; Kitagawa et 
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al., 1990; Youssef & Mooberry, 2006), they show different mechanisms of activity. 
Misakinolide caps the barbed end of filaments while swinholide A severs actin 
filaments (Terry et al., 1997). Hurghadolide A (26) was 10 times more potent than 
swinholide A at disrupting microfilaments (Youssef & Mooberry, 2006). Compound 
26 showed in vitro cytotoxicity against human colon adenocarcinoma (HCT-116) 
with IC50 values of 5.6 and 365 nM (Youssef & Mooberry, 2006). 
Further work by Fusetani, Matsunaga and coworkers on the T. swinhoei collected in 
Hachijo-jima Island, Japan has led to the discovery of the complex bicyclic peptide 
theonellamide F (30) (Matsunaga et al., 1989) and theonellamides A-E (31-35) 
(Matsunaga and Fusetani, 1995). Theonellamide F (30) showed antifungal activity 
that inhibited the growth of Candida albicans with an MIC 6.3 µg/ml (Fusetani and 
Matsunaga, 1993). Subsequently, Faulkner and co-workers isolated theonegramide 
(36) and theopalaumide (37) from T. swinhoei collected in the Philippines (Bewley 
and Faulkner, 1994) and Palau (Schmidt et al., 1998) (Fig. 1.3.3).  
 
Figure 1.3.3 The antifungal complex cyclic peptide theonellamides F and A-E from 
Japanese T. swinhoei (Matsunaga et al., 1989; Matsunaga and Fusetani, 1995), which is 
closely related to theonegramide from Philippines T. swinhoei (Bewley & Faulkner, 1994) 
and theopalaumide from Palauan T. swinhoei (Schmidt et al., 1998). The unsual amino 
acids are indicated with red color for Aboa, green color for (2S,3R)-3-hydroxyasparagine (α-
AhAA), and blue color for L-ρ-bromophenylalanine (L-BrPhe). 
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Theonegramide and theopalaumide are structurally similar to theonellamide F, but 
differ by the addition of a sugar moeity to the histidoalanine-bridge, in which 
theonegramide harbors D-arabinose whereas theopalaumide contains D-galactose. 
Interestingly, these three antifungal peptides have the unusual amino acid residue 
(3S,4S,5E,7E)-3-amino-4-hydroxy-6-methyl-8-(p-bromophenyl)-5,7-octadienoic acid 
(Aboa), which is structurally similar to 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-
4,6-decadienoic acid (Adda) present in microcystins associated with the bloom of 
cyanobacterium Microcystis spp. (Namikoshi et al., 1992), suggesting the possible 
symbiotic bacterial origin of theonellamides and its analogs. 
Experimental support of the microbial origin of sponge-derived secondary 
metabolites was initially provided by Faulkner and coworkers who investigated the 
cellular localization of swinholide A and the complex cyclic peptide theopalauamide 
in the Palauan T. swinhoei (Bewley et al. 1996). In their experiments, three different 
types of bacterial cells were initially separated from the sponge cells by differential 
centrifugation: (i) the filamentous heterotrophic bacteria (found in the endosome 
part), (ii) the unicellular cyanobacteria (identified as Aphanocapsa feldmanni) 
(present only in the ectosome), and (iii) the unicellular heterotropic bacteria 
(distributed throughout the sponge tissue, both endosome and ectosome). Chemical 
analysis showed that swinholide A was accumulated in the mixed unicellular 
bacterial fraction, whereas the antifungal theopalaumide was located mainly in the 
filamentous bacteria (Bewley et al., 1996). In contrast, work of Gerwick and 
coworkers on free-living cyanobacteria collected from two different locations led to 
the isolation of swinholide A (Andrianasolo et al., 2005). At this point, it was unclear 
which one the actual producer of this compound was, the sponge-associated 
cyanobacteria or the unicellular heterotrophic bacteria (Andrianasolo et al., 2005; 
König et al., 2006). Another possibility is accumulation of swinholide A in a certain 
type of bacterial population due to the transport of such compound across cellular 
membranes and whole tissues (Uria & Piel, 2009).  
Identifying the taxonomy affiliation of the filamentous heterotrophic bacterial fraction 
containing theopalaumide was subsequently pursued (Schmidt et al., 2000). 
Although over 100 efforts to cultivate these filamentous symbionts, no growth was 
observed under any condition (Schmidt et al., 2000). Using J agar with sodium 
thiosulfate, sponge extract, and sodium silicate, Schmidt et al (2000) observed 
colonies containing some cells identified as “Candidatus Entotheonella sp.” cells 
together with other bacteria, suggesting that E. palauensis is probably an obligate 
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symbiont requiring specific conditions present inside the host T. swinhoei. 
Transmission electron microscopy (TEM) analysis showed that the cell integrity was 
maintained during the separation procedure and has confirmed that the 
cyanobacterium Aphanocapsa feldmanni was limited only to the ectosome (Bewley 
et al. 1996). In a separate study, Brück et al (2008) reported also the presence of 
the symbiotic “Entotheonella sp.“ in the mesohyl of the Caribbean Sea marine 
sponge, Discodermia dissoluta. This sponge is well known as the source of 
discodermolide, a natural product with potential anticancer properties. TEM analysis 
on its thin tissue section showed a large number of large filamentous microbes in 
the mesohyl as well as other unicellular microorganisms. The filamentous microbial 
population was subsequently obtained by differential centrifugation. Further 16S 
rDNA analysis of the filamentous microbe-containing fractions indicated the 
sequence similarity to uncultured “Entotheonella sp.“ This result was supported by 
FISH probing showing that the filamentous structures were bound and illuminated by 
the probes targeting “Entotheonella sp.” (Brück, et al., 2008). 
 
Further work by Fusetani, Matsunaga, and coworkers on T. swinhoei with the bright 
yellow inner body, designated as chemotype yellow, led to the isolation of the 
cytotoxic cyclic peptides cyclotheonamides (Fusetani, et al., 1990) and orbiculamide 
A (38) (Fusetani et al., 1991) (Fig. 1.3.4). Interestingly, orbiculamide A (38) contains 
three unusual amino acids, namely brominated hydroxytryptophan, theonalanine, 
and theoleucine (Fusetani et al., 1991), suggesting the involvement of non-
ribosomal peptide synthase in the biosynthesis of orbiculamide A. Closely related 
peptides to orbiculamide A include keramamides B-D (39-41) from Okinawan T. 
swinhoei (Kobayashi et al., 1991), and discobahamins A (42) and B (43) from 
Bahamian Discodermia sp. (Gunasekera et al., 1994). All of these peptides contain 
5-hydroxytryptophane and thiazole moieties (Fig. 1.3.4). The structural characteristic 
of orbiculamide A and keramamides B-D is the addition of a bromide atom to the 
hydroxytryptophan (Fusetani et al., 1991; Kobayashi et al., 1991), which is absent in 
discobahamins A and B. 
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Figure 1.3.4 Oxazole-containing cyclic peptides isolated from marine sponges: 
orbiculamide A (Fusetani et al., 1991), keramamides B-D (Kobayashi et al., 1991), 
discobahamins A and B (Gunasekera et al., 1994). They contain unusual amino acid 
residues including hydroxytryptophane (blue color), theonalanine (red), and theoleucine 
(green). 
Orbiculamide A is also closely related to other reported cyclic peptides from 
Okinawan T. Swinhoei, which include keramamides F (44) (Itagaki et al., 1992), 
keramamides E, G (45), H (46), and J (47) (Kobayashi et al., 1995), keramamides K 
and L (Uemoto et al., 1998), keramamides M and N (Tsuda et al., 1999), and 
calyxmides A (48) and B (49) recently reported by Wakimoto, Abe, and colleagues 
for the sponge Discodermia calyx collected near Shikine-jima Island (Kimura et al., 
2012). It is proposed that the oxazole rings in the theonalanine of compounds 33-43 
are biosynthetically derived from serine, whereas the thiazole rings present in 44-49 
are presumably derived from cysteine. It is also of interest to understand how the α-
keto group in the theoleucine is biosynthetically formed. 
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Figure 1.3.5 Thiazole-containing cyclic peptides isolated from marine sponges: 
keramamides F (Itagaki et al., 1992), keramamides G, H, and J (Kobayashi et al., 1995), 
and calyxamides A and B (Kimura et al., 2012). They contain unusual amino acid 
residues including tryptophane (blue color), theoleucine (green), and oxymethylated 
theonalanine (red). Keramamides F and G differ from keramamide J for the presence of 
an α,β-Z-double bond in the Δ-Trp. 
Other closely related peptides include keramamide A (50), and konbamide (51) 
isolated from the Okinawan Theonella sp. (Kobayashi et al., 1991) (Fig. 1.3.6). 
These two peptides are lack of neither theoleucine nor theonalamine. However, they 
are unique peptides due to the presence of a halogenated hydroxytryptophan and 
an unusual ureido bond between two amino acid monomers (Kobayashi et al., 
1991). Interestingly, in separate studies by Harada et al (1995) and Murakami et al 
(1997), anabaenopeptin B (52) (Fig. 1.3.6), closely related to 50 and 51 in structure, 
was reported for the cyanobacteria, Anabaena flos-aquae NRC 525-17 and 
Oscillatoria agardhii NIES-204, respectively. This suggests that symbiotic 
cyanobacteria might be the actual producers of compounds 50 and 51 (Murakami et 
al., 1997). 
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Figure 1.3.6 Ureido bond-containing cytotoxic cyclic peptides. Keramamide A and 
konbamide was isolated from the marine sponge Theonella sp. (Kobayashi et al., 1991), 
and anabaenopetin B was from the cyanobacteria, Anabaena flos-aquae NRC 525-17 
(Harada et al., 1995) and Oscillatoria agardhii NIES-204 (Murakami et al., 1996). 
Besides ureido moiety (red color), they contain other unusual amino acid residues 
including halogenated hydroxytryptophan (blue) or homotyrosine (green). 
Other complex compounds discovered from the T. swinhoei are polyketides of the 
onnamide and theopederin series. Onnamide A (5) was initially discovered from 
Okinawan Theonella sp. by Higa and coworkers (Sakemi et al., 1988). This 
compound showed potent antiviral in vitro activity against herpes simplex virus type-
1, vesicular stomatitis virus, and coronavirus A-59 (Sakemi et al., 1988). 
Subsequently, Fusetani, Matsunaga, and Nakao isolated a series of additional 
compounds closely related to onnamide A from the T. swinhoei collected in Hachijo 
Island, which included dihydroonnamide A (53), onnamides B-E (54-57) (Matsunaga 
et al., 1992), and theopederins A-E (58-61) (Fusetani et al., 1992) (Fig. 1.3.7). 
Theopederins showed stronger cytotoxic activity than onnamides. In particular, 
theopederins A and B exhibited promising antitumor activity against P388 cells 
(Fusetani, 1996). 
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Figure 1.3.7 Onnamide-type compounds from various sources: dihydroonnamide A, 
onnamides B-E (Matsunaga et al., 1992), theopederins A-E (Fusetani et al., 1992) from 
Hachijo-Jima T. swinhoei, pederin from Paederus and Paederidus (Kellner and Detter, 
1996), mycalamide A from New Zealand Mycale hentscheli (Perry et al., 1990), and 
psymberin from Psammocinia aff. bulbosa (Cichewicz et al., 2004). 
Onnamide and theopederin series are strikingly similar to pederin (62), a highly 
antitumor toxin of rove beetles of the genera Paederus and Paederidus (Kellner & 
Detter, 1996), mycalamide A (63) from the New Zealand sponge Mycale hentscheli 
(Perry et al., 1990), and psymberin (5) from the sponge Psammocinia aff. bulbosa 
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(Cichewicz et al., 2004) also known as irciniastatin A from the Indo-Pacific sponge 
Ircinia ramosa (Pettit et al., 2004) (Fig. 1.3.7). The occurrence of these closely 
related compounds in different sponges and animals suggested a microbial origin in 
their biosynthesis. They all show similar cyototoxic activities, and only pederin and 
mycalamide A are highly dermatoxic (Piel, 2010). Psymberin showed highly 
selective antitumor activity (Cichewicz et al., 2004), and is therefore the most 
promising to be developed as a drug candidate. Due to the rarity of this compound, 
it took over 11 years (1990-2001) to process approximately 600 Psammocinia 
fractions for structural elucidation (Cichewicz et al., 2004).  
 
Onnamide-type natural products and many other complex sponge-derived natural 
products including those mentioned above belong to the class of polyketides or 
hybrid polyketide/non-ribosomal peptides. To obtain insights into the biosynthesis 
and biosynthetic origin of complex polyketides of pharmaceutical relevance from 
marine sponges, Piel and colleagues have developed metagenomics-based 
strategies using onnamide-type compounds as a polyketide model (Piel et al., 
2004a; Piel et al, 2004b, 2007; Fisch et al., 2009). These onnamide-type 
metabolites were considered as an ideal model for such studies because in the 
previous work, the entire gene cluster for the biosynthesis of the related compound 
pederin was successfully cloned from the beetle Paederus fuscipus (Piel, 2002). 
Discovery of the pederin gene cluster provided guidance to isolate the biosynthetic 
pathways of sponge-derived onnamide-type compounds (Piel et al., 2004b). Piel 
and coworkers have developed metagenomic strategies that feature screening tools 
to rapidly identify biosynthetic genes for sponge polyketides in highly complex 
sponge assemblages (Piel et al., 2004b; Nguyen et al., 2008; Fisch et al., 2009). In 
addition, another exciting strategy developed by the Piel group was to generate 
methods that enable one not only to catch representative genomes from the wide 
diversity of microbial symbionts in nature, but also to facilitate rapid screening of the 
biosynthetic pathways of interest among many diverse non-target pathways present 
in a sponge symbiotic system (Hvartin and Piel, 2007). With these strategies, Piel 
group have successfully isolated the entire gene clusters encoding the biosynthesis 
of onnamide A, theopederin and psymberin from complex sponge systems, thereby 
providing the first genetic evidence of the bacterial origin of marine natural products 
(Piel et al., 2004b, 2007; Fisch et al., 2009).  
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1.4 Biosynthetic Insights into Microbial Secondary Metabolites 
Many potent antitumor secondary metabolites isolated from marine sponges are 
complex polyketides (PKs) and hybrids with non-ribosomal peptides (NRPs) (Piel, 
2004; Fusetani, 2010). This sub-section highlights the biosynthetic insights of 
microbial secondary metabolites that belong to group of PKs, NRPs, and PK/NRP 
hybrids. Subsequently metagenomic strategies to isolate biosynthetic gene clusters 
will briefly be described.  
1.4.1 Polyketide biosynthesis 
Polyketides are a large family of structurally diverse natural products, which include 
many important pharmaceuticals, agrochemicals, and veterinary agents. These 
natural products are used clinically as antitumor agents (epothilone and 
doxorubicin), the antihelminthic agent (avermectin B1), antibacterial agents 
(erythromycin A, tetracycline, and nystatin) (Cane et al., 1998), and others. 
Interestingly, the enormous diversity of polyketides are built from simple carboxylic 
acid monomers through a number of programmed events catalyzed by 
multifunctional proteins termed polyketide synthases (PKSs) (Cane et al., 1998; 
Llewellyn & Spencer, 2007; Hertweck, 2009). These programmed catalytic events 
may include selection of starter and extender units, carbon chain length, folding, 
degree of reduction, termination, and tailoring (Moore & Hertweck, 2001).  
 
In general, PKS-catalyzed processes are similar to those of fatty acid synthases 
(FASs) that use simple precursors such as acetyl-CoA and malonyl-CoA monomers 
to build fatty acid chains through repetitive decarboxylative condensations 
(Hopwood, 1997; Hertweck, 2009). These enzymatic processes are mediated by the 
repeated groups of protein domains called modules. Each module usually catalyzes 
one cycle of chain elongation by incorporating one building block and passes the 
elongated product on to a downstream module (Cane et al., 1998; Piel 2010). Each 
module is subdivided into domains, each of which is responsible for a single 
chemical manipulation. A ketoacyl synthase (KS) domain catalyzes the chain 
elongation, an acyltransferase (AT) domain selects the correct acyl-CoA extender, 
and an acyl carrier protein (ACP) domain serves as anchor to the polyketide chain. 
Various functional modifications on the β-position of the polyketide backbones are 
performed by optional domains, such as a ketoreductase (KR) that converts the β-
keto into a hydroxyl group, a dehydratase (DH) that generates double bonds, and an 
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enoylreductase (ER) that reduces the double bonds to a saturated intermediate 
(Rawlings, 2001; Calderone et al., 2007; Piel., 2010) (Fig. 1.4.1). The most 
significant difference between PKSs and FASs are the reductive steps in each 
elongation. In PKSs, the reductive steps are optional, an intermediate can be partly 
or fully reduced before being transferred to the next round of elongation. This results 
in a much more structurally diverse natural product. In contrast, FASs typically fully 
reduce units after individual elongations (Rawlings, 1998; Rawlings, 2001; 
Hertweck, 2009).  
 
Figure 1.4.1 General biosynthetic steps of a bacterial modular PKS. In a cis-AT PKS 
system, the AT domain is integrated in each module. Notes: x, optional domain(s); 1a, 
extension with malonyl-CoA; 1b, extension with methylmalonyl-CoA; 2, reduction; 3, 
dehydration; 4, reduction. Abbreviations: KR, β-ketoacyl reductase; DH, dehydratase; and 
ER, enoyl reductase. 
Bacterial modular PKSs usually employ malonyl-CoA or methylmalonyl-CoA 
monomers in chain extension. When methylmalonyl-CoA is used as extender units, 
the resulting intermediates harbor methyl branches at the α-position. Therefore, 
polyketide structures can be predicted from PKS domain sequences or vice versa, 
because the module architecture and function of PKSs corresponds to the resulting 
intermediates. This correspondence is known as the colinearity principles 
(Hertweck, 2009; Piel 2010). These canonical rules are usually applied for a 
subclass of modular type I PKSs called “cis-AT PKSs”, in which the AT domain is 
present in each module. Type I refers to linearly arranged and covalently fused 
catalytic domains within large multifunctional enzymes (Hertweck, 2009). The 
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modular cis-AT PKS is best exemplified by the well-studied 6-deoxyerythronolide B 
synthase (DEBS) (Fig. 1.4.2).  
 
Figure 1.4.2 The well-studied AT PKS, deoxyerythronolide B synthase (DEBS). The loading 
module containing ATL loads propionyl-CoA starter unit and transfers the activated propionyl 
grout to the adjancent ACP. Subsequently the ACP-bound propionyl group is assembled 
with six (2S)-methylmalonyl-CoA extender units catalyzed by a set of core domains (KS, AT, 
and ACP). The assembly line process is initiated by the KS domain that receives the 
growing polyketidyl chain from the ACP domain of the preceding module. The AT domain 
transfers a CoA-linked carboxyacyl extender unit to the Ppant arm of the ACP. The KS then 
catalyzes decarboxylative condensation between the growing chain and the extender unit to 
generate a β-ketoacyl thioester-ACP intermediate. Each intermediate undergoes β-keto 
processing events catalyzed by up to three optional/auxiliary domains (KR, DH, and ER). 
The resultant final intermediate undergoes macrocyclization and release from the DEBS, 
resulting in 6-dEB (Hertweck, 2009; Yuzawa et al., 2011). This 6-dEB undergoes further 
enzymatic elaboration by a series of tailoring enzymes such as glycosyl transferases, methyl 
transferases, and regiospecific hydroxylases, leading to the formation of erythromycin A 
(Staunton & Wilkinson, 1997). Abbreviations: AT, acyl transferase; ACP, acyl carrier protein; 
KS, β-ketoacyl synthase; KR, β-ketoacyl reductase; ER, enoyl reductase; DH, dehydratase; 
TE, thioesterase; and mMCoA, methylmalonyl-CoA. 
This PKS system assembles one unit of propionyl-CoA and six units of 
methylmalonyl-CoA into 6-deoxyerythronolide B (6-dEB) (64) scaffold of 
erythromycin A (Staunton & Wilkinson, 1997, Rawlings, 2001). Erythromycin A 
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(Ilotycin, Lilly) (65) has been well known in clinical medicine to fight against Gram-
positive bacterial infections as well as pulmonary infections (Staunton, 1997). It was 
isolated in 1952 from Sacharopolyspora erythraea (formerly Streptomyces 
erythreus) (McGuire et al., 1952), and five years after its discovery, the chemical 
structure was elucidated (Wiley et al., 1957). 
 
Cloning of the three giant genes coding for DEB biosynthesis was simultaneously 
reported by Leadlay and coworkers (Cortes et al., 1990) and Katz and coworkers 
(Tuan et al., 1990). This subsequently has allowed the detailed biochemical and 
structural studies of this multifunctional megasynthase (Khosla et al., 2007) by 
heterologous expression of the entire DEBS in Streptomyces coelicolor (Kao et al., 
1994) and in E. coli (Pfeifer et al., 2001), in vitro enzymatic reconstitution of 6-dEB 
(Pieper et al., 1995), elucidation of the 3-D structural model (Staunton et al., 1996), 
and genetic engineering of DEBS proteins to generate diverse polyketide structures 
with certain size and functional groups (Caffrey et al., 1992; Roberts et al., 1993; 
Brown et al., 1995; Kao et al., 1995; Kao et al., 1996; McDaniel et al., 1999; Xue et 
al., 1999). Due to most of current knowledge about modular PKS derived from 
DEBS studies, DEBS has recently emerged as the prototype of modular PKS 
systems (Cane, 2010).  
 
DEBS is a giant multifunctional megasynthase (>3000 amino acids) consisting of 
three large polypeptides, designated as DEBS1, DEBS2 and DEBS3 (Cortés et al., 
1990; Donadio et al., 1991). Each harbors two modules that are responsible for 
chain elongation and modification of the newly generated β-ketone. Each module 
contains a set of catalytic domains (100-400 amino acids each) that controls the 
incorporation of each precursor into the polyketidyl chain (Khosla et al., 1999; Chan 
et al., 2008). The first module, called loading module, harbors an AT domain 
(designated as ATL) that preferentially loads and transfers propionyl-CoA to the 
loading ACP (ACPL) (Fig. 1.4.3A), whereas the AT domains in the extender modules 
specifically load (2S)-methlymalonyl-CoA (Marsden et al., 1994; Lau et al., 1999). In 
DEBS, the resulting activated propionyl starter unit undergoes repetitive Claisen 
condensations with six (2S)-methylmalonyl-CoA extender units (Fig. 1.4.3A). During 
erythromycin biosynthesis, all seven DEBS modules containing 28 domains 
performs 21 steps to make a linear polyketide chain that is subsequently released 
by TE through direct lactonization, resulting in 6-dEB (Cortes et al., 1995; Kao et al., 
1995; Cane et al., 1998; Lau et al., 2000). The number of the modules is equivalent 
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to the number of precursors incorporated into the assembly line. Therefore, the 
number of modules and the precursors dictate the chain length, while the domain 
composition in each module determines the structure of each elongation unit 
(Yuzawa et al., 2011).  
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Figure 1.4.3 Basic mechanisms of initiation by AT domain in type I PKS. [A] The initiation 
module may harbor no KS domain at the N-terminus of the assembly line, as reported for 
deoxyerythronolide B (6-dEB) biosynthesis. DEBS initiation module consists of the didomain 
ATL fused with an ACP. In the case, the ATL selects propionyl-CoA and transfers the activated 
propionyl group to the P-pant of the adjancent ACP. Subsequently this ACP donates the 
propionyl group to the next linear modules (Keating & Walsh, 1999; Khosla, 1997). [B] 
Proposed mechanism of the AT domain in DEBS biosynthesis. The active-site Ser (S642 in 
DEBS AT5) in the highly conserved GHSXG motif forms a canonical catalytic dyad by hydrogen 
bonding to the conserved active His (H745 in DEBS AT5), leading to the activation of nucleophilic 
attack by the active site Ser hydroxyl group on the methylmalonyl thioester carbonyl group. This 
enhanced nucleophilicity of the Ser then results in the formation of a tetrahedral intermediate, in 
which the negative charge is stabilized by an oxyanion hole. The active site His protonates the 
existing CoA moiety, resulting in the replacement of the CoA moiety with ACP. Through a 
nucleophilic attack on the ester carbonyl group activated by the cysteamine thiol of the ACP 
phophopantetheine, the second tetrahedral intermediate is generated. This intermediate is 
resolved again by the active site His, followed by reprotonation of the active site Ser, resulting in 
the release of the acyl-ACP product (Khosla et al., 2007; Smith & Tsai, 2007; Tsai & Ames, 
2009).  
Using mutantional and computational approaches, key residues within AT domains 
that correlate with specificity have been successfully identified (Reeves et al., 2001; 
Smith & Tsai, 2007). There are four conserved motifs identified to be responsible for 
the AT specificity. The first is the RVDVVQ motif located 30 residues upstream of 
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the catalytic Ser (Haydock et al., 1995). Further AT domain analysis by Yadav et al. 
(2003) determined more detailed motifs: [RQSED]V[DE]VVQ for methylmalonyl-AT 
and ZTX$[AT][QE] for malonyl-AT, in which Z is a hydrophilic residue and $ is an 
aromatic residue (Smith & Tsai, 2007). Secondly, the GHSXG motif around the 
catalytic Ser was also identified to contribute to specificity. The X residue is a 
branched hydrophobic amino acid, in which it is glutamine (Q643 in DEBS AT5) in 
methylmalonyl-specific ATs, whereas in malonyl-specific ATs, the X residue is either 
valine or isoleucine (Haydock et al., 1995; Smith & Tsai, 2007). Third, the YASH 
motif located 100 residues downstream of the active site Ser were found in 
methylmalonyl-specific extender ATs in DEBS, while the HAFH motif was identified 
in malonyl-specific ATs (Haydock et al., 1995; Reeves et al., 2001; Smith & Tsai, 
2007). Fourth, starter AT domain in DEBS has the following specificity motifs: 
RVEVVQ instead of RVDVVQ, GHSIG instead of GHSQG, and MAAH instead of 
YASH, suggesting the motif difference between extender and starter ATs (Khosla et 
al., 1999; Smith & Tsai, 2007). The transfer of acyl moieties between CoA and ACP 
by the AT domains occurs through a ping-pong bi-bi catalytic mechanism using a 
Ser-His catalytic dyad on the basis of studies of the reactions catalyzed by the type 
II malonyl-CoA:ACP transacylase from E. coli (Fig 1.4.3B) (Ruch & Vagelos, 1973; 
Smith & Tsai, 2007; Khosla et al., 2007; Tsai & Ames, 2009).  
 
The KSs in modular PKSs employ a Cys-His-His triad at the active center to form a 
new carbon-carbon bond through a catalytic mechanism that is similar to that of 
porcine FAS KS domains (Witkowski et al., 2002; Zhang et al., 2006; Smith & Tsai, 
2007) (Fig. 1.4.4). In principle, the KS catalytic mechanism begins with the transfer 
of the upstream acyl group to the KS active site, followed by the KS-catalyzed 
decarboxylation of the downstream (methyl)malonyl-S-ACP, resulting in a carbanion 
that elongates and translocates the intermediate to the downstream ACP (Keating & 
Walsh, 1999). 
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Figure 1.4.4 Basic mechanisms of elongation by KS domain in type I PKS. [A] In 6-
Deoxyerythronolide B (6-dEB) biosynthesis, chain extention occurs through a series of 
sequential condensation of one unit of propionyl CoA and six units of methylmalonyl-CoA units. 
The KS domain accepts the growing chain from the upstream ACP onto the thiol group (-SH). 
Then the KS decarboxylates the downstream ACP-attached methylmalonly thioester to create a 
carbanion that attacks the upstream acyl-S-ACP thioester in a Claisen condensation, resulting 
in a C-C bond. [B] During chain extension with malonyl-CoA units, decarboxylation of the 
downstream malonyl-S-ACP results in a nucleophilic thioester enolate that subsequently attack 
the upstream acyl-S-ACP thioester. This leads to the formation of a C-C bond through a Claisen 
condensation (Keating & Walsh, 1999; Fischbach & Walsh, 2006; Chan et al., 2008). [C] In acyl 
transfer step, the negative charge on the thioester carbonyl is neutralized by the oxyanion hole 
generated by the backbone amides of the active site cysteine and an amino acid residue near 
the C-terminus, resulting in the stabilization of the tetrahedral intermediate.The free ACP is 
released and the chain extender (malonyl- or methylmalonyl-S-ACP) binds to the enzyme. In 
decarboxylation step, the malonyl C3 carboxylate is attacked by an active-site water molecule 
likely activated by a conserved histidine, resulting in the release of bicarbonate. The second 
conserved histidine likely facilitates the formation of the carbanion at C2, thereby stabilizing the 
enol intermediate. In the condensation step, the tetrahedral intermediate is generated by the 
attack of the carbanion on the acyl-thioester. This is stabilized initially by the oxyanion hole that 
then breaks down to form the β-ketoacyl product (Smith and Tsai, 2007). 
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The type I KRs belong to the short-chain dehydrogenase family (Persson et al., 
2003). Their structure harbours two principal subdomains: the N-terminal structural 
subdomain and the C-terminal catalytic subdomain (Khosla et al., 2007; Smith & 
Tsai, 2007). The catalytic subdomain has the typical SDR motifs that include the 
TGxxxGxG motif, the D63 and NNAG motifs, the active-site tetrad Asn-Ser-Lys-Tyr, 
and the PG motif (Persson et al., 2003). The active-site tetrad in the act KR is 
composed of N114-S144-Y157-K161. In DEBS KR1 and Tyl KR1, the positions of the Asn 
and Lys are switched (K1776-S1800-Y1813-N1817) (Keatinge-Clay, 2007; Keatinge-Clay 
and Stroud, 2006). The active-site tetrads of these KR domains relies on the proton-
relay mechanism as proposed for the E. coli FabG in the reduction of the ketone to 
the alcohol (Fig. 1.4.5A) (Zhang et al., 2003; Price et al., 2001; Price et al., 2004; 
Smith & Tsai, 2007; Tsai & Ames, 2009). Active KR domains are indicated by the 
presence of the conserved Rossmann fold motif (GGXGXXG) as well as the 
conserved catalytic motif (K-S-Y) (Reid et al., 2003). The stereochemistry of a β-
hydroxyl group formed by the modular PKS KR domains can be predicted based on 
the presence or absence of LDD and PxxxN motifs. The presence of these motifs 
predicts the 3R stereomer (or D-stereomer) whereas the absence of these motifs 
predicts the 3S stereomer (or L-stereomer) (Fig. 1.4.5B) (Caffrey, 2003; Reid et al., 
2003; Baerga-Ortiz, 2006). A functional DH domain is usually recognizable by the 
presence of the conserved HxxxGxxxxP motif near to its N-terminus (Bevitt et al., 
1992), in which the histidine and gylcine (G) form the catalytic dyad for the activity 
(Cortes et al., 1995; Tsai & Ames, 2009; Valenzano et al., 2010). In addition, a 
functional DH domain usually contains the conserved Dxxx(Q/H) motif, in which the 
catalytic aspartic acid (D) is essential for the activity (Fig. 1.4.5C) (Keatinge-Clay, 
2008; Valenzano et al., 2010).  
 
The ER active site may reside in a cleft containing the NADPH-binding site and 
other active site residues. The NADPH-binding site is recognized by the 
GxGxxG/AxxxG/A motif as has been confirmed by mutagenesis of the animal FAS 
KR (Witkowski et al., 2004). Cofactor binding is assumed to be stabilized by 
hydrophilic residues in the active site via hydrogen bond interactions with the 
hydroxyl groups on the nicotinamide ribose. In particular the active site Tyr and Lys 
should be important for the cofactor binding and catalytic mechanism, as proposed 
for type II FAS ER domain (Smith & Tsai, 2007). 
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Figure 1.4.5 Proposed mechanisms of modifications by KR and DH domains in modular type I 
PKS. [A] The proposed stereospecific reduction of KR domain based on SDR homology 
modeling. The substrate is rotated about the axis of the reduced carbonyl bond to orient the 
substrate differently in the two types of KRs. The relative positions of the catalytic residues and 
the NADPH are maintained for the two different stereochemical products, and only single active 
site geometry is required for each type of KRs (Reid et al., 2003). [B] The proton-relay 
mechanism of KR domain in the reduction of the ketone to the alcohol. Tyr (K161) and Lys (Y157) 
form hydrogen bonds with the NADH ribose and nicotinamide ring. Four crystalline water 
molecules form hydrogen bonds with N114 and K161. These waters form a proton-relay network 
as proposed by Price et al (2004) for E. coli FabG-NADP
+
 (Korman et al., 2004; Tsai and Ames, 
2009). [C] The proposed mechanism of DH4 of DEBS. The conserved Gly as a part of the 
HxxxGxxxxP motif serves to make a turn, enabling van der Waals interactions between H44 and 
P53. The catalytic D206 as a part of the Dxxx(Q/H) motif makes hydrogen bonds with the side 
chain of Q210 (Tsai and Ames, 2009). 
Once the resultant DEB intermediate reaches the final carrier domain at the last 
module, the intermediate is subsequently released by a specialized thioesterase 
(TE) domain. In principle, there are two general mechanisms for chain release from 
by TE domains: (i) intramolecular capture by a nucleophile leading to 
macrolactonization with concomitant release, as has been shown for erythromycin 
and DEBS3) (Fig. 1.4.6), and (ii) intermolecular hydrolysis that releases the free acid 
(Keating & Walsh, 1999; Staunton & Wilkinson, 1997); Tsai et al., 2002; Khosla et 
al., 2007; Du & Lou, 2009) as shown by linear PKs such as thailandamide (Nguyen 
et al., 2008) and bacillaene (Moldenhauer et al., 2007; Butcher et al., 2007). 
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Figure 1.4.6 Basic mechanisms of termination in 6-deoxyerythronolide B (6-dEB) 
biosynthesis.Termination in DEBS system occurs via a TE-mediated release mechanism, 
resulting in the direct lactonization of the final intermediate in DEBS. The active site of the 
TE domain contains a catalytic triad consisting of Ser142, His259, and Asp169. It was proposed 
that the His259 residue stimulates nucleophilic attack by Ser142 on the polyketide acyl-ACP-
TE, resulting in transfer of the polyketide acyl chain from the thiol of the neigbouring ACP to 
the OH group of the Ser142 on the TE. The resulting oxygen-ester on the acyl-O-Ser 
intermediate is then cleaved by nucleophilic attack of the OH group at C-13 to release the 
product DEB. Adapted from Staunton and Wilkinson (1997), Tsai et al (2002), Khosla et al 
(2007), and Du & Lou (2009). 
The classical colinearity principles do not always apply for bacterial modular PKSs. 
In some cases, the module architecture does not fit to the resulting polyketide 
structures. The PKS systems that deviate from the coliniearity rules are often 
characterized by the lack of AT domains in each module. Instead, a free-standing 
AT domain is responsible for loading acyl building blocks. Due to the absence of 
integrated AT domains in individual modules, as only one type of building block is 
loaded, usually malonyl-CoA. In these PKS systems termed “trans-AT PKSs” (Fig. 
1.4.7), methyl branches are introduced at the α-positions of growing intermediate 
through S-adenosylmethionine (SAM)-dependent α-methylation by 
methyltransferase (MT) domains present in the PKS modules (Piel, 2010).  
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Figure 1.4.7 Basic mechanisms of trans-AT PKS, showing precursor loading and 
elongation with various reductive modifications at β-positions [A], α-methylation by 
methyltransferase [B], and β-methylation that involves HMGS-mediated aldol addition of 
a free standing acetyl-ACP with β-ketoacyl ACP, and further ECH1-catalysed 
dehydration and ECH2-catalysed decarboxylation [C]. Notes: 1, condensation; 2, 
reduction; 3, dehydration; 4, reduction; 5, methylation; 6, aldo addition; 7, dehydration; 8, 
decarboxylation; and x, optional domains. Adapted from Nguyen et al (2008), Gu et al 
(2009), and Piel (2010). 
Interestingly many trans-AT PKS systems are able to perform unusual branching at 
the β-position of acyl-ACP intermediates (Piel, 2002; El-Sayed et al., 2003; Edwards 
et al., 2004; Piel et al., 2004; Calderone et al., 2006; Chang et al., 2007; Fisch et al., 
2009) in a process resembling isoprenoid-like methylation. The β-branch 
incorporation occurs through a KSo-mediated decarboxylation of malonyl-ACP to 
acetyl-ACP. This is followed by an HMGS-mediated aldol addition of acetyl-ACP to 
β-ketoacyl ACP and subsequent ECH1-catalysed dehydration and ECH2-catalysed 
decarboxylation (Calderone et al., 2006). Further work by Piel and coworkers on 
relocating the terminal TE domain to the up-stream modules deduced the timing of 
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β-branching in the bacillaene PKS, which occurs during elongation (Moldenhauer et 
al., 2007). The presence and biochemistry of HMGSs, ECHs, and other enzymes 
may determine the β-branching types in polyketides, including methyl-, ethyl-, 
methylene, ester, or heterocyclic moieties. Variation in these β-branching 
components can generate remarkably diverse polyketide moieties (Gulder et al., 
2011). 
1.4.2 Nonribosomal peptide biosynthesis 
Many microorganisms produce peptide antibiotics and other biologically active 
substances through biosynthetic pathways catalyzed by large multimodular protein 
templates, termed nonribosomal peptide synthetase (NRPS) (Finking & Marahiel, 
2004; Marahiel & Essen, 2009). Many of the nonribosomal peptides are clinically 
used drugs. Notable examples are cyclosporine A, penicillin, and vancomycin 
(Kleinkauf & Döhren, 1990). The remarkable structural and functional diversity in 
nonribosomal peptides arises from 20 proteinogenic amino acids and a larger 
variety of nonproteinogenic amino and aryl acids as the building blocks during chain 
elongation and post assembly (Fischbach and Walsh, 2006). Nonproteinogenic 
amino aryl acids incorporated into the NRPS assembly lines includes D-isomers, 
carboxy acids, N-methylated residues, heterocyclic rings and fatty acids. Common 
transformations that further diversify NRP structures during chain elongation include 
α-ketone reduction, epimerization, and heterocyclization (Walsh and Fischbach, 
2010). Post modifications also contribute to the diversity of NRP structures, 
including glycosiylation and oxidative cross-linking (Sieber and Marahiel, 2003).  
 
NRPSs apparently use a similar strategy as PKSs for peptide biosynthesis (Du et 
al., 2001). It has a modular structure that is composed of a series of modules. Each 
module is responsible for the incorporation and modification of an amino acid unit 
into the growing peptide chain. Therefore the order and number of the modules in a 
NRPS system indicate the sequence and number of building blocks in the resulting 
peptide product (Cane, 1997; Du et al., 2001). A typical NRPS module harbors at 
least three domains: an adenylation (A) domain responsible for amino acid 
activation and incorporation, a thiolation (T) domain for thioesterification of the 
activated amino acid residue, and a condensation (C) domain for elongation of the 
growing peptide chain thorugh transpeptidation (Cane et al., 1998; Cane & Walsh, 
1999; Konz & Marahiel, 1999; Du et al., 2001; Schwarzer & Marahiel, 2001).  
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In NRPS, selection and activation of the substrate amino acids are performed by 
adenlyation (A) domains to generate the corresponding aminoacyl adenylate. The 
resulting adenylated products are then attacked by the nucleophilic thiol group of a 
4`-phosphopentethein covalently bond with a peptide carrier protein (T) (Fig 1.4.8A). 
Resolving the 3-D structure of the phenylalanine activating A-domain of Gramicidin 
Synthetase A1 (PheA-GrsA1 in a complex with AMP and phenylalanine has enabled 
the identification of their amino acid residues generally responsible for the 
coordination of ATP and substrate (Conti, et al., 1997; Schwarzer and Marahiel, 
2001; Schwarzer, et al., 2003). These residues are then shown to be highly 
conserved, forming ten core motifs (A1-A10) based on the alignment with other A-
domains (Schwarzer, et al., 2003). Subsequently, general rules, also known as 
nonribosomal codes, for the substrate specificity of A domains have recently been 
established, thereby offering exciting opportunities for engineered production of new 
peptide analogs (Stachelhaus et al., 1999; Challis et al., 2000).   
 
There are various other strategies of monomer activation for the formation of peptide 
bond in secondary metabolites. One of them has recently been reported by Walsh 
and coworkers for a peptide bond-forming enzyme in the biosynthesis of the 
antibiotic pacidamycin. This enzyme, called tRNA-dependent aminoacyl transferase 
(PacB), uses tRNA-bound amino acids as substrates to generate peptide bonds (Fig 
1.4.8B) (Zhang et al., 2011; Walsh & Zhang, 2011). Another strategy for substrate 
activation is based the acyl-AMP ligase family as reported for the biosynthesis of the 
tripeptide antibiotics dapdiamides (Hollenhorst et al., 2009; Dawlaty et al., 2010). 
This enzyme mediates the formation of a peptide bond between the activated acyl-
AMP intermediate and an amino group of a free cosubstrate (Fig. 1.4.8C) (Kadi et 
al., 2007; Giessen & Marahiel, 2012). Another substrate activation strategy relied on 
the ability of cyclodipeptide synthases (CDPSs) to use two tRNA-bound amino acids 
as substrates for the direct formation of two new peptide bonds. These tRNA-bound 
amino acids are generated by the activity of aminoacyl-tRNA synthetases (aaRSs) 
(Fig 1.4.8D). This strategy was reported in the biosynthesis of a diketopiperazine 
(Vetting et al., 2010; Bonnefond et al., 2011) and albonoursin (Lautru et al., 2010). 
Another monomer activation strategy involves the activity of ATP-grasp ligases 
containing an atypical ATP-binding site, called the ATP-grasp fold, as reported for 
the DdaG of dapdiamide synthetase. This enzyme family catalyzes the attachment 
of a phosphate group on the substrate carboxylate to form an acylphosphate 
intermediate through the hydrolysis of ATP into ADP. The resultant activated 
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carboxylate is subsequently attacked by an amino group of a free substrate leading 
to the formation of a new peptide bond (Fig. 1.4.8E) (Fawaz et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.8 Various strategies of amino acid activiation to form peptide bonds in 
secondary metabolite biosynthesis. [A] In NRPS, selection and activation of building 
blocks are performed by adenlyation (A) domains to form adenylated products. Then the 
aminoacyl moiety of the adenylate is covalently tethered to a prosthetic 
phosphopantetheinyl (Ppant) group of a T domain. When a peptidyl-S-Ppant donor is 
attacked by a monomeric aminoacyl-S-Ppant nucleophile, peptide-bond formation and 
chain translocation occur (Eppelmann et al., 2002; Cane & Walsh, 1999). [B] tRNA-
bound amino acids are initially generated by aminoacyl-tRNA synthetases (aaRSs). The 
the tRNA-dependent aminoacyl transferase uses a tRNA-bound amino acids as donor 
and delivers it to a T-loaded nonribosomal dipeptide as acceptor, thereby forming a 
peptide bond (Zhang et al., 2011). [C] The substrate carboxylate as an adenylate is 
initially activated by an acyl-AMP ligase. The resultant activated carboxylate reacts with 
CoA to form the CoA-thioester that is subsequently attacked by an amino group of free 
cosubstrate, thus resulting in a new peptide linkage (Kadi et al., 2007; Dawlaty et al., 
2010; Koetsier et al., 2011; Giessen & Marahiel, 2012). [D] CDPs activate carboxylates 
for nucleophilic attack by donor amino groups to bring together monomers in the 
assembly (Hollenhorst et al., 2009). [E] ATP-grasp ligase activates carboxylate 
substrates via acyl-phosphate formation with distinct ATP cleavage patterns to form 
tandem peptide bonds (Fawaz et al., 2011). 
In the incorporation of an amino acid into a growing peptidyl chain, the activated 
amino acid (aminoacyl-adenylate) is attacked by the enzyme-attached thiol moiety 
4`-phosphopantetheine (4`-PP) results in an aminoacyl-S-Pant thioester.  
Subsequently acyl-S-Pant thioesters on two adjancent PCP domains facilitate amide 
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formation. This occurs through the transfer of the carboxyl group of one amino 
residue to the adjancent amino group of the next amino acid (Marahiel et al., 1997) 
(Fig. 1.4.9A).  
 
Recently there have increasing numbers of secondary metabolites, in which their 
biosynthesis are encoded by NRPS-PKS hybrid assembly lines combining both 
NRPS and PKS modules. Some examples are surfactin (Cosmina et al., 1993), 
rapamycin (Aparicion et al., 1996), yersiniabactin (Gehring et al., 1998), 
mycosubtilin (Duitman et al., 1999), bleomycin (Du et al., 2000), nostopeptolide A 
(Hoffmann et al., 2003), and nostocyclopetide (Becker et al., 2003). An interesting 
aspect of these hybrid assembly lines is the mechanisms underlying the elongation 
of a PKS-bound growing polyketidyl chain with an NRPS module or vice versa. This 
hybrid chain elongation occurs through the formation of either C-N or C-C bonds in 
NRPS/PKS interfaces. At the PKS/NRPS interface, a ketide chain formed by an 
upstream PKS module is accepted by the C domain of the downstream NRPS 
module. The C domain subsequently mediates a C-N bond formation, allowing the 
elongation of the polyketide chain with an amino acid (Du et al, 2001; Fischbach & 
Walsh, 2006) (Fig 1.4.9B). At the NRPS/PKS interface, the KS domain accepts an 
upstream peptide chain rather than a ketide chain and catalyzes the formation of a 
C-C bond leading to the elongation of the peptide chain with a short carboxylic acid 
(Fig 1.4.9C) (Du et al., 2001; Fischbach & Walsh, 2006). The C-N or C-C bond 
formation in PKS/NRPS hybrid assembly lines are best exemplified by the HMWP2 
and HMWP1 proteins of yersiniabactin synthetase (Miller et al., 2002) and the first 
NRPS subunit of FK520 synthase (Gatto et al., 2005). 
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Figure 1.4.9 Bond formation in nonribosomal peptides and hybrids with polyketides. [A] 
C-N bond formation in the NRPS system. The C domain catalyzes nucleophilic attack of 
the amino group of an amino acyl-S-T donor on the acyl group of an upstream 
electrophilic acyl- or peptidyl acyl-S-T chain, resulting in the formation of peptide bond 
(Cane and Walsh, 1999). [B] C-N bond formation in the PKS/NRPS hybrid system is 
mediated by the C domain. In particular the C domain catalyzes the nucleophilic 
substitution between the acyl group of the growing polyketidyl chain of acyl-S-ACP from 
the upstream PKS module and the amino group of the downstream aminoacyl-S-T, 
resulting in the integration of the polyketide chain with an amino acid via C-N bond 
formation (Du et al. 2001) [C] C-C bond formation in the NRPS/PKS hybrid system. This 
is catalyzed by the C domain by transferring the growing peptide chain of peptidyl-S-T 
from the upstream NRPS module to the KS active site Cys to generate a peptidyl-S-KS. 
Subsequent decarboxylative condensation with its cognate malonyl-S-ACP leads to the 
extension of the peptide chain with a short carboxylic acid (Du et al. 2001; Fischbach 
and Walsh, 2006; Giessen and Marahiel, 2012). Note: x, optional domain(s). 
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1.4.3 Metagenomic strategies to isolate biosynthetic pathways 
Searching for biosynthetic pathways of interest in complex symbiotic systems such 
as a sponge is extremely challenging due to the high microbial complexity. Sponge 
symbiotic systems, for example, can harbor a high density range of bacterial cells 
between 6.4 x 108 to 1.5 x 109 bacterial cells per ml of sponge extract 
(Scheuermayer et al., 2006) and may contains hundreds to thousands of microbial 
species (Taylor et al., 2007). The high microbial complexity of a sponge system 
suggests that the symbiotic assemblage contain numerous homologous genes from 
diverse pathways (Piel et al., 2004a).  
 
One of the strategies to access biosynthetic pathways of pharmaceutical relevance 
from a complex microbial consortium is based on phenotypic detection of growing E. 
coli clones on plates, such as antibacterial activity, color production, and signaling 
phenomena (Courtois et al., 2003; Banik & Brady, 2006; Brady, 2007; Brady et al., 
2009). Using top agar overlay assays, Brady and Clardy screened a cosmid library 
for antibacterially active E. coli clones that led to the characterization of various new 
long-chain N-acylated amines with antibacterial activities (66) (Brady and Clardy, 
2000) and a new antibiotic isonitrile functionalized indole (67) (Brady and Clardy, 
2005).  By observing color production, Brady et al (2001) identified some blue-
colored clones in a cosmid library constructed from soil eDNA. They found that one 
of these clones produced the broad-spectrum antibacterial pigment violacein (68) 
(Brady et al., 2001). Based on visual screening of pigmented clones, Gillespie et al 
(2002) isolated brown-colored clones, in which one of them produced the antibiotics 
turbomycin A (69) and turbomycin B (70) (Gillespie et al., 2002) (Figure 1.4.10). 
 
Screening of library could also be performed by combining direct cloning approach 
and chemical analysis to detect the biosynthetic products, as has successfully been 
shown for cyanobactin family by Jaspars group (Long et al., 2005) and Schmidt 
group (Schmidt et al., 2005). Cyanobactins such as patellamide A (9), 
ulithiacyclamide (71), and trunkamide (72) were isolated from the ascidian 
Lissoclinum patella (Degnan et al., 1989) (Figure 1.4.10). Through cell separation 
studies, it was suggested that the ascidian`s symbiont Prochloron as cyanobactin 
producer (Degnan et al., 1989). 
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Fig. 1.4.10 Some examples of molecules from the metagenomic expression of biosynthetic 
pathways. Compounds 66-70 were discovered by Clardy lab and Brady lab on the basis of 
phenotypic detection of growing E. coli clones on plates, such as Long-chain N-acylated amines 
(antibacterial activity), color production, and signaling phenomena (Brady and Clardy, 2000; 
Brady et al., 2001; Brady and Clardy, 2005; Gillespie et al., 2002). Molecules 9, 10, 71, and 72 
of which the biosynthetic pathways have been cloned from enriched fractions of the ascidian 
symbiotic bacterium Prochloron spp. by Jaspars group (Long et al., 2005) and by Schmidt group 
(Schmidt et al., 2005). 
Jaspars and coworkers generated a large-insert library from Prochloron-enriched 
DNA using the λRed system, which was subsequently stored in 96-well microtitter 
plates. Clones from each plate were combined and fermented in broth medium. The 
cells in the culture were removed by centrifugation, leaving free-cell broth. To 
remove HPLC interferences, the broth was concentrated by solid-phase extraction 
and eluted with methanol. The dried residue was cleaned by 
water/didchloromethane partitioning and subsequently analyzed by HPLC-MS. Once 
plates containing patellamide D and ascidiacyclamide were located, combined 
clones from each plate column were cultured and analyzed by LC-MS. 
Subsequently individual clones from each column containing the desired metabolites 
were fermented separately for patellamide clone selection (Long et al., 2005). In the 
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same year in 2005, Schmidt and coworkers reported the identification the 
biosynthetic gene clusters for ribosomal precursor peptides encoding cyanobactins 
through shotgun sequencing of Prochloron mategenome. Subsequent expression of 
the gene clusters in E. coli led to the production of patellamides A (9) and C (10) 
(Schmidt et al., 2005; Schmidt & Donia, 2009). 
 
Alternatively, libraries can be screened by directly blotting colonies from agar plates 
onto Nylon membranes, which are then analyzed by hybridization as described by 
Ginolhac et al. (2004). However, libraries on agar plates can not be stored for a 
longer time. As the alternative, clones on a plate can be combined into pools that 
can be added with glycerol and stored at -80oC for a long time. All clone pools can 
be screened by combining pool dilutions and PCR-based approach (Piel, 2002). 
This strategy enabled cloning of a trans-AT PKS gene cluster from the metagenomic 
DNA of the beetle Paederus fuscipes. Bioinformatic analysis predicted that the 
isolated gene cluster code for the biosynthesis of pederin (Piel, 2002, Piel et al., 
2004a), which were subsequently supported by functional studies (Zimmermann et 
al., 2009). This discovery marked the first report of an entire biosynthetic gene 
cluster of an uncultivated symbiotic bacterial origin. 
 
Discovery of the pederin gene cluster subsequently provided guidance to isolate 
onnamide-type compounds from much more complex symbiotic systems, marine 
sponges. By phylogenetic analysis, Piel et al (2004b) identified trans-AT PKS genes 
among various diverse PKS types obtained from the metagenome of the Japanese 
sponge T. swinhoei. Based on the information obtained from the isolated trans-AT 
PKSs, the metagenomic library was constructed from total T. swinhoei DNA and 
then screened. This led to the cloning of a large part of onnamide gene cluster (Piel 
et al., 2004b). In the studies of onnamide-type compounds, Piel group developed a 
method that enabled to rapidly identify or target the biosynthetic genes in highly 
complex sponge symbiont assemblages (Hrvatin & Piel, 2007; Fisch et al., 2009). 
The method termed a liquid gel pool analysis involves the construction of a 
metagenomic library in a 3-D format, allowing well-separated colonies grow in the 
average density of 1000 clones/ml. This is followed by rapid screening by whole-cell 
PCR. In PCR-screening step, clone pools in the same rows were combined into 
super-pools and screened by whole-cell PCR. Positive clone pools were amplified at 
lower densities and screened further until individual positive clones were detected. 
This approach enables one not only to catch representative genomes from the wide 
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diversity of microbial symbionts in nature, but also to facilitate rapid screening of the 
biosynthetic pathways of interest among many diverse non-target pathways present 
in a sponge symbiotic system. The advantages of employing this screening method 
are that the whole procedure from transfection to the pure clone was completed in 
four days by a single person, being highly economic in terms of labor, consumables 
and freezer space (Hrvatin & Piel, 2007). With these screening strategies, Piel group 
have successfully isolated the entire gene clusters encoding the biosynthesis of 
onnamide A, theopederin and psymberin from complex sponge systems. The 
architectures of the cloned biosynthetic gene clusters indicated bacterial origin, 
thereby providing the first genetic evidence of the bacterial origin of marine 
invertebrate-derived natural products (Piel et al, 2004b, 2007; Fisch et al., 2009).  
 
Recently, Piel and coworkers have developed a novel predictive approach to enable 
the accurate prediction of the structures of polyketides encoded on trans-AT PKS 
genes  (Nguyen et al., 2008). The approach was developed on the basis of 
functional and phylogenetic studies (Nguyen et al., 2008), in which its utility has 
been demonstrated in the genome mining of thailandamide and elansolid 
polyketides (Nguyen et al., 2008; Teta et al., 2010) and the metagenome mining of 
psymberin (Fisch et al., 2009). Therefore, the approach is especially very useful for 
targeting biosynthetic pathways of pharmacological significant from complex 
microbial consortia due to the high complexity of genomes coding for many diverse 
biosynthetic pathways. In addition, this approach is particularly very useful for 
natural product discovery research from marine sponge, due to the fact that only 
small percentage of sponge PKS genes were found to encode complex polyketide 
(Fieseler et al., 2007; Hochmuth & Piel, 2009). Subsequent expression of 
biosynthetic gene clusters in culturable microbes not only reveals fundamental 
insights into the chemistry and ecology of uncultured symbionts but also provide 
access to sustainable production systems. Moreover, with the genes in hand, 
pathways could be genetically altered to produce structurally novel analogs with 
improved pharmacological profiles (Uria and Piel, 2009). 
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Chapter 2 
Research Goals 
Highly complex consortia of bacterial symbionts associated with sponges have been 
frequently proposed to be the true source of many sponge-derived metabolites. 
However, the majority (>99%) of these symbionts are uncultivable (Amann et al., 
1995; Hugenholtz et al., 1998; Friedrich et al., 2001; Webster and Hill, 2001), 
thereby hampering efforts to test the symbiont hypothesis and to study 
biotechnological applications. Using metagenomic-based approaches, Piel and 
coworkers have verified the symbiont hypothesis by cloning entire gene clusters 
from bacterial symbionts responsible for the production of the antitumor polyketides, 
onnamide A (5) from Japanese specimens of Theonella swinhoei (Piel et al., 2004b; 
Hrvatin & Piel, 2007; Nguyen et al., 2008) and psymberin (6) from the sponge 
Psammocinia aff. bulbosa (Fisch et al., 2009).  
 
       
 
 
 
 
 
 
 
 
Figure 2.1 Two forms of T. swinhoei: chemotype Y [A], chemotype W [B]. 
In the Piel group, the sponge T. swinhoei has been chosen as a symbiotic 
assemblage model to study natural product biosynthetic pathways. This is due to the 
wide variety of pharmaceutically important secondary metabolites isolated from this 
sponge as well as the high complexity of the associated bacteria, which might play 
an important role in metabolite biosynthesis (Matsunaga and Fusetani, 2003; 
Matsunaga et al., 1989; Matsunaga et al., 1992).  The T. swinhoei specimens occur 
in two chemotypes that grow side-by-side at Hachijo Island, Japan. The chemotype 
with the bright yellow inner body (Y) (Fig. 2.1A) especially contains onnamides (5, 
52-56) and theopederins (57-60) (Matsunaga et al., 1992), aurantosides A (73), B 
Photo by Y. Nakao Photo by J. Tanaka 
[A]       [B]       
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(74) (Matsunaga et al., 1991), nazumamide A (75) (Fusetani et al., 1991), 
cyclotheonamides A-B (76-77) (Fusetani, et al., 1990), orbiculamide A (38) 
(Fusetani et al., 1991), and pseudotheonamides (78, 79) (Nakao et al., 1999). The 
chemotype with white interior (W) (Fig. 2.1B) contains theonellamides (30-35) 
(Matsunaga et al., 1989), misakinolide A (also known as bistheonellide A) (24) 
(Kato, et al., 1987), and keramamides (39-41, 44-47) (Itagaki et al., 1992) (Fig. 2.2). 
 
Figure 2.2 Structures of some bioactive secondary metabolites isolated from the 
chemotype Y of the Japanese T. swinhoei , including aurantosides A and B (Matsunaga et 
al., 1991), nazumamide A (Fusetani et al., 1991), cyclotheonamides A and B (Fusetani, et 
al., 1990), orbiculamide A (Fusetani et al., 1991), and pseudotheonamide B2 (Nakao et al., 
1999). 
The first goal of this work was to clone at least one new biosynthetic pathway of 
pharmacological relevance from the Japanese T. swinhoei by employing and 
developing metagenomic strategies. If possible, information on modified peptides 
should be gained, since sources of these compounds had previously not been 
examined in sponges.  
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Although metagenomic methods are able to distinguish between prokaryotic and 
eukaryotic origins, these approaches do not usually provide specific taxonomic 
information. Therefore, the second goal of this work was to provide taxonomic 
information of the uncultured bacterial symbionts harboring the biosynthetic 
pathway(s) of interest. A special interest was directed to “Candidatus Entotheonella 
spp.”, filamentous heterothropic δ-proteobacteria associated with T. swinhoei of both 
chemotypes (Y and W) (J. Piel, S. Matsunaga, unpublished observations). These 
symbiotic bacteria are considered as a good model to study marine natural product 
biosynthesis, because they are uncultivable as of yet, easy to isolate by mechanical 
separation, and loosely related to myxobacteria, an important group of free-living 
polyketide producers. In addition, these symbionts occur in different sponges and 
feature large unusual morphology (Schmidt et al., 2000; Brück et al., 2008). The 
outcomes of this work were expected not only to further test the symbiont 
hypothesis, but also to provide specific taxonomic information as well as to facilitate 
the sustainable supply of rare marine drug candidates.  
 
 
 
 
 
 
 
 
 
 
 
 
                      Photo by C. Gurgui 
Figure 2.3 The symbiotic “Candidatus Entotheonella spp.” in the homogenized sponge 
sample of T. swinhoei chemotype W (indicated by red arrows). 
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Chapter 3 
Results and Discussion 
Finding a biosynthetic pathway of interest in a sponge system is highly challenging 
due to the high complexity of the associated symbiotic assemblage. The fact that the 
majority (>99%) of the symbiotic bacteria present in the sponge are as-yet 
uncultivable (Amann et al., 1995; Hugenholtz et al., 1998; Friedrich et al., 2001; 
Webster and Hill, 2001) has hampered attempts in accessing biosynthetic pathways 
by cultivation-based approaches. Even if cultivation conditions can be met for 
individual symbionts, the target compound might not be produced due to the lack of 
required environmental signals (Uria and Piel, 2009). To tackle the challenge, the 
Piel group has recently developed efficient cultivation-independent approaches to 
access the biosynthetic pathways of secondary metabolites from a complex 
symbiotic system. These molecular approaches, called metagenome mining, have 
enabled to clone the biosynthetic pathways of pharmaceutically valuable secondary 
metabolites from the complex sponge symbiotic assemblage (Piel et al., 2004b; 
Hrvatin & Piel, 2007; Nguyen et al., 2008; Fisch et al., 2009).   
 
Because all of these pharmaceutically important compounds mentioned above 
belong to polyketides and non-ribosomal peptides, the metagenomic approaches 
developed in this work have focused on the biosynthetic systems that generate 
these two compound classes, namely modular polyketide synthetases type I (PKS) 
and nonribosomal peptide synthases (NRPS), respectively. The experimental results 
discussed in this chapter will encompass (i) molecular detection of the key 
biosynthetic genes in the symbiotic assemblage, (ii) isolation and analysis of 
complex PKS/NRPS gene clusters, and (iii) preliminary biosynthesis insights from 
the genome sequencing of an uncultivated bacterial symbiont. 
3.1 Metagenomic Survey of Biosynthesis Genes 
To obtain insights into the diversity of biosynthetic genes present in the T. swinhoei 
chemotype W, we conducted metagenomic survey of PKS/NRPS genes by 
amplifying, cloning, and sequencing of KS and A domain fragments. The genes 
encoding KS domains were used as the diagnostic target, since their sequences are 
most conserved sequences among PKS domains (Aparicio et al., 2000). In addition, 
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genes coding for A-domains were chosen as the cloning target for NRPS detection 
due to the highly conserved amino acid sequences throughout this domain in 
comparison with other NRPS domains (Turgay et al., 1992). Due to the huge 
diversity of homologous genes from various pathways present in the total DNA of 
sponges, cultivation-independent strategies were developed, which combined 
techniques for simplifying the symbiotic complexity and designing effective 
diagnostic primers. By performing the PCR technology along with gene cloning, 
sequencing, and bioinformatic analysis, important information on potential PKS and 
NRPS genes from this chemically rich sponge was obtained, which will be discussed 
in this sub-section. 
3.1.1 PCR cloning of biosynthesis genes from sponge metagenome 
PCR amplification of KS domain-containing genes was based on using 
oligonucleotides designed on two highly conserved motifs in KS domains: DPQQ 
and HGTGT (Piel, 2002) (methodology section Table 4.3.1). In this work, at first we 
prepared the metagenomic DNA from the Japanese sponge T. swinhoei chemotype 
W using a CTAB-based DNA isolation (Piel et al., 2004b; Hrvatin and Piel, 2009; 
Gurgui and Piel, 2010). The extracted total DNA was separated by electrophoresis 
and purified from the agarose gel. Using the purified sponge DNA as the template, 
we detected the PCR products of the expected size (~700 bp). The PCR products 
were then purified from the gel and cloned into E. coli (Fig. 3.1.1). Some of the 
clones were sequenced and analysed by the BlastX program (Altschul et al., 1990).  
 
The BlastX results showed that all of the five clones (supplementary S3.1.1) 
exhibited high similarities (88 to 95%) to KS domains of the module SupA identified 
from both the sponges Theonella swinhoei and Aplysina aerophoba (Fieseler et al., 
2007). SupA contains a single complete PKS module (KS-AT-DH-MT-ER-KR-ACP) 
with additional KS and inactive AT domains in the C-terminus. This domain 
architecture is typical for animal FASs (Schweizer & Weissman, 2001), in which the 
presence of KR-DH-ER-MT domains fully reduces the product backbone, resulting 
in a methyl-branched fatty acid (Fieseler et al., 2007). To determine the phylogenetic 
affiliation of the isolated KS sequences, their translated proteins were aligned with 
three protein homologs from FAS (SupA, SA1_PKSA, SA1_PKSB) and 19 known 
KS domains of both cis-AT and trans-AT PKSs retrieved from the GenBank 
database. The cis-AT PKSs included nostophycin synthase from the 
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cyanobacterium Nostoc sp. Strain 152 (Fewer et al., 2011), cryptophycin synthase 
from the cyanobacterium Nostoc sp. (Magarvey et al., 2006), and nodularin 
synthetase from the cyanobacterium Nodularia spumigena (Moffitt & Neilan, 2003). 
The trans-AT PKSs included onnamide A synthetase from T. swinhoei (Piel et al., 
2004), difficidin synthase from Bacillus amyloliquefaciens FZB42 (Chen et al., 2007), 
and bacillaene from Bacillus amyloliquefaciens FZB42 (Chen et al., 2007). The 
multiple alignments were conducted in BioEdit (Hall 1999) using ClustalW program 
(Thompson et al., 1994). The alignment result was transferred to MEGA4 software 
(Tamura et al., 2007). The phylogenetic analyses were performed using the 
Neighbor-Joining method (Saitou & Nei, 1987) and evaluated based on 
Felsenstein`s bootstrap test (Felsenstein, 1985).  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1.1 Isolation of KS domain-encoding genes from the metagenome of T. swinhoei 
chemotype white (TSW). [A] PCR amplification was carried out at four different annealing 
temperatures (Tms). [B] The ~700 bp PCR product obtained at the optimal Tm (61.8
o
C) was 
purified from the agarose gel and cloned into E. coli using pBlueScript II SK(-). Some clones 
were picked up based on blue-white screening and subjected to EcoRI-HindIII restriction to 
check the presence of inserts (indicated by red arrows). [C] The positive clones were further 
subjected to RsaI-HhaI digestion, and sequenced. 
The resulting phylogenetic tree shown in Figure 3.1.2 revealed that the protein 
sequences of the five isolated KS clones (marked with red color) did not group into 
the trans-AT and cis-AT PKS clades, indicating that none of them are responsible 
for the biosynthesis of complex polyketides. Instead, they fell into the same clade as 
KS domains of SupA, suggesting their possible roles in the lipid or methyl-branched 
fatty acid biosynthesis. Similar results were previously reported by Piel, Henstchel 
and coworkers who detected a large number of clones harbored sup (sponge 
ubiquitous PKS) genes involved in the fatty acid biosynthesis (Fieseler et al., 2007). 
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The extremely low probability in obtaining KS sequences of pharmacologically 
relevant PKS from the sponge metagenome is due to the huge amount of fatty acids 
in sponges that can account for an average of 86% of all KS sequences in average 
based on the study on 20 different sponge species, as reported by Fieseler et al 
(2007). 
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Fig. 3.1.2 Phylogenetic analysis of partial KS amplicons (TSW4, TSW8, TSW9, TSW12, TSW30) 
cloned from the metagenomic DNA of T. swinhoei chemotype W. This phylogenetic analyses 
were performed in MEGA4 program (Tamura, 2007) using the Neighbor-Joining method (Saitou 
and Nei, 1987). The bootstrap percentages are shown next to the branches. The boostrap 
consensus tree was inferred from 500 replicates. McyG of microcystis (YP_001658877) JerC of 
jerangolid (ABK32289), DszA of disorazoles (AAY32964), CorL of corallopyronin A (ADI59534), 
SorD of sorangicin (ADN68479), Bat3 of batumin (ADD82941) DszA of disorazoles (AAY32964), 
StiG of stigmatellin (CAD19091), JamM of jamaicamides (AAS98784), 6-dEBS of 6-
deoxyerythronolide-B synthase (ZP_08988403.1), NpnA (AEU11005.1), CrpA (ABM21569.1), 
BarE (AAN32979.1), NosB (AF204805_2), BryC (ABM63528.1). 
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3.1.2 PCR cloning of biosynthesis genes from uncultivated bacteria 
To tackle the problem, we used an uncultured bacterial cell fraction prepared from T. 
swinhoei chemotype W. In collaboration with Prof. S. Matsunaga (University of 
Tokyo), Prof. J. Piel performed differential centrifugation to separate bacterial cell 
types from sponge cells (Fig. 3.1.3). Two types of the bacterial populations were 
obtained (Piel et al., 2004b): (i) a filamentous bacterial fraction and (ii) a unicellular 
heterothrophic bacterial fraction. Based on microscopic observation, the filamentous 
bacterial fraction obtained was mainly dominated by “Entotheonella sp.“ (J. Piel, S. 
Matsunaga, unpublished observation). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.3 Compound localization in the Japanese T. swinhoei chemotype W. The sponge 
sample was homogenized in calcium/magnesium-free artificial seawater (CMF-ASW) and 
the suspension was filtered through a nylon sieve to remove larger particles. The filtrate was 
subjected to differential centrifugation at increasing speed, thereby resulting in the 
separation of cell types with different size and densities. Based on earlier studies of Bewley 
et al (1996), it was proposed that theonellamide F and misakinolide A are located in the 
filamentous bacteria and unicellular heterothropic bacteria, respectively.  
This mechanical separation was not only intended to obtain an enriched filamentous 
fraction, but also to reduce the complexity of the sponge symbiotic assemblage, 
thereby simplifying the access to potential biosynthetic pathways present in the 
sponge. Based on the earlier localization studies by Bewley et al (1996), we 
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hypothesized that theonellamide F reported from this sponge (structurally similar to 
theopalaumide, see Introduction) was located in the filamentous bacteria identified 
as “Candidatus Entotheonella sp.”, whereas misakinolide A (structurally similar to 
swinholide A) was accumulated in unicellular heterotrophic bacterial fraction. 
“Entotheonella sp.“ is an especially interesting model to study the biosynthetic 
capacity of an uncultivated bacterial symbiont. Besides potentially producing the 
promising antifungal compound theonellamide F, it has large unusual morphology 
and occurs in different sponges. In addition, it is easy to isolate by mechanical 
separation, and taxonomically distant from known cultivated bacteria (Schmidt et al., 
2000; Brück et al., 2008).  
 
Because “Entotheonella sp.“ was proposed as the true producer of theopalauamide 
based on compound localization studies (Schmidt et al., 2000), our initial studies on 
theonellamide F were focused on gaining access to the biosynthetic pathway of this 
antifungal cyclic peptide from the filamentous fraction. For this purpose, the 
biogenesis of some unusual building blocks of theonellamide F was theoretically 
predicted in order to determine whether or not a PKS system and other enzymatic 
modifications are involved in the theonellamide biosynthesis. This information was 
useful not only to confirm if the existing KS-based primers could be used, but also to 
get insights about which other parts of the pathway could be targeted by PCR.  
 
One of the unusual amino acids forming theonellamide F is the L-ρ-
bromophenylalanyl residue. As shown in Fig. 3.1.4, this brominated residue is 
presumably formed via L-phenylalanine bromination catalyzed by a halogenase, 
suggesting that diagnostic PCR-primers could be designed based on the 
halogenase enzyme, especially for a phenylalanine or tyrosine halogenase. Another 
unusual building block is (2S)-2-amino-4-hydroxyadipic acid that could arise from 
the hydroxylation of L-α-aminoadipic acid, which is an intermediate in the lysine 
biosynthetic pathway (Velasco et al., 2002). The NRPS system that involves loading 
L-α-aminoadipic acid was reported for the biosynthetic pathway of the tripeptide d-(L-
α-aminoadipyl)-L-cysteinyl-D-valine (ACV), a common intermediate in β-lactam 
antibiotic families, the penicillins and cephalosporins (Martín et al., 2000). This 
suggests the possibility to design screening primers based on the adenylation 
domain specific for aminoadipic acid.  
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Figure 3.1.4 The proposed biogenesis of some building blocks in theonellamide F. The 
incorporated brominated phenylalanine (BrPhe) is presumably from L-Phe via halogenation 
(blue color). The proposed Aboa biosynthesis (red color) starts from the L-Phe-derived 
PheAc, which is loaded by an NRPS (I) and processed through a PKS assembly line 
involving a double bond shift by β,γ-dehydration and α-methylation (II), α-hydroxylation (III), 
and aminotransferase (IV). The α-AhAA probably arises from α-aminoadipic acid, which is 
derived from α-ketoglutarate in lysine biosynthesis (green color). Abbreviations: α-AhAA is 
(2S,3R)-3-hydroxyasparagine, (2S,4R)-2-amino-4-hydroxyadipic acid, L-His-D-Ala  is Z-L-
histidino-D-alanine, L-p-bromophenylalanine, and Aboa is (3S,4S,5E,7E)-3-amino-4-
hydroxy-6-methyl-8-(p-bromophenyl)-5,7-octadienoic acid. 
Another unusual amino acid is (3S,4S,5E,7E)-3-amino-4-hydroxy-6-methyl-8-(ρ-
bromophenyl)-5,7-octadecanoic acid (Aboa), which is a close structural analog of 3-
amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6-decadienoic acid (Adda) present in 
microcystins (Namikoshi et al., 1992). The Adda biosynthetic pathway involves 
loading phenylacetate (PheAc) and a subsequent extension reaction by a series of 
PKS modules (Tillet et al., 2000). For Aboa, the biosynthetic pathway presumably 
arises from L-phenylalanine that is converted into PheAc through transamination 
and oxidative carboxylation. Subsequent decarboxylative condensations of PheAc 
with malonyl-CoA-derived extender units catalyzed by a series of PKS modules 
involving a double bond shift, α-methylation and α-hydroxylation would lead to the 
formation of the Aboa residue, as described in Fig. 3.1.4. Therefore, all of the 
building blocks, except Aboa, were assumed to be enzymatically incorporated into 
theonellamide F by NRPS modules. Because the biosynthesis of theonellamide F 
most likely involves a PKS system for Aboa residue formation, we initially targeted 
the PKS genes using the existing KS-based primers. 
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By using the KS-based primers with the filamentous bacterial fraction as the PCR 
template, we attempted to detect of PKS type I genes by performing a whole cell 
PCR technique. A gradient PCR was done at different Tms (52, 55.5, 60 
oC) to know 
the optimal annealing temperature (Fig 3.1.5). The target band of around 700 bp 
was observed at the Tm of 60 
oC, which was used further as the optimal Tm to get 
more amplicons. The resulting PCR product was subsequently purified from the gel 
and cloned into the host, E. coli XL1 Blue MRF. White clones that appeared on the 
solid media (based on blue-white screening) were picked, cultivated, and checked 
for the presence of correct-sized inserts. The positive clones were then sequenced 
and analyzed to predict the functional properties.  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 3.1.5 Cloning of KS sequences from the uncultivated filamentous bacterial fraction of 
the Japanese marine sponge, T. swinhoei chemotype white. [A] PCR detection of 700-bp 
DNA fragments at three different Tms (52
o
, 55.5
o
, 60
o
C). [B] The target PCR product 
amplified at optimal Tm (60 
o
C) was cloned into E. coli using pBlueScript II SK(-). Some 
resulting white clones were subjected to digestion with BamHI, EcoRV and HindIII. The 
clone harboring inserts (shown with red arrows) were sequenced. 
Sequence analysis indicated that all of the five sequenced clones belong to KS-
domains of trans-AT PKSs. To get insights into the diversity of PKS genes, more KS 
genes were isolated from the filamentous fraction, leading to the isolation of eight 
additional PKS gene fragments. Three KS sequences shared high similarity (70-
78%) with those known from cis-AT PKS modules, McyG in the microcystis (Tillet et 
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al., 2004), JerC in jerangolid (Julien et al., 2006), JamM in jamaicamide (Edwards et 
al., 2004) biosynthesis (supplementary S3.1.2). Other KS sequences exhibited high 
similarity (67-78%) with those known from trans-AT PKS modules, DszA in the 
disorazoles (Carvalho et al., 2005), CorL in the corallopyronin A (Erol et al., 2010), 
SorD sorangicin (Irschik et al., 2010), Bat3 in the batumin (Mattheus et al., 2010), 
and StiG in the stigmatellin (Gaitatzis et al., 2002) biosynthesis (supplementary 
S3.1.3) (Table 3.1).  
 
As described previously, our work on PCR detection of KS genes in the entire 
metagenome of T. swinhoei led to the isolation of KS sequences involved in the lipid 
or methyl-branched fatty acid biosynthesis (see above). None of these 
metagenome-derived KS sequences is involved in the biosynthesis of complex 
polyketides. However, using the cell fraction separated from the sponge T. swinhoei, 
we isolated ten KS genes predicted to be involved in the biosynthesis of complex 
polyketides, suggesting that we have mechanically enriched PKS genes in a fraction 
predominantly consisting of an “Entotheonella sp.” symbiont.  
 
Table 3.1 Hypothetical identities of the gene sequences cloned from the filamentous bacterial pellet 
using degenerate KS primers.  
Clone AA 
Protein homolog (BLAST) I/S 
(%) 
Group 
Homolog Organism Accession no. 
EKS14 762 McyG (microcystis) Microcystis aeruginosa  YP_001658877 55/70 Cis-AT PKS 
EKS30 596 JerC (jerangolid) Sorangium cellulosum ABK32289 75/85 Cis-AT PKS 
EKS27 762 DszA (disorazoles) Sorangium cellulosum AAY32964 53/67 
Trans-AT 
PKS 
EKS37 387 CorL (corallopyronin A) Corallococcus coralloides ADI59534 63/78 
Trans-AT 
PKS 
EKS48 746 SorD (sorangicin) Sorangium cellulosum  ADN68479 59/73 
Trans-AT 
PKS 
EKS50 739 Bat3 (batumin) 
Pseudomonas 
fluorescens 
ADD82941 61/74 
Trans-AT 
PKS 
EKS64 745 DszA (disorazoles) Sorangium cellulosum AAY32964 58/72 
Trans-AT 
PKS 
EP2 711 StiG (stigmatellin) Stigmatella aurantiaca CAD19091 66/79 
Trans-AT 
PKS 
EP3 699 phenolpthiocerol  Sorangium cellulosum ZP_08782289 52/69 
Trans-AT 
PKS 
EP5 719 JamM (jamaicamides) Lyngbya majuscula AAS98784 60/76 Cis-AT PKS 
Note: AA, amino acids; I/S, identities/similarities 
To obtain insight into the NRPS diversity within the filamentous symbiont 
preparation, NRPS genes were detected by cloning of the A domain sequences 
responsible for selecting amino acids as building blocks in nonribosomal peptide 
biosynthesis. To clone the A domain sequences, three degenerate primer pairs, 
(designated as JP, Öz, and AG) designed on the basis of adenylation catalytic 
motifs (A2-A8, A2-A9 & A3-A7) were initially used (methodology section Table 
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4.3.2). The accuracy of these primer pairs were verified with the genomic DNA of 
Bacillus amyloliquefaciens FZB42 as the PCR template. The reason for choosing 
this bacterial strain as the positive control was due to the presence of the gene 
clusters in its genome for nonribosomal peptides, such as surfactin, bacillomycin D, 
fengycin, siderophore bacillibactin, and bacilysin (Koumoutsi et al., 2004; Chen et 
al., 2009).  All of the three tested primer pairs gave PCR products with the desired 
sizes, indicating their suitability for being used in targeting the A domain sequences 
(Fig. 3.1.6).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.6 Detection of bacterial NRPS genes based on A domain sequences. [A] 
Amplification strategy with three different degenerate primers. [B] Verification of the 
primers at various PCR reaction conditions with the genomic DNA of Bacillus 
amyloliquefaciens B42 as the PCR template. A1-A10 = conserved catalytic motifs of 
A-domain, M1-M3 = conserved catalytic motifs of methylation domain. AG, JP, Öz 
are three different degenerate primers targeting A-domain sequences (See 
Methodology section). PCR reaction conditions: +BSA (with bovine serum albumin) 
and +DMSO (with dimethylsulfoxide). 
The three primer pairs (JP, Öz, and AG) were subsequently used to amplify A 
domain sequences from the filamentous bacterial fraction by whole-cell PCR. The 
cell suspension was initially rinsed with ddH2O three times and then used as PCR 
template. The whole-cell PCR condition was set at three different Tms (55, 58, 61 
oC). The results showed that only the primer pair designed based on the A3-A7 
motifs gave a target band of the expected size at the Tm of 61 
oC (Fig. 3.1.7).  
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Figure 3.1.7 Molecular detection of bacterial NRPS genes based on A domain sequences in 
the filamentous bacterial fraction of the Japanese sponge T. swinhoei. [A] The target 
amplicon (~700 bp), as indicated by a red arrow, was purified, subjected to nested PCR to get 
more amplicon, cloned into E. coli using pBlueScript II (SK-) vector. [B] Some resulting 
clones were checked for the presence of inserts by EcoRI-HindIII digestion. Three clones 
containing correct-sized inserts (as indicated by red arrows) were subsequently sequenced. 
[C] Sequence analysis indicated that the isolated genes encoded adenylation domains 
specific for arginine due to the presence of arginine-conferring specificity codes. The 
position of the specificity code (ten decisive residues) was based on the residue numbering 
in PheA of GrsA. The 10
th
 residue position marked with “-“could not be identified, because it 
was located outside the A3-A7 regions. M = 1-kb DNA marker, S = sample. 
Since the target 700 bp fragment was appeared as a single band on the gel, the 
PCR products were directly purified to remove primers and primer dimmers formed 
during the PCR reaction. The purified PCR product was subsequently cloned and 
sequenced. The resulting clone sequences were analyzed using the online software 
VecScreen (http://www.ncbi.nlm.nih.gov/VecScreen) to remove the vector 
backbone. The isolated sequences were then compared to each other at the 
nucleotide level, followed by predicting their putative function using the online 
software NRPS predictor1 (Rausch et al., 2005).  We found that three of the four 
sequenced clones were identical. The two unique clones, designated as pAU1 and 
pAU2, were each predicted to encode an A domain specific for arginine (ArgA) (Fig. 
3.1.7) (supplementary S3.1.4). Because arginine (Arg) or its derivatives are not 
building blocks forming theonellamide F, the isolated ArgA sequences might not be 
involved in the biosynthesis of theonellamide F.  
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To target the biosynthetic pathway of theonellamide F in this work, we focused on 
cloning of the A-domain sequences specific for an amino residue that is encoded 
more than once in theonellamide F. Because there are three likely L-serine residues 
in the theonellamide F structure, the degenerate primers for A domain amplification 
were designed based on the active site of the serine-activating adenylation domain 
(SerA). To design the primers, some sequences of A-domains with serine specificity 
from different biosynthetic gene clusters were initially retrieved from GenBank. 
These sequences were aligned together in BioEdit (Hall 1999) using Clustal W 
program (Thompson et al., 2007) and compared to those with the specificity for 
phenylalanine and arginine. The reason of choosing PheA for sequence comparison 
is that the 3-D structure of gramicidin synthetase A1 (PheA-GrsA1) in a small 
complex with AMP and phenylalanine has been solved, which provided a basis for 
the identification of 10 core motifs (A1-A10) generally involved in the coordination of 
ATP and the substrate (Conti, et al., 1997; Schwarzer & Marahiel, 2001; Schwarzer, 
et al., 2003). The reason of choosing the ArgA sequence in the alignment is to avoid 
selection of amino acid residues conferring arginine specificity. The unique motifs 
located between A4-A5 on the serine-specific adenylation sequences were used as 
the basis for designing the degenerate primers (Fig. 3.1.8).  
 
The core motifs A4-A5 are flanked by the A3-A6 motifs that contain all residues 
involved in forming the substrate-binding pocket, thereby determining the A-domain 
specificity (Cosmina et al., 1993) (Fig. 3.1.8). Subsequently, a similar strategy was 
used to design primers targeting sequences encoding asparagine-activating 
domains (AsnA) and tryptophan halogenase (Trp-Hal). AsnA was chosen as target 
due to the presence of L-Asn in theonellamide F structure, which is presumably 
activated by AsnA, while Trp-Hal was proposed to be involved in brominating L-Trp 
of theonellamide F. When the SerA-based primers were tested at different Tms, one 
of them, designated as A4F1-A5R1, gave a correct-sized DNA fragment at a Tm of 
58 oC (Fig. 3.1.8). 
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Figure 3.1.8 Strategy for designing degenerate primers specifically to target the A domain for L-serine 
developed in this work. [A] The primers were designed based on the serine active site located in the A-
domain core motifs, A4 and A5. [B] Several A domain sequences (320 bp) specific for serine, 
phenylalanine, and arginine were retrieved from GenBank and aligned together with the A-domain for 
arginine from the filamentous fraction of T. swinhoei. [C] The catalytic core motifs located in A4 and A5 
that are unique for serine specificity were used as the basis for primer design. EntF-1, -2, -3 = 
Enterobactin synthase component F from E. coli, Shigella flexneri, and Enterobacter sp., CbsF = 
chrysobactin synthetase from Chromobacterium violaceum, VabF = vanchrobactin sythetase from 
Listonella anguillarum, ArfA = arthrofactin synthetase, McyA = microcystin from Microcystis aeruginosa, 
GrsA = gramacydin S synthetase from Brevibacillus brevis, PedH = pederin synthase symbiont of 
Paederus fuscipes, pAU1 = arginine-specific A-domain sequence from the filamentous bacterial 
fraction of T. swinhoei.  
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A5R1 Reverse                                                                      TCN GTN GGN CCR TAN RRT TRT G- 
A5R2 Reverse                                                                      YTV YTN STN ACR TCN CAN GCN GC 
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This fragment was purified, cloned into E. coli XL-blue, and then screened based on 
ampicillin resistance and blue-white screening. White colonies were picked and 
cultivated overnight. The recombinant plasmids were checked for the presence of 
approximately 320-bp inserts by enzymatic restriction. Recombinant plasmids with 
correct inserts were subsequently subjected to HhaI digestion for restriction pattern 
comparison. All of the selected clones showed similar digestion patterns, and 
therefore three of them were sequenced (Fig. 3.1.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.9 Cloning of the A domain-encoding fragments specific for L-serine. [A] At 
first, degenerate primers were designed based on the A-domain sequences for serine 
retrieved from GenBank. The designed primers were applied at different Tms using the 
filamentous bacterial fraction as template. [B] The PCR products were cloned into E. 
coli. Some positive clones were subjected to HhaI digestion and chosen for sequencing. 
[C] Sequence analysis indicated that two clones harbored different A-domain genes that 
were predicted to be specific for serine (SerA genes). 
The obtained DNA sequences were aligned with functionally verified sequences in 
public databases using BlastX to predict their putative function. The sequences 
exhibited highly similarity with L-serine-specific A domains, suggesting that they 
code for L-serine (supplementary S3.1.5). This was confirmed by using the online 
software NRPS-predictor1 that showed specificity codes for serine (Rausch et al., 
2005). Obtaining two different A domain sequences specific for L-serine (SerA) 
demonstrated the success in developing an approach to target the NRPS A domain 
with the substrate specificity of interest. The two isolated SerA homologs might be 
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responsible for the incorporation of two L-serines present in theonellamide F or 
alternatively, involved in the biosynthesis of other serine-containing peptides, of 
which several have been reported from other T. swinhoei chemotypes (Fig. 3.1.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.10 The predicted functional role of the isolated SerA homologs. They are 
predicted to be involved in the incorporation of serine in the theonellamide F assembly 
line, in the formation of O-methylated serine in keramamide biosynthesis, in oxazole 
formation in orbiculamide biosynthesis, or in the biosynthesis of as-yet undescribed 
compounds. 
For example, in orbiculamide biosynthesis, a serine is expected to be converted into 
the oxazoline ring through cyclodehydration and subsequently oxidized into the 
oxazole by an FMN-dependent dehydrogenase, as reported by Li et al. (1996) for 
the oxazole-containing antiobiotic, Microcin B17 synthase. In this case, serine acts 
as the precursor for the oxazole ring. Another possible role of the isolated serA 
homologue is incorporating serine in keramamide biosynthesis, where such a 
residue is likely further modified by O-methylation, thereby resulting in the 
methylated serine residue found in this compound class (Fig 3.1.10). 
Br
HN
H
N
O
NH
O
HN
OH
H2N
O
NH2O
O
N
NNHO
HN
HO2C
HO
HN
O
OH
HN
O
OH
H
N
O
NH
O
OH
Br
O
O
NH
O
NHO
OH
O
H
N
N
H
O R2
H
N
N
H
O
NH
HO
Br
H
N
O
N O
R1
NH
O
O
HN
N
O
O
OH
HN
N O
O
OH
O
O
R1
R1
OH
O
OHH2N
I 
II 
III 
Serine 
I = Serine incorporation in    
      the growing peptide 
II = Cyclization 
III = Dehydrogenation 
Orbiculamide A (R1 = CH3, R2 = CH2CH3) 
Orbiculamide B (R1 = CH2CH3, R2 = CH2CH3) 
Orbiculamide C (R1= CH2CH3, R2 = CH3) 
Orbiculamide D (R1 = CH3, R2 = CH3) 
Orbiculamide E (R1 = CH3, R2 = CH2CH2CH3) 
Theonellamide F 
L-Serine 
L-Serine 
L-Serine 
H N
H
O
N
H
OH
O
H
N
O
HN
O
N
H
R2
NH
N
S
NH
OCH3
OO
H
N
O
N
H
O
R1
O
OH
OH
O
H2N
NH
OH
O
HN
Keramamide H, R1=Br, R2=OH 
Keramamide J, R1=R2=H 
 
Serine 
Seryl intermediate  
I = transpeptidation 
II = O-methylation I 
II 
Chapter 3 Results and Discussion 
__________________________________________________________________________________ 
63 
 
3.2 Metagenomics Discovery of a Polyketide Biosynthetic Pathway 
The Japanese sponge T. swinhoei used in these studies harbors high density of 
bacterial symbiotic cells (Fusetani & Matsunaga, 1993). The diversity of the bacteria 
associated with this sponge derived from at least seven different bacterial divisions, 
including Acidobacteria, Chloroflexi, Actinobacteria, Alphaproteobacteria, 
Gammaproteobacteria, Deltaproteobacteria, Cyanobacteria, and Nitrospira 
(Hentschel et al., 2002). Therefore this sponge can be viewed as highly 
concentrated reservoirs of so far uncultured marine bacteria, which is termed `a high 
bacterial abundance sponge` or `bacteriosponge` (Hentschel et al., 2002; Hentschel 
et al., 2006). The term `high bacterial abundance sponges` refers to the bacterial 
symbiotic community in the density range of 6.4 x 108 to 1.5 x 109 bacterial cells per 
ml of sponge extract, which exceed bacterial isolates from seawater by two to four 
orders of magnitude (Friedrich et al., 2001; Scheuermayer et al., 2006) and may 
consist of hundreds to thousands of microbial species (Taylor et al., 2007). Due to 
the high microbial complexity of this sponge, we expected that the symbiotic 
assemblage contains numerous homologous genes from diverse pathways (Piel et 
al., 2004a; Piel, 2010). To capture the majority of bacterial pathways present in the 
sponge, a metagenomic library needs to be generated as large as possible in order 
to make sure that the biosynthetic pathway of interest is entirely covered in the 
library. In our work, this involves preparation of metagenome from either the whole 
sponge or its associated bacteria, cloning of the isolated HMW DNA, amplification of 
individual clones in the resulting libraries, and subsequent efficient screening 
strategies for such huge libraries (Fig. 3.2.1). 
3.2.1 Metagenomic library construction and screening 
As shown previously, mechanical separation not only reduced the microbial 
complexity, but also enriched the desired biosynthetic genes. In this work, a small 
library was constructed from the filamentous symbiont fraction of T. swinhoei.  Our 
rationale to use the enriched bacterial fraction for library generation was that the 
library size required to cover a biosynthetic pathway of interest would have to be 
relatively small, thereby simplifying the screening steps (Fig. 3.2.1). Since the 
existing filamentous cell pellet was available in a very limited amount, we optimized 
first the experimental steps for library construction by using the cultivated cells of an 
engineered strain of Acinetobacter baylyi ADP1 harboring a 77-kb gene cluster 
coding for the antitumor polyketide, pederin. The techniques tested with this small 
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amount of cultured cells were thus validated and proceeded to generate a library 
from the filamentous fraction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.1 General strategies for the construction and screening of a metagenomic library 
from the Japanese marine sponge Theonella swinhoei chemotype W. HMW DNA is initially 
prepared from either the whole sponge or its associated bacteria and be separated by 
electrophoresis on a low-melting-point (LMP) agarose gel. DNA fragments with the desired 
size (~40 Kb) are purified from the gel by Gelase or filtration column, repaired at both 
termini, and ligated with dephosphorylated fosmids. The ligation products are packed in 
bacteriophage particles and used to transfect E. coli. The resulting library can then be 
amplified in semi-solid media and screened by clone dilution and whole cell PCR. Before the 
metagenomic library was constructed, the presence of Candidatus `Entotheonella` sp. and 
SerA-encoding gene were checked first in the isolated total DNA.  
We attempted to construct a fosmid library from a very limited amount of the 
filamentous bacterial fraction. The total DNA was initially isolated from the fraction 
by a simple heating method (Syn & Swarup, 2000) followed by cloning the DNA into 
E. coli using the fosmid vector pCC1FOSTM (Epicentre), resulting in a ~2000-clone 
fosmid library distributed into 18 pools in semi-liquid medium (Fig. 3.2.2).  
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Fig. 3.2.2 Generation of a fosmid library from a filamentous cell pellet prepared from T. 
swinhoei chemotype W. The cell suspension stored in ethanol was rinsed three times with 
ddH2O. Then HMW DNA was initially isolated from the rinsed cell pellet (step 1), and 
subsequently end-repaired (step 2). The end-repaired DNA fragments (~80 ng) were ligated 
with a fosmid vector (step 3) and packaged into the lambda phage particles (step 4). The titer of 
the phage particles was determined (step 5 and 6). The phage particles were transfected into E. 
coli cells (step 7), and the recombinant clones were grown in semi-liquid media (step 8) at a 
density of ~120 cfus per ml. Abbreviations and symbols: PDB, phosphate dilution buffer; vol, 
volume; HMW, high-molecular-weight; ∑, amount/number; Ā, average number of colonies; B, 
dilution factor; C, volume taken from the dilution. 
We screened the library using primers designed based on three KS-encoding 
sequences (EP2, EP3, EP5) cloned from the filamentous cell pellet (see Table 3.1). 
PKS screening of all 18 pools in the library by whole cell PCR (Hrvatin & Piel, 2007) 
indicated no target PCR product observed on the gel. Subsequently, we tried to 
optimize the PCR condition to know whether a target PCR product could be 
observed. The PCR reaction was set up at different Tms using a combined aliquote 
from all 18 pools as the PCR template. However, no target DNA PCR product was 
detected on the gel (Fig. 3.2.3A). Subsequent pool screening with one of the KS 
primer pairs also did not give positive DNA fragment (Fig. 3.2.3A). Based on these 
negative results, we assumed that PKS gene cluster regions might not be contained 
within the library. There are some possible reasons for the low probability or lack of 
a target gene cluster being present within the library. First, the simple heating 
method might not be sufficient to lyse the cell membrane of bacteria harboring target 
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PKS genes, and as a consequence its genome was probably not well represented in 
the generated library. However, PCR detection of PKS sequences in both cell 
fraction and DNA isolated from the fraction gave positive results (Fig. 3.2.3B), 
suggesting the lysis of the cells harboring the PKS genes did occur. Second, the cell 
fraction used in this work might contain several types of bacteria including 
filamentous multicellular bacteria. If a sample contains many different bacterial 
species, then constructing libraries from it would be technically challenging 
(Riesenfeld et al., 2004). Since we do not have 16S rRNA analysis data for this cell 
fraction as an indicator of bacterial diversity, it is difficult to predict the fosmid library 
size required to cover the genomes of all different bacterial species present in the 
fraction. As an example, if there are 9 different bacterial species in the fraction, then 
the number of clones required to ensure a 99% probability of their genomes (the 
predicted average size = 4.7 Mb) being contained in a fosmid library of 40 kb inserts 
is ln (1-0.99/ ln (1-[4 x 104 bases/ 4.7 x 106 bases]) x 9, which is equal to 4149 
clones (Hohn, 1979; Epicentre 2012). The required fosmid library size would be 
much higher if the fraction sample is contaminated with eukaryotic cells. Third, the 
target PKS genes might be contained in a very rare member of bacterial species, 
and not in the dominant filamentous bacteria. If this is the case, then it would be 
difficult to obtain substantial representation of a rare member in the generated 
fosmid library.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.3 PKS screening of the fosmid library generated from the filamentous fraction of the 
sponge T. swinhoei chemotype W. [A] Detection of KS-encoding sequences in the superpool 
(the combined pools) of the library and the 18 pools. [B] Detection of KS-encoding sequences 
in the DNA of T. swinhoei chemotype W (TS), DNA of a filamentous cell pellet (Et), and the 
filamentous cell fraction (CP). The PCR products as indicated by red arrows were sequenced. 
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Our subsequent screening of the resulting fosmid library was focused on isolating 
NRPS genes using the specific primers designed based on two isolated SerA 
domains. This screening led to the identification of 9 positive clones. Restriction 
analysis by PstI suggested that the nine clones were identical (Fig. 3.2.4). 
Subsequently, we analyzed one of the clones (pET3.7a) by end-sequencing, PCR 
amplification, and sub-cloning. End sequencing of pET3.7a clone indicated high 
homology with phosphokinase coenzyme A and an integral membrane protein, 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.4 NRPS screening of a fosmid library contructed from a filamentous cell pellet prepared 
from T. swinhoei chemotype W. The 18 pools were combined into two superpools. Each 
superpool was subjected to a whole cell PCR at different Tms using three different primer pairs 
specific for adenylation domain-encoding region. All of the pools were screened by A3 primer 
pair (step 1). The positive pool (pool 3) was diluted 5 times and the resulting subpools were 
screened. One of the positive subpools (subpool 7) was plated (step 2). Colony PCR indicated 9 
positive colonies (step 3) that were subsequently subjected to enzymatic restriction (step 4). 
Restriction pattern of the 9 colonies were the same, suggesting that they were identical. 
A single amplicon coding for SerA was identified from the clone by using the library 
screening primers (Fig. 3.2.5A), suggesting the presence of an A-domain sequence 
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within the fosmid. This SerA-encoding sequence showed highest homology (70% 
maximal identity) to that present in a peptide synthetase of the cyanobacterium, 
Cyanothece sp. CCY0110 (acc. nu. ZP_01728834). However, when two fragments 
generated by PstI-digestion of the clone were subcloned and end-sequenced (Fig. 
3.2.5B), they only encoded hypothetical proteins instead of typical NRPS 
components, suggesting that the clone harbored only a small NRPS cluster instead 
of the expected complex multimodular system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.5 Analysis of the fosmid pET3.7a. [A] A SerA-encoding regions were amplified 
from the fosmid using two primer pairs A3 and D1. The PCR products were purified and 
cloned into E. coli (step 1). Some clones were checked by PCR for the presence of A 
domain encoding inserts (step 2), followed by digestion with the frequent-cutting enzyme 
HhaI. [B] Subcloning of pET3.7a. Restriction pattern of pET3.7a digested with different 
endonucleases, in which the recognition sites are present in the multi-cloning sites of the 
cloning vector pBlueScript II SK(-). The PstI-restriction pattern was chosen (red arrow). 
PstI-fragments of pET3.7a were separated by electrophoresis (step 1), individually 
extracted from the gel, and were individually cloned. Some potential clones representing 
each PstI-fragment were checked for the presence of inserts, as indicated by red arrows 
(step 2). Two clones containing inserts (red letters) were subjected to end-sequencing 
(step 3).  
A similar result has recently been reported by Hentschel and coworkers showing the 
wide distribution of a single small NRPS module in 12 marine sponge species from 
different geographic locations (Pimentel-Elardo et al., 2012).  Pimentel-Elardo et al 
(2012) isolated a cosmid clone containing a small NRPS structural gene flanked by 
efflux protein- and PPTase-encoding genes. This NRPS gene was predicted to 
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encode two complete NRPS modules (C-A-T-C-A-T-Te) that might be responsible 
for the biosynthesis of a dipeptide consisting of phenylalanine and tyrosine. The 
putative bioactivity and function of this dipeptide remain unknown (Pimentel-Elardo 
et al., 2012). A critical issue arises about the reason why a small NRPS gene cluster 
was detected in the library whereas PKS genes were not. A possible explanation is 
that the small NRPS and PKS genes were probably contained in different bacterial 
members in the fraction. Target large PKS genes might be located on the genome of 
rare bacterial species, and as the consequence, they were underrepresented in the 
generated fosmid library. In contrast, bacterial species harboring the small NRPS 
gene is probably abundant, and therefore, its genome was well represented in the 
library.  
 
Due to the failure in identifying complex PKS and NRPS pathways in the library 
constructed from the filamentous bacterial fraction, a highly complex metagenomic 
library was subsequently constructed from the total DNA of T. swinhoei chemotype 
white. Before library construction, we first checked the total sponge DNA for the 
presence of the SerA domain and “Entotheonella sp.” The same specific primers 
used for previous library screenings were employed to obtain the serA amplicon. In 
addition we detected the presence of “Entotheonella sp.” in the sponge DNA using a 
primer pair (238F and 1309R), targeting a unique region indicative of “Entotheonella 
sp.” 16S rRNA genes (Schmidt et al., 2000). Cloning, sequencing, and analysis of 
the target PCR products led to the isolation of a 1-kb 16S gene fragment having a 
unique region of “Entotheonella sp.” (Fig. 3.2.6) (supplementary S3.2.1). A similar 
unique region was previously reported for a Palauan T. swinhoei (Schmidt et al., 
2000) and a Caribbean Discodermia sp. (Brück et al., 2008).  
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Fig. 3.2.6 Detection of Candidatus “Entotheonella sp.” in the sponge T. swinhoei chemotype W. 
PCR amplification was carried out using Entotheonella 16SrDNA-targetting primer pair (238F-
1309R) using metagenomic DNA as PCR template. The PCR product obtained at optimal Tm 
was purified and cloned into the T-overhang pBlueScript II SK(-) vector. Several clones were 
selected by colony PCR using the primer pair (238F and 1247R-ad). The positive clones based 
on colony PCR were subject to a PstI-digestion. Two clones with different PstI-restriction 
patterns were sequenced. One of the sequenced clones showed a unique region as described 
by Schmidt et al. (2000). Note: 1, Japanese T. swinhoei W (in this study); 2, Palauan T. 
swinhoei  (Schmidt et al., 2000), and 3, Discodermia sp. (Brück et al., 2008).  
For library construction, total DNA was initially isolated from one gram of T. swinhoei 
sample. The isolated DNA was separated on low-melting-point (LMP) agarose gel, 
and the DNA fragments in the size range of 35-40 kb were purified from the gel. 
Subsequently the size-selected DNA fragments were end-repaired, blunt-ligated into 
the fosmid vector pCC1FOSTM (Epicentre), packaged into the lambda phage 
particles and finally transfected into E. coli (Epicentre, Hrvatin and Piel, 2007; 
Gurgui & Piel, 2010). The recombinant clones were grown in semi-liquid media 
according to the methods described by Elsaesser & Paysan (2004), Hrvatin & Piel 
(2007), and Gurgui & Piel (2010) at a clone density of up to 4000 cfus per ml, 
thereby resulting in a complex 3-D metagenomic library containing ~105,875 clones 
(Fig. 3.2.7). Subsequently we generated a second metagenomic library containing 
approximately 36,720 fosmid clones at a density of ~ 510 cfus per ml. Subsequently 
we expanded the library size to 350,000 clones, thereby increasing the probability of 
acquiring potential gene cluster. 
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Fig. 3.2.7 Generation of a 3-D metagenomic library from the Japanese marine sponge T. 
swinhoei chemotype W. [A] The crude extract obtained from the whole sponge was selected by 
LMP-gel extraction. The resulting pure ~40 kb DNA fragments was subjected to end-repair and 
ligated to a fosmid vector. The 8.1 kb fosmid vector used in this work was purchased from 
Epicentre. It is linearized at the Eco72 I (blunt) site and then dephosphorylated. The vector is 
ready for cloning end-repaired (blunt-end) genomic DNA of approximately 40 kb (Epicentre). [B] 
The number of the phage particles in the packaging extract was estimated. Based on the phage 
titration, the phage particles were transfected into E. coli cells, and the recombinant clones were 
grown in semi-liquid media at a density of ~4000 cfus per ml. [C] The library size was expanded 
up to ~357,245 clones by generating a second library (~36,720 cfus at a clone density of ~510 
cfus per ml) and a third library (~214,650 clones at a density of ~1820 cfus per ml). 
Abbreviations and symbols: PDB, phosphate dilution buffer; vol, volume; HMW, high-molecular-
weight; ∑, amount/number; Ā, average number of colonies; B, dilution factor; C, volume taken 
from the dilution. 
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3.2.2 Isolation of a polyketide biosynthesis genes and preliminary analysis 
 
Based on the sequence information of eight KS genes of the trans-AT PKS cloned 
from the uncultured filamentous bacterial fraction as described in section 3.1.2, we 
designed specific PCR primers to target the trans-AT biosynthetic pathway in the 
350,000 clone-member metagenomic library. In this work, screening of the highly 
complex 3-D library was significantly simplified by using whole-cell PCR analysis 
according to the method described by Hrvatin and Piel (2007) & Gurgui and Piel 
(2010) (Fig. 3.2.8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.8 Screening of a complex metagenomic library constructed from the Japanese T. 
swinhoei to isolate a PKS gene cluster. The library was initially grouped into pools that are 
arrayed in three boxes. One of the box (box 1) contains pools with the clone density of ~4000 
cfus/ml. Using the specific primers designed based on the isolated trans-AT KS domain genes, 
we detected two positive pools by whole cell PCR. One of the positive pools as indicated by a 
red arrow was diluted and screened further by PCR. When the clone density was ~20 cfus/ml, a 
small volume of it was plated at a density of ~200 cfus/ plate. By colony PCR, two positive 
colonies were detected. One of the colonies, designated as pTSW-AU1, was chosen for further 
analysis. Abbreviations: cfus, colony forming units. 
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Clone pools were screened by whole-cell PCR. A positive clone pool (for example 
pool A7) were re-grown at lower densities and screened further until individual 
positive clones were detected. The advantages of employing this screening method 
are that the whole procedure from transfection to the pure clone can be completed 
in four days by a single person, being highly economic in terms of labor, 
consumables and freezer space (Hrvatin and Piel, 2007). We screened the library 
consisting of 4000 cfus/ml, which led to isolation of one candidate 35-kb fosmid 
clone, designated as pTSW-AU1. The insert had regions with homology to KR and 
KS domains at its termini, suggesting that it is a part of a large PKS cluster. Then 
the clone was checked for the presence of the 7 isolated KS sequences of trans-AT 
PKS by PCR amplification. Five corresponding KSs (EKS27, EKS37, EKS50, 
EKS64, and EP5) were present on the cloned region. Based on this information, the 
clone was completely sequenced (Fig. 3.2.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.9 PCR detection of the cloned KS sequences in the positive recombinant fosmids 
isolated from the metagenomic library. [A] Checking for pTSW-AU1 fosmid. [B] Checking for 
pTSW-AU2 and pTSW-AU3 fosmid as well as pTSW-AU1. 
Screening for additional regions of the PKS gene cluster was conducted by 
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ends of pTSW-AU2 sequence. Then these primers were used to screen the library 
EKS31/EP2 EKS37 EKS50 EKS64 EKS27 
EKS27 EKS7 
EKS31 EKS37 
EKS50 EKS64 
1     2    3    +    - 1   2    3    -    + 
1   2    3    +    - 1     2    3    +    - 
1    2    3    +    - 1    2    3    +    - 
1 = pTSW-AU3 
2 = pTSW-AU1 
3 = pTSW-AU2 
- = negative control 
+ = positive control 
M = DNA marker 
 
EKS24/EP5 EKS7/EP3 
M   1   2   +   -   - 1   2   +   -   - 1   2   +    -    -    1      2       +    -    
- 
M  1  2   +   -   - 1   2   +   -   - 1   2  +   -    
[A] 
[B] 
EKS27 
EKS37 
EKS50 
EKS64 
EP2/EKS31 
EP3/KS7 
EP5/KS24 
KS48 
pTSW-AU1    pTSW-AU2    pTSW-AU3 
 x  x x 
 x  x x 
 x  x  x 
 x x x 
x x  x 
x x x 
 x  x nd 
 x Yes (positive) 
x No (negative) 
nd Not determined 
nd nd nd 
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by combining clone dilution and whole cell PCR techniques in a similar way as 
described in Fig. 3.2.3. Employing this screening approach enabled us to isolate two 
clones, designated as pTSW-AU2 and pTSW-AU3. BLAST analysis revealed that 
the end sequences of the pTSW-AU2 encoded a KS region and a 
phosphoenolpyruvate (PEP) synthase. The KS region is overlapped with the 
previously sequenced clone. To determine whether the PEP synthase gene was 
located within or outside of the cluster, we digested the pTSW-AU2 clone into five 
fragments with PstI enzyme and individually sub-cloned them (Fig. 3.2.10A-C). The 
end sequences of the subclones revealed a 7.5 kb fragment coded for a PEP 
synthase and an AT, a 3.7 kb fragment encoded ER and DH domains, and a >10-kb 
fragment for KS and KS-KR domains (Fig. 3.2.10D). The other cloned fragments 
were parts of the cloning vector. On the basis of this information, we decided to 
sequence pTSW-AU2 fosmid completely.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.10 Sub-cloning of the fosmid pTSW-AU2. [A] Restriction pattern of pTSW-AU2 
digested with different endonucleases, in which the recognition sites are present in the 
multi-cloning sites of the cloning vector pBlueScript II SK(-). The PstI-restriction pattern 
was chosen (red color). [B] PstI-fragments of pTSW-AU2 were separated by 
electrophoresis and individually extracted from the gel. [C] PstI-fragments of pTSW-AU2 
were individually cloned. Some potential clones representing each PstI-fragment were 
checked for the presence of inserts, as indicated by red arrows. Representative clones 
containing inserts (red letters) were subjected to end-sequencing. [D] Subcloning and end-
sequencing of pTSW-AU2 fosmid. 
We annotated the sequence of PKS gene cluster fragments in pTSW-AU1 and 
pTSW-AU2 by finding the open reading frames (orfs) and searching for the 
homologous sequences in GenBank. We found four orfs on the two overlapping 
[A] 
[C] 
1 
2 
3 4 
5 
V 
M M 
XbaI 
SacI 
EcoRI 
PstI 
KpnI 
XhoI 
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HindIII 
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SmaI 
BamHI 
SpeI M 
M 
[B] 
M 1a 1b 1c 1d 1e 1f  1g  2a 2b 2c 2d  2e 2f  3a 3b  3c 
3d  3e  M 
M   4a  4b  4c  4d  4e  4f  4g   5a 5b   5c  5d   5e  5f  
3g  M 
Subclone 1b (>10 kb)……….. KS domain…………………… KS-KR domains 
Subclone 2b (7.5 kb)………… PEP synthase……………….. AT domain 
Subclone 3c (4.0 kb)………… Vector backbone……………. Vector backbone 
Subclone 4f (3.7 kb)………… ER domain…………………… ER domain 
Subclone 5f (1.7 kb)………… Vector backbone……………. Vecktor backbone 
 
T3 primer end      T7 primer end      
[D] 
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fragments, which were predicted to code for phosphoenolpyruvate (PEP) synthase, 
phosphopantetheinyl transferase (PPTase), and two PKS type I proteins (Fig. 
3.2.11). The PPTase located upstream of the PKS type I protein is assumed to be 
responsible for activating ACPs in the downstream modular PKS through the 
transfer of a phosphopantetheinyl group (Ppant) from coenzyme A to a conserved 
serine residue of the ACPs. The active holo-ACPs facilitate the transfer of 
intermediates between domain active sites during biosynthesis (Walsh et al., 1997; 
Weissman et al. 2004). 
 
We analyzed the deduced amino acid sequences of the two PKS ORFs by 
identifying conserved residue motifs, allowing prediction of the composition and 
order of the domains in each module. Our sequence analysis, as described in Figure 
3.2.11, revealed that both ORFs harbor 8 modules, in which module 5 is split in two 
separate proteins. All the PKS modules, except for the first module, do not have 
integrated AT domains, typical for trans-AT PKSs (Piel, 2010). Some examples of 
compounds encoded by trans-AT PKS systems include pederin synthetase (Piel, 
2002), leinamycin (Cheng et al., 2002; 2003), mupirocin (El-Sayed et al., 2003), 
lankacidin (Mochizuki et al., 2003), onnamides (Piel et al., 2004b), disorazols 
(Carvalho et al., 2005; Kopp et al., 2005), rhizoxins (Partida-Martinez & Hertweck, 
2007), and psymberin (Fisch et al., 2009).  
 
Although in our case the first module contains an AT fused with a KR, it is assumed 
that the AT is nonfunctional due to the lack of the conserved active site motif 
GHSXG. The serine in this signature sequence GHSXG is involved in the formation 
of the acyl-enzyme intermediate (Cheng et al., 2003). We expected that a functional 
stand-alone AT accepting acyl building blocks was encoded in the cluster as a 
separate protein (Cheng et al., 2003). The module containing the inactive AT 
displayed 41% homology to MlnB of macrolactin synthase (Schneider et al., 2007) 
and 43% homology to the first module in DszA of disorazole synthase (Carvalho et 
al., 2005). In particular, KS1 bears high homology (74% identity) to the acetyl-
accepting KS in the DszA of disorazole biosynthetic pathway, suggesting that 
module 1 of the PKS identified in this work may play a similar loading mechanism as 
proposed for macrolactin and disorazole biosynthesis (Schneider et al., 2007; 
Carvalho et al., 2005). 
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Fig. 3.2.11 Preliminary analysis of two overlapping fosmid clones to predict the biosynthetic 
pathway encoded on the isolated gene cluster. The segment of misakinolide A covered by 
the clued PKS section is in the range of C15 to C29 and C15´ to C29`. Parts of the gene cluster 
that are still missing code for the formation of the segment C1-C14 and C1`-C14`. 
We assumed that a malonate would initially be loaded by a separate trans-AT onto 
the ACP1, which is subsequently decarboxylated to generate an acetyl group. The 
resulting acetyl group would move to the KS1 to create the starter unit that is 
reloaded by the trans-AT onto the same ACP1. This allows the KS1-catalyzed 
condensation of the acetate starter with the first malonate to generate the first four-
carbon intermediate (Carvalho et al., 2005). Subsequent β-reduction of the 
intermediate by KR1 may lead to the formation of β-hydroxymalonyl-S-ACP. 
Sequence analysis showed that KR1 displayed 66% identity to KR19 of rhizopodin 
synthase that performed β-ketoreduction to form a β-L-OH group (Pistorius & Müller, 
2012). The absence of a key D residue in the stereospecific motif of KR1 (AGQMS) 
indicates L configuration of the β-hydroxyl moiety of the substrate loaded onto ACP1 
(Reid et al., 2003; Caffrey, 2003). 
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Based on the architecture of module 2 (KS-KR-ACP), it is assumed that KS2 would 
initially mediate a two-carbon extension. Subsequent β-ketoreduction by KR2 would 
result in a β-hydroxylated intermediate. KR2 has the stereospecific motif of D 
configuration (AGVISD), indicating the D configuration of the β-hydroxyl group. 
BLAST analysis showed the high homology (65% identity) of the ORF1 KS3 to the 
KS2 of macrolactin synthase that accepts a hydroxylated intermediate (Schneider et 
al., 2007). This suggests that the KS3 would accept the hydroxylated substrate from 
ACP2. However, the lack of a catalytic HGTGT motif in this KS makes it theoretically 
incapable of elongating the polyketide assembly line (Davies et al., 2000). The OMT 
domain next to the KSo is predicted to perform α-O-methylation of the β-hydroxy 
group, allowing the formation of an oxy-methyl group. This is consistent with the 
presence of an OMe group at the C27 of misakinolide A structure. Module 4 (KS-
DH*-KR-ACP) contains a B-type KR that has the stereospecific motif for D 
configuration (AGLTRD), indicating a β-D-hydroxyl group in the incorporated 
intermediate. The cognate DH domain in this module, designated as DH*, is 
predicted to be nonfunctional due to the lack of the essential G residue in the 
catalytic motif HXXXGXXXXP (Keatinge-Clay, 2008), and therefore it would not be 
able to perform β-hydroxylation, leaving the hydroxyl group. However, BLAST 
analysis of KS5 showing its high homology (73% identical) to the KS9 of batumin 
synthase that was proposed to accept incoming α,β-E-double bond (Mattheus et al., 
2010), suggesting that hydroxyl function might undergo further β-processing to form 
α,β-double bond by a trans-acting `hidden` DH. 
 
Module 5 is split in two separate ORFs. KS5 domain lies on the ORF1, while the 
other cognate domains (DH-KR-MT-ACP-ER) are located on the ORF2, 
representing unusual domain organization typical of trans-AT PKSs (Piel, 2010). 
The β-keto functionality generated by the KS5-catalyzed condensation would be 
reduced by DH5 and KR5 domains to form the α,β-double bond. The presence of an 
ER5 domain on downstream of the ACP5 subsequently reduces the double bond 
into a single bond. MT5 would subsequently introduce a methyl group at the α-
position. The architecture of module 5 showed that it installs the methylated 
intermediate bearing α,β-reduced moiety. This is supported by the high homology of 
KS6 (73% identity) to the KS6 of Rhizopodin biosynthetic pathway that accepts an 
α-L-methylated substrate with α,β-reduced moiety (Pistorius & Müller, 2012). This is 
consistent with the C22 methyl and the C22-C23 saturated bond in misakinolide A 
structure. Based on module 6 (KS-DH*-KR-MT-ACP) architecture, it is predicted that 
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it installs an intermediate carrying α-methyl and β-hydroxyl moieties. Highest 
homologous of KS7 (64%) was the KS4 in pederin biosynthesis that was proposed 
to accept the α-methylated intermediate with β-L-OH functionality (Piel, 2002). The 
α-methyl introduced by MT6 is consistent with the presence of the C20 methyl in the 
misakinolide A structure. The β-OH moiety would not be reduced into a double bond 
because the cognate DH is nonfunctional (Keatinge-Clay, 2008). The lack of the 
important conserved motif DXXX(Q/H) in this DH domain suggests its inability to 
perform dehydration (Keatinge-Clay, 2008), leaving a hydroxyl group at C21 with L 
configuration (VMVAQS) based on KR6 analysis. Module 7 is composed of KS-KR-
MT domains that were assumed to install the α-methylated and β-hydroxylated 
intermediate. MT7 is predicted to be responsible for introducing a methyl group at 
C18. KR-based analysis indicated a key D residue present in the KR7 stereopecific 
motif (ALILED), suggesting the D configuration of the C19/C19` β-OH moiety. At the 
end of the PKS assembly line, the C19/C19` hydroxyl groups would attack the C1`/C1 
thioester bonds to form the C19-C1´ and C19`-C1 ester bonds. Formation of these ester 
bonds is expected to be catalyzed by a TE to link two resulting monomers and 
release a dimer from the assembly line. The presence of MT and O-MT in modules 
6 and 7, respectively, suggest that this trans-AT PKS pathway is most likely loaded 
with malonyl-CoA both as the starter and extender units, instead of methylmalonyl-
CoA or other 2-branched malonyl-CoA derivatives. 
 
Taken all these features together, the predicted module architecture and sequence 
analyses showed that the partial gene cluster isolated in this work seemed highly 
likely to encode the formation of almost half of misakinolide A or swinholide A, a 
promising antitumor secondary metabolite. These complex dimeric polyketides are a 
potent actin inhibitor previously isolated from T. swinhoei sponges (Sakai et al., 
1986; Kato et al., 1987; Kitagawa et al., 1990). However, finding the remaining parts 
of the gene cluster and subsequent detailed phylogenetic analysis of the entire 
cluster sequence was required to confirm that we had identified the correct 
biosynthetic pathway. 
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3.2.3 Completion of the biosynthetic gene cluster   
As described above, our sequence analysis suggested that the isolated partial gene 
cluster might be responsible for the biosynthesis of misakinolide A. This preliminary 
result motivated us to isolate the remaining fragments of the gene cluster. Searching 
for the down-stream parts was performed by chromosome walking, in which the end 
sequences of the previously isolated fosmids were used as the basis for further 
screening of the library. Three additional clones, designated 1I9 (pTSW-AU4), 1B9 
(pTSW-AU5), 3A1 (pTSW-AU6), were successfully isolated. In the isolation of these 
three clones, a master student (Ms. Silke Reiter) was involved under my supervision 
during a 1.5-month practical course in the Piel group. End-sequencing of the clones 
indicated that pTSW-AU5 seemed promising because it showed a small overlap with 
the previously isolated misakinolide gene cluster portion. This clone was completely 
sequenced. Bioinformatic analysis showed that it harbored an extended downstream 
part of the misakinolide gene cluster as expected.  It was predicted that one more 
additional downstream clone would be required to reach the downstream end of the 
gene cluster. 
 
Our further screening efforts led to the isolation of five additional clones. Two of 
them were found to harbor overlapping downstream fragment (pTSW-AU10 or 1E9) 
along with an additional upstream clone (pTSW-AU11), thereby covering the entire 
cluster. These two positive clones were entirely sequenced. We analyzed the 
contigs obtained after the sequencing by removing the vector backbone and 
assembling the sequences by using the Seqman of the Lasergene program. We 
filled gaps between discrete contigs by PCR through the following steps: (i) 
designing PCR-primers flanking the gaps, (ii) PCR-amplification using the primers, 
(iii) purification and sequencing of the obtained amplicons, and (iv) sequence 
assembly of the amplified sequences with the existing gene cluster sequences, 
thereby resulting in a single complete contig. Sequence annotation of the gene 
cluster was performed by identifying potential ORFs, followed by homology 
sequence searches in the public databases. ORF identification was carried out 
using the software FramePlot 2.3.2 (Ishikawa and Hotta, 1999) and Geneious 5.4.6 
(Drummond et al., 2011). The genetic map of the annotated genes is shown in Fig. 
3.2.12.  
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Fig. 3.2.12 Genetic map of the ~103-kb DNA region containing a large trans-AT PKS gene 
cluster. The type I PKS gene cluster is flanked by genes coding for transposase (orf1), 
NhaP-type Na
+
/H
+
 and K
+
/H
+
 antiporter (orf2), nonspecific acid phosphatase precursor 
(orf3), SAM-dependent methyltransferase (orf4),  and naringenin-chalcone synthase (CHS) 
or PKS type III (orf5). Abbreviations: RBS, ribosome binding site; P1, P2, and P3 are 
primers for filling gaps. 
The presence of some transposase genes prior to the NhaP-type antiporter (NAH) 
and PEP synthase genes indicated the upstream end of the misakinolide A gene 
cluster. The downstream end of the cluster was marked with the presence of a gene 
coding for a thioesterase (TE) domain. This ~103-kb DNA region harboring 
biosynthetic genes (misA-misG) exhibited typical bacterial gene features, such as 
the absence of introns, the presence of ribosome binding sites, and small intergenic 
distances between putative genes, strongly indicating that the producer of 
misakinolide A is a symbiotic bacterium. However, the taxonomic status of the 
bacterial producer is still unknown yet and awaits further analysis either by single 
cell studies or its combination with complete genome sequencing. The screening 
system used to isolate the gene cluster was based on the sequence information 
present in KS fragments cloned from the filamentous fraction dominated by 
“Entotheonella sp.” This preliminary information may provide a clue that the 
filamentous fraction dominated by “Entotheonella sp.” could be used as the starting 
material to conduct single cell studies. 
 
P2 
 
 
orf3 orf5 
misA 
misF misE misD misC orf1 
orf4 
RBS 
misB misG 
orf2 
P1 (AU10-1-r) 
P2 (AU10-38-f) 
 
 
 
HAD 
misF 
HIT 
misG 
P1 
 
 
P3 
 
 
Gaps 
CHS MT 
P1 (AU10-1-r) 
P3 (AU10-38-r) 
 
 
 
 Obtaining & sequencing amplicons 
from the gap regions 
 In silico assembly to fill the gaps 
0.5 kb 
1.1 kb 
pTSW-AU11 
pTSW-AU2 
pTSW-AU1 
pTSW-AU5 
pTSW-AU10 
5 Kb 
Transporter 
 
PKS type III genes 
 
Transposase gene 
 
PKS type I gene cluster 
 
PPTase gene 
 
Transcriptional Regulation 
 
Chapter 3 Results and Discussion 
__________________________________________________________________________________ 
81 
 
3.2.4 Bioinformatic analysis of the entire biosynthetic gene cluster  
We performed bioinformatic analysis of the entire assembled sequences derived 
from complete sequencing of five overlapping fosmids (see supplementary S3.2.2). 
The resulting continuous sequence covering ~103-kb DNA region was predicted to 
contain a trans-AT PKS gene cluster. The detailed annotation of the individual orfs, 
as summarized in Table 3.2.1, revealed 17 ORFs encoded on the gene cluster. Five 
of them (misC, misD, misE, misF, and misG) encode the trans-AT type I PKS 
system consisting of five multifunctional enzymes (MisC, MisD, MisE, MisF, and 
MisG). Two ORFs, designated as MisA and MisB, are homologous to many PEP 
synthases and putative phosphopantetheinyl transferase (PPTase), respectively.  
 
We initially predicted the module architecture present in the individual PKS proteins 
by BLAST analysis (Altschul et al., 1990) and confirmed the prediction by finding the 
highly conserved motifs in each domain (Supplementary 1). Subsequently we 
checked individual domains for the presence or absence of catalytic important 
conserved motifs or essential conserved residues. Sequence analysis showed that 
all the ACPs present in each module contain the highly conserved GXDS motif, in 
which the serine (S) residue is essential for binding the 4`-phosphopantetheine site. 
This suggests that all the ACPs are able to undergo posttranslational modification 
from the inactive apo form to the active holo form by the transfer of a 4`-
phosphopantetheine group to a conserved serine of the individual ACPs (Lambalot 
et al., 1996; Findlow et al., 2003).  
 
Sequence analysis of all DH domains in the PKS system showed that two DH 
domains (DH4 and DH6) are theoretically unable to perform dehydration because of 
the lack of the essential G residue in the catalytic motif HXXXGXXXXP (Keatinge-
Clay, 2008). Sequence analysis of all the 19 KS domains present in this pathway 
revealed that 15 of them contain the highly conserved TXCSSLV motif (including the 
active-site cysteine) and HGTGT (including the active site histidine) motif that are 
essential for chain elongation. Other four KS domains (KS3, KS11, KS14, and 
KS19) are assumed to be incapable of elongating the polyketide assembly line due 
to the lack of a catalytic HGTGT motif that is important for decarboxylative 
condensation (Davies et al., 2000).  
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Table 3.2.1 Deduced functions of the ORFs identified in this work 
Protein 
Size, 
aa 
Proposed function 
Closest protein homolog, 
(origin) 
S/I, 
%/% 
Acc. number 
TP1 178 Transposase 
NGR_c03400 (Rhizobium sp. 
NGR234) 
80/62 
YP_00282489
0 
TP2 227 Transposase 
all8065 (Nostoc sp. PCC 
7120) 
70/53 NP_478490 
TP3 322 Transposase 
PCC8801_4459 (Cyanothece 
sp. PCC 8801) 
65/43 
YP_00236471
0 
ORF1 803 Esterase/lipase-like protein 
Dole_1932 (Desulfococcus 
oleovorans) 
49/31 
YP_00152981
3 
ORF2 226 
NhaP-type Na
+
/H
+
 and K
+
/H
+ 
antiporters 
HCH_05288 (Hahella 
chejuensis KCTC 2396) 
64/43 
YP_436387 
 
TP4 227 Transposase 
all8065 (Nostoc sp. PCC 
7120) 
70/54 NP_478490 
ORF3 300 
sodium/hydrogen exchanger 
family protein 
PM8797T_03204 
(Planctomyces maris DSM 
8797) 
69/49 
ZP_01852948 
 
MisA 894 
phosphoenolpyruvate 
synthase 
PPSIR1_31263 (Plesiocystis 
pacifica SIR-1) 
64/49 
ZP_01910935 
 
MisB 250 
Phosphopantetheinyl-
transferase 
ORF16 (uncultured bacterial 
symbiont of Discodermia 
dissoluta) 
61/43 
 
AAY00051 
 
MisC 5870 
PKS: KS-AT-KR-ACP-KS-
KR-ACP-KS
o
-OMT-ACP-KS-
DH-KR-ACP-KS 
PKS (Kordia algicida OT-1) 54/38 KAOT1_04255 
MisD 9027 
PKS: DH-KR-MT-ACP-ER-
KS-DH-KR-MT-ACP-KS-KR-
MT-ACP-KS-KR-ACP-KS-
KR-MT-ACP-KS 
RhiC (Burkholderia 
rhizoxinica) 
51/35 
YP_00374815
7 
 
MisE 4474 
PKS: KR-ACP-KS
o
-OMT-
ACP-KS-KR-ACP-KS-KR-
ACP-KS
o
 
Bat2 (Pseudomonas 
fluorescens) 
60/44 ADD82940 
MisF 8075 
PKS: DH-ACP-KS-DH-PS-
KR-ACP-KS-KR-ACP-KS-
DH-KR-MT-ACP-KS-DH-
KR-ACP-KS
o
-ACP-TE 
PKS module containing 
protein (Paenibacillus 
polymyxa E681) 
66/49 
YP_00387137
1 
 
MisG 354 Trans-AT 
KAOT1_04365 (Kordia 
algicida OT-1) 
73/55 ZP_02163874 
ORF5 323 
putative nonspecific acid 
phosphatase precursor 
WH5701_02224 
(Synechococcus sp. WH 
5701) 
51/34 
ZP_01084293 
 
ORF6 145 phage shock protein A 
DVU2988 (Desulfovibrio 
vulgaris str. Hildenborough) 
50/33 
ADP87902 
 
ORF7 236 
SAM-dependent 
methyltransferase 
Complement 
(NZ_AAXU02000001.1) 
(Algoriphagus sp. PR1) 
55/37 
YP_00405432
6 
 
Note: TP, transposase; MCAT, malonyl CoA-acyl carrier protein transacylase; Bat2, batumin-related polyketide 
antibiotics; misA –F, misakinolide PKS genes; aa, amino acid; S/I, similarity/identity; Acc., accession. 
At the downstream end of the PKS type I gene cluster, it was found the presence of 
a discrete AT gene (misG) that is seemingly linking the biosynthetic gene cluster of 
modular PKS type I to that of the PKS type III family called chalcone synthase 
(CHS). MisG showed homology with many malonyl CoA-acyl carrier protein 
transacylase (MCAT) genes. It has 55% identity to the trans-acting 
malonytransferase PedD of pederin synthase (Piel, 2002; Jensen et al., 2012). MisG 
contains the conserved active-site GHSXG motif as well as the conserved malonyl-
CoA binding motif AFHS (Reeves et al., 2001), suggesting that this discrete AT 
enzyme is functionally active and presumably specific for malonyl-CoA 
incorporation. This enzyme showed 54% identity to MlnA involved in macrolactin 
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biosynthesis in Bacillus amyloliquefaciens FZB42 (Schneider et al., 2007) and 51% 
identity to BryP involved in bryostatin biosynthesis (Sudek et al., 2007). The MlnA is 
known as a discrete acyl transferase that acts iteratively in trans to load malonyl-
CoA onto the PKS modules of macrolactin synthase (Schneider et al., 2007). The 
BryP harbors tandem AT domains upstream of the bryostatin synthase ORFs 
(Sudek et al., 2007), which was shown to load malonyl-CoA in trans onto Bry PKS 
modules based on in vivo and in vitro functional studies by Lopanik et al (2008). 
Taken together all the information described above, we assume that the putative AT 
enzyme identified in this work performs in trans acylation to provide malonyl-CoA 
both as extender units in the biosynthesis of misakinolide A as well as in chalcone 
biosynthesis. 
 
By identifying the domain conserved motifs from the entire DNA sequence data, we 
predicted the module architecture (Figure 3.2.8). Non-elongation KSs (KSo) were 
identified in modules 3, 11, 14, and 19, suggesting the inability of these modules to 
perform chain elongation. The presence of 15 elongation modules correlates with 
the incorporation of 15 malonyl-CoA extender units. The predicted module 
architecture resembles a trans-AT PKS that exhibits unusual features such as AT-
less modules, three modules split between two distinct proteins (modules 5, 10, and 
14), presumed nonfunctional domains (KS3, KS11, KS14, and KS19), an ER located 
behind ACP (module 5) and a duplicated DH domain in module 17. As the 
consequences of these unusual features, the standard textbook collinearity rules 
cannot usually be applied to determine the final product structure accurately. 
However, the Piel group has recently developed a phylogeny-based approach that 
enabled determination of a polyketide structure from the trans-AT gene cluster 
sequence or KS sequences with high confidence (Nguyen et al., 2008).  Using this 
approach, Prof. Piel generated a phylogenetic tree from 521 KS sequences 
including all of 19 mis KS domains in order to obtain insights into the intermediates 
installed on individual modules (supplementary S3.2.3). In some cases, the 
stereochemistry of α-branches can be predicted by this phylogeny-based KS 
analysis. The phylogenetic analysis, as shown in Table 3.2.2 below, revealed that 
the KSs with similar function were grouped into the same clades, suggesting that the 
substrate specificity of all mis KSs can be predicted according to the clades where 
they were attributed.  
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Table 3.2.2 Analysis of KS domains present in the mis PKS 
Domain 
BLAST Search 
Substrate specificity 
predicted phylogenetic 
analysis
a
 
Intermediate moiety 
predicted based  on 
domain architecture 
Close relative 
S/I 
(%/%) 
Predicted 
substrate 
specificity 
KS1 
disorazole KS1 
(AAY32964) 
59/74 Acetyl-CoA  Acetyl unit 
Acetyl-CoA  (acetate 
starter) 
KS2 
macrolactin KS6  
(CCG49394) 
58/76 β-L-OH β-L-OH 
β-OH (macrocylization 
via an ester bond) 
KS3 
macrolactin KS2 
(YP_001421028) 
47/65 β-D-OH β-D-OH (KS
o
) β-OH 
KS4 
corallopyronin A 
KS7 (ADI59534) 
62/75 
β-Me + α,β-
double bond  
α-D-OMe β-OMe (C29) 
KS5 
batumin KS9 
(ADD82941) 
60/73 
α,β-E-double 
bond 
β-L-OH or D-pyran 
β-OH (C27) converted to 
pyran ring via ester bond 
KS6 
rhizopodin KS6 
(CCA89326) 
58/73 
α-L-Me + α,β- 
reduced moeity 
α-L-Me + reduced α,β 
moeity 
α-Me (C24) + reduced 
α,β (C24-C25) 
KS7 
pederin KS4 
(AAS47564) 
46/64 α-diMe + β-L-OH α-L-Me + β-L-OH 
α-methyl (C22) + β-OH 
(C23) 
KS8 
corallopyronin A 
KS6 
(ADI59534) 
45/70 
β-Me + α,β-E-
double bond  
α-D-Me + β-D-OH   
α-Me (C20) + β-OH  (C21) 
formed an ester bond  
KS9 
rhizoxin KS13 
(CAL69893) 
31/50 β-L-OH β-L-OH   β-OH  
KS10 
psymberin KS6 
(ADA82585) 
59/72 α-diMe+ β-D-OH α-L-Me + β-L-OH α-Me + β-OH 
KS11 
bryostatin KS12 
(ABK51303) 
53/71 β-OH β-D-OH (KS
0
) 
β-OH converted into β-
OMe (C15) 
KS12 
sorangicin KS 19 
(ADN68482) 
59/78 β-L-OH β-D-OMe β-OMe (C15) 
KS13 
onnamide A KS 6 
(AAV97877) 
71/83 β-L-OH  β-D-OH 
β-OH converted into 
Pyran ring 
KS14 
(KS
o
) 
bacillaene KS3 
(YP_0014212992) 
64/79 KS
o
 (β-OH)  β-L-OH   
KS
o
 (β-OH) converted 
into α,β -Z-double bond 
KS15 
bacillaene KS4 
(EHM05018) 
69/83 
α,β-Z-double 
bond  
α,β-Z-double bond α,β-double bond  
KS16 
bryostatin KS9 
(ABK51301) 
67/79 
α,β-E-double 
bond  
Pyran ring α,β-double bond 
KS17 
bryostatin KS9 
(ABM63537) 
70/84 β-D-OH  β-D-OH β-OH  
KS18 
sorangicin KS12 
(ADN68478) 
67/84 
α-dimethyl + 
double bond 
α-Me + α,β-E-double 
bond 
α-Me + α,β-double bond 
KS19 
rhizoxin KS16 
(AEG71853) 
60/78 
α,β-E-double 
bond  
α,β-E-double bond 
(KS
o
) 
α,β-E-double bond  
a 
Phylogenetic analysis was conducted by Prof Piel using all the KSs present in the pathway and 521 KS sequences 
from GenBank (supplementary S3.2.3). 
 
All of the modules, except modules 3, 11, 14, and 19, contain the reductive domain 
KR. The KR domain is usually responsible for modification of the oxidation state and 
stereochemistry of the growing ACP-bound intermediates (Valenzano et al., 2009). 
Therefore, the presence or absence of KR domain in each PKS module may lead to 
different oxidation states (Staunton & Weissman, 2001; Kwan et al., 2008). In this 
work, we predicted the stereochemistry of β-hydroxyl generated by KRs present on 
individual mis modules by performing sequence alignment and identifying the 
stereo-specific motifs according to Caffrey (Caffrey, 2003; Reid et al., 2003; Caffrey, 
2005). The presence of a key aspartic acid (D) in the motifs indicates D-configured 
β-OH groups. In contrast, L configuration is attributed to the absence of a key 
aspartic acid (D) residue in the streospecific motif (Caffrey, 2003; Reid et al., 2003; 
Caffrey, 2005; Baerga-Ortiz, 2006).  
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Based on the KS phylogeny (supplementary S3.2.3) and KR analysis (Table 3.2.3), 
we deduced the functionality and stereochemistry of substrates installed on 
individual modules (Fig. 3.2.13). In principle, the predicted substrate specificities of 
mis KSs are grouped according to the following functionalities: acetyl unit, β-L-OH 
group, β-D-OH group, β-L-OMe group, α-L-Me and β-L-OH group, α-L-Me and 
reduced α,β moiety, α-Me + α,β-E-double bond, pyran ring, α,β-E-double bond, and 
α,β-Z-double bond.  
 
Table 3.2.3 Analysis of KR domains present in the mis PKS 
Domain 
Sequence alignment analysis Moiety present in the misakinolide A 
structure Stereo-specificity motif
a
 predicted product 
KR1  AGQMSAVSFAEKSLADF β-L-OH  β-ether bond (C29-C25) in a pyran from β-OH 
KR2 AGVISDALVFNKTHHQT β-D-OH  β-D-OMe (C29) from β-D-OH 
KR4 (+DH*) AGLTRDASLVNKTVRID β-D-OH  β-D-OH (C25) 
KR5 (+DH, 
ER) 
AGLTRDASLVNKTVRD 
β-D-OH converted 
to reduced moiety) 
Reduced (C22-C23) 
KR6 (+DH*) VMVAQSTPMRSLSEA β-L-OH β-L-OH (C23) 
KR7 ALILEDRAIADMDEKTL β-D-OH  β-L-OH (C21) forms L-ester bond with C1` 
KR8 AGIAPSESLLNKDIDAF β-L-OH β-L-OH (C19) 
KR9 ALVFKLDNSIAKTSEED β-L-OH  β-L-OH (C17) 
KR10 AGVIHDNFIIKKTPQELE β-D-OH  β-D-OMe (C15) from β-D-OH 
KR12 AGIVRDNFVINKTSAEFQ β-D-OH  β-D-OMe (C13) 
KR13 SGAVDSETPAFVRKPIAK β-L-OH  β-D-OH to Z-double bond (C8-C9) 
KS15 (+DH, 
PS) 
AGLTRDAYIHNKTREEMI 
β-D-OH converted 
to a pyran ring 
Pyran ring (C7-C11) 
KR16 AGLIRDSFMIRKTVDQLH β-D-OH β-D-OH (C5) 
KR17 (+DH) AIVLADKSLANMDERQFL 
β-D-OH converted 
to a double bond 
α,β-E-double bond (C2-C3) 
KR18 (+DH) AGVIQDNFIIRKAVREFQ 
β-D-OH converted 
to a double bond 
α,β-E-double bond (C2-C3) 
a
) Diagnostic site is bold and underlined 
The PKS module architecture suggested that nine mis modules (modules 1, 2, 4, 8, 
9, 10, 12, 13, and 16) install the β-hydroxyl functions. This is in good agreement with 
the substrate specificities predicted for the downstream mis KSs based on the 
phylogenetic analysis. In particular the phylogeny-based KS analysis indicated the L 
configuration of the β-OH functionality accepted by KS2, KS5, and KS9, which is 
consistent with the hydroxyl configuration predicted based on KR analysis, except 
for KS5. The hydroxyl groups installed on modules 8, 9, 12, and 16 correlate to 
those at the C17/C17`, C15/C15`, C11/C11`, and C5/C5` of the misakinolide A structure. In 
the phylogenetic tree, mis KS5 was placed in the clade specific for β-L-OH or D-
pyran function, suggesting the β-hydroxyl function might undergo further processing 
towards the formation of a pyran ring.  
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Fig. 3.2.13 Bioinformatic analysis of the isolated entire PKS gene cluster. [A] The module 
architecture and the substrate specificity and configuration predicted based on phylogeny-
based KS analysis and KR analysis. [B] The correlation between the predicted substrates 
accepted by KS domains and the structure of misakinolide A and swinholide A. 
A possible explanation for the pyran ring formation is that a trans-acting functional 
DH might access the intermediate tethered on module 6, allowing to generate an 
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et al., 2010), suggesting the double bond might occur during the assembly line. 
Subsequent in trans-action of a PS domain allows Michael addition of the hydroxyl 
group to an unsaturated thioester, leading to the formation of a pyran ring, as shown 
at the C25-C29 of misakinolide A structure. This pyran formation mechanism was 
previously proposed by Piel (2002). 
 
Based on the phylogenetic analysis, two mis KSs (KS4 and KS12) were predicted to 
accept β-D-OMe functions. The predicted specificity of these two KSs is in 
consistency with the architecture of the upstream modules 3 and 11 (KSo-OMT-
ACP) as well as the OMe groups at the C27/C27` and C13/C13` of the misakinolide A 
structure. Module 5 was predicted to install a substrate bearing α-methyl and α,β-
reduced moieties. KS and KR analyses indicated the D configuration for the α-
methyl group. Three mis modules (modules 6, 7, and 9) contain domains required to 
form the β-hydroxylated intermediate bearing an α-methyl group. KR analysis 
indicated the L-configuration of the β-OH functionality installed on module 6, 
whereas the D-configuration of that installed on modules 7 and 9. Phylogenetic 
analysis of the KSs upstream of the modules provided a clear suggestion that 
module 6 installs α-D-methyl and β-L-hydroxyl function whereas modules 7 and 9 
incorporate α-D-methyl and β-D-hydroxyl function. Three mis modules (modules 14, 
17 and 18) were assumed to install α,β-double bond functionalities based on the 
module architecture. The double bond functionality bound on the ACP14 is derived 
from the DH14-catalyzed conversion of β-L-OH group into the cis olefinic moiety. 
The β-L-OH group is generated through the β-ketoreduction activity performed by 
KR13 that has the stereospecific motif for L configuration. The double bond 
functionalities in modules 17 and 18 are predicted to be trans, because the cognate 
KRs contain the D configuration motifs. The presence of a MT corresponds with the 
α-methyl branch at the substrate installed on module 17. This is supported by the 
phylogenetic analysis that classified KS15, KS17 and KS19 into the clades of cis 
double bond, α-methylated and trans olefinic moiety, and the trans double bond, 
respectively. This is in good agreement with the C2/C2` α-methyl and the C2-C3/C2´-
C3´ olefinic moieties present in the misakinolide A structure. KS16 was predicted to 
accept a pyran ring functionality. This is in good agreement with the architecture of 
module 15 that contains all domains required for the formation of a pyran ring. Since 
KR15 has a key D residue of D configuration (AGLTRD), it is expected to produce a 
β-D-OH group that would subsequently be converted by DH15 to form α,β-E-double 
bond functionality. The presence of PS domain in module 15 would catalyze Michael 
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addition of the C12/C12` hydroxyl group to the cis double bond, forming ether bonds. 
This is in consistent with the pyran rings generated via the C7-C11/C7`-C11` ether 
bonds. The domain architecture, phylogeny-based KS analysis and KR analysis 
described above revealed that the number and deduced functions of the five PKS 
type I genes perfectly correlate with the structure of misakinolide A or a related 
compound. This provides convincing evidence that we have successfully cloned the 
correct biosynthetic pathway. A PKS type III located on the downstream of the type I 
PKS is most likely not involved in misakinolide A biosynthesis. 
3.2.5 Proposed model of the discovered biosynthetic pathway 
Based on our sequence analysis of the entire trans-AT PKS gene cluster as 
described above, we proposed a model of misakinolide A biosynthetic pathway (Fig. 
3.2.14). The pathway is catalyzed by giant multienzymes consisting of 5 separate 
proteins, designated as MisC, MisD, MisE, MisF, and MisG. Based on the 
phylogenetic analysis, mis KS1 belongs to the acetyl-accepting KS clade, 
suggesting its function as a loading domain that specifically accepts acetate as the 
starter unit. Mis KS1 showed 74% identity to the acetyl-accepting KS in the DszA of 
disorazole biosynthetic pathway, which was proposed to generate an acetate starter 
through the “backloading” process (Carvalho et al., 2005). The “backloading” 
process proposed for mis module 1 begins with loading a malonate unit by a 
separate trans-AT (MisG), followed by subsequent KS1-catalyzed decarboxylative 
condensation of the loaded malonate to generate an acetate starter (24a) onto the 
KS1 of MisC. Subsequent KS1-catalyzed condensation of the activated acetate 
starter with the first ACP1-loaded malonate would produce the β-keto functionality. 
Subsequently the β-keto functionality would be reduced by KR1, thereby resulting in 
a β-L-hydroxymalonyl-S-ACP1 (24b) (Carvalho et al., 2005; Schneider et al., 2007). 
This is supported by the phylogeny-based KS analysis showing that mis KS2 
belongs to the KS clade of β-L-OH function. The architecture of module 2 (KS-KR-
ACP) reveals that it would elongate the resulting β-L-hydroxylated intermediate 
(24b) and then reduce the β-keto functionality of the elongation product. This begins 
with the transfer of the 24b intermediate tethered onto ACP1 to the KS in module 2 
(KS2). Following loading a malonyl extender unit by the trans-AT (MisG) onto ACP2, 
KS2 would elongate 24b by catalyzing its decarboxylative condensation with the 
ACP2-bound malonyl unit to form an intermediate bearing a β-keto functionality. 
Because mis KR2 has the stereospecific motif for D configuration 
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(AGVISDALVFNKTHHQT), it would reduce the β-keto functionality to generate a β-
D-hydroxylated intermediate (24c).This is consistent with the phylogeny-based 
analysis of mis KS3 showing its predicted substrate specificity towards a β-D-OH 
functionality.  
 
Mis module 3 contains a non-elongating KS, and therefore it would not elongate the 
intermediate 24c accepted from the upstream module, leaving D-OH group at the β-
position. However, the presence of OMT3 would methylate the β-hydroxyl group of 
24c, resulting in an intermediate with the β-D-oxymethyl moiety (24d). This is 
supported by phylogenetic analysis of mis KS4 showing its predicted specificity 
towards the α-D-OMe functionality. A homologoue of KS4 is present in the KS7 of 
CorL in corallopyronin biosynthesis, which was proposed to accept a β-methylated 
intermediate bearing an α,β-double bond (Erol et al., 2010). This is in good 
agreement with the presence of the β-D-OMe moieties found at the C27/C27` of 
misakinolide A structure. It is assumed that this non-elongating KS would mediate 
the transfer of 24d from the ACP3 to the downstream KS4. Subsequent KS4-
catalyzed condensation of 24d with the ACP4-loaded malonyl unit, followed by β-
ketoreduction of the elongation product by KR4 (D configuration motif) would lead to 
the formation of a β-D-hydroxylated intermediate (24e). DH4 is predicted to be 
nonfunctional, and therefore it would not perform β-dehydration, leaving 24e with the 
β-D-hydroxyl group (at C25/C25`). However, the KS-based phylogenetic anaylsis 
revealed that the downstream mis KS5 belongs to the clade for β-L-OH or D-pyran, 
suggesting that the hydroxylated intermediate might undergo further β-reductions 
towards the formation of a pyran ring upon its attachment on the ACP4 or during its 
transfer to the downstream module. A possible explanation for the pyran formation is 
that a functional trans-acting DH might access the β-L-hydroxylated intermediate 
tethered on module 4 (24e), allowing conversion of the β-L-OH function into an α,β-
E-double bond. Subsequent in trans action by a DH-like domain, termed pyran 
synthase (PS), either during or post the assembly line would allow Michael addition 
of the hydroxyl group to an unsaturated thioester, leading to the formation of a pyran 
ring, as shown at the C25-C29 of misakinolide A structure. Pyran formation 
mechanism was previously proposed by Piel (2002).  
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Figure 3.2.14 The proposed biosynthetic pathway for misakinolide A (24) isolated from the 
metagenome of the Japanese sponge T. swinhoei. It consists of multifunctional enzymes 
(MisC-MisG). It contains 15 elongation modules that correspond with the incorporation of 15 
malonyl extender units. MisF contains module 18 that presumably facilitates the formation of 
swinholide A (25) and hurghadolide A (26). 
Module 10
KR
KSO
OMT KR
KS
KR
KS KSO
OMe
S
O
OMe
HO O
S
OH
S
O
OMe
HO
S
OH
O
Module 11
Module 12
Module 13
KS
DH PS
KRDH KRKS KS
DH KR
MT
KS
DH
KR TEKSO
HO
S
O
HO
S
O
O
S
OH
O
O
OH
S
O
O
OH
S
O
13
13
13
13
13
9
9
9
9
5
5
1
Module 14
Module 15
Module 16
Module 17
Module 18
Module 19
O OMe
OH
OH
OH
OH
29
25
21
17
23
15 15
13
11 11
27
19
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
OMe
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
OMe
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
OMe
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
OMe
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
OMe
O OMe
OH
OH
OH
OH
29
25
21
17
23
27
19
15
13
15 15
15
15
15
15
11
11
11
11
7
7
7
3
AT
24k 24l
24m
24n 24o
24p
24q
24r
24s
Misakinolide A, n1 = n2 = 0 (24) 
Swinholide A, n1 = n2 = 0 (25) 
Hurghadolide A, n1 = 1, n2 = 0 (26) 
 
 
 24 
 
 
MisC 
 
 
MisD 
 
 
MisE 
 
 
MisF 
 
 
MisG 
 
 
 25 
 
 
 26 
 
 O
OH
OMe OH OH
O
OH
O
OMe
O
OH
OMeOHOH
O
OH
O
OMe
O
O
n1
n2
5
7
9
11
131517
19
2123
25
27
29
29`
27`
25`
23`21`
19`
17`15`13`
11`
9`
7`
5`
 x 2  
 
 
 x 2  
 
 
x 1 each 
 
 
AT
KR
KR
KS KSKSO
OMT
DH*
KR KS
S
OHO
S
O
HO
OMe
HO
HO
OMe
S
O
S
O
HO
OH
29
29
29
DH
KR
MT ER KS
DH* KR
MT KS
MT
KR
KR
KS KS MT
KR
KS
O OMe
S
O
O OMe
OH
S
O
O OMe
OH
OH
S
O
O OMe
OH
OH
OH
S
O
O OMe
OH
OH
OH
S
O
OH
29
29
29
29
29
25
25
25
25
25
21
21
21 19 17
Module 1
Module 2
Module 3
Module 4
Module 5 Module 6
Module 7
Module 8
Module 9
Module 10
23
23
23
23
27
27
S
O
KS
27
27
27
27
19
2924a
24b
24c
24d
24e
24f
24g
24h
24i
24j
Chapter 3 Results and Discussion 
__________________________________________________________________________________ 
91 
 
Mis Module 5 (KS-DH-KR-MT-ACP-ER) is split in two separate proteins (MisC and 
MisD), in which KS5 is present on MisC whereas the remaining module 5 domains 
are on MisD. KS5 would accept and elongate the β-hydroxylated intermediate (24e) 
through decarboxylative condensation of it with the ACP5-loaded malonyl extender 
unit. The elongation product would be passed to the reductive activities for β-
processing. At first, KR5 harboring a stereospecific motif for D configuration 
(AGLTRD) would reduce it to produce a β-D-hydroxyl functionality. Then DH5 would 
convert the β-D-hydroxyl moiety into a trans double bond that is further reduced by 
ER5 to generate an α,β-single bond. Interestingly, the ER domain is positioned after 
ACP5, which is quite unusual on this trans-PKS system. MT5 would add a methyl 
group at the α position, resulting in an ACP5-tethered intermediate bearing a (2S)-
methyl branch and an α,β-single bond (24f). Phylogenetic analysis predicted that the 
downstream KS6 accepts the reduced substrate bearing α-L-Me moiety, suggesting 
the incorporated methyl group has L configuration. This is consistent with the 
presence of the C23-C24 saturated bond as well as the C22 L-methyl of misakinolide A 
structure. 
 
The intermediate 24f would be transferred to the downstream module 6 (KS-DH*-
KR-MT-ACP). KS6 would initially condense it with one decarboxylated malonyl unit 
loaded onto ACP6. KR6 (VMVAQS) and MT6 would catalyze β-ketoreduction and α-
methylation, respectively, resulting in an intermediate bearing α-methyl and β-L-OH 
groups (24g). The β-L-OH function installed on ACP6 would not be reduced further 
due to the non-functionality of DH6. These intermediate functionalities were 
supported by phylogentic analysis of KS7 showing that it belongs to the KS clade 
accepting α-methyl and β-L-OH functions. This is in perfect agreement with the 
presence of methyl moieties at the C19/C19´ as well as L-OH groups at the C20/C20` in 
the misakinoldie A structure. As in module 6, module 7 would generate an 
intermediate bearing L-OH and methyl groups (24h) through the activities of KR7 
and MT7. The intermediate incorporated into module 8 would bear L-OH at the β 
position (24i) due to the presence of KR8 with L stereospecific motif. The KS in 
module 9 would elongate the intermediate 24i and its cognate KR and MT domains 
would subsequently introduce a β-D-hydroxyl group as well as an α-methyl group, 
thereby generating the intermediate 24j. These predicted substrate specificities 
were supported by the phylogenetic anaylsis. 
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Module 10 contains KS and KR that would extend the intermediate 24j with the 
ACP-loaded decarboxylated malonyl unit and subsequently reduce the β-keto 
moiety into β-D-OH group, thereby resulting in the intermediate 24k. Module 11 
contains a nonfunctional KS, and therefore it would not be able to elongate 24k. The 
presence of its cognate OMT would methylate the β-OH, thereby producing the 
intermediate 24l that bears an OMe group. This is consistent with the presence of 
OMe groups at the C13/C13` in the misakinolide A structure, respectively. The 
presence of two consecutive modules (modules 12 and 13) with the same domain 
composition (KS-KR-ACP) would elongate the intermediate 24l with two malonyl 
units to form the intermediate bearing β-D-OH (C11) and β-L-OH (C9) (24n). Module 
14 (KSo-DH-ACP) is split in two separate proteins (MisE and MisF). This KSo (KS14 
in MisE) forms a biomodule with the upstream module (module 13), which would 
lead to the formation of a double bond, a similar process reported by Chen et al. 
(2006) in the Difficidin pathway. In the process of generating a double bond, KS14 
would initially accept the β-L-hydroxylated intermediate (24n), but would not 
elongate it due to the absence of the catalytic HGTGT motif. When the intermediate 
24n is tethered at ACP14, the cognate DH in MisF would reduce the β-L-hydroxyl 
moiety into the α,β-Z-double bond to form an intermediate containing α,β-Z-olefinic 
moiety (24o). The KS13 is 83% identical with the KS6 of onnamide A synthase (Piel 
et al., 2004b), and therefore it was also proposed that KS13 would accept a β-
hydroxylated intermediate from module 12. During the assembly line, the β-OH 
moiety would form an ether bond catalyzed by a PS domain, resulting in the 
formation of a pyran ring. This is in consistent with the presence of a pyran ring at 
the C7-C11 and C7`-C11` of the misakinolide A structure. The KS14 shares 79% 
identity to the KS3 of Bacillene synthetase (Chen et al., 2006), and therefore it is 
assumed to be specific for a β-hydroxylated intermediate. Both mis KS14 and bae 
KS3 are non-elongating KSs. Because module 14 contains an additional DH 
domain, the β-OH moiety would be converted into a double bond that is observed at 
the C8-C9 and the C8`-C9` of the midakinolide A structure. 
 
Interestingly, module 15 contains a repeated-like DH domain, in which the second 
copy, annotated as a pyran synthase (PS) domain, is proposed to be responsible for 
generating the tetrahydropyran ring (Fig. 3.2.15). KS15 would initially accept the 
intermediate 24o that contains an α,β-Z-double bond (C8-C9) and subsequently 
catalyze decarboxylative condensation between 24o and the downstream malonyl-
S-ACP substrate to generate a β-keto-S-ACP intermediate (24o-1). Further β-
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ketoreduction by KR15 (AGLTRD) would generate a β-D-hydroxylated intermediate 
(24o-2). The cognate DH would dehydrate the C9 β-D-OH group of 24o-2 into an 
α,β-E-olefinic moiety (C6-C7), resulting in 24o-3. Subsequent Michael addition of the 
hydroxyl group (C11) to the unsaturated thioester would lead to closure of the pyran 
ring (C7-C11) (24p) (Fig. 3.2.15). A similar mechanism is previously proposed for the 
biosynthetic pathways of pederin (Piel, 2002) and bryostatin (Sudek et al., 2007).  
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Figure 3.2.15 Formation of the intermediate bearing a pyran ring in module 15. The upstream 
cis-2,3-enoyl-S-ACP intermediate (24o) would be transferred to KS15. KS5 would catalyze the 
decarboxylative condensation between 24o and downstream malonyl-S-ACP to generate a β-
keto-S-ACP (24o-1). This elongation product would undergo β-ketoreduction catalyzed by DH15 
to form an intermediate bearing β-D-OH moiety (24o-3). Subsequent PS-catalyzed Michael 
addition of the C11 hydroxyl group to the C7 olefinic moiety (24o-3) would lead to the formation 
of an intermediate bearing the C7-C11 pyran ring (24p). 
The KS in module 16 would accept the intermediate 24p from the upstream module 
15 and catalyze the subsequent decarboxylative condensation between 24p and the 
ACP15-bound malonyl extender unit incorporated by a trans-acting AT domain 
(MisG). Subsequent β-ketoreduction by KR16 would generate an intermediate 
bearing β-hydroxyl in the D configuration (24q) (Fig. 3.2.14). Module 17 contain 
three optional tailoring domains (KR, DH, MT), and therefore the elongation product 
tethered on the ACP17 would be modified by the additional domains. First, KR17 
would reduce the β-ketone moiety to from a β-D-hydroxyl moiety. Subsequent β-
dehydration at the C5 and α-methylation at the C4 would generate a methylated 
intermediate with α,β-Z-olefinic moiety (24r). This intermediate 24r is an ACP-bound 
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monomeric subunit of misakinolide A made from one round of biosynthesis. 
Interestingly, this pathway contains an additional module (module 18) downstream 
module 17. This module (KS-KR-DH-ACP) is predicted to elongate 24r with the 
decarboxylated malonate-S-ACP and modify the β-functionality into a trans double 
bond, resulting in an ACP-bound monomer of swinholide A (24s) (Fig. 3.2.16).  
 
Figure 3.2.16 Proposed role of KS18 in the formation of swinholide A, misakinolide A, and 
hurghadolide A. [A] If KS18 is functional, the misakinolide A monomer bound onto ACP17 
(24r) would be transferred to KS18 and subsequently undergo elongation with the 
decarboxylated malonyl-S-ACP18. Subsequent β-processing by KR18 and DH18 would lead 
to the formation of the ACP18-bound swinholide A monomer (24s). [B] However if KS18 is 
nonfunctional as proposed in this work, it would not accept the misakinolide A monomer 
bound on ACP17. Instead KS18 might play in facilitating the chain transfer from ACP17 to 
ACP18 through a mechanism proposed by Thomas et al (2002). The KS18 active site is 
assumed to recognize and dock the prosthetic groups of both ACPs simultaneously, leading to 
the transfer of 24r to ACP18. [C] This ACP-to ACP transfer could be enhanced if the priming 
rate of ACP18 is slowed, thereby increasing the chance for 24r to be primed onto ACP18. At 
the point where ACP-to-ACP transfer is controlled so that ACP18 could be primed by malonyl 
unit in one side and by 24r in another side might lead to the formation of ACP19-bound 
swinholide A monomer as well as ACP18-bound misakinolide A monomer. TE-catalyzed 
dimerization and macrocyclization of these two monomers could form hurghadolide A. 
Since this pathway contains an additional module that would match to further 
elongated structures such as swinholide A or hurghadolide A rather than 
misakinolide A, an interesting issue is about how misakinolide A would be produced 
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on this pathway template. A possible explanation is that the KS in this additional 
module (KS18) has lost its function and therefore no elongation takes place 
although there is no sequence based evidence for nonfunctionality. We assume that 
the reduced or lost function of this KS might lead to the transfer of a complete 
monomeric subunit of misakinolide A (24r) from ACP17 to ACP18 through a 
mechanism resembling a module skipping as described by Leadlay group for a 
hybrid polyketide synthase (Thomas et al., 2002) (Fig. 3.2.16). Therefore KS18 
might play a key role in controlling the type of structures produced by this pathway, 
whether swinholide A (25), misakinolide A (24), or hurghadolide A (26).  
 
Module 19 (KSo-ACP) is presumably unable to perform chain elongation due to the 
presence of a non-elongating KSo domain, raising a question regarding the role of 
this non-elongating module in this trans-AT PKS system. The importance of non-
elongating modules was investigated by altering the active serine residue of the KSo 
in a mupirocin module to an alanine as reported by Thomas and coworkers (El-
Sayed et al., 2003), in which they found this residue alteration abolished mupirocin 
production (El-Sayed et al., 2003). Subsequently, the ACPs downstream of the KSo 
in the misakinolide A synthase are assumed to be catalytic functional due the 
presence of the catalytic conserved GxDS motif, in which the active site serine (S) is 
essential for the attachment of the 4`-phosphopantetheine (Lambalot et al., 1996; 
Findlow et al., 2003). Other studies by Müller and colleagues revealed that ACPs in 
non-elongating modules from rhizopodin biosynthesis can be primed with malonyl-
CoA (Pistorius & Muller, 2012). This suggests the important role of non-elongating 
modules (KSo-ACP) in the biosynthetic assembly line. Based on this information, the 
three non-elongating modules in the misakinolide A biosynthesis (mis modules 11, 
14, and 19) may play role in facilitating the transfer of the growing polyketide chain 
to the next module, as previously proposed by Julien and coworkers for disorazole 
biosynthesis (Carvalho et al., 2005). The possible mechanism of chain transfer by 
such three non-elongating modules are that the KSo initially accepts the polyketide 
chain from upstream ACPs and subsequently transfers it to the next module, as 
proposed by Müller and colleagues for the biosynthesis of myxochromide (Wenzel et 
al., 2006) and rhizopodin (Pistorius & Muller, 2012).  
 
At the downstream end of the misakinolide assembly line, a TE domain on the C-
terminus of MisF is predicted to act as a chain termination catalyst. The general 
process of TE-catalyzed cyclic polyketide release usually involves transferring the 
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acyl chain loaded on the terminal ACP to an active site serine hydroxyl of the TE, 
thereby generating a TE-bound O-acyl moiety. The acyl chain of this intermediate is 
then usually cyclized to form a cyclic polyketide macrolide (Kohli & Walsh, 2003). 
However, for a dimeric polyketide such as misakinolide A, the TE presumably plays 
a role not only in cyclization but also in dimerization, provoking an interesting 
question about how macrocyclization occurs to release this dimeric polyketide from 
the assembly line. As described in Fig. 3.2.17, the possible mechanism of 
misakinolide A release might resemble the TE-catalyzed dimerisation demonstrated 
in vitro for thiocoraline (Robbel et al., 2009) and gramicidin S through peptide-bond 
formation (Hoyer et al., 2007) as well as the TE-mediated cyclotimerisation for 
enterobactin through ester-bond formation (Shaw-Reid et al., 1999). 
 
Some interesting features typical of trans-AT PKSs were observed in the domain 
architectures in the misakinolide A biosynthetic pathway, such as AT-less modules, 
three modules split between two distinct proteins, presumed nonfunctional domains, 
the presence of a duplicated DH domain in module 15. Split modules are located 
between MisC and MisD (module 5), MisD and MisE (module 10), and MisE and 
MisF (module 14). In module 14, KSo is located on MisE and DH-ACP is on MisF, 
forming a bimodule that presumably plays a role in creating a double bond, a similar 
process reported by Chen et al. (2006) in the Difficidin pathway. Another intriguing 
feature of this pathway is the presence of multiple MTs and O-MTs within the PKS. 
Five MT domains, located in MisD and MisF, are proposed to introduce methyl 
groups at the α-positions of the extending polyketide through S-adenosylmethionine 
(SAM)-dependent α-methylation. Interestingly, the pathway contains a penultimate 
module (module 18) that is predicted to facilitate the formation of swinholide A as 
well as hurghadolide A.  It is assumed that the KS domain in this module has lost its 
function and therefore no elongation takes places. All three compounds are potent 
actin polymerization inhibitors (Camely et al., 1985; Kitagawa et al., 1990; Youssef & 
Mooberry, 2006).  
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Fig. 3.2.17 Proposed TE-catalyzed release in misakinolide A biosynthesis presumably 
involves dimerization, in which one polyketide monomer of misakinolide A might bind to 
the terminal ACP while another monomer is bound to the TE. The two monomers might 
be ligated by TE, resulting in an acyl-S-ACP that is transferred to the TE and cyclized to 
form the dimeric polyketide. 
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Misakinolide A is closely related to many compounds that have been reported from 
remarkably diverse sources, including luminaolide from algae (Kitamura et al., 2009) 
and lobophorolide from seaweed (Kubanek et al., 2003). Our data suggest that all of 
these compounds are made by symbiotic bacteria. Based on a compound 
localization study, swinholide A was previously found in high concentration in the 
unicellular bacterial preparation of T. swinhoei (Bewley et al., 1996; Bewley et al., 
1998). Gerwick and coworkers found swinholide A in free-living cyanobacteria 
collected from two different locations (Andrianasolo et al., 2005). However, our 
genetic work on misakinolide A suggests that this seemingly contradictory result 
might have been caused by export and absorption or sequestering of the polyketide. 
Some other possible explanations are that (i) misakinolide A is made by a bacterial 
contaminant present in our Entotheonella fraction, (ii) swinholide A and misakinolide 
A are made by different bacteria, and (iii) swinholide A moves from the producer to 
another bacteria (absorption scenario).  
3.3   Metagenomics Insight into the Biosynthesis of a Nonribosomal Peptide  
As described in the previous section (section 3.1.2), we have successfully cloned 
two gene regions coding for different serine-specific adenylation domains, which 
might or might not be involved in the biosynthesis of theonellamide F. Another 
possibility is their association with other cyclic peptides containing L-serine, 
orbiculamide and keramamide that were also reported from T. swinhoei. This 
suggests the possible involvement of these genes in the biosynthesis of the two 
later compounds. To clarify this issue, we needed to isolate the NRPS pathway 
harboring such serine-specific A domains. This was carried out by screening of the 
fosmid library generated from T. swinhoei metagenome followed by analysis of the 
cloned NRPS gene cluster. 
3.3.1 Isolation of a non-ribosomal biosynthetic pathway 
Using the sequence information of one of the genes, we designed two specific 
primers and employed them to screen the complex metagenomic library (~350,000 
clones) constructed from T. swinhoei chemotype W. This screening effort finally led 
to the isolation of two potential 40 kb fosmid clones (2G4 and ADU2a) (Fig 3.3.1). 
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Fig. 3.3.1 Screening of a complex library constructed from T. swinhoei to isolate a NRPS gene 
cluster. The library was disributed into pools arrayed in three boxes. To simplify the screening, pools 
from the same columns were combined into superpools. Using the primers designed based on the 
serine-specific adenylation domains, two positive superpools were detected as indicated by red 
arrows. [A] Subsequently, the pools from the corresponding superpool were screened. The positive 
pool (red arrow) was diluted and screened further. When the clone density was ~40 cfus/ml, colonies 
were plated and then screened by colony PCR, leading to the isolation of a single positive clone. [B] 
Another superpool was screened in a different way. Instead of checking individual pools, this positive 
superpool (~9000 cfus/ml) was diluted to ~1000 cfus/ml. Several dilutions were done and whole cell 
PCR screening of each dilution step was conducted. When the clone density was ~60 cfus/ml, clones 
were plated and screened, which led to the identification of two positive colonies. One of the colonies 
(ADU2a) was chosen for further analysis. 
We analyzed the two fosmid clones by end-sequencing and subsequent subcloning 
in order to obtain more sequence information. The end-sequences of 2G4 showed 
high similarity with condensation domains and hypothetical proteins, respectively. 
The end sequences of ADU2a (supplementary S3.3.1) were highly similar to many 
PP-binding domains of PCPs and condensation domains, respectively, suggesting 
that the entire clone might be a part of a giant NRPS gene cluster. Subcloning was 
conducted by digestion of both clones with SalI, followed by gel extraction and 
cloning of the individual SalI-fragments (Fig. 3.3.2).  
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Fig. 3.3.2 Subcloning of two potential fosmid clones. [A] Each clone was digested with a 
variety of restriction enzymes with recognition sites are present in the multicloning site of the 
vector pBlueScript II SK(-). [B] SalI restriction gave well-separated fragments in the agarose 
gel, and therefore it was used to generate SalI-fragments in larger scale. Individual SalI-
fragments were separated on the gel and purified. [C] The purified individual SalI-fragments 
were cloned into the SalI-linearized pBlueScript II SK(-). Some clones were selected and 
checked for the presence of the correct-sized inserts. Clones harboring individual SalI-
fragments (shown with red arrows) were sequenced at both ends. 
The clones with correct-sized inserts were subjected to end-sequencing. The protein 
sequences of the 2G4 subclones containing a 7.5 kb fragment exhibited homology 
to a kinase-associated protein phosphatase (KAPP)-loop domain protein and 
methytransferase. The end sequences of the subcloned 5.0 kb fragment encoded 
proteins that were similar to a hypothetical protein and a MaoC domain protein 
dehydratase, whereas the other fragment (~3.4 kb) coded for a protein that showed 
similarity to 1-(5-phosphoribosyl)-5-amino-4-imidazole-carboxylate (AIR) 
carboxylases (Table 3.3.1).   
 
Table 3.3.1 Subcloning of the fosmid 2G4  
Subclone 2G4 BlastX analysis of end-sequences 
Fragment (code) Size kb Primer T3 Primer T7 
1 (2G4-1a) ~7.5 KAP P-loop domain protein & Methytransferase - 
2-3 (2G4-2) ~5.0 
hypothetical protein  
MaoC domain protein dehydratase 
MOSC domain-
containing protein 
4 (2G4-4a) ~3.4 
1-(5-phosphoribosyl)-5-amino-4-imidazole-
carboxylate (AIR) carboxylase  
- 
 
The clone pADU2a consisted of 11 SalI-fragments, of which 10 were subcloned and 
end-sequenced. End-sequence results (Table 3.3.2) revealed that some fragments 
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shared homology to sequences coding for typical NRPS components, such as C 
domains, PCPs, and TEs (supplementary S3.3.2). Interestingly, one of the end 
sequences of a ~15 kb subclone showed high similarity to McbC-like 
oxidoreductases. These enzymes are responsible for oxidizing a cysteine-derived 
thiazoline or serine-derived oxazoline into a thiazole or oxazole moiety, respectively 
(Schneider et al., 2003, Schmidt et al., 2005, Engelhardt et al., 2010). Another 
interesting feature is the end sequence of the ~2.8-kb fragment that is similar to 
many tryptophan halogenases. Because orbiculamides and keramamide H from the 
Japanese sponge T. swinhoei are known to contain halogenated tryptophan and 
oxazole/thiazole residues (see structures in Section 3.1.2, Fig. 3.1.10), the 
sequence data are in agreement with the structures and motivated us to perform a 
more detailed analysis. 
 
Table 3.3.2 Sub-clones of the fosmid ADU2a  
Sub-clone ADU2a BlastX analysis of end-sequence 
Fragment (code) Size kb Primer T3 Primer T7 
1 (ADU2a-1a) ~15.0 Condensation domain 
mcbC-like oxidoreductase, Acyl-protein 
synthetase, PP-binding 
2-3 (ADU2a-2.1a) ~8.5 Vector backbone - 
3-4 (ADU2a-2.2a) ~5.0 
69% GMC oxidoreductase  
54% NAD-dependent 
epimerase/dehydratase  
NADH:flavin oxidoreductase/NADH 
oxidase 
5 (ADU2a-3b) ~2.8 Tryptophan-5-halogenase Tryptophan-5-halogenase 
6 (ADU2a-4c) ~1.8 Galactose oxidase Galactose oxidase 
7 (ADU2a-5a) ~1.5 
Peptidyl carrier protein, 
Thioesterase 
Peptidyl carrier protein, Thioesterase 
8-9 (ADU2a-6a) ~1.0 Condensation and reductase Condensation and reductase 
10 (ADU-2a-7c) ~0.8 Mostly vector part - 
 
Based on the sub-cloning results, the clone pADU2a looked very promising and 
therefore we decided to sequence the isolated fosmid entirely. For the purpose of 
complete sequencing, the fosmid DNA was initially treated with ATP-dependent 
DNase provided by Epicentre (http://www.epibio.com/) in order to remove the linear 
host chromosomal DNA. This enzyme has no activity on nicked or closed-circular 
dsDNA, thereby leaving circular fosmids intact. The vector backbone was then 
removed by treating it with the rare-cutting enzyme NotI. The resulting NRPS insert 
was completely sequenced through a de novo sequencing approach in collaboration 
with Dr. Vladimir Benes at EMBL-Heidelberg.  Assembling of the sequencing reads 
resulted in 7 contigs: 7.5 kb, 14 kb, 5.6 kb, 1.7 kb, 1.1 kb, 2.9 kb, and 1 kb, 
respectively. Subsequently, we ordered the contigs and filled in the gaps between 
them by PCR (Fig. 3.3.3). We initially obtained amplicons that close the gaps 
between contigs 1 & 2, contigs 2 & 3, and contig 6 & 7. Filling these three gaps 
involved Mr. B. Pandey, a master student who was doing a 6-month practical work 
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under my supervision in the Piel Group. Subsequently, we were able to obtain 
amplicons from the gaps between contigs 3 and 4 as well as between contigs 5 & 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3.3 Preparing the fosmid pADU2a for complete sequencing and filling the 
sequence gaps to generate a continuous sequence. [A] The circular fosmid extracted 
from a recombinant E. coli clone was treated with ATP-dependent DNase to remove the 
host chromosomal DNA. Then the vector backbone was removed by digestion with the 
rare-cutting enzyme NotI. On the gel 2% (left side): lane 1 is ADU2a sample (10 ng), and 
lane 2 is 36-kb linear fosmid control (10 ng). On the gel 1% (right side) ): lane 1 is 
ADU2a sample (5 ng), and lane 2 is 36-kb linear fosmid control (10 ng). [B] Complete 
sequencing of pADU2a and subsequent sequence assembly resulted in 7 contigs. To 
generate a continuous sequence, we filled in the gaps between the contigs by PCR and 
sequencing. To fill in the gaps, we initially designed specific primers that bind to the ends 
of individual contigs. Using these primers with ADU2a DNA as the PCR template, 5 gaps 
between the contigs were closed, leaving one gap (gap 4 between contigs 4 and 5). 
Using primer walking, this remaining gap was finally filled in. [C] A scheme showing the 
strategy we used to close the gap between contigs. M is DNA marker. Primer pairs used 
for gap filling are 1f/2r, 2f/3f, 3r/4r, 4f/5r, 5f/6r, and 6f/7f. Acys is DNA sequence coding for 
cystein-specific adenylation domain.  
However, due to the large gap between contigs 4 and 5, we did not obtain any PCR 
product. Therefore, we applied primer walking to obtain more sequence data that 
cover the whole gap between contigs 4 and 5. For primer walking, sequence data 
obtained using a single primer was used as the basis for designing a new primer to 
sequence downstream regions. We reassembled all of the sequences derived from 
both contigs and gaps to generate a 40.9 kb continuous sequence. 
3.3.2 Analysis of the non-ribosomal synthase region 
The entire nucleotide sequence was translated into amino acid sequence. Open 
reading frames (ORFs) or potential genes were identified and annotated to predict 
the functions (supplementary 3.3.3). The annotation results of the sequenced clone 
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revealed that the 40.9 kb insert of the isolated clone pADU2a harbors 20 complete 
orfs. The genetic map, as shown in Fig. 3.3.4, shows that five orfs encode proteins 
homologous to NRPSs, one orf for a PKS, and five orfs for tryptophan-5-
halogenase, cytochrome C, galactose oxidase, a transcriptional regulator, 
tryptophan 2,3-dioxygenase, an oxidoreductase, and a monooxygenase. The 
detailed annotation results were presented in Table 3.3.3 below. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.3.4 Genetic map of the completely sequenced fosmid pADU2a, showing a mixed 
PKS/NRPS gene cluster and its module architecture. 
Interestingly, there are two TE domains encoded on the clone, which are present in 
different proteins. One TE domain is located in the C-A-T-TE module encoded by 
ORF1, in which the A domain is predicted to be specific for homopropargylglycine 
(HPG) (Table 3.3.4). The other TE domain is present in the NRPS module encoded 
by ORF14, in which the A domain is proposed to have specificity for phenylalanine 
(Table 3.3.4). Due to the presence of some proteins that are not involved in the 
NRPS biosynthesis between these two TE-containing modules such as galactose 
oxidase, it is most likely that both TE-domains are individually involved in two 
separate NRPS pathways. Between the two TE-containing modules there are a 
series of genes presumably encoding enzymes involved in the bromination and 
degradation of tryptophan encoded by ORF9, 10, and 12.  
 
A portion of an NRPS/PKS biosynthetic pathway was identified for the proteins 
encoded by orfs14, 15, 16, 17, 19, and 20 (Fig. 3.3.4). Four NRPS modules 
indentified in this pathway contain adenylation domains that play a role in substrate 
activation. Using NRPSpredictor2 (Rausch et al., 2005; Röttig et al., 2011), we 
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predicted the substrate specificity code of all adenylation domains present in the 
individual NRPS modules (Table 3.3.4). 
 
Table 3.3.3 Deduced function of genes in the completely sequenced fosmid pADU2a. 
Gene aa 
Protein homolog (BLAST) I/S 
(%) 
Proposed function 
Homolog Organism Acc. No. 
orf1 1272 ApnD 
Planktothrix agardhii 
NIVA-CYA 
ABV79988 47/65 
NRPS, C-A-TE 
domains 
orf2 205 SCO1/SenC 
Mesorhizobium 
ciceri biovar 
biserrulae 
WSM1271 
YP_004142340 32/52 
Electron transport 
protein SCO1/SenC 
orf3 806 
Galactose 
oxidase 
Methylobacterium 
extorquens DSM 
13060 
EHP91138 36/48 Galactose oxidase 
orf4 469 
NADH:flavin 
oxidoreductase 
Lyngbya majuscula ZP_08430361 47/65 
NADH:flavin 
oxidoreductase 
orf5 228 
Electron 
transport 
complex protein 
RsxA 
Vibrio 
nigripulchritudo 
ATCC 27043 
ZP_08735482 29/45 
Electron transport 
complex protein  
orf6 202 
Hypothetical 
protein 
α-proteobacterium 
BAL199 
ZP_02187391 43/58 Hypothetical protein 
orf7 153 
cytochrome c 
class I 
Chloroflexus 
aurantiacus J-10-fl 
YP_001634601 52/64 cytochrome c class I 
orf8 215 
Hypothetical 
protein 
Crassostrea gigas EKC28949 27/40 Hypothetical protein 
orf9 545 
FAD dependent 
oxidoreductase 
Burkholderia 
graminis C4D1M 
ZP_02882432 28/43 
FAD dependent 
oxidoreductase 
orf10 911 
MibH of 
microbisporicin 
Microbispora 
corallina 
ADK32563 46/65 
tryptophan-5-
halogenase 
orf11 325 
tryptophanyl-
tRNA synthetase 
Plesiocystis pacifica  
SIR-1 
ZP_01909982 28/43 
tryptophanyl-tRNA 
synthetase 
orf12 226 
tryptophan 2,3-
dioxygenase 
Ruegeria sp. 
TM1040 
YP_614220 26/40 
tryptophan 2,3-
dioxygenase 
orf13 530 
IcIR family 
transcriptional 
regulator 
Rhodococcus 
erythropolis PR4 
YP_002764363 29/48 
Transcriptional 
regulator 
orf14 1371 
OciC of 
Cyanopeptolin 
Planktothrix 
rubescens NIVA-
CYA 98 
CAQ48258 39/57 
NRPS, C-A-T-TE 
domains 
orf15 1560 JamP Lyngbya majuscula AAS98787 50/65 
PKS, KS-AT-KR-ACP 
domains 
orf16 406 CtaG 
Paenibacillus 
mucilaginosus 
KNP414 
YP_004643249 47/65 
Flavin utilizing 
monoxygenases 
(MOX) 
orf17 418 
linear gramicidin 
synthetase 
subunit D 
Stigmatella 
aurantiaca DW4/3-1 
ZP_01467592 45/63 NRPS, C domain 
orf18 365 Transposase Roseiflexus sp.  YP_001274820 47/63 Transposase 
orf19 992 KtzH Kutzneria sp. 744 ABV56588 44/61 NRPS, A-MT-A-T 
orf20 1356 HctF Lyngbya majuscula AAY42398 53/69 NRPS, C-A-OX-T 
Notes: aa, amino acid; Acc. No., Accession number; I/S, identity similarity. 
The A domain in ORF15 was predicted to activate phenylalanine (60% match). 
BLAST analysis revealed that the C domain in ORF14 was most homologous (44% 
identical, 61% similar) to that in CrpC of criptophycin biosynthetic pathway 
(Magarvey et al., 2006). The CrpC catalyzed the incorporation of O-methyl-tyrosine 
as well as L-phenylanalanine (Magarvey et al., 2006), suggesting the flexibility of 
ORF14 to accept not only L-phenylalanine but also tyrosine and tyrosine analogs. In 
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addition to that, there might be flexibility of ORF14 towards L-tryptophan, as has 
been observed in in vitro adenylation reactions with domains from the NRPS of 
tyrocidine (Schaffer & Otten, 2009).  
 
Table 3.3.4 Key amino acid residues for substrate specificity of the adenylation domains of the 
proposed biosynthetic pathway.  
Adenylation 
domain 
Specificity-conferring code of A domain Predicted 
Substrate
c
 
& % match 
Relative residue 
position 
235 236 239 278 299 301 322 330 331 517 
A4 (ORF1) 
Consensus sequence
a
 D I F L L G L L C K HPG 
(80%) Specificity sequence
b
 D A L H L G L V V K 
A1 (ORF14) 
Consensus sequence
a
 D A W T I A A V C K 
Phe (60%) 
Specificity sequence
b
 D A L H I G N V A K 
A2 (ORF19) 
Consensus sequence
a
 D V W H L S L I D K 
Ser (90%) 
Specificity sequence
b
 D V W H I S L I D K 
A3 (ORF20) 
Consensus sequence
a
 D L Y N L S L I W K 
Cys (80%) 
Specificity sequence
b
 D L Y D M S L I W K 
 Variability (%)
d
 3 16 16 39 52 13 26 23 26 0  
 
a 
Signature sequences derived from A domains activating the same substrate, as predicted by Stachelhaus et al (1999) 
b 
The positions of the ten specificity-conferring decisive residues identified in this work, which was 
  predicted using NRPSpredictor2 (Rötting et al., 2011; Rausch et al., 2005) 
c 
The predicted substrates, HPG: 4-hydroxy-phenyl-glycine, Phe: phenylalanine, Ser: serine, Cys:cysteine 
d 
Residue variability are shown in percentage and variable constituents within  
   specific-conferring codes are indicated by red color (Stachelhaus et al., 1999) 
 
ORF15 is a PKS module that is homologous to JamP in the jamaicamide A pathway 
(Edwars et al., 2004). This protein consists of a set of KS, AT, KR, and ACP 
domains. The presence of the integrated AT indicates a cis-AT type PKS, which is 
predicted to be specific for loading malonyl-CoA derived from acetate, the same 
substrate loaded by the AT in JamP (Edwards et al., 2004). The malonyl unit would 
then be transferred to the ACP of the ORF19 (Fig. 3.3.5). The β-keto group of the 
acyl-S-ACP would then be reduced by the KR to generate a β-hydroxy-acyl-S-ACP. 
The stereospecificity of the KR can be predicted by the presence or absence of an 
LDD motif on the upstream of the conserved motif GVxHxA (Caffrey, 2003, Caffrey, 
2005). Due to the absence of this LDD motif, it is assumed that the KR probably 
generates an L-3-hydroxyacyl moiety.  
 
Downstream of the PKS ORF15, we identified a protein (ORF16) that shared 
homology to a flavin-utilizing monooxygenase (MOX) in CtaG of cystothiazole A 
(Feng et al., 2005) and in the MelG of melithiazol (Weinig et al., 2003) biosynthesis 
pathways. MOX in CtaG is embedded in the A-domain between the A4 and A5 motifs 
and is responsible for removing the carbon backbone of the ACP-bound amino 
residue, thereby releasing a terminal amide structure (Feng et al., 2005). It is not 
clear whether ORF16 may serve a similar function as the MOX of CtaG or not, in 
which the carbon backbone of the ACP-bound serine is removed to release a 
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terminal amide hydroxy-malonyl structure. Instead, an interesting question araising 
whether this MOX may be involved in introducing the keto group at the α-position 
located between the valine and the methylated serine residues. BLAST analysis 
indicated that ORF16 showed homology (67%) to the MicA of microviridin 
biosynthetic pathway from Planktothrix rubescens NIVA-CYA 98 (Rounge et al., 
2009) as well as to MOX within NRPS NpnB in Nostophycin biosynthesis (Fewer et 
al., 2011). The NpnB MOX is proposed to oxidize the Ahoa polyketidyl chain 
following its transfer to the PCP, generating α-hydroxyl moiety (Fewer et al., 2011).  
 
There are some possible scenarios for the formation of the α-keto group. ORF16 
MOX might perform α-oxidation of the incorporated malonyl unit to form the α-
hydroxyl function. Subsequent oxidation of the α-hydroxyl group by another MOX 
would lead to the formation of the corresponding α-keto group. A similar way of the 
α-keto group formation was previously reported for rapamycin (Molnár et al., 1996; 
Aparicio et al., 1996) and FK506 (Motamedi et al., 1996, 1997, 1998) biosyntheses. 
Another possibility is the incorporated precursor in the PKS ORF15 is (2R)-
hydroxymalonyl-CoA instead of malonyl-CoA. This is supported by BLAST analysis 
of the ORF15 KR showing its homology (53% identity) with KR5 present in the 
ZmaA of Zwittermicin A biosynthetic pathway that generates β-hydroxyl moiety at 
the incorporated (2R)-hydroxymalonyl-CoA (Kevany et al., 2009). The α-hydroxyl 
moiety in the hydroxymalonyl-S-ACP would then be oxidized by the MOX (ORF16) 
to generate α-keto moiety upon the intermediate transfer to the downstream module. 
Enzymatic α-oxidation is exemplified by glycolate oxidase (EC 1.1.3.15) that 
catalyzes the conversion of various 2-hydroxy acids into the corresponding 2-keto 
acids (Adam et al., 1997; Kroutil et al., 2004). However, the possible involvement of 
this MOX domain in α-oxidation awaits functional studies. 
 
Downstream of this PKS module, we identified a NRPS module in two separate 
proteins (ORF17 and ORF19) that is split by a transposase (ORF18). ORF17 is 
homologous to a C domain, and ORF 19 contains A, O-MT, and PCP domains. The 
A domain present in ORF19 is predicted to activate a serine (Table 3.3.4). The O-
MT is embedded in the serine-activating A-domain of ORF19. This domain shares 
high similarity with the O-MT integrated in the module KtzN of the kutzneride 
biosynthetic pathway, which was proposed to methylate the hydroxyl group of the 
PCP-bound serine (Fujimori et al., 2005). In the assembly line, serine is activated by 
the A domain in ORF19, which should subsequently be O-methylated by the O-MT 
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domain integrated within the A domain.  The β-hydroxy-acyl intermediate mentioned 
above would be transferred from the PKS module (ORF15) to the PCP domain of 
the downstream module (ORF19) with the help of the C domain (ORF17). Therefore 
we proposed that this NRPS module is involved in the incorporation and O-
methylation of serine as well as in the formation of a C-N bond to integrate the β-
hydroxy-acyl chain from the upstream PKS module with the amino group of the 
downstream methylated seryl-S-PCP. The methylated seryl intermediate is then 
presumably transferred to ORF20. 
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Fig. 3.3.5 A putative PKS/NRPS pathway cloned from the Japanese sponge T. swinhoei. It 
presumably undergoes chain elongation by incorporating malonyl-CoA, L-Ser, and Cys, 
leading to the formation of half of keramamide series. 
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ORF20 is highly homologous to HctF of the hectoclorine biosynthetic pathway and 
contains all the domains usually involved in thiazole ring formation (Ramaswamy et 
al., 2007). In particular, the A-domain of ORF20 is presumably responsible for the 
activation of cysteine. The incorporated cysteine residue would be cyclized by the 
Cy domain (Rawling, 2001) (Fig. 3.3.6). The DAxxxDA motif in Cy is assumed to 
play a role in the heterocyclization of the incorporated cysteine residue (Stachelhaus 
et al., 1998). The FMN-dependent oxidoreductase (OX) in the ORF20 protein is 
presumably involved in the thiazole formation. A thioesterase domain is located at 
the C-terminal end of ORF14 and is proposed to catalyze hydrolysis and cyclization 
of the polyketide from the biosynthetic assembly line (Fig. 3.3.6).  
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Fig. 3.3.6 The proposed mechanism of thiazole formation in keramamide biosynthesis. This 
begins with a Cy-catalyzed attack on the serine carbonyl by the cysteine thiol, resulting in the 
cyclodehydration of the cysteine residue to form a thiazoline ring. The thiazoline would be 
oxidized by ORF20 oxidoreductase (OX) to generate a thioazole ring.  
Upstream of the genes encoding for NRPS and PKS modules, there are a series of 
genes presumably encoding enzymes involved in the bromination and degradation 
of tryptophan encoded by orfs 9, 10, and 12 (see Table 3.3.3). The protein encoded 
by ORF10 showed close homology to many tryptophan halogenases, suggesting the 
role of the protein in catalyzing the halogenation of L-tryptophan. ORF10 is 
particularly highly similar to the flavin-dependent tryptophan-5-halogenase of 
microbisporicin (MibH) from the actinomycetes Microbispora corallina, which is 
known to chlorinate tryptophan at C-5 before binding to the NRPS (Foulston and 
Bibb, 2010).  It is difficult to predict whether ORF10 is able to incorporate bromide 
(Br) or chloride (Cl). The mono-bromination of L-tryptophan at C-5 resulting in 5-
bromotryptophan has been shown in the pyrroindomycin B biosynthesis (Zehner et 
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al., 2005). However, since many know cyclic peptides isolated from marine sponges 
contain 2-bromotryptophan units, such as konbamide (Kobayashi et al., 1991), 
orbiculamide A (Fusetani et al., 1991), and various keramamides (Kobayashi et al., 
1991; Kobayashi et al., 1995), it is assumed that ORF10 may prefer to catalyse the 
bromination of L-Trp at C-2 position.  
 
An interesting question arises about the precise timing of this halogenation in the 
biosynthetic pathways, whether it occurs before tryptophan-binding to the NRPS, 
during its binding to the NRPS-ACP, or after NRPS biosynthesis (post-NRPS 
halogenation). Due to its close similarity to MibH, it is likely that tryptophan is 
brominated first and then the resulting product is attached to the NRPS assembly 
line. The FADH2-requirement of the ORF10 product for bromination is suggested by 
the presence of the N-terminal flavin-binding site motif, GxGxxG, as well as another 
conserved motif, WxWxIP (Keller et al., 2000; Unversucht et al., 2005; van Pée and 
Patallo, 2006). The FADH2 is presumably provided by FAD-dependent 
oxidoreductase encoded on orf9 or orf4 through FAD reduction using NADH. The 
requirement of FADH2 for halogenating activity was observed by van Pée lab for 
tryptophan-7-halogenase and monodechloroaminopyrrolnitrin 3-halogenase in 
pyrrolnitrin biosynthesis (Hohaus et al., 1997; Keller et al., 2000). Recently 
Heemstra and Walsh (2008) reported two flavin-dependent halogenase genes and a 
putative flavin reductase gene encoded together within Kutzneride gene cluster. 
They observed halogenating activity in the presence of soluble Cl- ions, FAD, NADH 
and a recombinant flavin reductase, suggesting that the reduced flavin (FADH2) was 
required for halogenation (Heemstra & Walsh, 2008).  
 
An interesting question arises about the reaction mechanism for this putative flavin-
dependent tryptophan 5-halogenase (ORF10). Some reaction mechanisms have 
been proposed for flavin-dependent halogenases (Keller et al., 2000; Unversucht et 
al., 2005; Dong et al., 2005; Yeh et al., 2005). All the proposed mechanisms require 
the reduction of FAD to FADH2 catalyzed by a flavin reductase and subsequent 
halogenation reaction. The halogenation begins with the reaction of the halogenase-
bound FADH2 with O2, resulting in a flavin hydroperoxide (van Pée and Patallo, 
2006). The resulting flavin hydroperoxide would react with a double bond of a 
tryptophan to form an epoxide ring (Keller et al., 2000) or a hypochlorite (HOCl) 
(Unversucht et al., 2005; Dong et al., 2005). Subsequent nucleophilic attack of a 
halide ion and accompanying H2O elimination would lead to the formation of a 
Chapter 3 Results and Discussion 
__________________________________________________________________________________ 
110 
 
halogenated tryptophan (Keller et al., 2000; Unversucht et al., 2005; Dong et al., 
2005).  
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Fig. 3.3.7 Hypothetical role of ORF4/ORF9 and ORF10 in tryptophan bromination in the biosynthesis of 
keramamides. [A] It is assumed that ORF4/ORF9 and ORF10 are required to activate Br by increasing 
its electrophilicity. A flavin reductase encoded on orf4/orf9 would provide FADH2 for halogenase 
catalysis. FADH2 would first be generated by ORF4/ORF9 (flavin reductases) using NADH for the 
reduction of FAD (step 1). The resulting FADH2 would bind to the ORF10 (tryptophan-5-halogenase). 
The presence of a flavin binding site (GxGxxG) in ORF10 indicates the strict dependence of ORf10 on 
FADH2 (van Pée and Patallo, 2006). The reaction of the ORF10-bound FADH2 with O2 would lead to 
the formation of a flavin hydroperoxide (ORF10-bound FAD-OOH) (step 2). Based on L-tryptophan 
halogenation suggested by Yeh et al (2005) for the formation of 7-chlorotryptophan in rebeccamycin 
biosynthesis, the flavin hydroperoxide would then react with Br
-
 ion to form a FAD-O-Br intermediate 
(steps 3a-4a). An alternative bromination was based on tryptophan chlorination proposed by Dong et al 
(2005), in which the flavin hydroperoxide would first be decomposed by Br 
–
 (step 4b) to form HOBr. An 
acidic residue would make a hydrogen bond to HOBr, thereby activating Br. [B] Attack of the aromatic 
electrons on the FAD-O-Br (step 5a) or on the ORF10-bound HOBr (step 5b) and subsequent 
abstraction of a proton at C2 would lead to the formation of 2-bromotryptophan (step 6) that would 
further be activated by A domain of ORF14. Pictures A and B were adapted from Yeh et al (2005) and 
Dong et al (2005). 
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An alternative mechanism was described by Yeh et al (2005) for the formation of 7-
chlorotryptophan in rebeccamycin biosynthesis (Fig. 3.3.7). The resulting flavin 
hydroperoxide would first be chlorinated. Subsequent attack of the tryptophan`s 
aromatic electrons on the FAD-O-Cl and proton abstraction would result in 7-
chlorotryptophan (Yeh et al., 2005). Dong et al (2005) elucidated the structure of 
tryptophan 7-halogenase (PrnA) in the biosynthesis of pyrrolnitrin from 
pseudomonas fluorescens. Based on the three-dimensional structure, Dong et al 
(2005) suggests the flavin hydroperoxide is decomposed by Cl- followed by 
chlorination of tryptophan to form a chlorinated product (Dong et al., 2005). We 
postulate that the mechanism for tryptophan bormination in the biosynthesis of 
keramamides might resemble that suggested by Yeh et al (2005) or Dong et al 
(2005) (Fig. 3.3.7). Functional studies of this putative tryptophan 5-halogenase are 
currently underway in collaboration with van Pée lab at TU Dresden. 
 
ORF12 shows homology to many tryptophan 2,3-dioxygenases. ORF12 is predicted 
to encode tryptophan-2,3-dioxygenase (TDO) that cleaves the pyrrole ring of L-Trp, 
to form N-formylkynurenine (Colabroy & Begley, 2005). TDO was previously 
reported in the biosynthesis of anthramycin (Hu et al., 2007), which was proposed to 
convert L-Trp to the N-formylkynurenine (NFK). The 4-methyl-3-hydroxyanthranilic 
acid half of anthramycin is derived from N-formylkynurenine (Hu et al., 2007). Some 
mechanisms for the convertion of L-Trp to NFK have been proposed (Efimov et al., 
2011). One of earliest hypothetical mechanisms was the base-catalysed abstraction 
mechanism suggested by Hamilton (1969). In this mechanism, an active site base of 
TDO initially catalyzes the deprotonation of the indole NH group of L-Trp. The distal 
histidine was proposed to play such a role (Zang et al., 2006). However recent 
computational studies have revealed that the proton abstraction process is not 
energetically favorable (Chung et al., 2008). Therefore, Efimov et al (2011) and 
Basran et al (2011) have recently suggested a radical addition mechanism for the 
the convertion of L-Trp to N-formylkynurenine, as described in Figure 3.3.8. The 
presence of this L-Trp modifying enzyme (TDO) in the partial gene cluster isolated in 
this work raises a question whether the tryptophan-incorporating module (ORF14) 
could also accept N-formylkynurenine. An example showing the relaxed substrate 
specificity between L-tryptophan and N-formylkynurenine can be observed from the 
structures of Brunsvicamides A and B. Brunsvicamide A isolated from the 
cyanobacterium Tychonema sp. is a cyclic peptide known to contain a kynurenine 
moiety. Interestingly, the analog brunsvicamide B has kynurenine is substituted with 
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tryptophan (Müller et al., 2006), suggesting a relaxed substrate specificity of the A 
domain in brunsvicamide biosynthesis. 
 
The resulting 5-bromotryptophan or N-formylkynurenine would be activated by A 
domain followed by the covalent binding via a thioester bond to the cognate PCP of 
ORF14. ORF14 is homologous to the NRPS OciC of cyanopeptolin synthetase in 
Planktothrix rubescens (Rounge et al., 2009).  The ORF14 C domain would catalyze 
the condensation reaction between the PCP14-bound bromotryptophan or N-
formylkynurenine and the peptidyl chain tethered to the other PCP. The full length 
peptidyl chain would be transferred to the hydroxyl of the active site Ser of TE 
domain in ORF14 to form a peptidyl ester. The TE-bound peptidyl-O-Ser 
intermediate would subsequently be attacked by an amino group of the intermediate 
to release a macrocyclic peptide (Du & Lou, 2010). For the macrocylization of 
keramamides, it is assumed that the amino group of L-2,3-diaminopropionic acid 
residue would attack the TE-bound peptidyl intermediate. 
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Fig. 3.3.8 Proposed mechanism for the convertion of L-Trp to NFK, as suggested by Basran et al 
(2011). The reductive activation of O2 by a TDO (ORF12) would generate a highly oxidized iron 
intermediate (a +3 ferrous oxy intermediate) (step 1). Subsequent stepwise insertion of O2 to the L-Trp 
(step 3) would lead to the formation of an epoxide ring and accompanying rapid cleavage of the O-O 
bond would lead to a +4 ferryl iron intermediate (step 3). Due to the nitrogen lone pair at the N1, the 
epoxide ring could undergo C2-O bond cleavage that would lead to opening of the epoxide ring (step 
5). Further C2-C3 bond cleavage would generate NFK (Efimov et al., 2011; Basran et al., 2011). The 
resulting brominated tryptophan or NFK would be activated by A domain in ORF14 followed by the 
covalent binding via a thioester bond to the cognate PCP (Marahiel et al., 1997). The picture was 
adapted from Efimov et al (2011) and Basran et al (2011). 
 
ORF7 is homologous to a transcriptional regulator of the IclR protein family, which 
probably plays a role in controlling the degradation of aromatic compounds (Molina-
Henares et al., 2006), including L-Trp, N-formylkynurenine, and L-kynurenine. The 
involvement of an IcIR protein was shown in the transcriptional regulation of 
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tryptophan biosynthetic pathway of Corynebacterium glutamicum (Brune et al., 
2007).  
Based on the description above, we have cloned a partial NRPS gene cluster from 
the metagenome of the marine sponge, T. swinhoei chemotype white. Bioinformatic 
analysis of the partial NRPS pathway revealed the module architecture and 
substrate specificity loaded by individual modules. The domain order and the 
predicted function of the A-domain in individual modules are consistent with the 
amino acid residues incorporated into the proposed structures, suggesting that a 
portion of this gene cluster presumably encodes the biosynthesis of keramamides. 
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3.4 Genomics-Guided Identification of a Biosynthetic Pathway  
As described above, efforts to target the biosynthetic pathway of theonellamide F 
has led to the discovery of other interesting clusters likely encoding misakinolide A 
and keramamide H biosynthesis. Another strategy to target biosynthetic pathway 
consists of genome sequencing of the enriched filamentous cell fraction, which 
could potentially lead to the identification of gene clusters for other known 
metabolites as well as biosynthetic pathways for previously undetected metabolites.  
3.4.1 Purity analysis of uncultured bacterial fraction 
The major obstacle to sequence the genome of an uncultured bacterial symbiont, 
exemplified by “Candidatus Entotheonella sp.”, is obtaining the uncultured cell 
fraction in the desired purity and quantity. However, the unusually large morphology 
of “Entotheonella spp.” can allow for the enrichment of those bacteria by simple 
mechanical separation. In collaboration with Dr. T. Mori, Prof. H. Takeyama 
(Waseda University), Dr. T. Wakimoto, and Prof. S. Matsunaga (University of 
Tokyo), we obtained a significant amount of the uncultured filamentous fraction not 
only from the white chemotype but also from the yellow chemotype of the sponge, T. 
swinhoei (Fig. 3.4.1).  
 
 
 
 
 
 
 
 
Figure 3.4.1 The uncultivated filamentous bacteria isolated from the yellow and white 
chemotypes of Japanese T. swinhoei. 
Before the cell fractions were subjected to genome sequencing, we detected first the 
presence of “Entotheonella sp.” by PCR using Entotheonella-targeting primers 
designed by us in this work as well as by Schmidt et al (2000). The primer design 
was based on the unique regions of several Entotheonella 16S rRNA genes both 
originally isolated from enriched cell pellet from T. swinhoei and retrieved from the 
public database, in comparison with 16S rRNA genes from other bacterial species 
that are commonly found in sponges. Figure 3.4.2 showed three unique regions 
Photo by T. Mori 
 
Yellow chemotype  White chemotype  
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within Entotheonella 16S rRNA genes (as indicated by blue, red, and yellow lines). 
The forward primer 238-F designed by Schmidt et al (2000) was based on an 
upstream region at the relative positions of 270 to 240 bp (circled with a blue line). 
Using this unique region, we designed an alternative forward primer, termed 
Ento271F.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.2 Sequence alignment of 16S rRNA genes of Entotheonella sp. with those from other 
bacterial species that are commonly found in sponges. The unique regions indicated by blue, red, and 
yellow circles were used as the basis for designing Entotheonella-targeting primers. Highly conserved 
bases are highlighted, in which black color for G, green for A, blue for C, and red for T. 16S rDNA 
sequences included in this alignment are from the filamentous cell pellet of Japanese T. swinhoei Y (1) 
isolated by Dr. T. Mori, the metagenome of Japanese T. swinhoei W (2) cloned by us in this work, 
Entotheonella sp. clone Dd-Ent-A94A of Discodermia dissolute (AY897123.1) (3), Entotheonella 
palauensis of Palauan T. swinhoei  (AFI130847.1) (4), Entotheonella sp. clone 343 of soil 
(AY493913.1) (5), Acidobacteria clone PAUC34f of T. swinhoei (AF186412.1) (6), α-proteobacteria 
clone TK51 of T. swinhoei (AJ347042.1) (7), α-proteobacteria clone TK03 of Aplysina aerophoba 
(AJ347025.1) (8), α-proteobacteria clone CN60 of C. nucula (AJ850097.1) (9), γ-Proteobacteria clone 
E01-9C-26 of (AJ581351.1) (10), γ-Proteobacteria clone TK38 (AJ347044.1) (11), 
Gemmatimonadaceae clone CN82 of C. nucula (AM259917.1) (12), Gemmatimonadaceae clone 
AD004 (EF076125.1) (13), Chloroflexi clone TK23 of A. aerophoba (AJ347038.1) (14), Poribacteria 
clone 236 of A. aerophoba (AY485289.1) (15), and δ-proteobacteria clone EC214 (DQ889875.1) (16). 
Subsequently we indentified another unique region at the nucleotide position of 740-
780 bp (circled with a red line) and used it to design a reverse primer. Schmidt et al 
1 
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5`- GGGAAASGTT - CGCB - - - - - - - - - - - - - - - - - -- - - - GGTCTG -3`  
 
5`- CC - - - - - - - - - - - - - - - - - - - - - - GGTCTGAGATGAGC - TT -3`  
 
238-F:  
Ento271F:  
5`- GACAAAGGGCYGCTACTT -3` 
 
1247R-rd: 5`- GY - -ATTAAGCCKYGGAAACKGT-3` 
 
Ento735F: 
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(2000) identified a downstream unique region and used it to design the reverse 
primer 1247R. In our work, we de-generated a single nucleotide (T) within the 
1247R primer sequence into Y (termed 1247R-rd primer). Two other reverse primers 
used in this work (1309R and 1290R) were designed based on the downstream 
region that are conserved well among 16S rRNA genes from different bacterial 
groups. However, combination of these reverse primers with those primers 
mentioned earlier has enabled us to target 16S rRNA genes of “Entotheonella sp.” 
At first, we prepared total DNA from the cell pellet of filamentous symbiotic bacteria 
(Fig. 3.4.3A). The DNA purification was based on the anion-exchange resin 
commercially provided by QIAGEN, which is designed for direct isolation of 
chromosomal DNA 20-150 kb in size. Using the total DNA purified from the 
filamentous cell fractions, we detected the presence of correct-sized PCR products 
from four combinations of primers (238-F & 1247-rd, 238-F & 1309-R, Ento271-F & 
Ento1290-R, Ento735-F & Ento1290-R) (Fig. 3.4.3B). All of these four primer 
combinations also gave correct-sized PCR products for the metagenome from the 
sponge T. swinhoei chemotype W.  
 
 
 
 
 
 
 
 
Figure 3.4.3 Detection of “Entotheonella sp.” in the filamentous cell fraction of T. swinhoei. 
[A] DNA isolation from the cell fraction. The DNA quantity and quality was measured. For 
the chemotype W cell pellet, the total amount is ~100 µg, A260/A280 of 1.8, and A260/A230 of 
2.36. For the chemotype Y cell pellet, the total amount was ~120 µg A260/A280 of 1.9, and 
A260/A230 of 2.17. M1, 36-kb fosmid control (20 ng); M2, 36-kb fosmid control (10 ng); lane 
1: DNA sample from the chemotype W (507 ng); lane 2: DNA sample from the chemotype 
W (253.5 ng); lane 3, DNA sample from the chemotype Y (668 ng); and lane 3, DNA 
sample from the chemotype Y (334 ng). [B] Four combinations of Entotheonella-targetting 
primers were tested. Lane 1, DNA of T. swinhoei chemotype W; lane 2, DNA from the 
filamentous cell fraction; and lane 3, negative control (without DNA template); and M, DNA 
marker. 
Subsequently we checked the cell purity using universal 16S rRNA primers in order 
to obtain a quantitative impression on how dominant are the “Entotheonella sp.” 
cells in the uncultured bacterial cell fraction in comparison with other interfering 
bacterial cell types. Universal 16S primers, 27F and 1492R (Lane, 1991; 
238-F & 
1247-rd 
238-F & 
1309-R 
Ento271-F & 
Ento1290-R 
Ento735-F & 
Ento1290-R 
1    2     3    4 1     2    3 M M M [A] 
238-F : 5`-CCG GTC TGA GAT GAG CTT GC-3` (Schmidt et al., 2000) 
1247R-rd : 5`-AAG TAG CRG CCC TTT GTC-3` (adapted from Schmidt et al., 2000) 
1309R : 5`- GCG TKC TGA TCT CCG ATT AC-3` (in our work) 
Ento271F : 5`- GGGAAASGTTCGCBGGTCTG-3` (in our work) 
Ento735F : 5`- GYATTAAGCCKYGGAAACKGT-3` (in our work) 
Ento1290R: 5`- GCCCRGCWYVACCCGGTA-3` (in our work) 
M1 M2 
[B] 1     2    3 1     2    3 1     2    3 
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Stackebrandt & Lieasack, 1993), were used for this biodiversity analysis. The PCR 
products (Fig. 3.4.4A) were cloned into the vector pBlueScript II SK(-). Around 47 
clones were selected and checked for the presence of inserts by XhoI and PstI 
digestion (Fig. 3.4.4B). The recombinant clones were subsequently subject to 
restriction length polymorphism (RFLP) analysis by RsaI and HhaI digestion (Fig. 
3.4.4C). Fifteen clones showing unique RFLP patterns were sequenced.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.4 Genetic diversity of bacteria present in the filamentous cell fractions of T. 
swinhoei. [A] PCR amplification of 16S rRNA genes from the filamentous cell fractions of 
white and yellow chemotypes. [B] Insert checking and RFLP analysis of some selected clones 
from the chemotype W.  [C] Insert checking and RFLP analysis of some selected clones from 
the chemotype Y. Insert checking was done by the XhoI-PstI digestion of individual clones. 
Clones containing inserts were subsequently subjected to RFLP analysis using the frequent 
cutting enzymes RsaI & HhaI. Several clones showing unique RFLP pattern (as indicated with 
red numbers) were sequenced. Numbers on the pictures refer to clone codes.  
The results (Table 3.4.1) of the chemotype Y showed that 4 clones (Y3, Y5, Y6, 
Y19) belong to “Entotheonella spp.” 16S-rRNA genes, two (Y14, Y16) were 
Spongiobacter spp. 16S-rDNA fragments, and one (Y4) belong to a member of the 
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Rhodobacteraceae, a novel marine methyl halide-oxidizing bacteria (Schafer et al., 
2005). However, the RFLP patterns of the four clones harboring “Entotheonella sp.” 
16S rDNA were the same as 10 additional unsequenced clones (Y20, Y5, Y9, Y12, 
Y13, Y18, Y19, Y7, Y8, Y21). This suggests that the majority of the amplicons 
belonged to “Entotheonella sp.” 16S rDNA, assuming little cloning bias. The clone 
Y19 showed 97% identity to Entotheonella palauensis, a novel symbiont of the 
Palauan sponge Theonella swinhoei (Haygood et al., 1999). This suggested that the 
filamentous fraction from the chemotype Y is dominated by “Entotheonella sp.” cells, 
which was only contaminated with other bacteria. In contrast, the 16S rRNA analysis 
of the filamentous fraction from the white chemotype showed that all amplicons 
belong to the Chloroflexi (W4), Spongiobacter (W2, W3, W10) and Spirochaeta 
(W19, W24) genera, while none were “Entotheonella sp.” 16S rDNA fragment (Table 
3.4.1). 
 
The negative result from chemotype W was unexpected and there are some 
possible reasons for this. First, the enzymatic treatment (lysozyme) step in DNA 
isolation was probably insufficient to disrupt the membrane of “Entotheonella sp.” 
cells from the chemotype white. Second, lysis of “Entotheonella sp.” cells might 
occur during mechanical separation from the sponge sample, for instance, due to 
cellular osmotic pressure. Heldal et al (2012) reported the importance of Mg2+ ions in 
cellular osmoregulation in marine bacteria, especially during periods of non-growth 
and dormancy when carbon and nutrient sources are limited. This suggests that 
using Mg2+-free artificial water to process the cell fraction could potentially lead to 
the disruption of certain bacterial cell types. Other possibility is that the isolated cell 
fraction was not dominated by “Entotheonella sp.” cells, and the abundant 
filamentous cells observed under the microscope were probably other bacteria. If 
“Entotheonella sp.” cells were present in very low quantity compared with other non-
target bacterial members in the fraction, this could affect the relative ratio of 16S 
rDNA amplicons. As the consequence, 16S rDNA amplicons amplicons of 
“Entotheonella sp.” were not well represented in clone libraries. Another possibility is 
that “Entotheonella sp.” cells from chemotype W might be sensitive to lysis when 
they were prepared from a frozen sponge sample (personal communications with 
Dr. T. Mori and Prof. J. Piel). This unique phenomenon was also observed in our 
recent effort to obtain DNA from the filamentous bacterial cells isolated from a 
frozen sponge, in which we did not get the DNA. 
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Table 3.4.1 The genetic diversity of the uncultured filamentous bacterial fraction isolated from the 
Japanese sponge Theonella swinhoei in this study. 
Clone 
Product 
Length 
(bp) 
Taxonomic affiliation Source 
Y3 1477 Entotheonella sp. FBC-TSY 
Y4 - Rhodobacteraceae FBC-TSY 
Y5 1419 Entotheonella sp. FBC-TSY 
Y6 1477 Entotheonella sp. FBC-TSY 
Y11 - Alpha-proteobacterium FBC-TSY 
Y14 - Spongiobacter sp. FBC-TSY 
Y16 - Spongiobacter sp FBC-TSY 
Y19 1428 Entotheonella sp. FBC-TSY 
Y20 - Spongiobacter sp. FBC-TSY 
pEntoSpo 1253 Entotheonella sp. M-TSW 
W2 1563 Spongiobacter sp., Endozoicimonas elysicola  FBC-TSW 
W3 740 Spongiobacter sp. FBC-TSW 
W10 1247 Spongiobacter sp. FBC-TSW 
W4 850 Chloroflexus sp. FBC-TSW 
W19 1300 Spirochaeta sp. FBC-TSW 
W24 - Spirochaeta sp. FBC-TSW 
Note: Y6= pEntoSpo; Y3 = Y5 = Y19; FBC, filamentous bacterial cell fraction; M, metagenome; TSY, Theonella swinhoei Y; TSW, 
Theonella swinhoei Y 
 
The clone W2 showed 93% identity to Endozoiciomonas elysicola (Accession no. 
AB196667), a bacterium isolated from the marine mollusc Elysia ornata (Kurahashi 
& Yokota, 2006 unpublished). It exhibits 94% identity to Spongiobacter 
nickelotolerans isolated from a marine sponge (Acc nu. AB205011) (Nishijima et al., 
2005 unpublished). The clone W4 showed high homology (94%) to uncultured 
Chloroflexus sp., sponge associated bacteria (Montalvo & Hill, 2011), and 88% 
identity to uncultured Caldilinea sp., chloroflexi from the intestine of the earthworm 
Eisenia fetida (Rattray et al., 2010). The clone W19 has 98% identity to the 
uncultured sponge associated bacteria Spirochaetes clone XD1F11 (Montalvo & 
Hill, 2011).  
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Figure 3.4.5 Phylogenetic analysis of 16S rDNA sequences that belong to “Entotheonella 
sp.” from the Japanese marine sponge, T. swinhoei, placing them in the same clade as 
Entotheonella palauensis from the Palauan T. swinhoei and Entotheonella sp. from 
Discodermia dissoluta. The distance three was based on ~1000 bp of 16S rRNA gene 
sequences. Clone Y3, identified as “Entotheonella sp.”, from the T. swinhoei chemotype Y is 
proposed to produce keraramide and orbiculamide based on genome sequencing. Clone 
pEntoSpo, identified as “Entotheonella sp.”, from the T. swinhoei chemotype W is proposed 
to produce theonellamide F based on the localization study by Schmidt et al. (2000), while 
misakinolide A and keraramide H based on the localization study combined with 
metagenome mining in this work. 
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3.4.2 Genome Analysis 
The 16S rDNA analysis suggested that the filamentous fraction from the T. swinhoei 
chemotype Y was more pure because it was dominated by Entotheonella 
sequences. Therefore the total DNA from the cell fraction was subjected to whole 
genome sequencing through collaboration between our group and that of Dr. Jörn 
Kalinowski (Bielefeld University) within the GenBioCom framework supported by the 
BMBF. The whole genome sequencing was based on Sanger, 454 and Illumina 
sequencing (Margulies et al. 2005; Droege and Hill 2008; Rothberg and Leamon, 
2008; DiGuistini et al., 2009). The first round of genome sequencing yielded 18.280 
contigs that contain at least 14 additional KS domains of PKSs and 41 PCPs of 
NRPSs. The presence of only a single 16S rRNA gene in the sequence data 
confirmed that the “Entotheonella sp.” cell fraction was fairly pure. The onnamide 
and polytheonamide gene clusters were found. However, there are still many gaps 
in the genome sequences that are necessary to be filled, indicating that many 
PKS/NRPS contigs have not been annotated.  
 
Some PKS/NRPS contigs were placed in order into scaffolds based on 
understanding the multimodular domain organization. We identified a promising 
scaffold containing 11 contigs, which was predicted to direct the biosynthesis of a 
keramamide or orbiculamide due to the presence of domains presumably involved in 
thiazole ring formation. We filled in this promising scaffold by PCR, amplicon 
sequencing, and sequence assembly. Ten of twelve gaps in the scaffold were 
initially filled (Fig. 3.4.6A). Another additional gap was subsequently filled in through 
the help of Mr. Bikram Pandey (a master student who did a practical work under my 
supervision in the Piel Group) (Fig. 3.4.6B). The amplicon covering the remaining 
gap 3 is quite large (>1.5 kb). End sequencing of it was not enough to obtain an 
entire amplicon sequence. Although containing a very small gap, the amplicon 
sequence could be functionally annotated and predicted to code for acyltransferase 
(AT) domain. We analyzed the resulting continuous sequence of approximately 26 
kb by finding the potential ORFs and subsequent functional prediction 
(supplementary S3.4.1). The potential ORFs were identified using the software 
FramePlot 2.3.2 (Ishikawa and Hotta, 1999) and Geneious 5.4.6 (Drummond et al., 
2011). Subsequent functional prediction of the identified ORFs were carried out 
using BLAST (McGinnis & Madden, 2004), PKS/NRPS analysis Web-site 
(Bachmann & Ravel, 2009), and NRPSpredictor2 (Rausch et al., 2005; Röttig et al., 
2011). 
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Figure 3.4.6 Filling the gaps in a promising scaffold and identifying potential ORFs. [A] Filing 
the gaps between the ordered contigs was initiated with designing primers that attach each 
contig at the distance of ~100 bp from the contig ends. The specific primers were then 
employed to obtain amplions. The individual amplicons were sequenced, and the amplicon 
sequence data was reassembled with the contig sequences. Ten gaps (shown by red colored 
numbers) were filled in after reassembly. [B] Filling three remaining gaps (gaps 3, 11, 12) was 
subsequently conducted by obtaining PCR-amplicons at two different elevated annealing 
temperatures (60
o
 and 62
o
C). Subsequent amplicon sequencing resulted in filling two 
additional gaps (gaps 11 and 12) and left a small niche on the gap 3. [C] After filling the gaps, 
the resulting continuous sequence of approximately 26 kb was annotated by finding the 
potential ORFs and subsequent functional prediction. 
Using PKS/NRPS analysis Web-site (Bachmann & Ravel, 2009), we predicted the 
domain organization on individual ORFS and confirmed the prediction by finding the 
highly conserved motifs in each domain. The ~26 kb gene DNA harbors six orfs: 4 
code for NRPS modules and 2 code for PKS modules (Fig. 3.18C). Each NRPS 
module contains adenylation domain responsible for activating amino acids. Using 
NRPSpredictor2 (Rausch et al., 2005; Röttig et al., 2011), we predicted the 
substrate specificity code of all adenylation domains present in the individual NRPS 
modules, as shown in Table 5 below. An incomplete ORF (ORF1) at the upstream 
end contains an A-T module, in which the A domain was predicted to be specific for 
ornithine (100% identity) or related amino acids. ORF2 harbors two NRPS modules, 
in which the A-domains were presumably specific for activating proline (90% 
identity) and isoleucin, respectively. Next to ORF 2, ORF3 encodes a PKS module 
(KS-AT-KR-ACP) in a separate protein, in which the integrated AT is presumably 
specific for malonyl-CoA. The KR domain in ORF3 showed 53% identity to KR5 
present in the ZmaA of zwittermicin A biosynthetic pathway, which generates 
hydroxyl moiety at the incorporated (2R)-hydroxymalonyl-CoA (Kevany et al., 2009). 
The downstream ORF4 codes for an NRPS module that is responsible for 
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incorporating alanine (90% identity). The subsequent module, ORF4, contains an A-
domain that might be responsible for activating alanine. 
 
Table 3.4.2 Key amino acid residues for substrate specificity of the adenylation domains of the 
proposed biosynthetic pathway.  
Adenylation 
domain 
Specificity-conferring code of A domain Predicted 
Substrate
c
 
& % match 
Relative residue 
position 
235 236 239 278 299 301 322 330 331 517 
A2 (ORF1) 
Consensus sequence
a
 D V G E I G S I D K Orn 
(100%) Specificity sequence
b
 D V G E I G S I D K 
A3 (ORF2) 
Consensus sequence
a
 D V Q L I A H V V K 
Pro (90%) 
Specificity sequence
b
 D V Q F I A H V A K 
A4 (ORF2) 
Signature sequence
a
 D A E S V G A I D K 
Arg (60%), 
Leu, or Ile 
Signature sequence
a
 D V A D V G A I D K 
Signature sequence
a
 D A W F L G N V V K 
Signature sequence
a
 D A F F L G V T - K 
Specificity sequence
b
 D V Y F V G A V I K 
A4 (ORF4) 
Consensus sequence
a
 D L L F G I A V L K 
Ala(90%) 
Specificity sequence
b
 D I Y N N A L T Y K 
A1 (ORF5) 
Consensus sequence
a
 D L Y N L S L I W K 
Cys (90%) 
Specificity sequence
b
 D L Y N M S L I W K 
 Variability (%)
d
 3 16 16 39 52 13 26 23 26 0  
a 
Signature sequences derived from A domains activating the same substrate, as predicted by Stachelhaus et al (1999) 
b
The positions of the ten specificity-conferring decisive residues identified in this work, which were predicted using NRPSpredictor2 
(Rötting et al., 2011; Rausch et al., 2005) 
c
The predicted substrates: Orn, ornithin; Pro, proline; Arg, arginine; Leu, leucine; Ile, isoleucine; Ala, alanine; Cys, cystein 
d
Residue variability are shown in percentage and variable constituents within  
  specific-conferring codes are indicated by red color (Stachelhaus et al., 1999) 
e
Specificity code for ArgA based on studies by Demirev (et al., 2005) for the oligopeptide moiety of cephabacin 
f 
Specificity code for ArgA based on studies by Guenzi (et al., 1998) for the syringomycin synthetase gene cluster 
g
According to nostocyclopeptides A1 and A2 primary structures (Hoffmann et al., 2003; Becker et al., 2004) 
ORF5 showed 51% identity to HctE of the hectoclorine biosynthetic pathway that 
contains domains required in the formation of thiazole ring (Ramaswamy et al., 
2007). The C terminus of ORF5 is homologous (70% similarity) to the condensation 
domain, designated as Cy, of the BarG in the barmamide biosynthetic pathway 
(Chang et al., 2002).  Cy is known to play a role in the heterocyclization of the 
incorporated cysteine residue (Stachelhaus et al., 1998). The A-domain of ORF20 is 
presumably responsible for the activation of cysteine. An oxidoreductase (OX) is 
present in the N terminus of ORF 5. The presence of the cystein-specific A domain, 
a Cy domain, and an OX domain in ORF5 suggest the role of this module in the 
formation of a thiazole ring through cysteine cyclodehydration and subsequent 
oxidation. A PKS module encoded at the downstream end of ORF6 contains the 
domain components KS-AT-DH-KR-ACP. The integrated AT in this module is 
responsible for selecting malonyl-CoA. The KR in this module contains the 
stereospecificity motif AGVLDDGILLQQSGARF (diagnostic site in red) that converts 
the β-keto moiety in the incorporated malonyl-ACP into a β-D-OH. This resulting 
hydroxyl group is subsequently converted to the α,β-E-double bond by the DH. 
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3.4.3 Proposed scheme of the identified biosynthetic pathway 
Our proposed scheme for this partial biosynthetic pathway, as shown in Figure 
3.4.7, begins with incorporation of ornithine onto the T domain of module 1. Proline 
would be loaded on module 2, resulting in a prolinyl-S-T. The C domain in module 2 
catalyzes nucleophilic attack of the amino group of the prolinyl-S-T donor on the acyl 
group of an upstream electrophilic ornithinyl-S-T chain, resulting in the formation of 
a peptide bond between these two amino acyl chains. Isoleucine would be loaded in 
module 3, and the amino group of this T-loaded isoleucine forms a peptide bond 
with the acyl group of the upstream peptidyl chain. Subsequently the downstream 
PKS module (module 4) would load a malonyl unit and modifies it by β-
ketoreduction. The KS domain accepts an upstream peptide chain and catalyzes the 
decarboxylative condensation with its cognate malonyl-S-ACP, leading to the 
elongation of the peptide chain with a short carboxylic acid via a C-C bond. Module 
5 would incorporate alanine loaded onto the T domain. This thioesterified alanine is 
integrated with the upstream peptide chain. The A domain in module 6 would 
activate cysteine. The T-load cysteine residue is subsequently cyclized by the Cy 
domain, resulting in a thiazoline, which is then oxidized by the oxidoreductase 
domain to generate a thioazole ring. The C domain in this NRPS module accepts the 
intermediate from the upstream PKS module, and subsequently mediates a C-N 
bond formation, allowing the elongation of this intermediate with an alanyl residue. 
The second PKS module (module 7) at the C terminus of this pathway would load a 
malonyl unit that is subsequently modified by KR and DH domains, resulting in an 
α,β-E-double bond. The KS domain in module 6 would accept the growing upstream 
peptide chain from the upstream NRPS module. Then the KS domain would 
catalyze the formation of a C-C bond to generate a peptide chain with a short 
carboxylic acid containing α,β-E-double bond. 
Sequence analysis of the partial biosynthetic pathway revealed that domain 
composition and substrate specificity loaded by each module is consistent with the 
formation of amino acid residues incorporated into the proposed structure. The 
module order and the predicted function of the A-domain in individual modules 
suggest that a portion of this gene cluster presumably encodes the biosynthesis of 
an orbiculamide-like structure. 
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Figure 3.4.7 The proposed biosynthetic pathway of a PKS/NRPS scaffold identified in the sequenced 
genome of “Entotheonella sp.” from the Japanese sponge T. swinhoei chemotype Y. Amino acid 
substrates are activated by A domain in individual NRPS modules through AT hydrolysis. Malonyl units 
are activated by an AT domain integrated in individual PKS modules. These unstable intermediates are 
then transferred onto T or ACP domains and bound as a thioester to an enzyme-bound 4`-
phosphopantetheinyl (4`-PP). The thiol-activated intermediates can undergo modifications. 
Thioesterified substrate amino acids are then integrated into the peptide product through a step-by-
step elongation by a series of transpeptidation reactions. 
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3.5   Summary and Outlook  
Highly complex consortia of sponge-associated bacterial symbionts have been 
frequently proposed to be the true source of many sponge-derived metabolites. 
However, the majority (>99%) of these symbionts are uncultivable (Amann et al., 
1995; Hugenholtz et al., 1998; Friedrich et al., 2001; Webster and Hill, 2001), 
thereby hampering efforts to prove the symbiont hypothesis and to study their 
biosynthetic potential. However, using cultivation-independent approaches recently 
developed in the Piel group have enabled us to pinpoint biosynthetic pathways of 
interest within diverse genetic mixtures from sponge symbiotic systems (Piel et al., 
2004b; Hrvatin & Piel, 2007; Nguyen et al., 2008; Fisch et al., 2009; Freeman et al., 
2012).  
 
The main goals of this project were to obtain further metagenomic insights into the 
metabolic potential of uncultured symbiotic bacteria by detecting the key genes 
involved in secondary metabolism, to clone at least one new complete biosynthetic 
pathway of pharmacological relevance, and to provide taxonomic information of the 
uncultured bacterial symbionts harboring the biosynthetic pathway(s) of interest. The 
sponge T. swinhoei has been chosen in this work due to the wide variety of 
pharmaceutically important secondary metabolites isolated from this sponge as well 
as the high complexity of the associated bacteria, which might play an important role 
in metabolite biosynthesis (Matsunaga and Fusetani, 2003; Matsunaga et al., 1989; 
Matsunaga et al., 1992).  
 
Achieving such goals mentioned above is a very challenging task due to the high 
complexity of the microbial communities in many sponges. The microbial consortia 
can account up to 60% of the total biomass in many sponges and can consist of 
thousands of species with at least 18 bacterial and archaeal phyla (Taylor et al., 
2007). The genetic variation within a single species as well as possible dominance 
of different species makes the symbiotic community even more complex. To clone 
new biosynthetic pathways from this complex symbiosis model, we applied and 
developed metagenome mining strategies. There are three challenges that we 
encountered in metagenome mining to obtain a high probability of finding a target 
biosynthetic pathway: (i) obtaining high molecular weight sponge metagenome, (ii) 
creating complex metagenomic libraries that represent genomes present in the 
sponge system, and (ii) rapid library screening, which is also highly economic in 
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terms of labor, consumables and required space (Hrvatin & Piel, 2007; Uria & Piel, 
2009; Gurgui & Piel, 2010).  
 
The first challenge, obtaining high molecular weight sponge metagenome, was 
overcome in this work using a CTAB-based DNA extraction in combination with gel-
based DNA purification developed by Piel group (Piel et al., 2004b; Hrvatin & Piel 
2007; Gurgui & Piel, 2010). Subsequently, we performed the PCR detection of PKS 
genes in the metagenome of T. swinhoei chemotype W. However, all of the 
amplicons obtained from the sponge metagenome came from lipid metabolism, with 
none of them predicted to be responsible for complex polyketide biosynthesis. The 
difficulty to detect the PKS genes involved in complex polyketide biosynthesis might 
be due to the huge amounts (86% in average) of fatty acids contained in the 
sponge, in comparison with the very small percentage of trans-AT polyketides 
(around 2%), based on the previous study by Piel, Hentschel and coworkers on 20 
different sponge species (Fieseler et al., 2007).  
 
To tackle such challenge, we used a filamentous cell fraction predominated by 
“Candidatus Entotheonella sp.”, a heterothropic delta-proteobacterium associated 
with T. swinhoei chemotype W. The species diversity of this fraction was previously 
simplified by differential centrifugation. This mechanical separation not only reduced 
the complexity of the bacterial community associated with the sponge host and 
enriched the target bacterial population, but also remove contaminants from the 
sponge tissue such as carbohydrates. Based on the earlier localization studies by 
Faulkner and coworkers (Bewley et al., 1996; Schmidt et al., 2000), we 
hypothesized that theonellamide F (structurally similar to theopalaumide, see 
Introduction) was located in “Entotheonella sp.” Therefore, our initial studies were 
focused on gaining access to the biosynthetic pathway of theonellamide F from this 
filamentous fraction. We hypothesized that theonellamide biosynthesis involves a 
PKS/NRPS system, and theferore, we initially used universal PKS and NRPS 
primers to target the biosynthetic genes coding for the hybrid system. By PCR 
cloning and sequencing, we obtained 8 KS amplicons belonging to complex PKS 
systems as well as two adenylation sequences of NRPS with the predicted 
specificity for arginine (ArgA). This demonstrated that reducing the microbial 
complexity by mechanical separation has enriched PKS and NRPS genes.  
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However, the isolated ArgA sequences mentioned above might not be involved in 
the biosynthesis of theonellamide F, because arginine (Arg) or its derivatives are not 
building blocks forming theonellamide F. This prompted us to develop a strategy to 
clone the A domain sequences specific for amino acid residues encoded more than 
once in theonellamide structure. One of the targeted residues is L-serine that is 
encoded three times in theonellamide structure. Using the strategy, we obtained two 
amplicons coding for serine-specific A domains (SerA) from the filamentous fraction 
from T. swinhoei chemotype W. 
 
To obtain biosynthetic gene clusters that harbor the KS- and SerA-encoding DNA 
regions, we constructed a fosmid library from the filamentous bacterial fraction. 
Screening of the library using the specific primers based on the KS amplicons did 
not give a positive clone. However, when using the primers based on SerA 
amplicons, we isolated a positive fosmid clone. Analysis of this clone indicated that it 
harbored only a small NRPS cluster instead of the expected complex multimodular 
system.  
 
Due to the failure in identifying complex PKS and NRPS pathways in the library 
constructed from the filamentous bacterial fraction, a highly complex metagenomic 
library (~350,000 clones) was subsequently constructed from the metagenome of T. 
swinhoei chemotype W. Screening of this library led to the isolation half of a trans-
AT PKS gene cluster. By chromosome walking, we isolated additional PKS regions, 
resulting in an entire trans-AT PKS gene cluster. Our bioinformatic analysis 
predicted that the isolated PKS gene cluster encoded the biosynthetic pathway of 
misakinolide A. This dimeric polyketide is a potent actin inhibitor isolated from T. 
swinhoei sponges (Sakai et al., 1986; Kato et al., 1987; Kitagawa et al., 1990). With 
misakinolide A biosynthetic genes in hand, the stage is now set to perform functional 
studies and to establish a heterologous expression system to create a renewable 
misakinolide A source. Furthermore, using the information present in the SerA 
amplicons, we isolated a NRPS gene cluster from the sponge metagenomic library. 
Our bioinformatic analysis revealed that the isolated NRPS genes are a good 
candidate for the biosynthesis of keramamide H. Finding the additional regions of 
the putative keramamide H gene cluster as well as functional studies will be 
pursued.  
 
Chapter 3 Results and Discussion 
__________________________________________________________________________________ 
129 
 
Two different gene clusters isolated in this work as mentioned above exhibited 
typical bacterial gene features, such as the absence of introns, the presence of 
ribosome binding sites, and small intergenic distances between putative genes, 
strongly indicating that the producer of both misakinolide A and keramamide H is a 
symbiotic bacterium. The taxonomic status of the bacterial producer(s) is still 
unknown yet. However, due to the screening system used to isolate the gene 
clusters was based on the PKS and NRPS amplicons from the filamentous fraction 
dominated by “Entotheonella sp.“, we assumed that both misakinolide A and 
keramamide H could be produced by “Entotheonella sp.” To confirm this taxonomic 
status, further analysis either by single cell studies or its combination with complete 
genome sequencing is currently underway using the filamentous fraction as the 
starting material. 
 
Preliminary genome sequencing of the uncultured “Entotheonella sp.“ fraction from a 
different chemotype of T. swinhoei (chemotype Y) yielded 18.280 contigs that 
contain at least 14 additional KS domains of PKSs and 41 PCPs of NRPSs. We 
identified a PKS/NRPS scaffold containing 11 contigs, which was predicted to direct 
the biosynthesis of a keramamide or orbiculamide due to the presence of domains 
presumably involved in thiazole ring formation. We filled in this scaffold by PCR, 
amplicon sequencing, and sequence assembly. Our bioinformatic analysis 
confirmed that the identified gene cluster encoded the putative biosynthetic pathway 
of orbiculamide-like structure. The presence of only a single 16S rRNA gene of 
Entotheonella sp. in the sequence data confirmed that this symbiontic bacterium is 
the producer of the orbiculamide-like structure. The onnamide and polytheonamide 
gene clusters were also found. However, there are still many gaps in the genome 
sequences that are necessary to be filled, indicating that many PKS/NRPS contigs 
have not been annotated. Next rounds of genome sequencing for obtaining the 
complete sequence data of uncultured “Entotheonella sp.” are currently underway. 
Subsequent genome mining could potentially lead to the identification of other 
biosynthetic pathways. 
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Chapter 4 
Methodology 
This methodology section described the methods applied or developed in this work 
to pinpoint biosynthetic pathway of pharmaceutical relevance among diverse 
pathways present in a sponge symbiotic system. In principle, the methods include 
generating a highly complex metagenomic library that presumably contains 
representative bacterial genomes present in the sponge and subsequent screening 
the library rapidly. All of the experimental approaches used for a sponge sample in 
this work can be divided into following main experimental parts: (i) finding key 
biosynthetic genes, (ii) generating a complex metagenomic library, (iv) rapid 
screening of a metagenomic library for obtaining biosynthetic gene cluster(s) of 
interest, and (v) clone analysis. In addition, genetic analysis of an uncultured 
bacterial type, in which the microbial complexity was reduced by cell separation, 
was also described. Some basic knowledge behind the experimental steps is briefly 
described. 
4.1. Materials 
4.1.1 Organisms and Vectors 
This subsection lists all of the organsisms and vectors used in this work. In addition, 
most of genetically modified bacteria as well as DNA constructed made in this work 
are presented. 
Table 4.1.1 Organisms used in this work 
Microorganisms/ bacterial hosts Source/genotype 
E. coli EPI300™-T
1
R Phage T1-resistant F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 recA1 
endA1 araD139 Δ(ara, leu)7697 galU galK λ
-
 rpsL nupG trfA dhfr 
E. coli XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F'proAB lacI
q 
ZΔM15 Tn10 (Tet
R
)] 
An engineered strain of Acinetobacter 
baylyi ADP1 
harboring a 77-kb gene cluster coding for pederin 
The sponge Theonella swinhoei  W 
(white) specimen 
collected by scuba diving at Hachijo-jima Island, Japan, at a depth of 
15 m. Immediately after collection, it was shock-frozen in liquid 
nitrogen and stored at -80 
o
C. Provided in 2002 through collaboration 
with Prof. S. Matsunaga (University of Tokyo) 
Uncultivated filamentous bacterial 
fraction 1 (in sub-chapters 3.1 & 3.2) 
prepared from T.  swinhoei chemotype white. Provided in 2002 
through collaboration with Prof. S. Matsunaga (University of Tokyo)  
Uncultivated filamentous bacterial 
fraction 2 (described in sub-chapter 3.4) 
prepared from T.  swinhoei chemotype yellow. Provided in 2010 
through collaboration with Dr. T. Mori, Prof. M. Takeyama (Waseda 
University), Dr. T. Wakimoto, and Prof. S. Matsunaga. 
Uncultivated filamentous bacterial 
fraction 3 (described in sub-chapter 3.4) 
prepared from T. swinhoei chemotype white. Provided in 2010 
through collaboration with Dr. T. Mori, Prof. M. Takeyama, Dr. T. 
Wakimoto, and Prof. S. Matsunaga  
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Table 4.1.2 Vectors used in this work 
Vectors Source/genotype 
pBluescript II SK (-)  Stratagene (Amsterdam, Netherlands) 
pCC1FOS Epicentre (Hess. Oldendorf, Germany) 
 
Table 4.1.3 Genetically modified organisms (GMO) generated in this work 
Microorganisms/ bacterial hosts Source/genotype 
Fosmid library of an engineered strain of 
Acinetobacter baylyi ADP1 hosted in E. 
coli  EPI300™ using pCC1FOS 
An engineered strain of Acinetobacter baylyi ADP1 harboring a 77-kb 
gene cluster coding for the antitumor polyketide, pederin 
Fosmid library of filamentous bacteria 
(~2000 clones, 18 pools) hosted in E. 
coli  EPI300™ using pCC1FOS 
The filamentous bacteria were prepared from T.  swinhoei chemotype 
white 
Fosmid library of sponge metagenome I 
(~200,000 ; 4000 cfus/ml) hosted in E. 
coli  EPI300™ using pCC1FOS 
The metagenome were prepared from T.  swinhoei chemotype white 
 
Fosmid library of sponge metagenome II 
(~200,000 ; 1000 cfus/ml) hosted in E. 
coli  EPI300™ using pCC1FOS 
The metagenome were prepared from T.  swinhoei chemotype white 
 
Fosmid library of sponge metagenome 
III  (~200,000 ; 500 cfus/ml) hosted in E. 
coli  EPI300™ using pCC1FOS 
The metagenome were prepared from T.  swinhoei chemotype white 
 
Table 4.1.4 Overview of the DNA constructs made in this work 
Vectors Host Descriprion 
pAU1, 3, 4, 5, 6, 7 E. coli XL1-Blue pBluescript II SK (-)  with a A domain sequences for arginine 
pEt-A3, -B2, -D1 E. coli XL1-Blue pBluescript II SK (-)  with a A domain sequences for serine 
pAU12 E. coli  EPI300™ pCC1FOS with a pederin gene cluster fragment 
pAU14 E. coli  EPI300™ pCC1FOS with a pederin gene cluster fragment 
pET3.7a E. coli  EPI300™ pCC1FOS with a probably small NRPS gene cluster 
pTSW4, 8, 9, 12, 30 E. coli XL1-Blue pBluescript II SK (-)  with KS fragments of PKS-like FASs 
pEKS14, 30, pEP5 E. coli XL1-Blue pBluescript II SK (-)  with KS fragments of cis-AT PKSs 
pEKS27, 37, 48, 50 E. coli XL1-Blue pBluescript II SK (-)  with KS fragments of trans-AT PKSs 
pEKS64, pEP2, 3 E. coli XL1-Blue pBluescript II SK (-)  with KS fragments of trans-AT PKSs 
pTSW-AU1 E. coli  EPI300™ pCC1FOS with a misakinolide A gene cluster fragment 
pTSW-AU2 E. coli  EPI300™ pCC1FOS with a misakinolide A gene cluster fragment 
pTSW-AU5 E. coli  EPI300™ pCC1FOS with a misakinolide A gene cluster fragment 
pTSW-AU10 E. coli  EPI300™ pCC1FOS with a misakinolide A gene cluster fragment 
pTSW-AU11 E. coli  EPI300™ pCC1FOS with a misakinolide A gene cluster fragment 
pADU2a E. coli  EPI300™ pCC1FOS with a keramamide gene cluster fragment 
pAG E. coli  EPI300™ pCC1FOS with a small NRPS gene fragment 
pW2, pW3, pW10 E. coli XL1-Blue pBluescript II SK (-)  with 16S rDNAs of Spongiobacter sp. 
pW4 E. coli XL1-Blue pBluescript II SK (-)  with 16S rRNA fragment of Chloroflexus sp. 
pW19, pW24 E. coli XL1-Blue pBluescript II SK (-)  with 16S rRNA fragment of Spirochaeta sp. 
pY3, pY5, pY6 E. coli XL1-Blue pBluescript II SK (-)  with 16S rRNA fragment of Entotheonella sp. 
pY4 E. coli XL1-Blue pBluescript II SK (-)  with 16S rDNA of Rhodobacteraceae 
pY11 E. coli XL1-Blue pBluescript II SK (-)  with 16S rRNA fragment of α-proteobacterium 
4.1.2 Chemicals, solutions, and instruments 
Table 4.1.5 Chemicals utilised in this work 
Chemical Source 
acetic acid 
Agar 
VWR 
Merck-Eurolab,  
Agarose, NEEO ultra Carl Roth GmbH 
Agarose, low melt Carl Roth GmbH 
Ammonia, liquid Merck-Eurolab 
Ammonium chloride Merck-Eurolab 
Ammonium sulfate Fluka/ Sigma-Aldrich 
Ampicillin Merck-Eurolab 
Boric acid Merck-Eurolab 
Bromophenol Blue Sigma-Aldrich 
Calcium chloride dihydrate Fluka/ Sigma-Aldrich 
Calcium carbonate Merck-Eurolab 
Casaminoacids  Life Technologies (Gibco BRL) 
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Chloramphenicol Sigma-Aldrich 
Chloroform SDS GmbH 
Coomassie
®
 Brilliant Blue G250 Sigma-Aldrich 
CTAB (Cetrimonium bromide) 
Deoxynucleoside triphosphates (dNTP’s)  
Fluka 
Invitrogen GmbH 
Dimethyl sulfoxide (DMSO) Carl Roth GmbH 
Dithiothreitol (DTT) Fluka/ Sigma-Aldrich 
D-Sorbitol 
Ethanol 
Carl Roth  
SDS GmbH 
Ethidium bromide   Carl Roth GmbH 
Ethidium bromide solution (1%) Merck-Eurolab 
Ethyl acetate  SDS GmbH 
Ethylenediamine-tetraacetic acid (EDTA) Fluka/ Sigma-Aldrich 
Glacial acetic acid (99%) Merck-Eurolab 
Glucose Merck-Eurolab 
Glutamic acid  Fluka/ Sigma-Aldrich 
Glycerol Merck-Eurolab 
IPTG (Isopropyl-ß-D-thiogalactopyranoside) Carl Roth GmbH 
Isopropanol 
Kanamycin 
Aldrich 
Sigma-Aldrich 
LMW-SDS Marker Kit GE Healthcare Bio-Sciences 
L(+)-Arabinose 
Lithium chloride 
Lysozyme  
Acros Organics 
Alfa Aesar 
Merck-Eurolab 
2-Mercaptoethanol 
Magnesium chloride hexahydrate 
Carl Roth 
Merck-Eurolab 
Magnesium sulfate heptahydrate Merck-Eurolab 
Manganese chloride tetrahydrate  Merck-Eurolab 
Mercaptoethanol Serva 
Methanol SDS GmbH 
Nicotinamide adenine dinucleotide (ß- NAD
+
) Sigma-Aldrich 
Nitrogen, liquid Institut für Strahlen- und Kernphysik 
Orange G Sigma-Aldrich 
Peptone  Carl Roth GmbH 
Phenol-chloroform-isoamyl alcohol mixture (25:24:1) Carl Roth GmbH 
Potassium acetate (KOAc) Carl Roth GmbH 
Potassium chloride Carl Roth GmbH 
Potassium dihydrogen phosphate Merck-Eurolab 
di-Potassium hydrogen phosphate Merck-Eurolab 
Potassium sulfate Fluka/ Sigma-Aldrich 
2-Propanol Merck-Eurolab 
SeaPrep Agarose Biozym 
Sodium acetate Carl Roth GmbH 
Sodium chloride Merck-Eurolab 
Sodium dodecyl sulfate (SDS) Carl Roth GmbH 
Sodium hydroxide Merck-Eurolab 
Sodium hydroxide solution 50% Sigma-Aldrich 
Sodium tetraborate  Fluka/ Sigma-Aldrich 
Sucrose  Merck-Eurolab 
TES-buffer (N-[Tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid) Fluka/ Sigma-Aldrich 
Tris-Base (Tris-[hydroxymethyl]-aminomethane) Merck-Eurolab 
Tryptone Carl Roth GmbH 
Urea 
X-gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside) 
Roth 
Life Technologies (Gibco BRL) 
Xylene Cyanol FF Sigma-Aldrich 
Yeast Extract (Select
®
) Life Technologies (Gibco BRL) 
 
Table 4.1.6 Kits used in this work  
Name Manufacturer 
Epicentre
®
 CopyControl
™
 Fosmid Library Production Kit 
CCFOS110 
Epicentre Biotechnologies, Madison, WI 53713, USA 
QIAquick Gel Extraction Kit Qiagen GmbH, 40724 Hilden 
RNeasy
®
 Mini Kit Qiagen GmbH, 40724 Hilden 
peqGOLD Gel Extraction Kit PeqLab Biotechnologie GmbH 
QIAquick Gel Extraction Kit Qiagen 
GFX PCR DNA and Gel Band Purification Kit GE Healthcare 
CopyControl™ Induction Solution Epicentre 
RNeasy Mini Isolation from Bacteria Qiagen 
Expand High Fidelity plus PCR system Roche 
SuperScript™ III One-Step RT-PCR System  Invitrogen 
QIAGEN Genomic-tip 20/G Qiagen 
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Table 4.1.7 Enzymes employed in molecular biological experiments 
Enzyme Manufacturer 
Antarctic phosphatase New England Biolabs, 65926 Frankfurt  
Bovine serum albumin (BSA) New England Biolabs, 65926 Frankfurt  
DNase (RNase-free) Promega, 68199 Mannheim 
GoTaq
®
 DNA Polymerase (5u/µl) Promega, 68199 Mannheim 
RNAse A Invitrogen GmbH, 76131 Karlsruhe 
T4 DNA Ligase New England Biolabs, 65926 Frankfurt 
Restriction endonucleases New England Biolabs, 65926 Frankfurt 
Proteinase K Carl Roth GmbH, 76185 Karlsruhe 
 
Table 4.1.8 Molecular weight markers for gel electrophoresis 
Name Source 
1 Kb DNA Ladder Invitrogen GmbH, 76131 Karlsruhe 
1 Kb DNA Extension Ladder  Invitrogen GmbH, 76131 Karlsruhe 
GeneRuler
™
 DNA Ladder Mix Fermentas, 68789 St-Leon-Rot 
 
Table 4.1.9 Solution, buffers and media 
Solution, Buffer and Media Composition Store 
Alkaline lysis solution I (P1) 50 mM Tris-HCl pH 8, 10 mM EDTA, 100 µg/ml RNAse 4 oC 
Alkaline lysis solution II (P2) 200 mM NaOH, 1% SDS RT 
Alkaline lysis solution III (P3) 3 M KOAc pH 5.5   
Gel loading dye 
0.05% bromophenol blue, 0.05% xylene cyanol, 0.05% orange G, 
40% sucrose 
4
o
C 
Sarkosyl lysis buffer pH 7.6 
8 M urea, 2% sarkosyl, 350 mM NaCl, 50 mM EDTA, 50 mM Tris-HCl, 
pH 7.5 
 
TAE 50X 
242 g Tris-base, 7.1 ml Glacial acetic acid. 100 ml EDTA (0.5M), add 
1 l H2O 
RT 
TE buffer 10 mM Tris-HCl (pH 7.5) 1 mM EDTA (pH 8.0) RT 
Luria broth (LB) 1% tryptone, 1% NaCl, 0.5% yeast extract RT 
LB agar 1% tryptone, 1% NaCl, 0.5% yeast extract, 1.5% agar RT 
Semi-liquid SeaPrep medium 1% tryptone, 1% NaCl, 0.5% yeast extract, 0.6% SeaPrep agarose RT 
All media were autoclaved at 121
o
C. Put in microwave in 5 min 
 
Table 4.1.10 Antibiotics for the counterselection of recombinant strains 
Antibiotic 
Concentration 
Medium (µg/ ml) 
Concentration 
Stock solution (mg/ ml) 
solvent 
Ampicillin 100 100 water 
Chloramphenicol 25 25 ethanol 
Kanamycin 25 25 water 
 
Table 4.1.11 Enzymes 
Enzyme Source 
Antarctic phosphatase Roth, Karlsruhe 
Hot Start Polymerase Jena Bioscience, Jena 
Lysozyme Roth, Karlsruhe 
Restriction enzymes NEB, Frankfurt/Main, Jena Bioscience,  Roth, Karlsruhe 
RNase Roth, Karlsruhe 
RNase-free DNase set Qiagen, Dusseldörf 
T4 DNA ligase NEB, Frankfurt/Main, Jena Bioscience, Jena 
Taq DNA Polymerase 
Plasmid-Safe™ ATP-Dependent DNase 
NEB, Frankfurt/Main 
Epicentre 
 
Table 4.1.12 Equipments 
Equipment Manufactory 
Agarose gel electrophoresis Biometra, Göttingen 
Autoclave V65 Systec, Wettenberg 
Balance Sartorius, Germany 
Cellophan paper Roth, Karlsruhe 
Concentrator 5301/ speedvac Eppendorf, Hamburg 
Clean bench Bio-flow Technik, Meckenheim 
Electroporation cuvette 2mm Bio-Rad, München 
Filter Merck, Darmstadt 
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Equipment Manufactory 
Gel documentation Gene Genius Syngene, Cambridge (UK) 
Glass wool Roth 
IKA-combimag Janke and Kunkel 
Shaking incubator Sartorius, Göttingen 
Incubator Thermo, Langenselbold 
Membranvacuumpumpe Vacuubrand, Wertheim 
Microcentrifuge Micro200 Hettich, Tuttlingen 
Microcentrifuge, cool 5417R Eppendorf, Hamburg 
Microcentrifuge, cool Micro200R Hettich, Tuttlingen 
Microprocessor pH meter Hanna instruments 
MicroPulser Electroporator  Bio-Rad, München 
Microwave Lifetec Medion, Essen 
Mixer uzusio VTX-3000L Harmony 
Photometer (Biophotometer) Eppendorf, Hamburg 
Photometer BioMate 3 Thermo Electron, Cambridge (UK) 
Pipett Pipetman P2 - P10 ml Gilson, Middleton (USA) 
Poly-prep column Bio-Rad, München 
Rotamax 120 Heidolph, Kelheim 
Sonipulser Badelin electronic, Berlin 
Thermomixer Eppendorf, Hamburg 
Thermocycler T-Gradient PCR Biometra, Göttingen 
Pipette tip Sarstedt 
Ultraviolet crosslinker UVP, Cambridge, UK 
UV cuvettes Sarstedt 
Pipette tip Sarstedt 
Ultraviolet crosslinker UVP, Cambridge, UK 
UV cuvettes Sarstedt 
4.2. General Molecular Biology and Microbiology Techniques 
This section describes general biomolecular and microbiology methods regularly 
used in this work. 
4.2.1 DNA isolation and electrophoresis 
The basic steps for isolation of bacterial DNA include bacterial cultivation, cell lysis, 
protein-nucleic acid complex disruption, protein removal, and DNA precipitation. 
PCR applications often require less purified DNA or crude DNA extract (Chachaty 
and Saulnier, 2000). The protein is dissociated from nucleic acids by detergents 
such as SDS. Protein removal is usually done by extracting cell lysates with 
phenol:chloroform:isoamyl alcohol (Kirby, 1964). Subsequent extraction with 
chloroform removes traces of phenol from the DNA preparation. Before extracting 
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with such organic solvents, proteins are often degraded by treating in the nucleic 
acid solution with proteolytic enzymes, such as proteinase K (Sambrook & Russel, 
2001).  
4.2.1.1  Bacterial cultivation  
Overnight cultures were performed either for genomic DNA extractions, preparation 
of circular vectors (e.g. plasmids), or preparation of competent cells. At first, a sterile 
test tube was filled with 3-5 mL of LB medium containing an appropriate antibiotic. 
Using a sterile toothpick or innoculating needle, bacterial cells were picked from a 
single colony growing on a plate or from the stock culture frozen at -80 °C frozen, 
and then innoculated into the LB medium. The tube was placed in a shaking 
incubator at 37 °C overnight (~16 h) at 200 rpm. For long term storage of the 
bacterial strains and vectors, 850 μL of an appropriate overnight culture were 
transferred in 2 ml screw-capped tubes and added with 150 ml of 100% steril 
glycerol. After a short time vortex, the tubes were stored at -80 °C for a long term. 
Glycerol has been well known for its utility in preserving viable E. coli cells at very 
low temperatures.   
4.2.1.2  Genomic DNA isolation 
To prepare genomic DNA from bacteria, we used the procedure described by Jones 
and Bartlet (1990) with slight modifications. An overnight culture (1 ml) was 
transferred to a 1.5 ml eppendorf tube and centrifuged at 10,000 rpm for 5 minutes 
to precipitate the cells. The free-cell supernatant was decanted, and another 1 ml 
culture was added, followed by centrifugation. The resulting cell pellet were 
suspended with 438 µl lysis buffer (100 mM NaCl, 10 mM Tris-HCl pH 7.8, 1 mM 
EDTA, 2.5 mM MgCl2, 1% SDS) and then stored at -80 
oC for 15 minutes. Then 50 
µl of 100 mg/ml lysozime was added into the tube. The tube was incubated on dry 
ice for 20 minutes and then at room temperature until the frozen lysate melts. 
Subsequently the lysate was treated with 2 µl of 30 mg/ml proteinase K, followed by 
1 hour incubation at 37 oC. The nucleic acid solution was extracted by adding a 
mixture of phenol:chloroform:isoamyl alcohol (25:24:1), followed by centrifuging it at 
14,000 rpm for 2 minutes. The upper layer was transferred into a new eppendorf 
tube, and then extracted once with chloroform. One volume of isopropanol was 
added, mixed gently, and centrifuged at 14,000 rpm for 30 minutes (4 oC). The 
resulting DNA pellet was washed with 500 µl of 70% ethanol, and then vacuum-
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dried for around 15 minutes. The dried DNA pellet was dissolved in 20 µl of EB 
buffer (Qiagen). 
 
The following procedure used for high molecular weight DNA isolation from 
uncultivated bacterial cells was reported by Syn and Swarup (2000) with slight 
modification. Cell suspension was initially centrifuged. The resulting cell pellet was 
washed once with 750 µl NE buffer (0.15 M NaCl, 50 mM EDTA) to remove 
extracellular exopolysaccharides (EPS) and then repelleted by centrifugation. The 
cell pellet was then resuspended in 750 µl of TES (10 mM Tris-HCl, 10 mM EDTA, 
pH 8.0, 2% SDS), and incubated at 75 °C for 5 min (15 min) to improve cell lysis. 
The lysate was treated with two rounds of phenol:chloroform:isoamyl alcohol 
(25:24:1, v/v) extraction, followed by a chloroform extraction. DNA precipitation was 
done by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 1 volume of 
isopropanol (room temperature). The sample was mixed by gently inverting the tube 
several times. The DNA was precipitated by centrifugation at 14,000 rpm for 30 
minutes (room temperature).  The DNA pellet was washed with 70% ethanol and 
centrifuged at 14,000 rpm for 10 minutes. It was then air-dried, and resuspended in 
15 µl of EB buffer (Qiagen). 
 
The following DNA isolation method was developed in this work. The cell pellet 
stored in 1 ml ethanol at 4 oC was suspended by inverting several times. A half 
volume of the cell suspension (200 µl) was taken out and rinsed three times with 
dH2O. The rinsed cell pellet obtained was weighed and suspended in 230 µl of 
buffer lysis I (10 mM Tris-HCl pH 7.0, 1 mM EDTA, 100 mM NaCl, 0.08 mg/ml 
RNase). To cell suspension were then added 20 µl of 20 mg/ml lysozyme and 
incubated at room temperature for 30 minutes. Subsequently, the mixture was 
treated with 250 µl of buffer lysis II (10 mM Tris-HCl pH 6.0, 50 mM EDTA, 100 mM 
NaCl, 5 mM MgCl2, 2% SDS, 4 M urea) and 3 µl of 20 mg/ml proteinase K 
containing 0.02 mM CaCl2, followed by a 10-min incubation at room temperature. An 
equal volume of phenol/chloroform/isoamyl alcohol (25/24/1) (Roth) was added to 
the lysed mixture, mixed gently by inverting it several times, and centrifuged at 
13,000 rpm for 5 min at 4 oC. The upper layer was pipetted into a 1 ml centrifuge 
tube, and re-extracted with equal volume of phenol/chloroform/isoamyl-alcohol as 
before. The upper layer was transferred into a 1 ml centrifuge tube containing 200 µl 
chloroform, mixed gently and centrifuged at 13,000 rpm for 5 min. An equal volume 
of cold isopropanol and 1/10 volume of 3 M sodium acetate was added to the DNA 
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solution, mixed gently and stored at -20 oC for 20-30 minutes. The precipitated DNA 
was recovered by a 30-min centrifugation at the top speed (14,000 rpm), rinsed with 
500 µl of 70% ethanol, and air-dried. The DNA pellet was dissolved in 20-30 µl EB 
buffer (Qiagen) diluted two times with dH20. 
4.2.1.3  Plasmid or fosmid DNA isolation 
Preparation of plasmid or fosmid DNA from recombinant E. coli cells was based on 
the alkaline lysis in combination with SDS (modifified from Birnboim and Doly, 
1979). The modified alkaline lysis procedure of the cells described below was 
performed for small-scale preparation of plasmid/fosmid DNA (1.5 ml overnight 
culture). An overnight E. coli culture (0.75 ml) was transferred into a 1.5 ml 
Eppendorf tube and centrifuged at 10,000 rpm for 3 min. The cell-free supernantant 
was discarded, and another E. coli culture (0.75 ml) was transferred into the same 
tube. After centrifugation at 10,000 rpm for 3 min, the cell-free supernatant was 
removed. The resulting cell precipitate was suspended with 200 µl P1 buffer (50 mM 
Tris-HCl pH 8, 10 mM EDTA, 100 µg/ml RNAse), and then mixed well by inverting 
the tube or by vortexing. The RNAse solution was boiled for 2 min before being 
added into the P1 buffer to inactivate DNAse activity. The suspended cells were 
added with 200 µl of P2 buffer (200 mM NaOH, 1% SDS), and mixed by inverting 
the tube several times. The suspension was added with 200 µl P3 (3M KOAc pH 
5.5), mixed again and centrifuged at 13,000 rpms for 5 min. The supernatant was 
transferred to a new Eppendorf tube containing 500 µl chloroform, mixed well and 
centrifuged at 13,000 rpm for 5 min, resulting two layers of solution. The upper layer 
containing plasmid DNA was transferred to a 1.5 ml tube containing 350 µl 
isopropanol, mixed well, and centrifuged at top speed for 20 min. The supernatant 
was poured off and the resulting small white pellet was rinsed with 500 µl of 70 % 
ice-cold ethanol. After spinning the pellet down shortly, the ethanol was carefully 
poured off and the remaining liquid was removed. The pellet was then vacuum-dried 
for 20 min and dissolved in 50 µl water. One µl of the plasmid solution was checked 
by restriction digest and agarose gel analysis. For large-scale preparation of plasmid 
or fosmid DNA from 150 ml overnight culture, the volume of all the buffers and 
solutions used were multiplied by 100. The Eppendorf tubes were substituted with 
50 ml facon tubes. 
4.2.1.4  DNA purification and quantification 
Low-molecular weight contaminants in the isolated DNA samples may inhibits 
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downstream applications such as PCR amplification, enzymatic restriction, DNA 
ligation or DNA sequencing. Inhibitors can be removed from crude DNA preparations 
either by drop dialysis (Sambrook and Russel, 2001), gel permeation 
chromatography (Zadražil et al., 1974; Jakson et al., 1997), affinity chromatography 
(Chockalingam et al., 2001), or gel purification using agarase digestion (Zhou et al., 
1996).  In our work, additional DNA purification step was usually carried out using 
gel purification kits that combines spin-column technology and silica-gel matrices or 
anion-exchange carriers, such as QIAquick Gel Extraction Kit (Qiagen), the 
GeneJETTM Gel Extraction Kit (Fermentas), and the illustra™ GFX™ PCR DNA 
and Gel Band Purification Kit (GE Healthcare).  
 
The target DNA fragment was first excised from the agarose matrix after the 
electrophoretic separation. One of the gel extraction kits were then used according 
to the manufacturer’s instruction manual. To avoid DNA damage by exposure to UV 
light, ethidium bromide was not added into the agarose gel. A larger well was made 
by sealing some wells in the comb with a gel-sealing tape. Using this comb with a 
larger well formed a wide slot on the solidified gel. Then the DNA sample was 
loaded into a wide slot of the agarose gel, with a DNA marker on the right and left 
sides. After electrophoresis, both sides of the gel including the marker lines were cut 
off with a sharp scalpel, and then stained with 1 µg/ml ethidium bromide solution for 
20 minutes. The stained parts of the gel were observed under UV light and the 
position of target DNA band(s) was marked with a scalpel. The gel parts were 
subsequently reassembled, and the target fragments were marked, excised from the 
gel, and subjected to gel extraction. The concentration and purity of the purified DNA 
samples were then measured using a spectrophotometer. This spectrophotometric 
measurement is based on the amount of UV irradiation absorbed by the DNA bases 
at wavelengths of 260 nm and 280 nm. Using a cuvette with a seam of 1 cm, the 
OD260 of 1 corresponds to a concentration of 50 µg/ml for double-stranded DNA and 
40 µg/ml for single-stranded DNA or RNA. The ratio between OD260 and OD280 
indicates the estimated purity of the DNA preparations. Pure DNA samples have 
OD260/OD280 of 1.8 to 2.0 (Sambrook & Russel, 2001). 
4.2.1.5 DNA electrophoresis 
The first modern electrophoresis apparatus, reffered to horizontal “submarine” gel 
system, was developed by Walter Schaffner, who was then a graduate student at 
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Zurich. This gel electrophoresis model has developed as the standard technique 
widely applied to separate, identify and purify DNA fragments (Sambrook & Russel, 
2001; Rickwood & Hames, 1982). The DNA separation on the gel is based on the 
negative charge of DNA molecules due to the negatively-charged oxygen of the 
phosphate group of their backbone. Therefore, when the gel containing DNA 
fragments are placed in an electrical field, they migrate toward the positive pole of 
electrophoresis chamber. Their speed of movement in the gel decreases as their 
length increases, which is proportional to electric field strength (Sambrook & Russel, 
2001).  
An agarose gel was made by mixing agarose with 1X TAE and dissolving by 
heating. The concentration of agarose gel depended on the size of analyzed DNA, 
normally ranged from 0.5-2%. We routinely used 1% agarose gels for the DNA size 
range of 500 bp to 10 kb, whereas 1.5-2.0% for the DNA fragment size of less than 
500 bp. While the agarose solution was cooling to <60 oC, it was added with 
ethidium bromide (EtBr) to a final concentration of 0.1 µg/ml followed by stirring to 
mix it. The warm agarose solution was poured into the plastic mold/tray and an 
appropriate comb was placed in the molten agarose. When the gel hardens, a small 
amount of electrophoresis buffer was poured on the top of the gel and then the 
comb was carefully removed. The gel along with the mold was placed in the 
electrophoresis tank, and the electrophoresis buffer was poured to cover the gel. 
Individual DNA samples were mixed with 1/10 volume of the loading dye. This dye 
contained a mixture of glycerol, xylene cyanol FF (migrates at ~5000 bp), 
bromophenol blue (migrates at ~300 bp) and orange G (migrates at ~50 bp). Each 
DNA sample mixture was loaded into the slots of the gel. Size markers were usually 
loaded on the right side. The lid of the gel tank was closed and a voltage of 80-120 
V was applied. Then the DNA samples in the gel were visualized under UV light in 
the gel documentation system. If EtBr was not directly included in the gel matrix, 
staining of the gel can be done after electrophoresis by immersing it in 1X TAE 
containing 1 µg/ml EtBr for 15-20 min. Gel analysis was performed using a UV 
transilluminator and a digital camera (Sambrook & Russel, 2001) 
4.2.2 PCR Amplification 
Since polymerase chain reaction (PCR) was first described in 1986 (Mullis et al., 
1986; Saiki et al., 1988), it has rapidly developed as an invaluable tool for molecular 
biology research (Bej et al., 1991; Sambrook and Russel, 2001; Jena Bioscience; 
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Invitrogen). PCR is intended to amplify a target DNA to yield millions of identical 
copies. It is routinely used in laboratories around the world for a widespread of 
applications, including cloning, sequencing, gene expression analysis, and 
mutagenesis (Sambrook and Russel, 2001; Jena Bioscience; Invitrogen).  
4.2.2.1  Standard PCR amplification 
A PCR procedure commonly includes three major steps: denaturation, annealing, 
and elogation (Sambrook & Russel, 2001). At denaturation step, the double-
stranded DNA is denatured to single-stranded DNA by heating to 94 oC. At the 
annealing step, the temperature is lower to 40-60 oC that allows primers to anneal to 
the single-stranded DNA. At the elongation step, polymerase binds to the primer-
DNA template hybrid for DNA synthesis in direction 5’-3’. Sometimes, the first cycle 
is preceded by a predenaturation step at 94 to 95 oC for 3-5 min. The elongation 
step is often followed by final elongation step by heating to 70-72 oC for up to 10 min 
to ensure that the single-stranded DNA is completely extended. A PCR typically 
consists of about 20-35 cycles, relying on the concentration of PCR compositions 
(Bej et al., 1991; Sambrook & Russel, 2001, Jena Bioscience). The following PCR 
composition and program are generally used in the Piel group. 
PCR component   Volume   
10X ThermoPol buffer (NEB) : 2.5 µl    
10 mM of dNTPs 10 mM : 0.5 µl    
50 µM of forward primer : 0.25 µl    
50 µM of reverse primer : 0.25 µl    
Taq polymerase (NEB) : 0.125 µl   
DNA template   : 0.5 µl    
dH2O    : up to 25 µl     
PCR program    Temperature & duration 
Lid preheating   :  105  oC  
Predenaturation  :  95 oC 2 min 
Denaturation   : 95 oC 30 sec  
Annealing    : Tm 
oC 1 min (Tm is annealing temperature) 
Elongation    :  72 oC 1 min 
Final elongation  :  72 oC 5 min 
Storing   :  4 oC pause 
Thermal cycles  :  35 
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4.2.2.2  Hot-start PCR amplification 
To reduce nonspecific amplification and obtain the higher yield of the desired PCR 
product, we used Hot-start polymerase (Jena Biosciences). The activity of this 
enzyme is inhibited at ambient temperatures, thereby reducing nonspecific priming 
and primer oligomerization during PCR set-up (Birch et al., 1996; Chou et al., 1992; 
Kellogg et al, 1994). During the initial denaturation step of the PCR program, the 
enzyme becomes fully active (Jena Bioscience). The Hot start polymerase has 
proofreading activity but also has the template-independent activity that creates a 
single additional adenosine at 3`-OH termini (Jena Bioscience), thereby facilitating 
direct ligation with a vector carrying T-overhang (Clark, 1988). For DNA targets with 
a high G + C content, primers are often difficult to reanneal at the secondary 
structure regions. To solve this problem, certain organic chemicals such as DMSO 
(dimethyl sulfoxide) often need to be added into the PCR reaction (Bej et al., 1991). 
The addition of DMSO in low concentration can often greatly improve yield and 
specificity without affecting Taq DNA polymerase activity (Bej et al., 1991; Varadaraj 
and Skinner, 1994). Furhermore, the addition of either bovine serum albumin (BSA), 
dithiothreitol, or glycerol in the PCR reaction mixture allowed the specific 
amplification, which were previously failed under standard conditions (Nagai et al., 
1997). In this work, we used hot start polymerase (Jena Bioscience), sometimes in 
combination with DMSO and BSA, to obtain target amplicons from the sponge 
metagenome or uncultered symbiotic bacteria. The PCR composition and program 
are as follow. 
 
For crude sponge DNA as the template: 
The PCR composition for a 25-µl PCR mix: 10x buffer, 0.5 µl of 10 mM dNTPs, 0.25 
µl of 100 mM forward primer, 0.25 µl of 100 mM reverse primer, 1.5 µl of 25 mM 
MgCl2, 1.25 µl of 100x BSA, 2.5 µl of 100% DMSO, 2.5 µl of DNA sample, 0.125 µl 
Hot-start DNA polymerase, 1 µl DNA template (diluted 10x, 100x, and 1000x) and 
ddH2O up to 25 µl. The PCR reaction program was composed of lid heating at 105 
oC, predenaturation at 96 oC for 5 minutes, denaturation at 96 oC for 45 seconds, 
annealing at 55, 58, 61 oC, elongation at 72 oC for 1 minute, and final elongation at 
72 oC for 7 minutes. 
 
For pure sponge DNA as the template: 
The PCR components for a 25-µl PCR mix are composed of 21.25 µl ddH2O, 2.5 µl 
of 10x thermophol buffer (NEB), 0.5 µl of 10 mM dNTPs, 0.25 µl of 50 mM forward 
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primer, 0.25 µl of 50 mM reverse primer, 0.125 µl of Hot-start DNA polymerase or 
high-fidelity polymerase, 0.4 µl pure sponge DNA or bacterial cell suspension.  
 
For suspension of bacterial cells as the template: 
The PCR composition for the total volume of 25 µl consisted of 17 µl ddH2O, 2.5 µl 
of 10x thermophol buffer (NEB), 0.5 µl of 10 mM dNTPs, 1 µl of 25 mM MgCl2, 2 µl 
of 50 mM KSDPQQF primer, 2 µl of 50 mM KSHGTGR primer, and 0.125 µl Hot-
start DNA polymerase or high fidelity polymerase. The thermal cycle program was 
composed of lid heating at 105 oC, predenaturation at 95 oC for 2 minutes, 
denaturation at 95 oC for 1 minute, annealing at 55, 58, 61 oC, elongation at 74 oC 
for 1 minute, and final elongation at 74 oC for 10 minutes. 
4.2.3 DNA Modifications 
A wide range of commercially available enzymes can be used to modify DNA, such 
as restriction/ digestion, phosphorylation/ dephosphorylation, ligation, and 
polymerization. In this work, we used a variety of endonucleases and exonucleases 
for DNA digestion, phosphatases for removing 5` phosphate groups to prevent self-
ligation, a DNA polymerase for adding additional nucleotides on the DNA termini, 
and DNA ligase to combine DNA molecules. In addition, combination of T4 DNA 
polymerase and terminal phosphotransferase is usually used to repair the DNA 
termini. T4 DNA polymerase fills the recessed 3` termini and remove the protruding 
3` termini, thereby converting the frayed ends into blunt ends. Terminal 
phosphotransferase converts the hydroxyl group at the 3` termini to a phosphate 
group using that is also present in the end-repairing enzyme mix (Brown, 2006). 
4.2.3.1  DNA restriction 
Two µl of the total 50 µl miniprep was used to check the presence of an inserted 
amplicon by treating it with suitable restriction enzymes that flank the insert. The 
following composition was used for double digestion: 5.5 µl of ddH2O, 2 µl of DNA, 1 
µl of NEB buffer, 0.2 µl of enzyme 1 and 0.2 µl of enzyme 2. The reaction mixture 
was incubated at 37 oC for 3-5 hours. Then the digestion products were run on the 
electrophoresis to check for the correct insert size. The clones harbouring correct-
size inserts were subjected to restriction fragment length polymorphism (RFLP) in 
order to obtain insight into the difference in restriction pattern. The restriction 
enzymes used for RFLP in this work were RsaI, HhaI, or combination of both. The 
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clones showing unique restriction patterns were sequenced. The sequence data 
was analyzed by BLAST search to find the homology in the public database. For KS 
and adenylation domain sequences, the highly conserved motifs were identified. 
4.2.3.2  Preparation of T-vectors for PCR cloning 
PCR cloning was based on the ability of Taq polymerase to deoxyribonucleotide to 
the 3`-OH terminus of a PCR amplicon through its template-independent terminal 
transferase activity (Clark, 1988). As the result, the PCR products tend to harbor A-
overhang at their ends, usually adenosine, which can readily be ligated with a 
phagemid vector harboring T-overhang at both ends (Marchuk et al., 1990). This 
template-independent activity of Taq polymerase can be exploited to create a 
cloning scheme which has the efficiency of sticky end cloning, but requires no 
additional enzymatic modification of the PCR product. To make T-cloning vector, the 
phagemid pBluescript II (SK-) was liniearized first by using EcoRV (Jena Bioscience) 
to create blunt-end sites. At first, pBluescript (Stratagene, La Jolla, CA) plasmid (10 
µl from 50 µl standard miniprep) was added with 32 µl ddH2O, 5 µl NEB buffer 3, 0.5 
µl BSA, and 2.5 µl of EcoRV. After 2-hours incubation at 37oC, the digestion reaction 
was inactivated by heating at 80oC for 20 min. The digestion product was treated 
with 0.5 µl of Taq polymerase (1 unit/ µg plasmid/20 µl volume) and 10 µl of 10 mM 
dTTP and incubated at 70 oC for 2 hours. The linear plasmid was recovered by 
chloroform extraction and isopropanol precipitation. The resulting T- vector is ready 
to ligate with PCR product containing A-overhang (Marchuk et al., 1990). 
4.2.3.3  Preparation of vectors for subcloning 
For the subcloning of cosmid DNA fragments into pBluescript II SK (+) vector, both 
insert and vector DNA were digested with the same restriction enzyme. The 
following standard protocols were regularly used in the Piel group: 
 
Reaction for insert DNA: 
Cosmid DNA  : 50.0 µl 
Endonuclease  : 10.0  µl 
Buffer   : 15.0 µl 
BSA (100x)  : 1.25  µl 
Purified water  :          23.75 µl 
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Incubation time at 37 °C was extended to 3 hours to ensure complete digestion. The 
restriction reaction was applied to a gel without ethidium bromide. The DNA 
fragments were excised separately, as far as possible, and were then recovered 
from the gel for usage in ligation reactions. 
 
Reaction for vector DNA: 
Vector DNA  : 20.0 µl 
Endonuclease  : 2.5 µl 
Buffer (10x)  : 5.0 µl 
BSA (10x)  : 5.0 µl 
Purified water  : 17.5 µl 
After 2 hours of incubation at 37 °C, inactivation of the enzyme was achieved by 
heating at 65 °C for 20 minutes. The DNA was then dephosphorylated (section 
4.2.3.4).  
4.2.3.4  Dephosphorylation of vectors 
Antarctic phosphatase was used to catalyses the removal of 5´ phosphate groups 
from a vector DNA. The following treatment was used for the dephosphorylation of a 
linearized vector according to NEB Inc: 
 
Dephosphorylation reaction for a linearized vector DNA: 
Linear pBluescript DNA   : 40 µl 
10x Antarctic phosphatase reaction buffer : 6 µl 
Antarctic phosphatase   : 2 µl 
dH2O      : 12 µl 
Total      : 60 µl 
The dephosphorylation mixture was incubated for 15 min at 37 oC for 5` extensions 
or blunt ends, and then 60 min for 3` extensions. This was followed by heat 
inactivation at 65 oC for 5 min and subsequent purification using gel extraction kit. 
The vector was ready to use for ligation (section 4.2.3.5). 
4.2.3.5  DNA ligation 
One µl of each DNA sample is checked on a gel. The relative DNA concentrations 
are estimated. For a ligation, approximately three times more insert than vector is 
used. The following composition is typically used: 6 µl insert, 1 µl vector, 2 µl of T4 
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ligase buffer, and 1 µl DNA ligase. The ligation mixture is mixed briefly and 
incubated for three hours at 16 °C or for best results overnight at 4 °C. The enzyme 
activity is deactivated at 65 °C for 10 min and it proceeds with DNA transformation 
(Jena Bioscience) (section 4.2.4). 
4.2.4 DNA Cloning 
The routine cloning of PCR-generated or enzymatically generated DNA fragments 
used in our work include preparation of electrocompetent cells, ligation of vector and 
DNA fragments (section 4.2.3.5), electroporation/ transformation of ligated products 
into the competent cells, clone slection, and clone analysis by restriction (section 
4.2.3.1) and clone sequencing. 
4.2.4.1  Preparation of electrocompetent E. coli cells 
A 5 ml overnight E. coli culture was transferred to 200 ml of LB medium in a 500 ml 
Erlenmeyer flask, followed by incubation at 37 °C and 200 rpm. When the cell 
density reached the OD600 between 0.4 and 0.6, the culture was put immediately on 
ice. All subsequent steps were conducted on ice. The 200 ml culture broth was 
divided into 50 ml falcon tubes followed by centrifugation at 5000 rpm for 5 minutes. 
The cell-free supernatant was discarded and the resulting cell pellet was 
resuspended in 25 ml of 10% glycerol and sedimentation. The cell pellets were 
washed twice with 10 ml of 10% glycerol. The two tubes were combined and added 
with 5 ml of 10% glycerol to a volume of 25 ml.  After centrifugation at 5000 rpm for 
5 min, the cell pellet was resuspended in 5 ml of 10% glycerol followed by 
centrifugation. The cell pellet was resuspended in 1 ml of 10% glycerol. The cell 
suspension was distributed to eppendorf tubes (each eppendorf tube contained 70 
µl) and immediately shock-frozen in liquid nitrogen followed by storage at -80 °C. 
4.2.4.2  Electroporation 
This electric transformation termed “electroporation” was initially used for E. coli by 
Dower et al. (1988) and Calvin & Hanawalt (1988) by subjecting concentrated cell 
suspensions and vector DNA to electrical fields at a very high amplitude. Because 
electroporation is simple and fast, it becomes a regular method of choice for 
bacterial transformation in many laboratories, not only using small DNA molecules 
but also large molecules such as DNA from bacterial artificial chromosomes (BAC), 
ranging from 7 to 240 Kb as reported by Sheng et al. (1995). The electroporation 
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procedure we used was based on that described by Sambrook and Russel (2001). 
At first, one vial (70 µl) of electrocompetent E. coli cells per transformation was 
taken from –80 °C freezer and thawed on ice. The pulser was set to “bacteria” (i.e. 
1.8 kV). The ligation mixture (1-10 µl) was added to a vial of cells, and mixed gently 
by pipetting up-down three times. The suspension was transferred to an ice-cold 2 
mm cuvette and placed into the cuvette holder of the pulser Bio-Rad electroporator 
set at 2.5 kV. The “flash” button was pushed to create electric current. The cuvette 
containing cell suspension was immediately added 1 ml LB, mixed and transferred 
into an empty 1.5-ml eppendorf tube, incubated at 37 °C with shaking for 1 hour. 
4.2.4.3 Lac-based clone selection 
Lac selection is based on the use of an antibiotic and x-Gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside) and IPTG (isoprophylgalactoside). Clones harboring 
no insert appear blue on the selective media because lacZ´ gene on the vector is 
not disrupted, and as a consequence such gene is expressed to produce β-
galactosidase that breaks the x-Gal down to a deep blue colored product.  IPTG 
here functions as an inducer of the enzyme. The colonies with a disrupted lacZ´ 
gene are unable to produce β-galactosidase, and therefore they look white on the 
selective media (Brown, 2006).  For Lac selection, at first a LB plate containing an 
appropriate antibiotic was spread with 40 µl of 20 mg/ml X-Gal and 40 µl of 0.1 M 
IPTG. Then 100-300 µl of 1 ml transformed cell suspension (section 4.2.12) was 
spread on an LB plate containing antibiotic as well as IPTG and X-Gal. The plate 
was incubated at 37 °C overnight. Some white colonies were picked up and 
individual colonies were cultivated in 5 µl LB containing appropriate antibiotic. The 
plasmid from each culture was prepared (Section 4.2.1.3). The presence of inserts 
was then checked by enzymatic digestion (section 4.2.3.1). 
4.3 Molecular Diagnostics of Key Biosynthetic Genes (methods for chapter 3, 
section 3.1) 
Detection of polyketide and non-ribosomal peptide biosynthetic genes in this work 
was performed by PCR using primers based on KS and A domains, respectively. 
This consists of (i) isolation of metagenomic DNA, (ii) PCR amplification of 
biosynthetic key genes, (iii) cloning of PCR products, and (iv) clone selection and 
analysis. Primers were specifically designed and employed to target certain A 
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domain encoding sequences. Subsequent cloning of the PCR products was 
streamlined using TA-cloning (Clark, 1988).  
4.3.1 Isolation of metagenomic DNA from a sponge sample 
Most sponges contain polysaccharides in their tissue (Bucior and Burger, 2004; 
Parish et al., 1991; Esteves et al., 2011). The polysaccharides can co-precipitate 
with the isolated DNA and may inhibit enzymatic reactions in DNA modifications 
(Kaufman et al., 1999). Therefore removing polysaccharides is very important step 
when dealing with obtaining pure DNA from a sponge sample. The 
cetyltrimethylammonium bromide (CTAB)-based DNA isolation procedure modified 
by Piel et al (2004b) was found very useful to remove polysaccharides from the 
sponge cell extract (Schirmer et al., 2005; Hrvatin & Piel, 2007; Gurgui & Piel, 
2010). In solutions of high ionic strength, CTAB is a cationic detergent that can bind 
nucleic acids to form an insoluble complex, leaving polysaccharides and proteins 
(Jones and Walker, 1963). The presence of NaCl can break the complex down, 
thereby leaving nucleic acids that can be concentrated by ethanol precipitation 
(Rogers & Bendich, 1985; Wilson, 2001). This CTAB procedure was subsequently 
optimized by adding lauryl sarcosyl and urea to improve cell wall lysis. CTAB and 
NaCl solution are added at concentrations of more than 0.5 M to remove the 
polysaccharides (Hrvatin & Piel 2007; Gurgui & Piel, 2010). 
 
The following CTAB-based DNA isolation protocol was applied in our work to obtain 
total DNA from one gram of a sponge sample (Hrvatin & Piel 2007; Gurgui & Piel, 
2010). At first, the sponge sample (1 gram) was cut into small pieces. The sample 
pieces were pulverized in the mortar under the liquid nitrogen and the nitrogen was 
evaporated. The homogenized sample was immediately transferred into a 50 ml 
Facon tube and suspended with 10 ml of lysis buffer (50 mM Tris-C  pH 7.5, 50 mM 
EDTA, 700 mM NaCl, 2% Sarkosyl, 8 M EDTA), followed by a 10-min incubation at 
60 oC. The cell suspension was extracted two times with an equal volume of 
phenol/chloroform/isoamylalcohol (in ratio 25:24:1) and centrifuged at 11.000 rpm at 
5 min for each extraction. The upper layer was transferred into an empty tube and 
the remaining phenol was removed by adding an equal volume of chloroform. CTAB 
(previously warmed at 55 oC for 15 min) was added to the final concentration of 
0.5%, mixed carefully and incubated at 60 oC for 10 min. The CTAB-treated extract 
was then centrifuged at 11,000 rpm to precipitate the polysaccharides. The 
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polysaccharide-free supernatant were subsequently added with 2 volumes of 100% 
cold ethanol, mixed gently by inverting the tube several times, stored at -20 oC for 
30 min to improve the DNA precipitation, and centrifuged at the maximal speed (4 
oC) for 30 min to precipitate the DNA. The resulting DNA pellet was washed two 
times with 70% ethanol to remove the remaining salts and CTAB traces, dried 
through air flow, and dissolved in 200 µl of ddH2O or EB buffer (EDTA 10 mM, Tris-
Cl 50 mM, pH 7.0). 
4.3.2 PCR amplification of biosynthetic genes  
The total DNA obtained by the CTAB-based DNA isolation protocol described above 
(Section 4.3.1) can be used as the template for PCR amplification. In our 
experiences, total DNA isolated from sponge tissue often gives variable results in 
PCR amplification due to the impurities in DNA preparation that can inhibits DNA 
polymerase activity. To solve this problem, a series of PCR reactions containing 
different dilutions (1/10, 1/100, and 1/1000) of the extracted DNA was set up. Each 
sample dilution was then used as the template for PCR optimization. The PCR 
composition used for the amplification of KS or A domain genes were based on the 
protocol described in the Section 4.2.2.2 for crude sponge DNA. As an alternative, 
the extracted DNA was purified by gel purification (PegLab, Epicentre). 
Subsequently the purified DNA was used for PCR amplification (section 4.2.2.2 for 
purified sponge DNA).  
 
To simplify PCR detection of target biosynthetic genes, we used the uncultured 
bacterial fraction as the PCR template. The filamentous bacterial fraction obtained 
was mainly dominated by large filamentous cells “Candidatus Entotheonella sp.“ 
based on microscopic observation. The bacterial fraction was prepared from the 
sponge T. swinhoei chemotype W through differential centrifugation (Piel et al., 
2004b). This mechanical separation was not only intended to reduce the complexity 
of the sponge symbiotic assemblage but also remove polysaccharides. The 
symbiotic cell pellet was stored in 1 ml ethanol at 4 oC. To detect the PKS/NRPS 
genes in the fraction, whole cell PCR amplification was performed. At first a small 
amount of cell suspension previously stored in ethanol were rinsed 3 times with 
sterile ddH2O. The rinsed cell pellet was then used as template for the PCR-
amplification (Section 4.2.2.2 for bacterial cell suspension). The oligonucleotides 
used for the PCR amplification of KS genes were based on two highly conserved 
motifs in the KS domain: DPQQ and HGTGT (Piel, 2002). The degenerate KS 
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primer pair, designated as KSDPQQF and KSHGTGR (Table 4.3.1), was applied for 
the PCR amplification of KS fragments using total sponge DNA. 
Table 4.3.1 Existing primers used in identifying KS sequences 
Primer Ort Sequence (5`-3`) 
Target 
motif 
Tm 
(
o
C) 
Reference 
KSDPQQF For MGNGARGCNNWNSMNATGGAYCCNCARCANMG DPQQ 
58 Piel (2002) 
KSHGTGR Rev GGRTCNCCNARNSWNGTNCCNGTNCCRTG HGTGT 
 
To clone the A domain sequences, three degenerate primer pairs based on the 
adenylation catalytic motifs (A2-A8, A2-A9 and A3-A7) (Marahiel et al., 1997) were 
used (Table 4.3.2). Those three primer pairs were checked and optimized first using 
the genomic DNA of Bacillus amyloliquefaciens B42 as the PCR-template. All of the 
three tested primer pairs gave PCR products of the expected sizes (~700 bp, ~950 
bp, ~1200 bp). The genomic DNA was prepared according to the protocol described 
in Section 4.2.1.2. 
Table 4.3.2 Existing primers used in identifying adenylation domain-encoding genes 
Primer Ort Sequence (5`-3`) Target Tm (
o
C) Reference 
JP-for 
JP-rev 
For 
Rev 
GCN GGN GGN GCN TAY GTN CC 
CCN CKD  ATY TTN  ACY TG 
A2 NRPS 
A8 NRPS 
58 Rolf Müller 
Öz-for 
Öz-rev 
For 
Rev 
- 
- 
A2 NRPS 
A9 NRPS 
55 
Provided by 
Özlem 
AG-for 
AG-rev 
For 
Rev 
GCS TAC SYS ATS TAC ACS TCS GG 
SAS GTC VCC SGT SCG GTA S 
A3 NRPS 
A7 NRPS 
61 
Ayuso-Sacido & 
Genilloud (2005) 
 
To target sequences coding for the A domains activating serine, we designed a 
series of degenerate primers based on the unique motifs located between A4-A5 on 
the serine-specific adenylation (SerA) sequences (Marahiel et al., 1997). At first, 
sequences of some A domain sequences with serine specificity as well as those 
with other amino acid specificity from different biosynthetic gene clusters were 
initially retrieved from the GenBank and subsequently aligned together in BioEdit 
(Hall 1999) using Clustal W program (Thompson et al., 2007). The unique 
conserved motifs responsible for serine specificity located on the A4-A5 region were 
identified and used as the basis for designing degenerate primers (see Figure 3.1.8, 
Chapter 3). All of the designed primers are listed in Table 4.3.3.  
Table 4.3.3 NRPS primers targeting certain A-domain sequences 
Primer Ort Sequence (5`-3`) Target Reference 
A4F1 
A4F2 
For 
For 
TTY GAY GTN AGY GTN TGG GAR TT 
TTY GAY GTN TCN GTN TGG GAR TT 
SerA (with A5R1 or A5R2) 
SerA (with A5R1 or A5R2) 
In this work 
 
A5R1 
A5R2 
Rev 
Rev 
TCN GTN GGN CCR TAN RRT TRT G- 
YTV YTN STN ACR TCN CAN GCN GC 
SerA (with A4F1 or A4F2) 
SerA (with A4F1 or A4F2) 
In this work 
 
A4AsnF 
A5AsnR 
For 
Rev 
TTY GAY YTN CAN GTN CAN WSN ATH 
CAT RCA NCC NAC NAC NGY RCT NGT 
AsnA (with A5AsnR) 
AsnA (with A4AsnR) 
In this work 
 
TH-for 
TH-rev 
For 
Rev 
ATHTGYGGNGGNGGNYTNGCNGGN YT 
AR NGG DAT NRD CCA NAC CCA RTA 
Tryp halogenase gene 
Tryp halogenase gene 
In this work 
 
Notes: ort, orientation; For, forward; Rev, reverse 
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The designed degenerate KS-specific primers were used using total DNA from a 
sponge as the PCR template. Since none of the amplicons likely falls to into the 
group of complex polyketides, uncultured filamentous bacterial fraction prepared 
from the same sponge was used as the PCR template. The designed degenerate 
NRPS primers were also applied using filamentous bacterial fraction as the PCR 
template (section 4.2.2.2 for bacterial cell suspension).  
 
4.3.3 Cloning of PCR products into T vectors 
Subsequently the amplified products with the desired size were checked on a 1 % 
agarose gel. If a single target fragment appears on the gel, the PCR product can 
directly be purified by using IllustraTM GFX PCR DNA and Gel Band Purification Kit 
(GE Healthcare). The purified PCR products with around 700-bp were ligated into a 
T-vector (Section 4.2.3.5). The T-cloning vector was prepared (Section 4.2.3.2).  
The ligation products were transformed into competent XL-Blue MRF` cells via 
electroporation (Section 4.2.4.2). The competent cells of E. coli XL-Blue MRF` used 
in this work were prepared by washing the cells several times with glycerine to 
remove the salts from the growth media. The prepared competent cells were 
suspended in 10% glycerol and stored at -80 oC. The transformed cells were grown 
overnight on the LB plates containing ampicilin, X-Gal and IPTG, thereby allowing 
Lac selection (Section 4.2.4.3). Some white colonies were picked up and cultivated 
in liquid media. The plasmid DNA was then extracted from the individual 
recombinant cultures (Section 4.2.1.3) and checked for the presence of the right 
insert (Section 4.2.3.1) 
4.3.4 Clone analysis and sequencing 
Each clone with the right insert was subjected to restriction fragment length 
polymorphism (RFLP) analysis using RsaI or another frequently cutting enzyme 
(Section 4.2.3.1). Inserts showing a unique restriction pattern were sequenced. 
Sequencing of some DNA samples was conducted at GATC Biotech AG service or 
4baseLab on an ABI 3730xl DNA Analyzer (Applied Biosystems) using the dideoxy 
mediated chain termination method (Sanger et al., 1977). The employed dideoxy 
nucleotides were linked with four fluorescent dyes, each base type carrying a 
specific colour. Therefore the nucleotide sequences were determined by means of a 
fluorescence detector subsequent to sample separation via capillary electrophoresis 
in a polyacrylamide matrix (Sambrook & Russel, 2001). The sequence data obtained 
Chapter 4 Methodology 
__________________________________________________________________________________ 
151 
 
were analyzed using BlastX to predict their functional properties in relation to the 
correspondent target compounds. This advanced BLAST X program was used to 
search a protein database provided on-line by NCBI using a translated nucleotide 
query that provides information about putative gene products and their functions 
(Altschul et al., 1997). Based on the data, specific PCR primer pairs were 
subsequently designed, which were further employed for screening of highly 
complex metagenomic libraries.  
4.4 Construction and Screening of Complex Metagenomic Libraries (methods 
for chapter 3, sections 3.2 and 3.3) 
To capture the majority of bacterial pathways present in the sponge, a metagenomic 
library needs to be generated as large as possible in order to make sure that the 
biosynthetic pathway of interest is entirely covered in the library. The technical 
challenges in generating a complex metagenomic library containing clones with 
relative large inserts include obtaining pure HMW metagenomic DNA (in the size 
range of 35 to 50), the stability of the cloned large fragments, amplification of clones 
in the library in a high density, and rapid screening of a highly complex library. 
 
Construction of genomic library was initially tested using the cultured cells 
Acinetobacter baylyi ADP1. Genomic DNA was initially prepared from this bacterium 
(Section 4.2.2) and subsequently cloned into E. coli. Clone amplification was done in 
the microtitter plates instead of in the semiliquid media since this library was 
generated from a single bacterial genome. This was initiated by transferring 400 
clones from the petri dishes into microtiter plates. After overnight incubation, 
individual culture in the same rows were pooled and be then screened by PCR. The 
clones which correspond to the positive row pool(s) were individually screened to 
detect single positive clones. A library construction steps optimized for the cultured 
cells Acinetobacter baylyi ADP1 were applied for the uncultured bacterial fraction. 
For this fraction, the resulting recombinant clones were generated and amplified in 
3-D fomat termed “semi-liquid library” as described by Hrvatin and Piel (2007). Since 
no complex biosynthetic gene cluster was identified in this small library and 
enlarging the library size was not possible due to the extremely limited amount of 
the existing uncultured bacterial sample, the library construction was subsequently 
carried out using total DNA of the T. swinhoei sponge specimens from which the 
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uncultured bacteria were derived (Sections 4.4.1-4.4.5). With this sponge sample, 
the library size could be expanded up to around 350,000 clones. 
 
This section describes methods used in this work for the construction of complex 
metagenomic libraries from the sponge T. swinhoei. Generating a fosmid library was 
initiated by purification and size selection of the HMW DNA (Sections 4.4.1 & 4.4.2) 
followed by repair of the DNA fragment ends (Section 4.4.2). Subsequently the 
repaired DNA was joined with a dephosphorylated fosmid (Section 4.2.3.5) and 
packed into phage particles (purchased from Epicentre). The packaged viral 
particles were used to transfect E. coli (Section 4.4.3). The resulting infected cells 
were amplified in the semi-liquid media, producing complex 3-D cultures (Section 
4.4.4) (Fig. 4.4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4.1 Construction of metagenomic library. HMW DNA is prepared from either sponge 
or its associated bacteria and be separated by electrophoresis on low-melting-point (LMP) 
agarose gel. DNA fragments with desired size (~40 Kb) are purified from the gel, repaired 
at both termini, and ligated with dephosphorylated fosmid molecules. The ligation products 
are packed in bacteriophage particles and used to infect E. coli. The resulting library can 
be amplified in semi-solid media. 
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4.4.1 Isolation of high-molecular-weight (HMW) metagenomic DNA 
There are three main important things that we considered in isolating metagenomic 
DNA for library construction: the DNA quality, size, and yield.  The methods 
described below were used in this work to meet these three criteria as a prerequisite 
for generating a complex metagenomic library.  Obtaining pure HMW DNA from a 
sponge sample was based on the CTAB-based DNA isolation as described 
previously (Section 4.2.1.2). DNA isolation from this filamentous fraction was 
performed using a simple heat treatment described by Syn and Swarup (2000) 
(Section 4.2.1.2).  
4.4.2 Size-selection and end-repairment of HMW DNA fragments  
The DNA fragments obtained either from a sponge sample or a bacterial cell pellet 
were separated b low-melting point (LMP) agarose gel electrophoresis in order to 
remove the remaining contaminants including RNA. However, handling a LMP gel 
before and after electrophoresis is difficult because the LMP gel is easily broken. By 
making two gel layers consisting of standard agarose gel (lower layer) and LMP gel 
(upper layer) (Sambrook & Russel, 2001) as shown in this work, the LMP gel break 
can easily be prevented.  The desired large fragments with the average size of 40 
kb are subsequently recovered from the gel either by enzymatic gel extraction using 
GELase or by column-based gel extraction. GELase commercially provided by 
Epicentre contains β-agarose-digesting enzyme that is able to break down the 
carbohydrate backbone of LMP gel, thereby releasing small, soluble 
oligosaccharides (http://www.epibio.com/item.asp?id=297). The standard agarose 
gel here serves as a support to strengthen the LMP gel. In addition, obtaining large 
DNA fragments (at least 30 kb) is necessary for subsequent construction of a 
metagenomic library based on fosmids and cosmids. 
 
The following procedure was used in this work to select DNA fragments of around 
40 kb (Epicentre, Gurgui & Piel, 2010). At first, a large well on an electrophoresis gel 
comb was made by covering the small wells with a clear sticky tape. The large well 
was flanked by two small ones, which are used for loading the DNA size marker. An 
agarose gel without ethidium bromide was prepared in two layers. The first layer 
was prepared by pouring 1% standard agarose exactly below the comb`s wells on 
the electrophoresis` template. When completely solidified, the comb was place on 
the surface of the first layer and 1% LMP agarose was poured on it. The functions of 
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the first layer are (i) to support the LMP layer, thereby avoiding it from breaking, (ii) 
to minimize the amount of the expensive LMP agarose required, and (iii) to reduce 
the thickness of the gel slice taken out. The DNA control of 36 kb was loaded into 
the two small wells flanking the large well. Then the DNA sample was uniformly 
loaded into the large well. The electrophoresis was run first at 70 V for 10 minutes to 
allow the DNA entered the gel. ~100 ng of 40 kb (or 36 kb) control DNA was loaded 
into each of the outside lanes of the gel. The isolated DNA was loaded in the lane 
between the 40 kb control DNA marker lanes. The gel electrophoresis was first run 
for 15 minutes at 60-70V and then overnight at 40-50V. Using a sharp razor blade, a 
2 cm slice of gel was removed from both the left and the right sides of the gel. The 
edge pieces were stained with 1 µg/ml ethidium bromide solution. Two water baths 
were set up, one at 45 °C and the other at 70 °C. The band of HMW DNA in the 
stained edge slices of gel was located using a UV light.  The position of the top and 
the bottom of the 40 kb marker was marked on each gel slice. Using the marks, the 
stained side pieces was put as guides to locate the band of HMW DNA in the 
unstained portion of the reassembled gel (Epicentre, Gurgui & Piel, 2010).   
 
The DNA repairing step is very important because the ends of the DNA fragments 
obtained by extraction and purification are fray or not blunt without phosphate 
residues. Therefore the DNA fragment termini were repaired prior being used for a 
blunt ligation. The end-repairing enzyme mix contains T4 DNA polymerase to fill the 
recessed 3` termini and remove the protruding 3` termini, thereby converting the 
frayed ends into blunt ends. The hydroxyl group at the 3` termini is converted to a 
phosphate group using terminal phosphotransferase that is also present in the end-
repairing enzyme mix (Brown, 2006). The following protocol was used in this work to 
repair the ends of the isolated HMW DNA fragments (Epicentre, Gurgui & Piel, 
2010). The following components were put into a 1.5 ml eppendorf tube: sterile 
dH2O (up to the final volume of 40 µl), 4 µl of 10x end-repair buffer, 4 µl of 2.5 mM 
dNTP mix, 4 µl of 10 mM ATPs, HMW genomic DNA (2.5-5.0 µg), and 2 µl of end-
repairing enzyme mix. All resulting bubbles were removed and the reaction was 
incubated at room temperature at exactly 45 minutes. The reaction was then 
inactivated by adding 1.6 µl of 500 mM EDTA (up to final concentration of 10 mM), 
followed by incubating at 70 oC for 10 min. The DNA was recovered by isopropanol 
precipitation, and then dissolved in 20 µl of EB buffer (Qiagen). The concentration of 
the blunt-ended DNA was determined by running 0.5–1 µl on an analytical 1% 
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agarose gel with known amounts of Fosmid Control Insert DNA (Epicentre, Gurgui & 
Piel, 2010). 
4.4.3 DNA packaging and transfection 
To deal with the instability problem of the cloned large fragments, a high-capacity 
vector that is present in low copy number was used in this work to clone large DNA 
fragments in the range of 30-40 kb. Using a low copy number vector not only 
maintains the stability of large inserts but also reduces significantly undesired 
modifications such as rearrangements and deletions as has been shown by Kim et 
al (1992) for complex mammalian genomic DNA inserts. The fosmid vector termed 
pCC1FOS was purchased from Epicentre. The low copy number (1-2 copies per 
cell) in the fosmid-based clones is controlled by the F factor system present in 
pCC1FOS. The presence of an oriV replication origin allows the copy number to 
increase to about 10-50 copies per cell under the condition when the vector is 
introduced into an appropriate host harboring a trfA gene, such as EPI300TM T1R. 
The trfA transcription is controlled by the araC-PBAD promoter/regulator system. 
Since this system is inducible by L-arabinose, the DNA yields can be increased by 
adding this sugar into the growth media (Westernberg et al., 2010, Epicentre, Wild 
et al., 2002). High yields of a cloned DNA are required especially for applications 
such as subcloning, sequencing, and recombination. The library construction steps 
using pCC1FOS followed the method described by Epicentre, which was 
subsequently optimized by Gurgui and Piel (2010).  
 
The following procedure was used in this work DNA packaging (Epicentre, Gurgui & 
Piel, 2010). Five mL of LB broth containing 10 mM MgSO4 was inoculated with a 
colony of EPI300-T1R E. coli cells (Epicentre) a fresh plate, and incubated overnight 
at 37 °C in shaking incubator (at 200 rpm). On the next day, the 5 mL overnight 
culture was inoculated into 50 mL of LB broth containing 10 mM MgSO4 and 
incubated at 37 °C with shaking (200 rpm). When the OD600 reached 0.8–1.0, the 
culture was stored at 4 °C until it is needed. One tube of the MaxPlax lambda 
packaging extracts (Epicentre) was thawed, and half of its volume (25 µl) was 
immediately transferred to a 1.5-mL microcentrifuge tube placing on ice. The 
remaining 25 mL of the MaxPlax Packaging extract was placed back to the −80 °C 
freezer for later use. The ligation reaction (10 µl) was added to the thawed extracts, 
mixed gently by pipetting the solutions up and down several times. The packaging 
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reaction was incubated at 30 °C for 1.5 hours in the water bath, and then added with 
the remaining 25 mL of MaxPlax lambda packaging extract. After incubating the 
reaction for an additional 90 min at 30 °C, PDB buffer was added to the final volume 
of 1 ml and mixed gently. The packaging reaction can be stored at 4 °C until 
needed. Before plating the library, the titer of the phage particles was determined to 
predict the number of clones inside the library. Serial dilutions of the 1-ml packaged 
phage particles was made using phosphate dilution buffer (PDB) buffer, ranging 
from 10 to 1000 times with the interval of 10. Then 10 ml of each dilution was added 
to 100 mL of EPI300-T1R E. coli host cells prepared before, followed by incubation 
for 20 min at 37 °C in a water bath. The remaining cell culture was stored at 4 °C 
until the 2nd day, as they will be used again when plating the entire library. The 
infected EPI300-T1R E. coli culture was spread on LB plates containing 12.5 µg/µl of 
chloramphenicol. The number of colonies was accounted and the titer of the 
packaged phage particles with the formula was calculated by multiplying the colony 
number with dilution factor and subsequent multiplying the calculation result with 
100 (Epicentre, Gurgui & Piel, 2010). 
4.4.4 Amplification and screening of 3-D libraries 
Screening of a complex metagenomic library containing a large number of clones 
requires effective methods that can be used rapidly at a high-throughput format. The 
resulting library can be generated in different formats, usually on plates or 
microtitters. However, libraries on agar plates cannot be stored for a longer time. As 
an alternative, clones growing on a plate can be combined into pools. These pools 
can be mixed with glycerol and stored at -80 oC for a long time. All clone pools can 
be screened by PCR. The positive pools are plated out at low colony number and 
rescreened until a single clone is detected (Piel, 2002). However, this approach is 
only effective for medium-sized metagenomic library (less than 100,000) (Hvartin & 
Piel, 2007). Another way is transferring individual clones from agar plates into 
microtiter wells, and subsequent screening of clone copies either by PCR or 
hybridization. Using this approach, glycerol can be added to the microtiter plates 
and then stored in the freezer for later screening. However for a highly complex 
library with a large number of clones, this is inefficient because it needs a lot of 
microtiters, lots of picking and larger storing space. In addition, performing 
hybridization by directly blotting individual colonies from agar plates onto Nylon 
membranes is not efficient because very large numbers of expensive membranes 
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are necessary for metagenomic screening (Uria & Piel, 2009). Recently Hrvatin and 
Piel (2007) have developed an elegant method for screening of a complex 
metagenomic library, which is highly economic in terms of labor, consumables and 
required space. The method termed a liquid gel pool analysis involves the 
construction of a metagenomic library in a 3-D semiliquid format, followed by rapid 
screening by whole-cell PCR.  
 
This library amplification described below allows growing well-separated clones at 
high densities (approximately 1000 clones/ ml). All the clones are organized into 
pools, in which each pool contains approximately 1000 clones in one ml semi-liquid 
medium (Hvartin and Piel, 2007). The following library amplification was based on 
the procedure described by Hvartin and Piel (2007) and Gurgui and Piel (2010). 
Sterile 2 ml screw cap vials as well as LB media containing 0.5% SeaPrep Agarose 
(Lonza, Switzeland) were at first prepared (Table 4.5). It is required one tube for 
each 100-1000 clones. One liter of media can be used to grow approximately 106 
colonies.  500 μl of the packaged DNA was added into 5 ml of the EPI300T1R 
culture (OD600 of 0.8-1.0) in a 50 ml Facon tube, and then mixed gently by using a 
10 ml Pasteur pipette. The mixture was incubated at 37 oC for 20 minutes. 35 ml of 
the LB medium containing SeaPrep Agarose was added into the transfected 
EPI300T1R culture and mixed slowly by a Pasteur pipette. Chloramphenicol solution 
was added to a final concentration of 12.5 μg/ ml and then mixed gently by using a 
Pasteur pipette. 100 μl of the transfected cell culture mixed with SeaPrep Agarose 
was plated on the LB media containing 12 μg/μl of chloramphenicol, and incubated 
at 37 oC overnight. The number of colonies on each plate was counted. The 
remaining 40 ml SeaPrep medium was distributed into screw-capped vials (1 ml in 
each vial), incubated on dry ice for 1 hour and subsequently at 37oC overnight. 
Colonies were clearly visible (even after 10-12 hours) as spatially growing in the 
complete volume of the media. Each screw-capped vial was mixed by vortexing until 
the suspension becomes homogenous (5 seconds) (Hvartin & Piel, 2007; Gurgui 
and Piel, 2010). 
 
To obtain the complete biosynthetic pathway of a complex polyketide or 
nonribosomal peptide, it usually needs more than one clone to cover the entire gene 
cluster involved in the biosynthesis. This can be performed by the homology-based 
screening relying on the ability of the sequence or probe to specifically recognize the 
target biosynthetic pathway. The following screening procedure was based on the 
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method described by Hvartin & Piel (2007). The library constructed in this work was 
grouped into pools that are arrayed in three boxes. In box 1, the clone density of 
each pool is ~4000 cfus/ ml. In boxes 2 and 3, the clone density per pool is ~500 
cfus/ ml and ~1000 cfus/ ml, respectively. For screening of the library to find 
individual positive clones, a small aliquot of all individual pools were combined 
together to super-pools that were then screened by whole-cell PCR. Pools 
corresponding with a positive super-pool were subsequently screened by PCR. 
Below is an example about how to calculate the volume of pool aliquot required for 
cell dilution. 
 
 Clone diversity Clone density 
Pool: 4000 cfus/ml/tube 2 x 10
8
 cells/ml/tube (OD600 overnight) 
        5x dilution         10
3
 x dilution 
Subpool: 800 cfus/ml/tube 2 x 10
5
 cells/ml = 2.5 x 10
4
 cells/125 µl 
          + 30 ml of 0.6% Seaprep medium 
          + 15 µl of 25 mg/ml Chloramphenicol 
          mixed well 
            100 µl of aliquot was plated 30 ml cell suspension in a 50 ml facon tube 
                                        O/N at 37 
o
C         distributed in 1 ml screw-capped vials 
 Number of colonies on a plate: ~100 
 
        Incubated 1 hour on dry ice, then O/N at 37 
o
C 
 Total colony number: ~1000 cfus/ml         10 µl aliquot was taken from each vial 
  1 µl for PCR screening by whole cell PCR 
 
The resulting positive clone pools were then diluted in new tubes at lower cell 
density and re-screened by PCR. Pool dilution was performed in the same way as 
described above. Combination of cell dilution and PCR screening until the clone 
density was ~20-40 cfus/ml. Then colonies were plated at the density of around 200 
cfus/ plate. Colony PCR was then carried out to isolate a single positive clone. The 
specific primers used for library screening was designed based on the sequence 
data of PKS-KS and NRPS-A genes cloned from the filamentous fraction of T. 
swinhoei (Tables 4.4.1 to 4.4.3).   
 
Table 4.4.1 Specific primers based on sequences for serine-specific adenylation domains of NRPS 
Spesific Primer Sequence (5`-3`) Lenght (bp) GC (%) Tm (
o
C) 
A3-F 
A3-R 
CCCGAAGGCCATCAGGATCCGAGTTAT 
TGTGGGGCCGTAGAGGTTGTGTAGTTC 
27 
27 
56.0 
56.0 
67.0 
64.0 
B2-F 
B2-R 
AGTGCTTACCTGGTGCGTCTGCT 
GTGGGGCCGTAAAGGTTGTGTA 
23 
22 
59.0 
57.5 
59.0 
57.5 
D1-F 
D1-R 
TTTTCTGGCCGTTGATGAGCG 
GTGTGGGGAAGTAGATGGGCTGATT 
21 
25 
59.7 
58.4 
59.7 
58.4 
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Table 4.4.2 Specific primers based on sequences for cis-AT KS domains of PKS gene cluster  
Spesific Primer Sequence (5`-3`) Lenght (bp) GC (%) Tm (
o
C) 
EtP5-F 
EtP5-R 
TCAGGGCTTGATCGGGGTGTATG 
CGTCTAAACTCGGGGCGGTGAA 
23 
24 
57.0 
59.0 
58.8 
58.6 
 
Table 4.4.3 Specific primers designed based trans-AT KS domains to screen the library  
Spesific Primer Sequence (5`-3`) Lenght (bp) GC (%) Tm (
o
C) 
EKS27-f 
EKS27-r 
CTTGGGCCGCGTTGGAAGAT 
CCGCTTCGCCAAGCACAAAG 
20 
20 
55.7 
55.3 
60.0 
60.0 
EKS31-f 
EKS31-r 
TTGAAGATGCGGGGCATGCC 
TGGGACAAAGCCATCCGCAC 
20 
20 
60.0 
60.0 
57.4 
55.3 
EKS37-f 
EKS37-r 
TGATTGGTTCCGCGTTGCACA 
GGTGCCGTGGGTTTCGATATAGCTA 
21 
25 
52.4 
52.0 
56.7 
56.1 
EKS50-f 
EKS50-r 
GACCCGCAGCAGCGTATGTT 
TTTTGCAGCGCCCATCCTG 
20 
19 
57.4 
59.2 
60.0 
57.9 
EKS64-f 
EKS64-r 
ACCCGCAGCAGCGCTTACTGTT 
ATCCAAGAGCGTATCCGGGGAC 
22 
22 
59.1 
59.1 
61.8 
60.0 
Et-KS2-F  
Et-KS2-R 
GGCCCGAGTTTTGCCCTTGATACC 
TCTCCTAGCGATGTGCCGGTGCC 
24 
23 
58.0 
65.0 
61.0 
62.0 
Et-KS3-F  
Et-KS3-R 
ATCGACTACAATCTTCTTGCGCGC 
GATCGCCCAGTGAGGTTCCGGT 
24 
22 
50.0 
64.0 
57.0 
60.0 
Et-KS5-F 
Et-KS5-R 
TAGCGAGGCGGTGCCGATGGAC 
GGTCGCCAAGGGAGGTGCCCGT 
22 
22 
68.0 
73.0 
62.0 
64.0 
 
4.4.5 Chromosome walking, fosmid analysis and sequencing 
Once a part of a target gene cluster is isolated, the remaining parts can be searched 
by chromosome walking. Particularly, the biosynthetic gene clusters investigated in 
this work were large up to hundreds of kilobase pairs. To find the remaining up- and 
down-stream parts of the gene cluster, specific primers (Table 4.4.4) were designed 
based on the end sequences of the previously isolated fosmid and employed to 
screen the additional portions of the gene cluster. This process was repeated until 
all target genes were isolated. 
Table 4.4.4 Primers for chromosome walking to find additional regions of misakinolide A gene cluster 
Spesific Primer Sequence (5`-3`) Lenght (bp) GC (%) Tm (
o
C) 
EKS27FP-f 
EKS27FP-r 
TGAATCAGCATATGGGCATTGGTGC 
TGGTATTAAAGCGCCTTAGCCGAGC 
25 
25 
48.0 
52.0 
58.4 
57.4 
EKS27RP-f 
EKS27RP-r 
TAGAGCATCCGGGATTTTCCTG 
AGTTGTTCACACGCGGGTGTTC 
22 
22 
50.0 
54.5 
52.0 
53.5 
EKS27FP2-f 
EKS27FP2-r 
GGACCGCACGTGGTTCTTTTCTGTGAA 
TGGAGGTCAACGCCCTTAACGAAGTCT 
27 
27 
51.9 
51.9 
61.5 
59.6 
PEP-f 
PEP-r 
GATGAGTGGTCAAGCCTGTGTCGTGAA 
CGCTATGAATTTGCTGCTGTACAACCAC 
27 
28 
51.9 
46.4 
59.1 
57.6 
AT-f 
AT-r 
CAACGTCTTTAAATGTCAAAACATCATCGC 
GATGACCTCTTCATCAGAGACTTGCAAAA 
30 
29 
36.7 
41.4 
57.6 
56.0 
 
 
 
Chapter 4 Methodology 
__________________________________________________________________________________ 
160 
 
A positive clone isolated from a metagenomic library need to be analyzed further in 
order to know whether it harbors a biosynthetic pathway of interest or not. The clone 
to be analyzed were initially prepared by a scaled-up standard miniprep and 
subsequently treated with ATP-dependent DNase provided by Epicentre 
(http://www.epibio.com/) to digest the linear host chromosomal DNA. The activity of 
this enzyme has no effect on nicked or closed-circular dsDNA, thereby leaving 
circular fosmid molecules that are relatively free of host chromosomal DNA. The 
pCC1Fos vector backbone of the purified clone can be removed by treating it with 
rare-cutting enzyme(s) such as NotI. The clone analysis in this work was initiated by 
end-sequencing and sometimes sub-cloning (Sections 4.2.3 & 4.2.4), followed by 
complete sequencing and bioinformatic analysis. The sequencing reads were 
assembled into contigs. The gaps between contigs were filled by primer walking, 
resulting in a continuous sequence. The primers used for filling in the gaps were 
designed to flank the gaps, as listed in Table 4.4.5 for PKS gene cluster and Table 
4.4.6 for NRPS gene cluster, which are complementary with the regions located 
approximately 100-200 bp from the ends of each contig library.  
 
Table 4.4.5 Specific primers for filling the gaps in the misakinolide A gene cluster 
Spesific Primer Sequence (5`-3`) Lenght (bp) 
1AU5.3-r 
1AU2.2-f 
GGCAAAGACTGTATTAGCGACGTGC 
CGACACAGGCTTGACCACTCATC 
25 
23 
2AU2.1-r 
2AU2.1-f 
GAATGAAGCCACCCAAGTGCGC 
CCTCCCGCTGAGGACAATAACTG 
22 
23 
3AU5.2-r 
3AU5.2-f 
GTGCAACGATAGGTTGACGCCTC 
CAATATTGGCCATACGGAGTCGG 
23 
23 
4AU5.1-r 
4AU5.1-f 
CGCGTTCATCTGGTGTTTGAGGTG 
GAATCCAGCAATACCGGCAGCC 
24 
22 
 
The entire nucleotide sequence was translated into amino acid sequence. Open 
reading frames (ORFs) or potential genes were identified and searched by BlastX 
for homology in GenBank. Finding the potential ORFs was carried out by the 
softwares, FramePlot 2.3.2 (Ishikawa and Hotta, 1999) and Geneious 5.4.6 
(Drummond, et al., 2011). The composition and order of the PKS domains were 
predicted by finding the typical residue motifs. Based on the predicted domain 
organization and function, the encoded biosynthetic pathway was predicted. 
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Table 4.4.6 Specific primers for filling the gaps in the keramamide H gene cluster 
Primer pair Sequence (5`-3`) Lenght (bp) 
NewContig1r 
NewContig1f 
CTCCTGTTTCGCTATCGTTGG 
CAAGAGCTTCGGACGCTTC 
21 
19 
NewContig2f 
NewContig2r 
CGTTATCAGACGAAGCTTAC 
GGAAGTTGCCAATAAACGCC 
20 
20 
NewContig3f 
NewContig3f 
GGCGTTTATTGGCAACTTCC 
CTATCTGGACCACGCCATC 
20 
21 
NewContig4f 
NewContig4r 
CAAACGGTCGACGGACCTC 
CAATCGTAGGTGTTTCAAATAG 
19 
22 
NewContig5f 
NewContig5r 
CTTCTCAATATCCTTTGTCAG 
GCTTCAGCATCCTGTTCAGC 
21 
20 
NewContig6r 
NewContig6f 
GATAAACAGGGTGTGCAGCAG 
CAACAGTTGCGCAGCTGAATG 
21 
21 
NewContig7f 
NewContig7r 
GATGCGCGAAGACGACCAC 
CGACACAGATCGATTTGATC 
19 
20 
 
The resulting NRPS insert was completely sequenced through a de novo 
sequencing approach (Margulies et al. 2005; Droege and Hill 2008; Rothberg and 
Leamon, 2008; DiGuistini et al., 2009) in collaboration with Dr. Vladimir Benes at 
EMBL-Heidelberg.  Assembling of the sequencing reads was conducted using using 
the Seqman of the Lasergene program and Geneious 5.4.6 (Drummond et al., 
2011). The potential ORFs were identified using the software FramePlot 2.3.2 
(Ishikawa and Hotta, 1999) and Geneious 5.4.6 (Drummond et al., 2011). 
Subsequent functional prediction of the identified ORFs were carried out using 
BLAST (McGinnis & Madden, 2004), PKS/NRPS analysis Web-site (Bachmann & 
Ravel, 2009), and NRPSpredictor2 (Rausch et al., 2005; Röttig et al., 2011). 
Advanced BLAST X program searches a protein database using a translated 
nucleotide query that provides information about putative gene products and their 
functions (Altschul et al., 1997). The computation was performed using the BLAST 
network service that utilises the NCBI (National Centre for Biotechnology 
Information). 
4.5 Genome Analysis (Methods for chapter 3, section 3.4) 
Before genome sequencing of an uncultured bacterial fraction, it is necessary to 
check the purity of the prepared fraction by genetic diversity analysis. Bacterial 
diversity analysis can be carried out using 16S rRNA subunit as a taxonomic 
chronometer.  
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4.5.1 Genetic diversity analysis  
To obtain information about how dominant is “Entotheonella sp.” cells in the 
uncultured bacterial cell fraction in comparison with other interfered bacterial groups, 
genetic diversity analysis was carried out. Several criteria making 16S rRNA 
subunits and their genes the most useful chronometer used today for determining 
the taxonomic indentity include (i) the ribosome function has not changed for very 
long time (about 3.8 billion years) (ii) the universal presence of16S rRNA genes 
among all cellular living organisms, (iii) the 16S rRNA gene size of 1540 nucleotides 
makes them easy to analyse, and (iv) the primary structure is invariable, more or 
less conserved to highly variable regions, and (iv) lateral transfer of these genes is a 
rare event and has been noticed mainly among closely related strains 
(Stackebrandt, 2009). The huge numbers of 16S rRNA gene sequences (from more 
than 7000 types of prokaryotes) in public databases enables to identify a 16S rDNA 
fragment cloned from any source (Stackebrandt, 2009).  
 
In this work, universal 16S primers, designated as 27F and 1492R (Weisburg et al., 
1991; Stackebrandt & Lieasack, 1993), were used for the biodiversity analysis of a 
sponge sample as well as an uncultured bacterial fraction. In addition to that, 
primers were designed in this work to detect the presence of “Entotheonella sp.“ in 
the fraction as well as in the total sponge DNA (Table 4.4.7). The primer design was 
based on the unique regions on several Entotheonella 16S rDNAs both isolated 
from the T. swinhoei cell pellet and retrieved from the public database, in 
comparison with 16s rRNA genes from other bacterial groups that are commonly 
found in sponges.  
 
Table 4.4.7 Primers for 16S rDNA amplification 
Primer Sequence (5`-3`) 
Tm 
(
o
C) 
Target Reference 
27F AGAGTTTGATCMTGGCTCAG 52 Universal Lane (1991) 
1492R GGTTACCTTGTTACGACTT 47 Universal 
Stackebrandt & 
Lieasack (1993) 
238F CCG GTC TGA GAT GAG CTT GC 55-59 Entotheonella sp. Schmidt et al. (2000) 
1309R GCG TKC TGA TCT CCG ATT AC 57 Entotheonella sp. In this work 
1247R-ad AAG TAG CRG CCC TTT GTC 57 Entotheonella sp. 
Adapted from Schmidt et 
al (2000) 
Ento271F GGGAAASGTTCGCBGGTCTG 57 Entotheonella sp. In this work 
Ento735F GYATTAAGCCKYGGAAACKGT 57 Entotheonella sp. In this work 
Ento1290R GCCCRGCWYVACCCGGTA 57 Entotheonella sp. In this work 
 
The PCR products were purified by gel extraction using QIAquick Gel Extraction Kit 
(Qiagen). The purified PCR products were subsequently cloned into E. coli by TA 
cloning (Sections 4.2.3-4.2.4). Several recombinant clones from the filamentous 
Chapter 4 Methodology 
__________________________________________________________________________________ 
163 
 
fraction were subjected to restriction length polymorphism (RFLP) (Section 4.2.3.1) 
by the RsaI and HhaI digestion. Clones showing unique RFLP patterns were 
sequenced. The 16S rDNA sequences obtained were analyzed and a phylogenetic 
tree was constructed to distinguish closely related microbial species based on 
sequence variation within the 16S rRNA genes. 
4.5.2 Gene cluster identification 
Based on genetic diversity, it was found that the filamentous bacterial fraction from 
T. swinhoei was fairly pure. Subsequently total DNA was prepared from the cell 
fraction for whole genome sequencing (around 60 ng for the first round of 
sequencing). One of simple ways to prepare genomic DNA for genome sequencing 
is using ion exchange chromatography based on resin. In principle, the cell extract is 
passed into a column containing resin. Because this extract contains very little salt, 
all the negatively charged molecules including DNA, RNA and protein bind to the 
resin. If salt solution at gradually increasing concentration is loaded onto the column, 
the molecules become unbound, starting with protein, then RNA, and finally DNA. 
The first salt solution is usually sufficient to elute the protein and RNA, thereby 
leaving DNA on the column. By passing a second salt solution at a higher 
concentration, the DNA is eluted, which can be concentrated and deslated using 
isopropanol/ethanol precipitation (Brown, 2006). In this work, purification of genomic 
DNA from a small amount of bacterial cell fraction was based on the anion-
exchange resin commercially provided by QIAGEN, which is designed for direct 
isolation of chromosomal DNA 20-150 kb in size. The procedure was done 
according to the manufacturer’s instruction manual (QIAGEN), which involved 
careful cell lysis and binding of genomic DNA to the resin. A medium-salt buffer is 
used to remove traces of RNA and protein as well as to disrupt nonspecific 
interaction that causes removal of nucleic acid-binding proteins. Using a higher-salt 
buffer, the DNA is efficiently eluted from the column (QIAGEN). The purified DNA 
from the cell fraction was subjected to whole genome sequencing in collaboration 
with Dr. Jörn Kalinowski (Bielefeld University). The whole genome sequencing was 
based on a novel sequencing-by-synthesis technology, called 454-pyrosequencing. 
The most significant advantage of this new sequencing technology, when compared 
with the whole genome shotgun approach, is that there is no need for cloning of the 
target DNA fragments, thereby avoiding cloning biases resulting from toxic 
sequences killing their cloning hosts (Huson et al., 2007).  Although the read lengths 
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are significantly shorter, in the range of 100 to 500 bp (Hall, 2007; Frasser-Liggett, 
2008; Wommack et al., 2008), newer algorithms have allowed for the assembly the 
short reads effectively (Huson et al., 2007).  
 
The genome sequence data was analysed using Geneious 5.4.6 (Drummond, et al., 
2011) to annotate each contig. Some contigs containing PKS/NRPS domains were 
tried to be ordered into scaffolds based on module architecture. Primers flanking the 
gaps between contigs were designed. Using the primers (Table 4.4.8), gaps in some 
scaffolds were filled in by PCR amplification and subsequent sequencing of the PCR 
products. The resulting sequences were then aligned together with the contigs in a 
scaffold to produce a continuous sequence. The nucleotide sequence was 
translated into amino acid sequence and the protein function was predicted. Based 
on this, module architecture was predicted, and the biosynthetic pathway was 
predicted. 
 
Table 4.4.8 Primers for filling the gaps in NRPS contigs in sequenced “Entotheonella sp.” genome 
Primers Sequence Contig 
Lenght 
(bp) 
Position 
Distance from  
the contig end 
14C-f 
15DHKR-r 
CATCATCCCAAAGTTTGATCCC 
CCGCAGATACGGTCACACGTCAG 
14 
15 
1646 
807 
1546-1568 
99-122 
100 bp 
99 bp 
15DHKR-f 
16DH-r 
GACGACATCATTTTGCACGGCAAC 
GAGGATAACGCTCACACACTATTTG 
15 
16 
807 
1264 
707-731 
98-121 
100 bp 
98 bp 
16DH-f 
17KS-r 
GAGCGTGCCGAAAGCATGCCGCGT 
ACTATTTGGCGAGCCAGACCGGCG 
16 
17 
1264 
1047 
1164-1187 
82-105 
100 bp 
105 bp 
17KS-f 
18AOPK-r 
CGCCAGGTGAACCGCGACCAGACCC 
TGGAGCACGCCGGCTTGGATGTG 
17 
18 
1047 
3242 
947-971 
101-123 
100 bp 
123 bp 
18AOPK-f 
19PCy-r 
GGCGGCCCGTTGCTTCAGTTGCT 
GGCATGAAGAAGAGGGGACACCG 
18 
19 
3242 
1873 
3078-3100 
100-122 
100 bp 
100 bp 
19PCy-f 
20A-r 
CATTGGGTGTCAGGGGCAAGCTGT 
TGGATTACCAGGTCAAACTGCG 
19 
20 
1873 
1465 
1772-1795 
101-122 
101 bp 
122 bp 
20A-f 
21C-r 
CGGCAACTGAACAATAGGCTGA 
GAGCGGGATTGGAGCCGCAATC 
20 
21 
1465 
1372 
1365-1386 
100-121 
100 bp 
100 bp 
21C-f 
22AKP-r 
GTCCCTCTTTGGAAACGTCTTACG 
GTCTGCGGGACGCCTTGCACCTC 
21 
22 
1372 
2091 
1271-1294 
79-101 
101 bp 
101 bp 
22AKP-f 
23PKA-r 
CGGACGCGAATCACGGGCGTGGG 
CCAATCTAACTGGCACCTGGATG 
22 
23 
2091 
3825 
1990-2012 
86-107 
101 bp 
107 bp 
23PKA-f 
24APC-r 
GGTCAGCATCGGTCATGTCATAG 
CGGGCCAATCAGCTGGCCCAC 
23 
24 
3825 
2823 
3725-3748 
100-121 
100 bp 
121 bp 
24APC-f 
25C-r 
GTTGTGCATTGAGATAGGCTAACA 
GCCTATGCCCATCAGGATATTCCG 
24 
25 
2823 
739 
2723-2746 
80-104 
100 bp 
104 bp 
25C-f 
26AP-r 
GACACCCATCGACCAGACGTCTGA 
GCAACAGATTCACCCGGAGCTG 
25 
26 
739 
1653 
638-661 
101-123 
100 bp 
123 bp 
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Supplementary 
Color highlights used to indicate conserved motif residues in PKS or NRPS domains:  
KS/ C, AT/A, KR, OMT/ MT, DH,  ACP/ T, TE 
Supplementary for Sub-chapter 3.1 
S3.1.1 The protein sequences encoded on the sup (sponge ubiquitous PKS) amplicons cloned from T. 
swinhoei chemotype W: 
 
>TSW4 
READEMDPQHRMMLETSWQALEDAGIDPDRLKESLTGVYTGISNDEYRMLVVDSTKPSGAAECLYALSGTNLNGTSGRVSFVLGLMGPAKAVDAACA
SSLVSVHDAVADLQQGKADLAIAGGVQAILNSRIYELRADAMMLSPDGQSKAFDASANGYVRGEGCGVVVLKRLSEAEADGDRIWAVIRGAAVNHGG
ASSGLTVPHTPALVQVIETALSQAGIPPSEVDYLEAHGTGTTLGDP  
 
>TSW8  
READAMDPQQRMMLETSWLALEDAGIDPAGLKGSRTGVYTGISNDEYRMLVVDSSRPTEAAGSLYALSGTNLNGTSGRVSFVLGLMGPAKAVDAACA
SAMVAVNDAVADLRQGKADLAIADGGVQAILNGRIYELRAEAMMLSPDGQCKTFDASANGYVRGEGCGVVVLKRLSEAEADGDPIWAVIRGTAVNNG
GTSVGLTVPHTPALEQVMETALSDAGVHPSEVEYLEAHGTGTRLGD 
 
>TSW9 
EAHPMDPQQRMMLETTWEALEDAGMDPDRLRGSRTGVYTGISNDEYRMLVVESRKPADAASCLYALSGTNLNGTSGRVSFVLGLMGPAKAVDAACAS
SMVSVHDAVADLQQGRADLAIAGGVQAILNSRIFELRADAMMLSPDGQCKTFDASANGYVRGEGCGVVILKRLSEAEEDGDRIWGVIRGSAVNNGGA
STGLTVPHIPALEQVMEAALSDAGVLASDVDYLEAHGTGTSLGDP 
 
>TSW12 
EALAMDPQQRMMLETSWQALEDAGIDPGQLKGGQTGVYTGISNDEYRMLVLDTTKPTEAAGCLYALSGTNLNGASGRVSFVLGLMGPAKAVDAACAS
SLVSVHDAVVDLQQGKADLAIAGGVQALLNGRVYELRADAMMLSPDGQCKTFDASANGYVRGEGCGVVVLKRLSEAEADGDRIWAVIRGAAVNHGGA
SVGLTVPNTPALEEVMETALSDAGVSPLEMDYLEAQAAPAPHWVTQ  
 
>TSW30 
REAEEMDPQQRMMLETSWLALEDAGIDPVRLKGTRTGVYTGISNDEYRMLVVDSSRPSEAAGSLYALSGTNLNGTSGRVAFILGLMGPAKAVDAACA
SAMVAVNDAVTDLQHGKADLALVGGVQAILNGRIYELRAESMMLSPDGQCKTFDASANGYVRGEGCGVVVLKRLSEAEADGDRIWAVIRGSAVNHGG
ASVGLTVPHTPALEQVMETALSEAGVLPSEVDYLEAHGTGTTLGD 
 
S3.1.2 The protein sequences of cis-AT KS amplicons cloned from the filamentous bacterial fraction of 
T. swinhoei chemotype W: 
 
 >EKS14 (identity/ similarity 55%/70% McyG Microcystis aeruginosa) 
REAKAMDPQQRLLLECCWHALEHAGYPPSQHGARTGVFAGSFLPSYLLHCLHGGGFMEPNNPGLGHLTEIGNDKDYLTTRVSHLLNLRGPSLSVQTS
CSTGLVAIATACQALLAGQCDVALAGASSLTLPQGGYQYLEGFVNSRDGQCRAFDADASGTVLGDGVGVVALKRLEDAEAAGDHILAVIKGFAVNND
GNLKADYSAPSVQGQVEVVAAAQAMAGVLAETISYVEAHGTGTCLLGDPIKLSNLD 
 
>EKS30 (identity/ similarity 78%/85% JerC Sorangium cellulosum) 
WRPLGSRFDSLLGEARLESLDGYQGTGQASSVLSGRLAYVLGLQGPAMTVDTACSSSLVALHLACAGLRQGECDLALAGGVQVMSTPATFVEFSRLR
GLAPDGRCKAFSAEADGTGWAEGCGVVVLKRLRDAERDGDRVLAVVRGSAVNQDGRSQGLTAPNGPSQQRVIDRALSVSGLSPDDTDAVEAHGTGTC
LGDP 
 
>EP5 (identity/ similarity 60%/76% JamM Lyngbya majuscule) 
SEAVPMDPQQRLFLEITWQALEHAGLDVTSYQGLIGVYAGSSMSSYYLNKVSKMPASSLASDLSAWLGNDKDYLTTQTAYQLNLQGPCVNVQTACST
GLAAVHLACQSLLNQECDVALAGGVTVKVPQESGYIYQENAILSPDGHCRTFDASARGTVFGNGVGMVVLKRLSEAREDGDNILAVIKGSAINNDGS
QKIGFTAPSLDGQAKVIAEAITVARVAPETITYVEAHGTGTSLGD 
 
S3.1.3 The protein sequences of trans-AT KS genes from the filamentous bacterial fraction of T. 
swinhoei chemotype W: 
 
>EKS37 (identity/ similarity 63%/78%, CorL Corallococcus coralloides) 
SALIGSALHIGLNGAGMLSPEGACKAFDQEANGFVLGEAVGVVVLKPLSKAVADGDSIHSLIIGSAINQDGKTNGIMAPNGPSQTALIESVYRKFEI
DPKTISYIETHGTGTSLGDPIKLSNLDPRGRH 
 
>EKS48 (identity/ similarity 59%/73%,SorD Sorangium cellulosum) 
XGGPSSRGIDSLISEAHAMDPQQRVFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERGVPGEPQSFWGNSSSLIASRIAYFLNLKGP
SITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHFHIIASNAGMLSPDGQCKTFDQGADGFVPGEGVGAVVLKPLSAALEAGNFIYGVI
RGSGSNQDGRTYGITAPSAASQMELEQRVYRNAKLDPASISYVEAHGTGTTFGDP 
 
>EKs50 (identity/ similarity 61%/74%, Bat3 Pseudomonas fluorescens) 
XPRVEVSISLIREALAMDPQQRMLLQTVWKTIEHAGYRASELSGGNTGVFVGVANSDYRELVQAAAPGVEAQSSTGTFSSILANRVSYIFNFTGPSE
PIDTACSSSLVALHRALNALSRGECASAIVGGVNALLTPTLHITGGKTGMLSQDGRCKTFDQTADGYVRGEGVAALLLKPLSLAKAHGDEIYALIRG
SSVNHGGHATSLTAPNPRAQAELLIRAYEDAGVDPTTVTYIETHGTGTTFGDP 
 
>EKS64 (identity/ similarity 58%/72%, DszA Sorangium cellulosum) 
VAAPRVEVR_LDREADAMDPQQRLLLQSVWATIEDAGYPAAALASENIGVFVGVQFNDYQQLMKQAGENGAQILTGNAHSVLANRISYLLDVRGPSL
AIDTACSSSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTLLDISQLGVLSLDGRCKTFDRGANGYVRGEGVGSFLLKPLSRALQDRDVIHGIIRG
SAVQHGGKANSLTAPNSEMQAALLLNAYRDAGVGLDTIGYIEAHGTAPARASGI 
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>EP2 (identity/similarity 66%/79%, StiG Stigmatella aurantiaca) 
VRPWRWIRSKRLLLEVAWEALEHAGQAPDKLVGSATGVFVGLSTADYFYLMSRGLDAEDIDAYVGVGSTASVAAGRLSYILGLQGPSFALDTTCSSS
VVATHLAMQSLRRAECKMALVGGVNLMLSPMSTIYFSKLRALAANGRCKTFDASADGYARSEGCGIVVLKRLSDAVADGDRVLAVLRGAAVNHDGRS
GGLTVPNGPSQQAVIRKALANAGVEPNEVSYVEAHGTGTSLGD 
>EP3 (identity/similarity 52%/69%, phenolpthiocerol Sorangium cellulosum) 
LRQWTRSSGCLLMTSVEAIQDAGLRPSELRQNETGVFVGASNIDYNLLARQRTGHGDIQAGTGTAFSILANRVSHQLDLKGPSLTVDTACSSSMVAL
DIACEKLLSGACDSALAGGVNILLDPRMFITFSRARMLSLRGEISAFDARADGFVRGEGAATILLKRESDALRDGNRIYAVIRATAINQDGATSTIT
APNEEAQTRLFEKAVALAGIDPKDVTFVEAHGTGTSLGD 
 
 
S3.1.4 The protein sequences of genes coding for adenylation domains from the filamentous bacterial 
fraction of T. swinhoei chemotype W: 
 
>pAU1 (60% Arginine code: DVEDIGAIT-) 
GCRNSIAYAIYTSGSTGQPKGVLIEHGALANHCRTMQDTYGLTASDHVLQFAALNFDVSLEQLLPPllagatvvlggLWPPSLFHKKVQECGLTVVD
LPPAYCQQVLEIWVADPALMRDTPLRLIIVGGEAASPELAAWWQRADLPSVRLLNAYGPTEATITATVFDVPRDIEPARHRLCLPIGRPLANCQVYV
LDAARQLVPIGVPGElylggaglargyLNRPELTEAAFIANPFGSGYLYRTGDLIKLIDTVDLE 
 
>pAU2 (60% Arginine code: DPKDLGLID-) 
AYEIYTSGSTVQPKGVVMSGKATHKLVTLSQELQLGSHDGIGSLTSIGFDPIFKQLVCSWSCGATTVLIPDGAMTDGSLFWSYVLTPHDRVLDTTPA
FLMSLLDAPPYDIRLRVLLIGGDVFPAAMLEALRCQLVSMAIYNLCRPTDTCIDATLFDATNHRVGGNVPIGKTQANYSISILDSCLEPLPIGVVGE
lyiaglglargylgrgglTTDRFLSNPYGSPLSRMYRTDDVNEFLQPGEIHFYSGR 
 
>pAU3 (substrate specificity was unidentified because the sequence is too short) 
ATITATVFDVPRHIEPARHRLCLPIGRPLANRQVYVLDAARQLVPIGVPgelylggaglargYVNRPELTEAAFIANPFGSGYLYRTGDVNQAYRYR 
 
S3.1.5 The protein sequences of genes coding for serine-specific adenylation domain from the 
filamentous bacterial fraction of T. swinhoei chemotype W: 
 
>pEt-A3 (70% serine code: DVWHISL-) 
FDVSVWEFFWPLFTGARLVVAQPEGHQDPSYLVSAIRNHQITTLHFVPPMLSIFLEAPEVETCDTLRRVICSGQALPYELQKRFFSKLSAELHNLYG
PT 
 
>pET-B2 (70% serine code DVWHISL-) 
FDVSVWEFFWPLITGACLVVADPGGHRDSAYLVRLLREQHVTVLHFVPSMLEVFLEEPALDDTPLPNLRKVICSGEALTGRHRDRFFEQLPGAELHN
LYGPT 
 
>pEt-D1 (70% serine code: DVWHLSL-) 
FDVSVWEFFWPLMSGASLLIAQPEGHQDPTYLCDLIQRERVTFLHFAPSMLRQFISDPNSQNCTSLRVILTSGEALPWDLAQDTAHLLPHTELHNLY
GPT 
 
Supplementary for Chapter 3.2 
S3.2.1 16S sRNA gene cloned from the metagenome of T. swinhoei chemotype W (unique regions 
(highlighted) was used as the basis for designing Entotheonella-targeting primers:  
> 16S sRNA gene cloned from the metagenome of T. swinhoei chemotype W  
TCCGGTCTGAGATGAGCTTGGGGGAAACGTTCGCCGGTCTGAGATGAGCTTGCGGCCCATTAGCTAGTTGGTGGGGTAATAGCCCACCAAGGCGACG
ATGGGTAGCTGGTCTGAGAGGACGATCAGCCACACTGGCACTGAGACACGGGCCAGACTCCTACGGGAGGCAGCAGTGGGGAATTTTGCGCAATGGG
CGAAAGCCTGACGCAGCAACGCCGCGTGAAGGATGAAGGCTTTCGAGTCGTAAACTTCTGTCTGGGGGAAAGATGATGACGGTACCCCCAAAGCAAG
CCCCGGCTAATTCCGTGCCAGCAGCCGCGGTAATACGGAAGGGGCGAGCGTTGTTCGGAATTATTGGGCGTAAAGGGCGTGTAGGCGGCTTCATAGG
TCTGAGGTGAAAGGATGCGGCTCAACTGCATTAAGCCTCGGAAACGGTGGAGCTTGAGGCTGGGAGGGGCTGGTGGAATCCCCTGTGTAGCGGTGAA
ATGCGTAGAGATGGGGGAGAACACTCGTGGCGAAGGCGGCCAGCTGGACCAGTTCTGACGCTGAGGCGCGAAAGCGTGGGGAGCAAACAGGATTAGA
TACCCTGGTAGTCCACGCCGTAAACGATGGGCACTAGGTGTCGGCGGTTCTTAATCCGTCGGTGCCGGCGCTAACGCAGTAAGTGCCCCGCCTGGGG
AGTACGGTCGCAAGGCTGAAACTCAAACGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGACGCAACGCGAAGAACCTTACC
TAGGTTTGACATGGACGGGACCGCCGGTGAAAGCCGGTTTCCCTTCGGGGCTCGTTCACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGAT
GTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGCCCTCTGTTGCTACCGGGTGATGCCGGGCACTCTGAGGGGACTGCCTCGGTTAACGGGGAGAA
AGGTGGGGATGACGTCAAGTCCTCATGGCCTTTATGCCTAGGGCTACACACGTGCTACAATGGTCAGGACAAAGGGCTGCTACTTCGCAAGAAGATG
CCAATCCCAAAAACCTGGCCCCAGTTCGGATGGTCGGCTGCAACTCGCCGGCTTGAAGCTGGAATCGCTAGTAATCGGAGATCAGCACGCA 
 
Unique regions: 
 “Entotheonella sp.” :  GACAAAGGGCTGCTACTT (in this work) 
E. palauensis : GACAAAGGGCCGCTACTT (Schmidt et al., 2000) 
 
S3.2.2 The protein sequences of the proposed misakinolide A biosynthetic pathway:  
 
>TP1, position 489-1022, length 178 aa, Transposase  
MISLQLCWRTHSVLQMRKISPNVSTARSITHRGPSMTTVTNNLNQSTWDCKYHGVFTPKYQKKVLYGAIRRDLREVFHRLAKQKECTIESGHLMPDH
VHMLIAIPPKHSVATIVGFLKGKSSIWVAENVDNKQRNFVGHKFWARGYFVSTVGANEQVIRAYSENQEKADQRFQNLFDR 
 
>TP2, position 2225-1545, length 227 aa, Transposase 
MCMRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGSEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVS
WTTALSDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLLKILDLSGATVTLDAMGCQKEIAQVITEQGA
DYVLALKKNHSTLYGDVKLFLDDAQASGFADLD 
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>TP3, position 3664-4659, lenght 332 aa, Transposase 
MRFIHPLSHETLQLLNRVHKQSRHHRVRQRAHCIVLSSQGYTTTHRADIFQVDRITIYHWFNAWEHNGFPGLYSRKASGRLPLFTPDQKEQIRQWIK
LFPRNLNKIRSLIHDEFGLKVSKQTIKRVLKSYRLIWKRMRKRVKGQPAPELYQQRKAALEILQTEDCDGIIDLRYFDESGFCLVPYVPYAWQQSGH
TISLESTQSKRLKVLGFMNKRNELEAYTFEGTVDGAVVIRCIDEFCKTLQGPTIVVMDNASLPTRPTFQAQLPRWEQQGLEIFYLPEYSPHLHLIEI
LWRFMKYEWIESWAYTSWSHLVRYIDEVIQNVGDKYKIHFG 
 
>ORF1 (position 7211-4803, length 803 aa, Esterase/ lipase-like protein) 
MSQPGRSTRTYHLDVDCRFERYNYERSRGLHHRISNRATLTMQPPELDLPPINTRNHNLTLFLLRRLESNLDVRIRLHGLTDQLDMGGGIIVANHFT
RLETFVVPFVVHRATNIILRILASHVLFGNKTFGDYLMSIGALPTNHPNKYELIARDILNGGWWLIFPEGLIKDRRVIEKGRLNVTTDAGQVRRRPR
SGSAILAMTVQRYKAALRQALEHNGDIQSICESLGLDDRRPSELKALAFRPTPIIPLNITYYPLNPQENAFKSLATHILPNLPHSTFGQELLEELTV
EGSMLLKGVEIDMRFGNPLLVGDDDLQFVDDWRIVPWSPSPWRRYLNALRSWRPMRPYTHLVDRWAVSSSWRQRQRAWQITRTTMQALYRLANIHIG
HLISAIVLQTLRTTKQRRFEVLELQKRLYLATRRLQEGGNLALHPNLTDPDLQYLLATETPHPFLEDFARRASELELLTVKDQMWEPNTEILLEPWS
FSSIRLKNFIQVYFNEIEPVTEVMQAVRYAMRAELGDYRELFSDAMHNYEDQLYEADHAEFVTPATAAKLTPLVPEHGRPALLRGHGSNRAIGILLL
HGFSASPGEVMPLAKTLNGRGYTVYVVRLRGHGTSPYDLQQRSWQDWYDSVQRGYAYLRTITDVQFVGGMSTGGGLALYLSVHEPTVCGVFAVAAPI
RLTNRAIHLAPIVKTVRGFVNSNPGNPHTNYLAFPVQALQELLQFISAYSKTLQDVTVPTLLIQAQGDTTVRPDSAQYIYDELGTETKELIWKDANQ
HVIVSDAFPDVHDDVLTFLQQHQPSS 
 
>ORF2, position 8065-7388, length 226 aa, NhaP-type Na
+
/H
+
 and K
+
/H
+
 antiporters 
MPWPERAFLAWVAPRGIVAAAMASIFTLRLQAEGYAQADQLVPITFLVIIGCVAVYGLTATPVARWLGVAQDNPQGGLFISASPLLQALADALRAED
IATCMADINWSHIATARLNGFKTHYGNALTENALDNMDLDGIGRVLALTPNDEANALAALHFAELFGHAEAYKLVPSTANRETVPHLRGHFLFDESA
NYNVLSLHLASGATIKTTGLSEQFDYEAFQDY 
 
>TP4, position 8253-8933, lenght 227 aa, Transposase 
MCMRVPSSFQDHFASLSDPRSFRTPNLRHDLIDILVMAVCAVIWGAEGWEDLEDYGYAQAAWFSDVLDLPHGLPSHDTFRRVLSQLDPDELTKCFVS
WTTALNDLAGGDIVAIDGKTLRQSFDRATSQSAIPMVSAWATANRLGLGQVKVDDKSNEITAIPKLKILDLSGATVTLDAMGCQKEIAQVITEQGAD
YVLALKKNHSTLYGDVKLFLDDAQASGFADLD 
 
>ORF3, position 10299-9400, length 300 aa, NhaP-type Na+/H+ and K+/H+ antiporters 
MTEHVLLGLASIVALGIAAQWLAWCIRIPSIFLLLLLGLVAGPFTGWLQPQHLFGELLFPAVSLSVAVILFEGGLSLRTVVLRDIGRVLRDLVTLGV
LVTWLITSAAAYVFLGLDGSMAILIGAMLVVSGPTVVGPLLRHVRPVERLRSTLQWEGILIDPIGVLLAVLVFEVILVGELQAATTLVITGMLKMVV
LGSALGWVSAKTVVWLIQRGFIPDYLHNAVTLMIVVVSFTFANVLHHEAGLFTVTVMGIVMANQKDILVRHIIEFKETLTVLLISGLFILLSARLNV
NDLAQLGQG 
 
>misA, 10649-13330, 894 aa, phosphoenolpyruvate synthase (PEP)   
MSMDSSPEPTRDHQILCVAFPGVTPAPLAEVGGKAHSLMLLAQQGFQVPPGIVLTTAFFQPWFEQIQRTACWAKLLAAEPDEWSSLCRELKALSAGL
TFGEAQQQALEGLREDLHALGDARFAVRSSSLEEDLPQASFAGGYETCLGVRSEDLEIAVRRCFASTLDERVLMYKRERGFDIRSPRLAVVVQQQIH
SEVAGVGFSLNPLNNDYDEAVINANWGLGESVVAGRVSPDHFVLDKVGRQVVERKQGAKQLSIWVSEAGGTTEKQGYRSQEFSLNDAQLSELIDAIC
EIETFYQRPIDIEWSYANDQLYLLQARPITTYIPLAPRMMTQPGERRCLYADMALSSGLTINAHISPLGLDWMREGLVLLADMTFGKLDFDLRFEEA
FCFCAGGRMYQNVSNVLWLTTPEQLAKMSAASDVLMAETQAYIDADRYRSQVKPPWAKVAMLKYLPRVMWRGRYFVGTLLWAILAPEHAWRSYQVKA
DGYKTELTGDLDYSLSLDAFRRQYTSTDNARLMLTFTMSVVWASVGAIAMVDVLVGKSAEGKALGDKLKRGFTGNIVVEMGITLFRLAKMLPPSDFD
DLDQLVERINTRQMPAQFCHAWDAFMAKFGCRGPLEMDLASPRYADDPVLALKQMSLMPLDDERFDPELTHQRQVEEREQAFAALMARSGWLRRRLL
RRVYHVIDLFAGIRDHPKYYMLLFYQGLRKRALSEGERLTREGRLDASEDIFDLTFDDIDSAVRDPALDLRAIRQQRTAFNQILSNQVHTFPAVIDS
RGRILRPPARESKPGEYRGMAVSAGLAKGPVKVLQRPDEKPVDKGDILVVYTTDPGWTPLFVSAAAIVIEVGGALQHGAVVAREYGKPCVVGIDQLI
SQFEDGQQVEVDGTAGMVRLL 
 
>misB, 13444-14193, 250 aa, phosphopantetheinyltransferase (PPTase) 
MICAMSCLRITLNRQDLTTDAGFAWVHAADYPALHDTCSRVLHVNELAYYQRVPAIRRKTSFLIGRYAAKQALSSLVHESDYTRIEIASGIFQQPIV
KYPSPEPLGVSISHTDKYACAIAFPLIHPLALDVERIDRVSVKAMKSQILPHELQTEALARLPEPTRCAIIWTAKEALSKVLKCGMMSPFCIFETMD
LSQEPDWIVGHFKNFGQYKFHAWVLDDHVVSMAVPKRTDIDVDLSTLLHDLLPIGD 
 
>misC, 15451-33060, 5870 aa, KS-AT-KRL-ACP-KS-KR-ACP-KS-OMT-ACP-KS-DH-KR-ACP-KS-  
LEAKDIAVIGVGVLFPGASHHDLFWENLIAGIDSIQEIPVSRWDIDAYYSPDFNEPGKSISKWGGLIQGIDQFDHQFFNISPREARNMDPQQRLLLQ
EAWHCVEDSGIALKTLQEKVTSVFVGVMAIDYHQHMAQSRQPVDSYACLGNYGSILANRLSFCLGLSGESKAIDAACASSLVAVHDARRSLQAGECD
YAIAAGVSVICHPWKYISFSKSRMLSPSGRCKTFDKSADGYVPGEGVGVLLMQSLERAQEQKCHIYGVLKGSALNNNGLHGQRHADDRGRKKASITA
PSIDAQRRVITDALRSADIDPASVSYVEAHGTGTSLGDPIEIEALKQVFAVPGRTTPSCAIGSVKTNIGHLEAAAGVAGVIKVLLMMKHKMIPQVLH
LNTVNPMIDLTDTSLYLSDQLHSWESKEGIQRRAGVSSFGFGGSNAHAIFEEYVDTRHTPQGTLQRTSGEHLFVLSAKSHSSLDGLLNDWVAFLNHP
QRSAISLEDMCATLMTGRESFPFRFALSVTDKKALRSALISPPESAFGHAEMPSVLLRIGSVNAEQAAVIASWYRKHPGFREPFDACRRLAKMLCSE
EAVRDWTAQFPKVLAEHEALYGFAAAYATARLLLDSGVQPRLICGEGIGHGVALCLSGLWTLSQGLRHAMRLIDQLDLSPQRLDYPIYDQIQGTTLS
PYQPSRGYLQALLKNIQVRDDLFIRDLQKALLLHEHQYTFKNYLESWNSALKEIGLEIYQLIGLHAELQEDISKKFLVYIIVAYSLKQLYEKWDLVE
YDASSDPFLNEFLDLIGDDVLTFKDVVTLIGNGWDTGKEDLFHGITARVIPVSSVKPYEYLQQYQFERFDHIRSWLEKIGDVPLETPIHEDDLLLTV
GDEGDVSRLKIVSNSGHSLSFLTRGQKASHLTEDVRQLWLHGLNIDWQSFVDAGSFTKASLPGYSFDGSPFWIENSRSDSPFIQGEGIKAEPVQNSY
YHFVWQASKHPTVLDRKPDVKNNEAILLFDSDASLAQLLREQWHAEIILIRPARAFDWKSWHDVEIDPDNENHYKLVCTALQQKNLRPVCAIFTWTL
QESTSTGESLLSHPEPWLSKGIYAVYHLLKSLSQSAHPPLSQLLFFFHGNEGQGNPLMEAVAGYGRSLKLTYPQMRFRSIQFETGSPDTIEVVTAVI
REFSLLKGEERQEVDTEVLYRHGQRLIKTPVRLHLDAVAQAPWKQSGVYLITGGMGALGSIWARYLAERYQARLILTGRSVCQGDIGKSIRVFIKQL
QQLGGDAVYLQADITEPHAVRQLIEQAYQAFGPVRGLIHAAGQMSAVSFAEKSLADFQQTLSAKIQGTLVLDRVLHESIEKQALDIVIYFSSAASTL
GDFGQCDYAIGNRFLDGYGRFREGLRTQGQRQGRTVVVNWPLWREGGMHLDSEAEALYLSASGLDYLEAEQGLDALDRILVSPHTQVMVFAGDPANI
DRNLGVNKVVDMQVDETFVASRIEADLQHLAAVLLQMQADEIALDDNLSAYGFDSIAIKEFADQLSQYYQLEISPIVFFAHASLRSLGAYFWEHFAA
DMKAFYAAEPSNQMPEARHAEAPARQVSQPARAEADQDIAIIGMSGVFPGSPDLATFWKHLSRGRDLVGEVPAGRWDWRVYDGDLMREHEAKKTAIK
WGGFIENVDRFDADFFSISRREAEFMDPQHRLFLQCVWATIEDAGYATAALSGENIGVFVGVQFSDYQQLLKQAGERGAQILTGNAHSVLANRISYL
LDVRGPSLAIDTACASSLVAVHQGVQAIRNGDCTAAIVGGVSLMLSPDTFLDINHLGVLSPDGRCKTFDRNANGYVRGEGVGSFLLKPLSRALQDRD
PIHGIIRGSAVQHGGKANSLTAPNSEMQAALLLKAYEDAGIGLDTVSYIETHGTATELGDPVEIEGLKQAYRTYRQQTGAAASRTGACGLGSVKTNI
GHLEPAAGIAGLAKVLLAMRHQILPATLHFDSLNPYIDLSESPFYIVDEKTPWQRRLDEQGEEIPRRAGVSSFGFGGAIAHLVLEEYRVPQDTLENG
DDDTSPYLIVLSAKNEARLKEVATNLYGHLIETASVAPIKLRDLAYTLQVGRDALPQRLALVVDETAHLLDGLAAYVQGEPDRGRWFAGTARRDRCP
LTSLVEAGEAMIAMRIEKEALREFAQSWVQGASINWQQMYPVNKPRRQSLPTYPFAQQRYWFDTSANTKPQERHAAVAPIDNKSNIERIYYRREWAQ
TALLSPVSIETGDQAQFVLLFETNPQIGEVWQTQLEQHGLRCIRVCIGERFRLLEPHYYQLNPRQYDDYASLAQALRQNASWPRRVVHLWQSNEPDV
NHDQHLSLQLERGFYSLCHFTRALMQHTFGDACDILYSYRAEAWQPEPACAAVSGFAHTLALEHPGFSCKTIEIPAFLSYRDARTIDLLLSELQGHA
LSDTTVRYQEQGTLQRWVQHFCEWQASPIEVVSKYPRPHGVYLITGASGSLGAQFARHIAAQVKATFVLCARSERTPACEQLINTLRTMGSEAVYIR
SDLSQRDHVFKLIEEIQARFKALHGIVHSAGVISDALVFNKTHHQIAQVLAPKVYGTVYLDEATKDIPLDFWVLFSSTTAVTGNVGQSDYACANRFM
DEFAVWREQLRGMKQRSGKTLAINWPYWRDGGMSMSEPGYQGWMERTGLQALPTSEGVAAWDDLLNAPSGHAYVVAYGFRELLSRMFARPQSAAAQP
SADERATSSETLYEDTMSWLQHEIASVVKASPQDIDVDTAFHQFGLDSVVMRQTNVVLEKKLGALPKTLLLEYTTIRDLTDHLSTQYIRELNGVLGS
AFLEQSPNGERQVRKRVGSENSMRNGIFSAEPIDSQALEQEQTNNLEEIAIVGLSGRYPQAEDLDEFWENLKAGKSAIADIPDSRWDYRAYYDADPD
QASRGKMYCSQGGFLNDIDQFDPLFFNITPLEAKSMPPEERLMLETVWSTLEDAGYAGEHMRSQKVGVFVGVTSNTYPLECDHSDGVRYQSPIDTSY
FNIPNRISYFFNFTGPSIAIDTACSSSLVAIHMACESLRHGECEMAIAGGVNLYLHPSKYILMCQKRLLSTKISTGMFEEGGDGFIPGEGVGAVVLK
PLTQAVRDRDNIYGVIKASSVFHKGRSNGYLLPSPESQTELLRQTLQQAKVAPETINYIEVQALGSEMVDQVEWRSLIQAYGAKGKSDEYKPYCGLG
SLKPNIGHLEAASGIAQLSKVLLQMKYCQFLPSNVSDRRDPILDASINHPDSPFYFQGEWRVWERVSRQRDDTVGLTVQPRRAGINSFGAGGVNAHV
IVEEYISPVESSHAPRLEEESAALIVVSSKTQQQLRQALVRLRAYLLREANRADGPSDRVSLADIAFTLQQGREAFAERWAMVAKSKAQLLESLTRF
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LDDKTVHAPLFVGRVPSTNHENHVFMTHDRIEALWHSHQLEKLAQLWRQGQNISWEHLSYRYSPRRVSLPTYPFEKRHCWWGTSDDKDPVEVTAQSM
PDLISQKTHETRVNMSDIGQVVADYYDQVTESLKQKIGSQEVYLLFAPFQERVEGFSWLKMFFEPEKHREHFELTLQKQHELKSMLYRLVEFANVHR
IFDIGCGYATDLIQLAKRHPQVRGWGFSISLNQVEFGQQRIQDEGLGERVQLSCNDSTKDPLPGLFDLIIGFEVVVHIADKQGVFGNMARHLSNNGT
IVLADCVANTVTSINTSYIGQYTSTAEEYSDILAQNGLAIVDCVDVGPEISNFLYDPNYLENAAYLSSIYPEMVNIEKEHQGWSNFGKALEVNLVRY
VLLTIRKATASQTYDHLLQINLERLGSGALSYAEALQAYPHIEQIVIEQIAETKSPDSNATTTSVADIEQTIVELAAQVLEMMPDEVNTQARFIDFG
VDSLRGLILLDAVNRRLGLTLQIPVLFDHSSIHELSIYIASQLPSSPQAVVSAPAASVPVVSPAVAVSSVRSVASSHTAHSDIAVIGMSGRFPGAPD
LHTFWQNLEQGIDSISEVPPTRWELTQYYDADRRLPNHSYSKWGGFLDDVDQFDPKFFNISPAEAELMDPQQRLFLQTSWNALEDTGYAGQTLDGMK
CGVYVGVLNHAYDILIDRANISQHRAYALLGNSSSILAARIAYLLNLKGPAVTLDTACSSSLVALHWACKSLRDDEVDMMLAGGVTLYLGEREYIEA
SQAGMLSPTGKCRAFSQEADGITLAEGVGVVVLKRLDKALQDRDAIYGVIKGTGINQDGKTNGITAPSAKSQYELQTEVYTRYGIRPERISYVEAHG
TGTKLGDPIEVEALTQSFRQYTQKQNYCAIGSVKSNIGHTSAAAGIAGLIKILLSLQHHSIPPTLHVEHKNEHINFRDSPFYVNTQLRPWTHEDDLP
RQAAVSSFGFSGTNCHVVVEEPPARIVHQHIASTLDAPVLMVLSAANQDRLRGYVALMIRYLEARKTRQHTRKAWPSDSLTDIAYTLQTGRTPLEQR
LAMVVASEDEWLDKLRRYERGENVIDACYEGQANAEPAKLDLLIEGEEGRAFIESIVRRKNLSKLAQLWVGGTDIDWTLLYHRPSSDAAVLPQRISL
PGYPFARESYWLAAPTLAASSLVVERLPHQDDICFKTVLSGDAFFLRDHCIDRQKVLPGVVYLEMARKAATSFRPDAPQPVLKNVIWLRPLMVNATD
VVAYTRLKQQAQRIDFEISTLDEQNNRVLHAQGQLHDPEPVTPQHPDWPSFDLRLIQERCPRTLEGEAFFQAIQAQGFRTGPSFQVVRKAWYNQTEA
LCELGLPALREADFQDYLLHPSLVNAALESVILLIAKDPSASDAPHLPYTLGTWAYDDTVWPTSLYAYARLTAPQPETEALTAATTVQRYEINLLDR
SGRLIARGKDFCVRALRSSGETRPASSAAQYPVKYYYPRWEACENERVAANIVVERSWLVFETENSLWHALDEKLRALGVTCIQVRPGYRFQVLEKR
RYEIHPERAGDYQKLVAELKRNHAIPERIIHAWSEEQWCDNAELDPRSLAWGFYSVFYLSQALISCWQDTPLHLLYLYRQDQDSPQAHYAAVRGFAQ
SLTHERLDWHWKTLALPTTLPQAQVANMLWDELRYANQLEREIRYDANRQRWVRRWHAGEGTPGQGPAAPDTSLLRQQGVYLITGGGGGLSLLLGEY
LAREYQAKVILVGRAEGTEAQQAKIDSWKRWGGEALYLQGDISRREDVDHVMAQLRSRFPVLHGVFHAAGLTRDASLVNKTVRDIDEVLAAKVYGTI
YLDQATRSEELDFFVLFSSLSGVVGNIGQSDYAYANSFLDHFAERREAQRSMQKRFGLTVAIDWPLWRHGTMQVDATTEKFLARSIGMQALETDDGW
MALQHALAGSKSQLLVLCGDQGRFSQALGVQQHHTVAERAESPSENLSETSSFDLLTHLQIDLRSIMAAVLKLSPQEIEWEREMSSFGFDSISFVAL
ANELNDTFELDLLPAVFFECLNAGDLLKHLHHHHCDALFAYYRRRVPEPAAQEVLGTPGQANVEGPVHVRQLEKPSGLNHHAGTEPIAIVGMSAVMP
QSPDLETFWQHLAAGQDLITEIPKDRWDWQNAGGDTTIRWGGFMPDIDQFDALFFGISPREADLMDPQQRLLLQTVWKTIEHAGYKASDLSGSDTGV
FVGVANSDYRELIHAAGPGIDAQSSTGTFSSILANRVSYIFNFTGPSEPIDTACSSSLVALHHALNALSRGECSSAIVGGVNALLTPTLHITSNKTG
MLSHDGRCKTFDQAANGYVRGEGVAALLLKPLSLAKAQGDEIYALIQGSNVNHGGHATSLTAPNPRAQAELLIHAYEDAGIDPTTVTYIETHGTGTS
LGDPIEISGLKQAFATLYERFGHVADVSAYHRCGLGSVKTNVGHLEAAAGMAGLLKVVLAMHHKTLPAHLHFHNLNPYIDLSGSPFYITRQTCSWDA
LQDAAGKALPRRAGVSSFGFGGVNAHVIVEEYVEDRHEDR 
 
>misD, 32948-60028, 9027 aa,  DH-KR-MT-ACP-ER-KS-DH-KR-MT-ACP-KS-KR-MT-ACP-KS-KR-ACP-KS-KR-MT-ACP-KS- 
MKTDSPNHPENQAINVNHYLMVLSAKTKERLQTVVENLLDYAKANRRLIESRLADVAFTLQTGREEMEARLAFVVSDYHDLMGQLSGYLEDAPNANT
IFRGQVDLFDQSAPVRQHRAAQERDCERMIRTHDLPGLAELFVQGVPIDWRRLYVQGRPRRIALPSYPFAPERHWVARREPDHLAADMPAVRQPHSL
LDGRDDRMSLESGVVFRKLLRINDGVLQDHQVNETPVFPGVAYIEMACEALAQLSFSDPEVLRKTVLNQMVWLQALAVTEAEHEILLCLEKDTHGLA
FEVKDHQTLYAKGRFDQSDDLSQGHQYLELETIKGDCPHEKHRSVIYHDFRLLGLNYGPWFQGLEHTWFSIDSAEGEGEALGYFNMPLICESEFSAY
TFHPGLLDAALQVVASVPGYADSGLLLPYAVEKLEWFHPFPACGYSHVRKLAKHRYDVTICDEQGKVCAKFSDLSVRPSRVAGSEPSLNQLTYRARW
SHQELGERRSPAGRPEETGVVFIIHTPEQQALVQELSSVLADMHGDHRVRRMCLNANDWDFKSLGNWNHRIRAVQDLRDIYFLAAMEHTVSSGQAHV
DPLSFTNRQEHGLLSLFRLLKALDQNQLLLQPLSLKVLTTGNYRVLPSDTICPLSAGLPGFCRSIAQEYPLLALSCIDLGCPDGDAMQPSSLKKLAQ
FIVAEPAHQPHETVGIRELRRYTRKLVPVRFPEPGGQRAFKSRGVYMIVGGAGGIGMVLAQYLAERVQARLVLVGRSALDEEKKQNLSTLTAAGGEA
LYIQADISRLYSMKDAVAQARQRFGNINGVVHSAMVLNDQSLARMSEEGLRASLAPKVEGCIVLQQAMAGEPLDFMLFFSSAISFSGNAGQSNYAAA
STFKDAFAHYLTQVEAYPVFNINWGYWGCVGVVANAAYRERWAARGVHSIDPEQGLQVIESILTNHIDQVAAVNVEPSFLERLGVELSQTQTVLPPR
RSSLIAKLNALPLPETGGFQDNVNRLEIVSAFRWAEVFKHMLDMSSTQGMYARSDLKRQLQISSEHDQLFDVLISMLIQEGYLHQQGKNLTPTPYLN
GEFFQQQREQVALLESELSQTDNAYLNLLSRCLDHYPAMLRGEVAATDVIFPQGSMEWVEGIYRSHASADYFNQQLAQRLVAYVEARLPSLGANESI
HILEIGAGTGGTSAIVLQALQPYAARLRYTYSDISPGFLNYGRKTFGDAYPFVEFRHLNIEHNGEAQGYQAGEYDLVLAANVLHATRHIGNTLARVK
FFMKRHGWLLLNEATQVRHFGTLTFGLLKGWWLFQDAENRLDGSPLLSTTAWQRLLSEEGFKHTLSLCDAVEEESIFQDVIVAESDGVIQMNQSDSP
VQPREPVDVSVDVHHVDDMMEPGQVADVVESRHDFIVNSVSQCMAQSLGVAFTDIHINRPFSLYGVDSITGVDFIHQINSRLGIVLRTTALFDHATI
FDLSRFIDESHGAAIDEQRQRLRSTPLTSSDTKPAERVAPPDEALPHIERGCHQAVVLEKPSQIEHLRFHPVKTREPAAHEVQIAVRAFSLNFGDLL
CVTGLYPTMPAYPFTPGFEVSGHVANVGAAVSHVAVGDEVIALAGQQLGGHSTLLTTAGHLVVHKPRQVSHEEACAFPGVFLTVYHAFQSANIQAGE
KVLIQGAAGGTGLIAVQMAQAVGAEIYATAGSPQKLDYLRERGVPHLINYQTDDFAEVILADTNGYGVDVIFNTAAGDAMQKGLDILAPNGRYLEIA
MVALKRSRSVDLSHLVDNQVFYSIDMRKLIAGNPQLISRYLNRMVEHLAEGHVQPTIGARFALDDIQSAYRLLHDRQNIGKVVVSIPDGMMDNQVGQ
RMVPESSTVEDYRVGNATVEQVAVKQPADMDEPIAVVGMSGRFPGANNLEQFWLNLIGGNNAITEVPADRWDVHQWYDPDPAVLDKTHCRWGGFLRD
IDKFDALFFKLSGREAELTDPQQRLFLEVAWAALEDAGHANRAISNARCGVFVGAGPSDYVTLMRERSVPGEPQSFWGNSSSLIASRIAYFLNLKGP
SITIDTACSSSLVALHLGCESIRRGECDMVIAGGVYIGVTPHLHVIASNAGMLSPDGQCKAFDQGADGFVPGEGVGAVVLKPLSVARQAGNFIYGII
RGSGSNQDGRTYGITAPSAASQTELEQSVYRQAELDPASIGYVEAHGTGTKLGDPIEIDALNRAFQSDAKKQHSCAIGSVKTNIGHAGAAAGIAGFI
KVLLCLQHQQLVPSLNYHTCNEHIDLDNSPFYVNTESKDWFVAQGEPRRAAVSSFGFSGTNAHILLEEYQHHEDEAQALGDDKDVLIVLSAKNQERL
KKAAENLHHFLESRVSYKLSDIAYTLQVGREAMEARVAFMVVSVLDLQQKLVSLLHDPTDEQDMYWGEVRDGEGPAGVAAFEDVALALANKQLDQLA
QWWVSGVEIDWTQLARVVKVRLVPLPTYPFSPDRYWFDSVGPATVVHAEHSASALYPLLNRIAPQASTQIANGCVFETCLKSSDPLLAQHLIDGQAV
FPAVGFLEMVIAGLREIQPDKAARLENVFWLRPLDVMDEQRVHLVFEVKQDRFQYRIVPAESHGDGAYFRGQGYWSNDMNPAIPMDIDRLKSRMRQQ
PLLNESSPRVRLGRLYQGATEGWTDGEQALIAFELPTAQPYRDGSPDQKSYPFHPAAFVAALQAYHWIHEAPKRLGMPFAVQKVELWRHRDQPAYAY
VALDEHGNADVHILDAGGQVCVCYRGMALQTLNNAHHDGRQESTQKDELGKLLFVPVWKRLDTKHGRAHGMHALARGTGVLLVYTHENGVEAEQLMQ
RYREEQCELLSVCLSAADRALDTLAARLKHLQSPLRHVCFLDRHQAALDPADKQIDERLREPQTLTGFLALVRTLSELGYDEQPLQWLVLTSSACAV
NQADPINPYAAAIVGLASCLAQEHRYWQVSVCDRGKGTSFTTIANHGETLRVIAERSGYSYVRHIKELELPPPRQSRLRHKGVYVLVGGAGYVGTLL
SRYLVQTYQAKVIWLGRREQDEQIEQNIALIATLGSRPQYLSLKTGSDDELHRAFAQIKAENGLIHGVFNLVMVAQSTPMRSLSEAQFRAGSFNSKV
NSAQALYRILKKEALDFMVFFSSMQSFAQQLNFMSANMSSYVAGCMFQDAFVHQINCELSYPVKTINWGYWSQESSESEKAKWYETYIADKGIYSLN
VGEAMQALEYILAHEPEQVIVTKVSHRVLSDMGFVQDDSENVDLQPVIDSNDDNTQLEDLIVNGILKTFETLDVLQVFDSACNLDVSRLQAHVPDKY
RRLWRELLLILVQAGKMAPQGAGFALRESYTSLASQLRLMDLDREAGLLRERHPTLASKLALLVPCLKDMAEVLTARKPATEVLFEHASLSRVEGIY
RGNPTTDYFNQRVADIVKAAVQQALPSLSVGKKVRILEIGAGTGGTSAYLFQALNTYADQLHYIYTDISKRFLIHADETFCEQYSFIETKLLNIEQD
VAGQGFDPASIDIVVAANVLHATRNISKTLQHVKDLLKNDGLLVLNELADVSPFLTVTFGLLDGWWLYDDEAIRQPGSPGLSAKNWQLVLKNQRFHN
ISLNDEKALTSEQQIIIAQNESKESVPVSSTVLLGTELIASVEASLIAQLSQCIKIEQNRLNTYTTFSDYGVDSILMLAYVDQINGDLGIDLNPSEL
FNYTTVERLTKFIVDYHGKEIISAKESVERSLLQNQESKFDLNDIDVITKAGNEAPEMARSLLFDNVLQVPSGNVHHHQSDKARPDIAVIGMSGQFP
GATNVQQFWQNLSAGVDSVSELPESRLDRQLYSPQPEAGKCYCQWGGILEEQASFDPLFFEISPKEAAEMNPSQRVFMQEAYRALEDAGLVNAGLSQ
LHCGIYVGCEPNGYTKQGFTGASEAIVASRISYFLNLQGPALVINSGCSSSLVAIHLACESLRHGENDIALAGGVFTNLNNELLVCLSSIEMLSFSG
KCHAFDEAANGTVLCEGVSVLVLKRLQDALDDGDVIYGVIKGSGMNQDGRSNGITAPNGLAQENLIKRIYQDYNIDASKISYIEAHGTGTKLGDPVE
ANAXKNVFSSRNTGLDFRCGIGSVKSNIGHAAAAAGVIGLVKVLLCMQHRQLPGLVHFNKLNPLIDFNDTGLYIVEQLQNWEPASGEPLMAGINSFG
HSGTNAHLVIQEPPVRPVRDSENPFHLICLSAKTEEALKQKISDLSAYLRRKEEPPTLGAISYTLNTGRAHFRKRCAFVVDSLEALQNALMGALDGL
VGNAERLSPQEQAFCKKAFDLIIKDLHDVENLESRADQTIYKDNLLALTGLYLKGFDLDWQRVYKGQSYHRVSLPTYPFSRDTYWIDEPKQISFTEP
GTDKPGNTSRNHQQDQKDEDVLGGQFYIPQWKRLDQTQSYASLSDHGKLTIASDPVVIFYPPTMTSLKDDIQTCYEQLPASQVASFELGCTPSSEVD
VRDPRAFERIFVSPRQALEELLEQGRTLTIYFILPEPDQNPDSGCNLECLEESLSLGLISLFRLIQALLAHHGYASELTLKIVTQQTQVCKASERIV
PYGADVVGFVQSLAKEYELWQISCVDINRQTWWTPAQSKNFAEALIALKPPADGRALCWRDGYVYHRVLTPANLVGVQGSAFKTRGVYLIIGGAGGL
GLVLSQYLLEHVQAKLVWVGRRSLEALAPDALRLFNTPGAHVLYEQADLCDPEALQRALQQAKGRFGYIDGVIHSALILEDRAIADMDEKTLRKVLA
PKVQGNVVLQQVLADEPLDFLLYFSAGQSFMSHAGQSNYAAACTFEDAWALCQDQRQNYPIKIINWGYWGEVGIVATADYRKQMARQGVLSIHPQEG
MEAVERCLASCATQAAYFKVEPRALSRLGLDGTGILHASRNRVPPQLIHVVIDATQAWSISMPYAQRYQQSLKKLDRLGCYLLLRVFQAMGVFSQPH
EHYEKQELASRLAISKGYHHLYQECLNLLDTSGFIAINGSHIEVQDVLPEEHDEHHSWLQPYPELAAHEKLLRICLQAFPDIIRGSVAATDIIFPDA
SVELVEGIYQGNPATDALNTKAKDAVVAYVKARLADCQEQIIFLEVGAGTGGMSHEVLKGLAPYGQYIEYYYTDVSEHFIQYARRRYGQDYPFVRFQ
RLDIEQEHSALSEGLLSACDVVLAANVLHATQSVRNTIQHVKALLKRHGLLILNEATTLESFATLTFGLLEGWWRYQDAGDRLPGGPLLSASMWHRL
LEEEGFDQVVSLGEPGEGDMLGQHLIVGRSDGWSLHQSARDDETRSAPVSPVAASDVIQGNRNDKPAELIKHVEAQIVQTLSAALDIAAARVERDVS
FSEYGVDSILSVAIINQLNQRLGIRLKRPDLFNYTTTESMAAHIVATFADHLTAALVEEAEPPTPVTVASPQPIKAAGQQDVLQQNLQTQPQVSQGV
WQTKPEPIAVIGMSACVPGADHVGAFWDNLVAGTDSVTRIPHERWQREAVNELPGGPDTSQRKAGFMDNIAEFDPLFFAISPQEAQWMDPTQRLFLQ
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QAWAALEDAGYNPRALAGASCAVMVGCAATGYGVKEGERTGYVSYAMTNSEAILPARISYFLDLKGPSIPINTACSSSLVAIHLACEQLRSGQSDMA
LAGGASALIGSALHIGLNGVGMLSPEGACKAFDKEANGFVLGEAVGVVVLKPLSKAVADGDSIHGLIIGSAINQDGKTNGIMAPNGPSQTALIESVY
RKFEIDPKTISYIETHGTGTQLGDPIEVNALAAAYENFTTSQTQYCAIGSVKTNIGHTTTAAGVCGLIKTLLCLKHQKLVPSLHYKEPNENIEFEKT
PFYVNTQVKDWPGHQNGVRRAAVSSFGYSGTNAYMVVEAFVETSPRAVGQQGPALIVLSARHEVRLKELASNLMAYLKRYGLNPDRPIQLEDMAYTL
QVGRQAMSERLAFVADSVADVVKHLATFVDGEANAQELYRGQVKPFGDKSDLLLEGEAGQAFLNTILRQQDYRKLAALWVAGTDLDWNLLYDGENRA
RRISLPTYPFARETYWLDEGIGSNEKELLRDQTQKELRDRDREQTTELMTFEEIWQEASLNNHSDSIKYKSIVCFLSGSEHQQEMRTAMQAIDPAIH
LTMIAQGHGYTKHSSDRYTVDPADIQSFREAFLDISQTHGEVDALLYLWPTEDWRLLYDPSAVVYMLQALVKSELKPSRCLLVAAFSTALERCYLES
WIGFERSLKLIMPGFQVAGLFQEHAGPDQTISMTHWSQHIVSELKAPKAQTVLIQNHRRYVNQIQKTELAAQGASVASAVKQGGTYLITGGCGGLGF
LVAQHLAEHLGQPAASASGKTVHLILTGRSSPDDAIQSKITQLEALGAKVGYVQADVADAVAMRRGLAQMKNRFGDIHGIFHIAGIAPSESLLNKDI
DAFQNVLGPKIAGTLMLDDLCRDEPLDVICYFSSSAAILGDFGACDYAIGNRFQMAYAAYRNHLLQQGMRQGKALVINWPLWQEGGMGFHQDENTKM
YLSSSGQRVLETQEALTVLDHVLNQDKTQHLVLVGQPGRVYGFLGLTEAPMTQMPVTEAPVTQTSTRPELRGLSTEQSVLWDLRNLIVQQLKVPWEQ
LGRDHNLADFGFDSISLLSFANRLSEHYQLDITPALFFGYSTLEQLTQYFLSEHCDFINAFYKEPEKSEIPVKKEAVEERAPIRIVSEETRPEKIDN
AKDEPIAIIGMSGRFPKAYDVEQMWQLLASGECAVEEISPHYFDWRRYFGEPSQEANKTNGKWCANIPGVAEFDPLFFQISPREAPNIDPRQRHLLQ
ESWNALEHAGYGPHQLNSQKIGTFVGAEEGDYYQRVKEGNITSNHSGILAARLAYFLNLKGPTMAINTACSSSLVAAHQACLSLRQGECDTAIAAGV
NLMLTPYGYISMGRAGMLSEDGHCYAFDERANGLVPGEAVVVVVLKRLSRALADGDPIHALILASGVNYDGKTNGITAPNGVSQAELVREVHQRAGV
HPQDIDYIVTHGTGTRLGDPVEVNALNEVFRDSQHLCAITSSKTNFGHTFSASGLLSLVNLVQALRHETIPKSLHFAQPNKFMTWDQGPLYVNTANK
PWLEKPGEKRIGGVSAFGMSGTNAHMLIQDYQLHRKEPRAVPPYALLVLSAKTAEALHLKVKAMVAFLQEGLADTATLADISYTLFEGRHHLQYRLA
IVVQDMTEAMCCWTQAGQPDKKPNIFQGKVPTEFSGQKVTQNYINQLVEQLDRSTGDDDVYRERLLGLADFYCQGYDVPWSRLYGDTRPRRISLPGY
PFAKQQFWLDFSPKDHGEQENVELPIGKMQRQVLNEKNTLETLSYIHKWEQQDKAEVKIEISQVCLLVYFESASQFEKTLASFFLQQGASQVIEIQL
GLETKPVSEHKWRCNVNDVDAFQRCLQAYAQTINSVYFLCVDTLQQGMEESEMQLLRLVKALKSRMQSHAFIDFTLLTLDNHRVDNSATSPNHGGLS
GLGYSVAQSDHRFRVRNIDLSREDLVSAEQQCTLPGMIVSEAPSDRGEVVKLQAGLRYKQRFFKLDWQTLQAAQPEAAGLKTGGVYVLLGGAGTVGA
IITRYLIQKYQANVVWLGRRALTSPAVQEQLHAFRSVDEGCVPLYIQADVTDQASMTQAVKEIKQHHPCIHGAIFSALVFKLDNSIAKTSEEDFNEV
LDTKKKGAQYFYHAFKDENLDFMCYFSSVQSFFFISSRESAGYATGITSADTFVHAIDHDSTFPVGIINWGYWEASLAGTEAEKRLPGHYDLISDHD
GCQFFDGFVPMLRSGLIKQAVCLGVSKAIEDFMGCDATQMITVNKLEADSLIFSLFNENECGQATCEETEIERLLDKDFNNELKQWLPRLLFSQLQQ
LGIFLNRGEQRDCTTWQQQAGVIKKYERWWRECCLGLLETSGYVQCEGERVEVTHHSPADEADQLWQGWESFQNLFLDKPERKPVLDLLESCLRSLT
QILCGDILATDILFPKSSMEKVENIYQRNALSDYCNTFVAKGIEAYIHQRIQAEPQARIRILEVGAGTGGTTALVLPQLRQVQHAIDEYCYTDISKA
FLIHAEKTYGPDYNYLDYKLLNLEQPLAPQGIEPGSYDMVIATNVLHATENIRQTLRHTKTALKRHGLLVINEVVEKSIVGILTFGLLDGWWLYQDE
SLRIPGSPLITLDTWRKILKEEGFARVLLPMRAASKLGQQVMVAESDGLVRREREDLPDEDESAVTDKTSVVQGMTLTPEQRIAQTPSVRELSSETL
REQVAELILTGLAETLGMAQENIDPLVSFSDYGIDSILGVGFIGQLTKSFGITINTAILYDYTNVVRLSDYLVEIYAEDIQNKIQNNRMSPVEKDAV
LYTETQLETTVDRNPEKSQLENSVPNMTSGENKSAKCQEIAVIGMSGQFPRAKDLDAFWQNLIQGRDGVVELPANYLNPALFSPHKQAGTTDCKWGG
ILEQRDCFDPLFFNLTPREAESMNPHQRLILSESWKALEDAGYNPKELDNTRVSVFIGAEPTDYYHETFTGSSDAIVASRLSYYLNLKGPALVVNTG
CSSSALAIHLACESLRRGESSMALTGGIFAAMHEEALVKLAQIDMLSATGRCRTFDQFCDGTVLSEGVGVVVLKRLDDAVRDNDPIYGVIQASGANQ
DGASNGITAPSGLSQEELLTSVYRQYDINPETITYIEAHGTGTSLGDTVEANALKRAFKQFTDKKQFCALGSAKSHIGHTGAAAGVIGLIKVLLSMR
YHQLPKLLHFEELNPSIELEDSAFYINQQQMEWTGQGVPLTAGLNSFGHSGTNVHLVVREYLPLSETKAEMEAVLIPLSAKTLESLRTYAESLSTFL
ENGHSGHGVSLTDLAFTLQLGREAMRERCIFLAGNVPDLVAQLKAFANDKTLNNVGWYGRVGRSKNSHSFNDHESRQMITQWLQQGKLDKIAAAWVQ
GLSIDWAALYRELTARKIHAPTYPFAQEHYWKPEQQSMVQKPVAPETQPETFGTLMLQPCWIDQPLEHS 
 
>misE, position 60205-73626, length 4474 aa, function KR-ACP-KS-OMT-ACP-KS-KR-ACP-KS-KR-ACP-KS
o
- 
MAAVDCLVYQSRSENIAERFQDYALRLFTEIQQLLTARAEAKILLQFVIRDLLEQQLFAGLAGLLKTAHLENPNLMGQLLCVAPGDDAEHLVATLKV
NAQTPLDQRVAYRNGKRRIAAWKEVPIANDEDVSIPWKENGTYLITGGLGGLGLLFTKEIAQQIRSGTVMLTGRSPLDESKRQMLQTLQQFCGQSRV
HLEYRQVDVCEPQGVASLIQEINHHVGPLDGVIHAAGVIHDNFIIKKTPQELENVLAPKVKGLVNLDEATKDQPLDFFFFCSSLAGGIGNVGQADYA
CANAFMDCYARYRNQLLQSHQRQGRTLSINWPLWQEGGMRVDAASENMMAQSIGLLAMPTSAGMRALYKAIASQQDQVMVVEGDLAKLRQTFLSLPE
KTAQPEIGDVEAALDTGQLQHKTLEKLKSLFAEMTKLPLERVNEEEPLDSYGIDSVMIAQLNQKLTAELGPVSKTLLYEFHTLEELAHHLVKAYFDR
CVNWTQLNSTLNFSEVSVETRNHKSEKGRYSNEYDMQMPDDTAQQPIAIIGLSGRYPKAKTIAEFWQNLKHGEACISEIPRQRWDWKRYYHADPNEA
VKSGKSYSKWGGFLEDFDQFDPMFFNMTPREAENIDPQERIFLQESWKALEDAGYSPSNLSADLRQRIGVFAGITKQGFNLYRMESGPDRQLACPAT
SFASLVNRVSYVLNLQGPSFPVDTMCSSSFVAIHEACAYIRSGQGDMAVVGGVNLYAHPSSYLELSLGRFVSNGSTCAAFEKDADGFVPGEGVGVVI
LKAYDQALKDRDSIYALIRGSAVNHDGKTNGYKTPNPGPKAAVIRQALQQSGIDARSISYIEAAAQGSDVGDAIEASALTDVFSGRNHVEGAYRIGS
VKPNIGHSESASGMSQLTKVILSLNHQTLPPTLRSRALSPSIDFDQLPFELQQELSEWQPVRVDGIEVPRRAGMMNIGAGGVNAHIIVEEPPPHEEP
VHDGHGPVLFVLSAKNEERLERYVQDWLIYITNGPILDLPSIAYTLQVGRESMACRLAFVVNQSEELATYLTRWLKTRELGDVGFYGDVTQERVKNS
EAVSTLVKAGDASHARELAALWVQGNAIAWDKWHRGTTLGRRSGLPTYPFANRTCWIARDDHDCSEDDRGEEKSDVEPRIDHTLDENKAVEFYTRMT
QDCDEAFQEEYLTFGAFPRRIPGFSMTRVAMNAERYPEELEMIKESQRELRQVLFCREDFDRVHTFLDIGCGHGTDVIQVAALYPHIQTHGFTITES
QAILGNRRIEHMNLGSRARIYHKDSSKEPFPDNCDMILGIEVTFHIRDKDALLQKMADALSDDGKILLMDYIANLRGSIVDPNVEISIPTQSQWIDL
LSQHDLIIDEIIDVSTEVSNYLYDPEHAEHTKHLPKVSQDSYRNYANQAIALEKGWITYCLLKLQRDTQRSEQERREYNAWKIANQTPYAQALEDML
RVGRMPYPLSGGLKMAVQPMDGQPPSTLDESVPDLGQIQTALAGIFVAILGFETRELDFIDQLPLTELGISSVNAVELLEAINTEFDLHLPTSLVFE
CHRLEDLAGHIQVELGRKPIAPAMSNASVAVQAEAESRQKTTVPVEEKAPIANEETAIIGLSCRCAGAKDQEQFWQVVSQGKDCIEDLKEPQWLDYI
AEHGSETFPIRYGVMPERDDFDPLFFHISPREAEAMDATQRVLLEECYRALEDAGYNPSSLKQQAVGTYIGAMGSASLRKGFSHLDMLGSETSILSA
RTAYFLDLTGPALTINTACSSSLVAIEVASQALKSGEINLAIAGGVTLYQHPGTFIAMHNASMLSPTGQCRPFDDDADGIVVGDGVGVVILKRLREA
ERDGDSIYGIIRGCGMNQDGQTASMTVPSFLAQSELESAVYQKANIDIEDLQYIEAHGTATKLGDPIEIHALNKSFQALTSKQKFCAIGSLKANVGH
TTAAAGVLGVIKVLLGMKYQQLPPSIHFNEGNRHIDFDNSPVYVNTTLKPWPKNAKDSRLAAISSFGFSGTNAHLVLEQYMPLPDTDSGVFIPLVLL
LSAESDDALQHYAHNVKCYLEDHPAIQYGHFLYTFQVGRDAFAYRLAIIAENQQELIQKLEQWLTTGGPVTDIHNKPDIGNREEEKASLQSLISGRK
VEPLAQLWEQGASVDWHAFYPDGRCRRLAGLPTYPFAREYFGAPQDEECQYGEAKQAPSEDCEGTIARSSTETLIACPYWKEKSVAGATESFAYSRH
LVLLCGMEHISAAKLQAQIPGVECVHLSSVNRFHRSTHVETIYQDEFTQVFEMIQDVLASKTRGNILIQCVVPQQPNQPCLSAISGMLKTAQLENPK
VSGQLIEVLADETEVSLLSKIHENGRCPEDKQIRYDQGQRVVQAWQELVVSDRACKTPWREGGVYLITGGAGGLGLMVAEEIASQTQRSTLILSGRS
SLSPEEVASFSYGLQALGTRVEYQPADISNPYDVDTLIQRISKAYGSLHGILHCAGIVRDNFVINKTSAEFQAVLAPKVAGVVYVDAASKDLNLDFF
VLFSSIAGAMGNAGQADYATANAFMDAFATYRNDLVRIGQRHGQTLSINWPLWRAGGMQVTAHQEAAMRQSVGLEMLDTARGMQALVKGLASGQSQI
LVAAGHLPTLRGWLFQEPLAPSTSDQPLANVHRVGRQPSLASVDKQRLYEETLVQLKGLLGTVFRLSPNRIKMHDAFERYGIDSVMIVQLNQEMEAV
FPELSKTVFFEYQTSHELVAYLLDEYPQECMVWTGLGAESDIDHGNGESSWPERAWRPKHSLATSVDRDLAQAQNPQIQEAIAIIGVSARFAQAETL
QAYWQNLQAGKDCIGEIPTNRWSLDGFFVDDIDEAIAQRKSYSKWGSFLESFADFDPLFFGIPPRDVLSIDPHERLFLQSSWEALEDAGYTRDTLRE
RYQQQVGVFAGVTKTGFDLYGPELWKRGEQAFPHTSFSSVANRTSYFLNLQGPSMPIDTMCSSALTAVHEACEHLRRRDCRLALAGGVNLYLHPSNY
VQMCALRMLSKDGQCKAFGQGGNGFVPGEGAGVVLLKPLSEAIREGDNIYAVIRASHVNHGGKTNSYTVPNPGAQADLIRQTLDKAGIEARSISYIE
AHGTGTALGDPIEITGLTQAFKTDTDDTGFCAIGSAKSNLGHLEAASGMAGLFKVLLQLKHRQLVPSLHAGSLNPNIAFEKTPFVVQQALSEWKRPI
VESSGEVKEYPRRAGISSFGAGGSNAHLIVEEYEANDEPYAEKAVDESVMIVLSAKNTDQLIQLARNLRRFIAETETKPPRLEDIAYTLQTGREAME
ERLALIVGSLEELEEKLHAFVEGQEPIASLYRGDLKQDLNLLSDFATEEELSNTIDDWMMSKQINKLLSLWVKGLTINWQKFYIYIYHKPRSRRISL
PTYPFAKEFYWFEPQAFNHGISTHSQKPAENQTSSRSIQYLQKQWLLDESEPDESYAKQVVARKIAILSGPQTRLLASLLEEEFPNSQIIEHDNIKE
HLEQSHADWQTHGGCIDLAGCSRDEEAGDALDWMLWLQRLIENGSKTGLTLLGVTRGLEFFQNSEVNLSGASRVGLYRMLQSEYAHIQSRHIDTDPS
LKTSALAEQIAREFVLNDENCEICYRDHKRYRAYLAASSLKAAKISDTDLQFAQEDVLLITGGTGGLGLLCAQHFVEHYGVKRLVLTGREALPSREQ
WADPQSDKVKQKIDVIQSLERQGVKVQVLPMVLSDHDAVRETLGQVTKNFGPIRGLLHCSGAVDSETPAFVRKPIAKVSQVLEPKVSGLQTLLAQCR
PQSLKFAVLFSSVAATIPRLASGLSDYAMANAYMDYVAQATGGKLVSIQWPSWQETGMGAANSRAYHETGLLRHNNQEGLRLLDDILSQQTEPVILP
AVVDSALWAPQQLMKHQSRRESISPVLHHHPQTPMHIEPATPNMASSQLTLNDLVALFSQELGIPTQNLALDKSFADYGLDSIWLAQLASKINQQLV
EPLDPSILYEYSSLNALASWLASEQAPALKSQAHDRDVEQKIDPKNAADSVVPRSSKKQALDIAVVGMSCRFPDANNLDEYWSLLSEGKQAIRPVPA
DRWSRPTPFYAGLIENSSHFDPAFFLIPPEDAKVLDPQALLLLEECLNLFYHAGYTLDEMKGRAIGVYLGGRSQHRIDEADLGQARNPIVAAQNYLA
THLSQFFDLNGPSLVIDTACSSALVGMNFAVQSLLSGEIDSAVVGGVSLLADEDAHRIFQQRDLLNRDASFHIFDQRASGITLGEGAGLVFLKTLPQ
AQRDGDQIYAVIKGLVINNDGRTAGPATPNFEALKSVMQRALKQSCQQPQDIVHIEANGSGSEVTDLLELKAMEAVYRSDNKAPCSLGSIKPNMGHP
LCAEGIASFIKLVCMLKYQQQVPFLSGQVPLTHYDLDASPFYFCRQSTKWTEHSPLLVALNCFADGGTNAHVIMEAWTQAESHQQRQPIPPPALNRV
NIRGAVSQHPWW 
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>misF, 73446-97670, 8075 aa, DH-ACP-KS-DH-PS-KR-ACP-KS-KR-ACP-KS-DH-KR-MT-ACP-KS-DH-KR-ACP-KS
o
-ACP-TE 
MDRTLPPSGGAQLFCGWWDQCTCDYGSLDAGRISPATAAHTTTRAKPSEYPRCSQPASLVVRWHILKRNLDNHAVPSYNRINNVKKEFHIHASHPIV
KHHQAYGQALLPGLAYIDLLYQFFREQGYEFAALELRNLSIYRPLLVGEDDGIQLLLQADDMAEGLWSVQLLDGEQRGAPESKAQQLYIKAEMYHHR
EAPVFDDVLDFQALQAVSHTQIPLNDIYAQCRSQGLVHSGMMKAEGTAYTLDDAQIIEVALPDEAASSAAGFMFHPALIDGSGVGSSNLFAALVEGE
QRLFLPLFYERFRASARFERTCLVRVKTASVWRKNDMMYMDIEFFNESGEKIAELKNFVNKLVREAALINPNLKPASQAQSSKLKPYEEASSESQAN
PPRLDKSEALEGMEDLLKEIIAPYVDGSPEQLDPEAGYYELGLDSAILLQVVTALEKRFDAKLMPTLLFEYTTIEELAAYFVNENFATKHVAKEPAT
PLAPVLPGPIQTGHEDDIAIIGISGRYPGANNINEFWQNLVVGKDCISDVPEERWDWRSVAKHKSPSGKSVSKWGGFIQDPDCFDHQFFRISPREAE
VLDPQERLFLQTCWECIEDAGYTPETLVTRQQAPHRRQSVGVFVGVMHKDYVFLGMEAIARGEQFHLSINNAPIANRVSYFCDFHGPSMVIDTVCSS
SLTAIHLALESIRHGESDIALAGGVNLSLHPNKYLTYGLLDMYSSDGRCRAFGRGGDGYVSGEGVGAVVLKPLAQAIQDRDHIYAVVKGSMINHVGK
VTGISVPNPVAQSDMILQCLEKTGIHPRTLSYVEAHGTGTSLGDPIEIQGLCKAFQTHTNDTQFCAIGSVKSNIGHTESAAGISGLSKVALQLHYQT
LVPSLHSEAINPHLDLEASPFFVQRQTQHWERTSDHPRRAGLSSFGATGSNAHVILEEYIPEQSETDLAQPAEGVEQRLPVLIPLSAKNEERLKEAA
RNFYHYLISKPEDVAGHQVARLSDIAYTLQVGRRAMETRAIFLVDHQQQLVESLQAFLDDDHTKGNSWLGKQVKQQRHARRGEYSEAMLQQWMVQGR
LDQLAQAWSEGVPLNWDALYSPESGVAKPSRVSLPTYPFAKARHWVPMEVKAVTPFAALHPLLHRNTSTLGEQRFSSTFSGEEFFLADHRVHGQKML
PGVAYLEMARAAVALATSAGEAQAIRFKNIIWQQPLVIDGTEKTIHIGLYAKANSQVDFTIYTGDEHGSDAPFPDEQNRRVHCRGIAMLTLSDRERE
TYLDLDHLQSQTGQNDFTPEQCYQAFAAMGIDYRDGHQGIAAVHAGADQILAELSLPASVLAHREPFVLHPSMMDSALQAAIGFALSAQVAGAQQPA
SLPYALESLDVRAACTPSMWVWIRYADNNSAGSPVQKFDLDLCDDRGKICVLMRGFSSRIFHAQASPCFAETLLPSQLHPLLHQHVPSENPVHDQFI
AQFTGEEFFLRDHQQVMLGMAYLEMAHRAGQHRASQKILGLKNVVWSQLLFIAGQAREVSVHVQNEVLQHRFRITTQNEDSLQNIHCQGMLVVDQAL
YPERPDQLNIQDIQSRCSASIETTECDQLLQYTHGPSLLTIKQLWHNEHEALALLQLPDGMRSGREDYTLHPSMMNGAILTSVLFSLLNGPQEHLPM
PFALDELWMYQEMPERAYAYVSMSSANNHDIELVDITGKCIVLFKGFTAAIQGAWQSQAPQNNVIYASTQWRESVLSGDEHANTAASAPIVMLAQDN
PELAGLLRQRWPEASIEMLAPIGEDIAKTVQANFLQVFDRVKTCILEQPQRIQPIVVLLPENENDYLHDGLAALFKTARFEYRKIVGKLIRYTIDID
IEELAKSILMEVSHDDQHVDVYYSQTGTRKVKTLNEIYDFEKSHAHLLVEADLLHEGDVVWITGGLGGLGQIFTRHLSHTKGLKLILSGRSPLNAAS
EKVLRELQQSDVEMSYLSCDISDQQAVATLVQSILNKYGKLNGVIHSAGLTRDAYIHNKTREEMIAVLRPKMAGILAIEAACQDIQLNFMVLFSSIA
GVFGSIGQADYAMANAFLDSFAEARNRRVQQGKCFGRTLSINWPLWRNGGMGVDAQNETLMQRNTGMIALETRAGLNAFELALSSEYSHILVAQGET
EKIRSRLLSPRFVEENLSSVEADTTEPLEHQNQSEPSKAEQDQRAWLIRLLLKDLAAFVCRLQKVQPEEIDLEAEFSVYGFDSIGFMSFVNHLNDMY
DLELMPTLFFEHSSLRALADALIEKHQEALLKKYESPKTAAQPSQDRMPIQARAVEMDKRQHPVSATMTPVESETTQGNPTPESLSTTDPIAIIGMS
GKFPGSENLTAFWQHLEANRDLVSEIPEDRWDWRDYYGDHLSESGKTKIKWGGFIEGIDHFDPLFFGISPVEAEIMDPQFRLFLQTVWATIEDAGYR
ASALSGSKTGVYVGVTTTDYKDLMQQARARENSQEYHGMFPFMLANRVSYLFNFRGPSEAIDTACSSSLVAIHRATESIRQGSCEMAVAGGVNIIAN
PQLVLSATQGGMLSEDGRCKTFDQSANGYVRGEGVGAILLKPLARAIEDHDPICGVIRGSAENHGGKATSPTAPNPVAQQELLVSAYAQAGITPETV
GYIEAHGTGTPLGDPIEINGLKSAFAQLYEQIGRPPANEPHCALGSVKTNIGHAEAAAGISGVLKVLLMMKHQKIPGNPHLKEPNPYLQLTGSPFHL
AQDTQDWRALHDEVHNPIPRRAGVSSFGIGGSNAHLVLEEYTAEPAAEPVVCGEASLIILSAKNRACLVEAAGNLYRFLIDNRESSRGELLRLADIA
YTLQVGREEMAHRLGFVASSLTELEERLQTFINVQGENQDLYEGHTKGNRSTLEAFESDDDLQEMLTKWVEGRRFEQILKLWVKGLAVNWESLYRGI
QPRRISLPSYPFARERYWIPASAESLPVPAASPVSPIQVDNAAGVLMCHPVWEEKAAPVQVGSFDPASLHDCQHLILFCHMDVPLGLQDRFGTSSVC
RVFQAQSDDVALGYSYLCEQVLTCLKEILENKPRDRVFVQIVIPGPETSEAEGASGLLHGLSALLKTAHLENPKVLGQLIEVGPRHTGDALIRCVQE
NCQSPDDVQVRYRHGRREVMAWEELPVSEPNAAPMPWKERGVYLITGGAGGLGFIVAREIARRVKAPILILAGRSHLSQAKRDELQQEAQRLGVQIE
YRQADVSQPQEVNDLIRSILRDFTKLNGILHAAGLIRDSFMIRKTVDQLHQVLAPKVFGTVYLDEASKDVDLDFFLLFSSGAAALGNAGQADYAAAN
AFMDAYAEYRHALFASKQRFGRSLSINWPLWQEGGMQVDEPTLTALEQYAGIRALQTGSGLDALYRALSVTPNQIMVLEGDLAKIRQGLFSASTEPY
RNESSRVEVDEERLLARTLHQCKTLFGGIIKLAADRVEAEEALEHYGIDSVIIAQMNLRLEEVFGEVSKTLLYEYQTLGELASYLATEYRDACMTWT
GLTAIPTSDMTTVPDDAIPAKPQITSEPRRSSGVDVHALTPKAPAPSQDEPIAIIGLAGRYAQADTPRAYWENLQSGTDCVTEIPPDRWSLSGFYHE
DLEEAIAQGKSYSKWGSFLNGFADFDPLFFSMSPREAIGIDPQERLFLQSSWEAMEDAGYTRETLRDQFQQRVGVFVGITKTGFSLYGPELWQRGDI
VYPTTSFSSVANRISYLFNLRGPSLPIDTMCSSSLTAIHEACEHIRRGECELAIAGGVNLYLHPSTYVQMCAAHLLSQDGKCKSFGEGGNGFVPGEG
VGTIVLKPLTQAIDDHDHIYAVIRASSVNHGGKTNGYTVPNPNAQAALIEDALDKAGVDARTLTYIEAHGTGTELGDPIEIRGLTQAFQKHTIDTAF
CAVGSAKSNLGHLEAAAGIAGLTKIILQLQHAKIAPSLHASTLNPNINFAKTPFVVPQALSEWKRPIVDMHGEVKEYPRRTGISSFGAGGSNAHLIV
EEYVKGTSVGETRASHHHDVIRNEAQVILLSAKNEDRLHCVAKDLHDYLNAEQGANLSLRDIAYTLQLGREAMDERLGLVVYSLDELRQKLNGFIAG
ESGIEDVYRGQVQGHKKALALFTEDDELQEAIEKWMQRGKFARLVELWSQGLAVDWNKLYCDREVIPYRVSLPTYPFEQHRYWIEDTLHASPKPVAE
SVGQSAVKLHPLIHENTSNFLAQRFRSCFRGDEFFLADHLVQGRRVLPGVAYLEMVRMAVSLAMDTQIEGYDLRFENVVWARPIIVDGQPLNMHTVL
QVEDSTTISFEIYSQVDTEENDADVLHCQGSVEICVLEKEQELEVSHLLGECQKHHLSAAQCYEVFESAGIQYGPGHRGLDTVYVGDQQVLAKLLLP
PSVASTAEQFILHPSLMDAALQASLGLAVGGVGSEPTPSLPYALETLDLCDAGARPSWAWIRESNQSSGEIQKLDIDLCDDQGRICVRMRGFSSRVL
ERAWGSQEDRLTLLSPVWNVISDPPTEGERDDVASEQVIIAGGSDLQRDILGQVHPGAVWLPADDFEAIDQQVKVLPSQMDVVHIIWVAPDQPMTSV
RQESLIREQVQGVLYLFRLMKVLLAHGYGEKELHWTVITTQAQAVRKKDIVNPTHASVHGFIGSLAKEYPHWKIRLLDMDADESWPVHDMLALPGDQ
NGDAVAYRAKEWFQQALVPVLETDQGLPPCYRSQGVYVVIGGAGGIGEAWSRWMIERYQAQIIWIGRRKKDALIQEKLDALDKLGTPPIYIEADAGD
LMALQNAYQQIKRRYGRIHGVIHSAIVLADKSLANMDERQFLAGLRAKVDVSVRLAQVFAKETLDFVLFFSSTQSVAKMPGQSNYAAGCTFKDAFAS
QLAQEWPCQVKVINWGYWGSVGVVAISSYRERMARAGVRSIEPAEGMAALQSLLQSSLDQLAVVNTLPTASIAQPSRNQALEEWITTYPDGLPVCVD
SLPQYLPNQPLPVVDSGTGVPDQTVTIEDLLPQLLLATLQSLGLIEGRAEQRAAALPAATFYRQWLEESLTFLWAKEYLEYDGQGYTNKLPSVDLAR
VWQEWEREKVLWLQDRNQKAIVSLVEACMRALPDILRGAQLATDVIFPDSSVALVEHIYKGNVVADYYNQILQNSVVAYIQARLAQAPTAQIRILEI
GAGTGGTTSGLLAELRPYQRHIVEYCYTDLSKAFLIHAERQYATEHPYLVTQIFDVEKPLAEQGIQANHYDVVIAANVLHATKNIRNTLRNAKAGLR
QHGLLFLNEISTKSLFTHLTFGLLEGWWLYEDAALRITGSPVLSSAIWADVLAEEGFNSITFPALLAAESGHDFGQQIIIAQSDGIVRQKARRQSSP
VLPSTPKKQSVKPKEITKLSPNTETLREKATVYIKKLVASTLQLPSDQIDSAQALEAYGLDSILVVQLTSTLRKAFHNISNTLFFEVQTIDGVVDYL
LERQPEVFSDLLGVDKQKIDERIVETSTPIESLESTRQANGRNHSLQKLNFRTTQKLNALAASKKHETVHDRDIAIIGLSGRYPQAENVNAFWECLK
AGQNCIREIPQERWDWRRYYDAEKGKEGTLYTKWGGFIDDVDKFDPLFFKLSARDAERMDPQGRLFLECAYSCMEDAGYTPSTLCDSRKVGVFVGVV
NSTYRRQPSFWSMANRVSYLFNFQGPSMSVDTACSSSLTALHLAIESLHSGTSECAIAGGVNLILDPIQYLTLSAMTMLSSSDACKSFGNQADGFVD
GEGVGAVILKPLAKAEQDGDAIYGIIKASMINAGGKTNGYTVPNPIAQSHLIREALARAEVDPRTISYVEAHGTATALGDSIEITGLSKAFGLSEDK
QFCPIGSVKSNIGHAESASGIASLTKVLLQLKHRQLVPSLHSQQLNPSIDFAETPFVVQQTLEPWHRPVLTIDGETKTYPRIAGISSFGAGGANAHV
IIQEYMNEKGDAAADAEGQGWPETSLIVVSARDEDRLRELVNHLCLYARACSLADQGKAQTAKLQAMAYTLQVGREAMEVRLGVVVASFAELSEKLQ
GFLDGQRDVDNLYRGQVRPHREAMAVLAGDDVFAETIDAWIHRHKYDKILELWVKGFVFDWNKLYGEQKPPRMHLPTYPFARERYWAKIIDLSLDGF
QVGAPQQVVEWIHPLVHKNTSNLEEQRFSSTFSGQEFFLANNRVDGEKVLPGVVYLEMARVAAEQARPHPSTSLAKSHIQLRNIGWATPFVCDHSSQ
SVHIRIVPGTYKGSDVSFEEMSYEIYSHIDTEREVVVHSQGVIALWQAREVAGLDLPALQASINQKCLSAQQCYDAFAAMGIEYGQGHQGIEDVYMT
PSQAGRCQVLAKLRLPAVVAETSHDFVLHPSMMDAALQACIGLTVEHAVPESGQMSLPFAIDAIEVIEKCTDTMWAWIRYADPHADPIQPLSSRVTK
VDIDLCDESGNLCVRIKGFSTRVVAIPESKAIGTWMSFPVWKEKSWSEHEPSEYAQRTVMLIEMEWVSDRLIESQIEGTTCVHLTTQANSLAERFQD
ISVQVFERVKALMEAKLRGSILIQLLVPHSGETLLFSALAGILRTAHLENPALLGQVIILEPSETQEGVIDKLQRDSSCPEDALIRYQQERRQTMAW
QELPMSEREQAVQVPWKEGGVYLITGGLGGVGFMFAKHLAQHSRSVSLVLTGRSELDEQRREQLKELEALGARVDYLSVDVSLKEAVERLIDYIESE
RGSLTGILHSAGVIQDNFIIRKAVREFQSVLVPKVDGVIHLDQATQALNLDFFVLFSSLSGINGNAGQVDYACANAFLDAYAHYRNRLVAINKRSGQ
TLSVNWPLWKEGGMQIDPQRAEAMFQHLGLVAMETSRGIQALIHGLSSGQSQLMVVAGDLERLKVAHPSRPSSPPSQMDREHNVIGENELDANALAS
RSIHYFKNLIASILKIPAHRIQNDELLELYGIDSIIIMQLINQLERDFGPLSKTLFFEYPTIEEVNQYFVDSYRQKLHVVLGLDKSKAPETDHSAVV
DPARPKVHRRSRLLAPTLDESPLPVAQTQDVAIIGVAGRYPQSPDLESFWENLSQGKNCITEVPESRWDPSLYVDFDPSNSGQVYSKWGGFLDDVDK
FDALFFNISPREAELMNPNERLFLETVWELVERSGYTPERIQEQHENNVGVYIGAMYQQYQALASEPLIESVLSLSSHSAIANRVSYFFDFQGPSLA
IDTMCSSSLIAIQLACDSLLKGECQMAIAGGVNLTIHPNKYIGLSLSQMISRQNTSKSFGEGDGYLPAEGVGAVLLKPLAKAIEDQDSILAVIKSIS
TNHSGHTYEFRVPNPNAQAQLFEANFRKSGIDPRTITYVESAANGSPLGDPIEVSALRKAFQKFTADQGFCAIGSVKSNIGHAEAASGISQLTKVIL
QLQHQQLVPSINADPLNPNLSFDGSPFYLQQQLQPWARPVFNIDGQEREFPRRATVSSFGAGGSNAHLIIEEYIASAGKNAVSPDIELAADRELMVF
SAKSCDRLQAMLQQMRHYVESNQALSLKKMAYTLQVGRMAMTHRIAMLVHNREELIQGIQDALHSLEQPAGIINTTIPIYMGDLEADHSEVKHLLSG
QSGEAMLKVLFAEENLEKIALYWVKGGHIPWLALHQKGQMSMLSLPTYPFSKRYCWVESKALSQVVTTAEAELLSKSTDDHISVDRNEESVLSEILC
RTLGLTAEEFNQKTPLVQYGVDSVMFVQIFQQIKDKIDNRVNLSQLLECQTMQDMIFYLTAKKEDAQTEPELVNLSGAGLSSSHDTRFPELVHMNSS
TRGRPVFWFHGIAGVTVYEPVAEKSQRPFYGVQPCSWINQTAGPSHIQAMVQGYLDAIRSVQPEGPYDFGGYSLGGMLAYEATRQLQDMGESVSTIV
MVDTLQSNPDRKDKYSRKTDYLVVLNRSFASSAWQSSENTVQDMLIRADELDASLSDDEYLTELIVLAKQRGLVKTETEIRASLEYATTLDEFYQTD
PFTVRPLSDPDAVNCYYFRNKNGAMLGDQAPYYFATPQDREIFVTTDQSADSRQWEKNLTNLHIIDIDSSNHMTMFSEEKPRQTILEFCEILYSEAG
LPNAFLDFFMAKAREIHGNIELDR 
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> misG, position 97718-98779, 354 aa, function trans-AT 
MIAYMFPGQGSQVREMGKELFSQFPDLIQKADAILGYSIEDLCLHDPHKELNQTQFTQPALYVVNALSYRSVIQATGKKPDFVAGHSLGEYNALEAS
GGVSFEDGLRLVQQRGALMSQAPIGGMAAVIGVTGEQVEALLKKFGFDAIDVANFNSPEQVVISGLKADIDKASDDFQEAGTRYIILNTSGAFHSRY
MQSSKVQFEVFLKGFSFSELQIPVISNVTARPYIQSDIVENLAKQITHSIQWTESMRYLLAQGVVEFQEMGVGTVLTKLITDIKAKEVPREQKEPSG
NWTAQEQVDRWNATHSIGLKVHVDGYENELETRTEAIVLFGHRAAIYMQGYNGYFALDEVTPA 
 
>ORF5, position 99817-98849, length 323 aa, function putative nonspecific acid phosphatase precursor 
MPMLKQMGMLLLMTCIYLLPILTAAHAQPQAPLPSWQDTANKKAIISFVQSVSTKGSPDFVPREQRVATFDQDGTILIEKPLPVQYEHIFRFFEEPK
PDPKLALVGRKPGEWANIGSGSLLAYQYMTLPEYSENAIKFVKENDHPTCRVPYFDLFYAPMLELIQYLRANKFRVYIVSGSWQIFLRSVAKAKLGL
RKSHFIGTQTGLVDFPANTFPLRIAGTIDNNLLNLNMGKPKNIQIQIGEKPILAFGNSSSDVAMLQYASTNSHKSLSLWLEHDDAEREYVYPSEITG
EKDWLKISMKNDFAKVFDKVNGEQVTCGLLPQ 
 
>ORF6, position 100789-101223, length 145 aa, function phage shock protein 
AMMPCRQRRYMIRKMSAACDCGKWWRNMAQCTTSNVVESVRANTSDFWTVISGYVVVRCRATSQMAGLKSTAVMLMAICWRRAQCTRAMGISAEPVP
ISRTLRDGQFPLDSKRESASREALMPPRKRLTYSISLSAATTSWPSIVA 
 
>ORF7, position 101270-100563, length 236 aa, function SAM-dependent Methyltransferase 
MVDFRQRSTAPEHMDHATIDGHEVVAALNEIEYVNRFLGGINASREALSRLLSSGNWPSLSVLDIGTGSADIPMALVHWARRQQIAINITAVDFNPA
ICEVARQRTTTYPEITVQKSDVFALTDSTTFDVVHCAMFLHHFPQSQAADILRIMYRLCRHGIIVNDLHRHPFAYYSITYLSRLLSLSPMFQHDGPI
SVLRGFQRPDLEALIKMGGLANAEITWRWPFRYVMTAWKLLA 
 
>ORF8, position 102567-101275, length 431 aa, function naringenin-chalcone synthase (CHS) or PKS type III 
MAISVHDDLRRARYLRLGGCYLRPNMERRLRRQVEGQAQSATSFRFATYCPHVPPATPDKELGVHHEIESTALWSIGTAVPTFQFSQQKALTYALSR
IPPAIARHVKFLYRRSQIDSRHTCSQALYNAIELDTGEAAGDEASTAERMQAYESQAADLAARAAKRALAQAPHFSAADITHLVMVTCTGFVSPGPD
VLLFEQLGLRSDVRRVQVGFMGCHGAMNGLHTAAAICRSEPQAVVVVASLELCTLHFQSTLTEENLVITSLFSDGAAAALLSGKAFTDGQPRCYLDA
FGSRVYPEARDAIAWRVGNQGFDMGLALSNAHDLRPLIPDFVGDWLSSYELHQDDIDLWAIHPGGRAVLDTCEWALGFAPDALASSRWVLRHYGNMS
SPTILFVMDHLLAKTKANRVRRGLSLGFGPGVTLEGILWHEGD 
 
 
S3.2.3 Phylogenetic analysis of all KS domains (MisKS1-MisKS19) in misakinolide A biosynthetic 
pathway. Note: Bae, bacillaene; Chi, chivosazol; Dif, difficidin; Dsz, disorazol; Cor, corallopyronin A; 
Sor, sorangicin; Lkc, lankacidin; Lnm, leinamycin; Mln, macrolactin; Mmp, mupirocin; Onn, onnamide; 
Ped, pederin; Ta, myxovirescin. Due to the complexity of this phylogenetic tree, it is not present here 
as the whole tree. Instead only clades containing KSs from misakinolide A pathway are presented.
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Supplementary for Chapter 3.3 
S3.3.1 End sequences of the pADU2a fosmid:  
 
>pSTW-ADU2a, T3 primer: PP-binding of PCP domain (clone end sequence) 
CCPSASRSWLYICTMRTELAPRSKKLVVTLICGSASSWRAVDVNYLIPDSGPPIRLR 
 
>pTSW-ADU2a, T7 primer: Condensation domain (clone end sequence) 
GAPRQIIHAAAPLHLPITDLQPHAPASQMAEAERLARDELQRPFDLASDLMLRAALLKRNADTHVLLLTLHHIATDGWSFGNLCQELAVLYDAHIQG
KPSPLTTLPIQYADFAYWQRQWEQSDAFAQQLAYWKEQLAGVPERLALPTDRAHPSRITFDGGVVPF 
 
S3.3.2 Protein sequences of the end of individual pADU2a subclones:  
 
>ADU2a-1a, T3 primer: Condensation domain 
PLPLSLDQERLWFINQFAPENAAYNIHTATRLIGNLDMAVLEKSFNAVIQRHDVLRTSFVAENGQPKQVIAPSLQLSIPIIDLQHLSQAEQDAEAMR
HASEEAEAPFDLSQAPLMRVWLLKMSLTEHVLYFNQHHIITDWWSAKLLFQEMATFYEALLSGQLPVLPEPYQYKDFVLWERERVENQDMARSLAYW
RKHLAEGTFQLDLPIAHRRPVEQTFGGRRQWVTIPPGLAHDLKAFSRRENVTLFITLTAAFKMLLFRYTGQTDITLGTPLANRSQVELERVLGFLIT
MLVLHTDLSGALSFKELVHKVRQVILEGVCASKMYPFAKTLDILQLARGLEPETQSSSFPSPYYDQIILT 
 
>ADU2a-1a, T7 primer: mcbC-like oxidoreductase, Acyl-protein synthetase, PP-binding 
VTGAKLLSSNRSRGPVSRAARTFTTPADYQIIQLSTTAAIGRDAHGGPNAEIFEHSAFSLFLVGELAAIEPMYGAAARDFCLLEAVYMSQLLMEEAP
GYEIGLCPIGGLNFDPLRPAFEIGDSQVLVHSLVGGGITPEQMRSLPQPEGALQSLEEDIKAYMGQKMPSSMVPKFFVSREAPPVSTNGKVNIQAIP
VPDLTAFEEDVVAPENETEDQIAAHVRDMFSLTQFSVTTKKATSATTPSSRCRCATISGGRGSCKPCGGPSY 
 
>ADU2a-2.2a, T3 primer: GMC oxidoreductase, NAD-dependent epimerase/dehydratase  
STGPMCIRTIGPRLFCWATGNERLGDFLKIFYLSGLSLCPGAALSPQLHSVAMRLRRPLAPEQIADAILVNLFAESALVAICNSLVLALTCIDQMLR
EPGRQSAHGVRGILITSCREHAAGADVEVRCVVYP 
S
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>ADU2a-2.2a, T7 primer: NADH:flavin oxidoreductase/NADH oxidase 
DDIIFTPLQIGSLEVKNRLFRSSISGRIDNYDGSGTPWRMNFEKRFARGGVGAIISSHVPIAVDARILPDYAMIDRDERIPFWRQVGEAVRQYDHCR
FILQLSHSGRQQDIAGVENLGQRPRSSTNRRDAFHGLRGRRMSQDEIQIVVQQFVdaarraadAGMDAIELHAGNGYLFSQFL 
SSAINDRTDPYGGSLENRYRIYREVISGIR 
 
>ADU2a-3b, T3 primer: Tryptophan halogenase 
PQVKPTFKMGIRFEWGGTTPEHYFNYPFGAHGQLLEAMTYQGHIRDYSLGSMLMSADKMAIFRTGDGAYESRLHYGAISYAYHIDNQRFVSWLQREA
KRAGLHHIDANIQDVVTDDSGQNVVALLTDDGARHEYDFYVDCSGFRSLLLEKALDSEWVPYDQTLFTDRAVTANVPHGGHIKPYTVAETMDHGWCW
NIPMREDDHRGYVFSSAFCDEETAIKEMQAKNPGMSDTKLVTFRSGRHRHFWKGNVVAIGNSYAFVEPLESTGVHMIAEEILAFIGNFPQSTHDDAN
RAALNRYMAAYWDELRWFLGLHFRFNTKLDTPFWKACRA 
 
>ADU2a-3b, T7 primer: Tryptophan halogenase 
VRPLESLFPRSTDVQMGIRFECRGTTPEHYFNYPFGAHGQLLEAMTYQGHIRDYSLGSMLMSADKMAIFRTGDGAYESRLHYGAISYAYHIDNQRFV
SWLQREAKRAGLHHIDANIQDVVTDDSGQNVVALLTDDGARHEYDFYVDCSGFRSLLLEKALDSEWVPYDQTLFTDRAVTANVPHGGHIKPYTVAET
MDHGWCWNIPMREDDHRGYVFSSAFCDEETAIKEMQAKNPGMSDTKLVTFRSGRHRHFWKGNVVAIGNSYAFVEPLESTGVHMIAEEILAFIGNFPQ
STHDDANRAALNRYMAAYWDELRWFLGLHFRFNTKLDTPFLEG 
 
>ADU2a-4c, T3 primer: Galactose oxidase 
FQAEIWNPETRTFRLVDSAKEVRNYHAVALLLPNGTVFTGGGGVPPFGKRDAHSSVNDGPGKKIKPNFTAEIYYPPYLFTDDGNGPRLADRPIMTLT
TADADISYGAVITADVSAGSRIDLVTFISLGSMTHSQNMDQRLIKPYFEQVGNELRITLPNNKNLLPPGDYMLHAVDDAGVPSIAEIVQLDQDNVAT
SSDATSVIELARTISLESVNVPGHLVRHATFQAFIAPIDADSTQIERDDAAFRIVNSLAGEGCVSFESRNFPGYYLRGTLPDF 
 
>ADU2a-4c, T7 primer: Galactose oxidase 
WRPLESTHDLGPSGVELWRESDDDLKFSGQDGRYIDLWTPAEGLVKEAHARPDGAQLSFATDSFCNAAKLLPQGLLLVAGNDFTGRPNGENNTDLFD
YTNNQLQLELADMRYPRWYGSLVRLADDRMVALGGAQSYEHNSFKVWRNGDYDMAGPNYDPALPNGGDDPSYTLGERRHSSIPEIFTYQSGNPAGLW
QEMTGAQNIKTFGRQDNAWWYPRAYLAPNGLIFGVSWNNLWTMDPDGGDATNPGSTAEHGTVAHNVGASGASVMFEGGHLLFAGGGQHSNEEIAPGL
NQATIIDITTPTDPIVTEVNPMTHARNWGIATALPTGEVLVTGGTTDSNRWNDNLAVFQAEIWNPETRTFRLVDSAKEVRNYHAVALLLPNGTVFTG
RGRLAPVWKKG 
 
>ADU2a-5a, T3 primer: Peptidyl carrier protein  and Thioesterase (PCP-TE) 
VLKRQQIGIHDDFFDTGGHSLLAIELLSHIQHVFDQPLPLDFLFQNPTIAQLAAQLGAEEKTSVTHVLPIQPTGTQTPLFCVAGANGYAFYFRDLAT
CLGADQPLYGLEAPGRDGFSPLPDSVEDHASQLVAALRQVQPQGPHLLAGYSAGCAVAFEMASQLEQQGETVRQLIILDTGLIAHPEHFTERSELDM
IWYMVRRVETLKAVSLGLDYQQLVQQPDDQARWQLAAEHLHRPGVLPEYESLSLLQTGLRVGQGLMDNYTIYHPARPIAAPIVLYRAKEIDALLLEE
HRASSHYDLPDWGWQAHTQGSVHVNWVPGNHGSILYEPQVQVLASDLQRRMDFGASW 
 
>ADU2a-6a, T3 primer: Condensation and Reductase 
GAPRQIIHAAAPLHLPITDLQPHAPASQMAEAERLARDELQRPFDLASDLMLRAALLKRNADTHVLLLTLHHIATDGWSFGNLCQELAVLYDAHIQG
KPSPLTTLPIQYADFAYWQRQWEQSDAFAQQLAYWKEQLAGVPERLALPTDRAHPSRITFDGGVVPFRLDAELTARLRQLSQQADTTLFMTLLAAFQ
ALLARYSGQNDIVVGTAIANRNRRELEPLIGFFVNMLALRADVSGNPTFRELLGQVRQVTQAAYENQDLPFERLVEVLQPARSMEHQPLVQVGFALQ
NMPASHLELSGLHAEP 
 
 
S3.3.3 Protein sequences of the partial gene cluster of pADU2a fosmid screened from the 
metagenomic library of T. swinhoei chemotype W 
 
>ORF1, position 1-3816, lenght 1272 aa, proposed function: C-A-T-TE, specificity code of A = DALHLGLVVK (hpg) 
VAAPRVDLEDPPDGAPRQIIHAAAPLHLPITDLQPHAPASQMAEAERLARDELQRPFDLASDLMLRAALLKRNADTHVLLLTLHHIATDGWSFGNLC
QELAVLYDAHIQGKPSPLTTLPIQYADFAYWQRQWEQSDAFAQQLAYWKEQLAGVPERLALPTDRAHPSRITFDGGVVPFRLDAELTARLRQLSQQA
DTTLFMTLLAAFQALLARYSGQNDIVVGTAIANRNRRELEPLIGFFVNMLALRADVSGNPTFRELLGQVRQVTQAAYENQDLPFERLVEVLQPARSM
EHQPLVQVGFALQNMPASHLELSGLHAEPVDLALNTSRLDLEMFLTETEGELDGMCLYKTVLFEASTIERMWGHYQTLLQQVVNDPEQRLSELPLLT
EAEQHQLLVAWNDTHVPFEPGACVYHGVEQQAQRTPHAMAIEYEGQQLTYDAFNQRANQLAHFLRQRGVGPETRVGICLERSVEMIVALLXICKSGG
AYVPLDPAYPRDRLAFMMQDSQMRLLVTQTSLLEQLPIPDGLPQMVCLDRDWPHIATMPSDNPVVQVAAEQLAYIIYTSGSSGAPKAVMVPHRGLRN
LVNWYLREFDVNASDRCIQFVNLSFDAYCLEIWPTLSRGAKLHLVKPELMSVALRLQDWLIKHDITLAHIPTPIAEQLIRLTWPDAMALRLLLTGGE
QLHLSGSASPLPFQFVNLYGPTENSVVSTWYVVSPDSPAIPPIGRALDNQCMYVVDGHLQPVPVGVAGELYVGGIGVGRGYLNRPGLTAEKFVPNPF
AQGRLYRTGDLVRYLPDGNLEFLGRIDNQVKLRGFRIELGEIEAVLSQHEWVKEAVVTLYEADGNRRLAAYVTGDITPEQLAVVKHGIKARLPNYMV
PSQIVVLNALPLNVNGKIDRNALPAPGNWGEDAYEAPRNEIEQRLAEVWSTVLKRQQIGIHDDFFDTGGHSLLAIELLSHIQHVFDQPLPLDFLFQN
PTIAQLAAQLGAEEKTSVTHVLPIQPTGTQTPLFCVAGANGYAFYFRDLATCLGADQPLYGLEAPGRDGFSPLPDSVEDHASQLVAALRQVQPQGPH
LLAGYSAGCAVAFEMASQLEQQGETVRQLIILDTGLIAHPEHFTERSELDMIWYMVRRVETLKAVSLGLDYQQLVQQPDDQARWQLAAEHLHRPGVL
PEYESLSLLQTGLRVGQGLMDNYTIYHPARPIAAPIVLYRAKEIDALLLEEHRASSHYDLPDWGWQAHTQGSVHVSWVPGNHGSILYEPHVQVLASD
LQRRMDFVASL 
 
>ORF2, position 3816-4532, length 239 aa, proposed function: SCO1/SenC superfamily 
VRVSWLLTAGSPKLAFVYPIHLFVLLVVRIAGGFMATRLARMSCGALLLCLLILTNSGATGSSGELLCAAPGGAQRGKIVDYGWSLMDQDGREFAIA
STQGQVTVLFFGFSRCRGVCPNLLAKMARAEAELGDKAEGVGFVMVSVDGDNDRPKHMKALMRRYSKRFVGLTAAPDIVAPIAKKYGVAFKTSDRPG
DDGLLHSGHIVLLNQQACPVQALPQESSTKALVKAIRSHNKVEKQ 
 
>ORF3, position 4532-6949, length 806 aa, proposed function: Galactose oxidase  
MTSITVQHISKTLFLIVLSLVALGAYGTSGAPASSPAPTAVVSPSATAAVTLSQAVADRLIDDLVNLEPNAPTHGMWTAPARWPVIPIHAALLPDGR
VLTYGSPEGVLLPEGVDTNDLGPSGVELWRESDDDLKFSGQDGRYIDLWTPAEGLVKEAHARPDGAQLSFATDSFCNAAKLLPQGLLLVAGNDFTGR
PNGENNTDLFDYTNNQLQLELADMRYPRWYGSLVRLADDRMVALGGAQSYEHNSFKVWRNGDYDMAGPNYDPALPNGGDDPSYTLGERRHSSIPEIF
TYQSGNPAGLWQEMTGAQNIKTFGRQDNAWWYPRAYLAPNGLIFGVSWNNLWTMDPDGGDATNPGSTAEHGTVAHNVGASGASVMFEGGHLLFAGGG
QHSNEEIAPGLNQATIIDITTPTDPIVTEVNPMTHARNWGIATALPTGEVLVTGGTTDSNRWNDNLAVFQAEIWNPETRTFRLVDSAKEVRNYHAVA
LLLPNGTVFTGGGGVPPFGKRDAHSSVNDGPGKKIKPNFTAEIYYPPYLFTDDGNGPRLADRPIMTLTTADADISYGAVITADVSAGSRIDLVTFIS
LGSMTHSQNMDQRLIKPYFEQVGNELRITLPNNKNLLPPGDYMLHAVDDAGVPSIAEIVQLDQDNVATSSDATSVIELARTISLESVNVPGHLVRHA
TFQAFIAPIDADSTQIERDDAAFRIVNSLAGEGCVSFESRNFPGYYLRGTLPDFRVDLVQDDGSAAFAAEASFCVREGLAGQGLSFEWAADTSRMMR
HRNTAVWVEQNDGTQLFGQDSSFLIKDAYR 
 
>ORF4, position 8508-7102, lenght 469 aa, proposed function: NADH:flavin oxidoreductase 
LGKEAVLDDIIFTPLQIGSLEVKNRLFRSSISGRIDNYDGSGTPWRMNFEKRFARGGVGAIISSHVPIAVDARILPDYAMIDRDERIPFWRQVGEAV
RQYDHCRFILQLSHSGRQQDIAGVENLGQRPRSSTNRRDAFHGLRGRRMSQDEIQIVVQQFVDAARRAADAGMDAIELHAGNGYLFSQFLSSAINDR
TDPYGGSLENRYRIYREVISGIRHILPNMPMIVKFSPVDRHNAVTFPLEWSQGNTIEDGVQVAKWIEADGADAIHVTTGSMFPHPWNPAGPLALEQT
AIIYQSMIASGELTFRNYLLFRYRWLRWLPRWAWQRTLGDRVSGEDRWCKLEGLNLEDSRAVKSVVSIPVICTGGFQTARTIRNAIEAGACDAVSMA
RPLLRDPDLPNKMRNASETGHANFEPPSGQECTLCNKCCVTVLEYPFGCYEENRYATRNDMMAHVLSFFAEQPEPETIGEG 
Supplementary 
__________________________________________________________________________________ 
174 
 
>ORF5, position 10029-9346, length 228 aa, proposed function: electron transport complex protein RsxA  
MALDEGIEAGDVVDVDIADIASDQRHAVYFRCSRKQIVNRMVGIHRTHATPFFRYLFSHGKKATPILLPQGVQRLFQTSGVLLVARAVTSANLLNAF
TNFADRHDTEKQIGILNLFKPVENTNIGGALVQLRDNIRIEQVTHQSLSRLGRSGPGSRVRSSPSSSRERKASLNPFLGGRIRVCSSSSILSRSAST
GLPVSLERAARTPCCSGVSSMCPVSIANLLFPPV 
 
>ORF6, position 10182-10787, length 202 aa, proposed function: hypothetical protein 
LTPFLIFITAELKGARMIGRLTVVIFALIITIWLISPMVSVAQHTPYAGQQHREIKALSSQEIQSYLSGHGMAFAKAAELNHYPGPMHVLEHAQALQ
LTKRQRTQTQAIFDAMRQEAIELGHQLVQAERHLDHLFSTQAVTEDTLQEATRTIATYRGRLRHVHLRAHLAQRRVLNAKQIQRYDDWRGYPASGFN
HPPHRHHH 
 
>ORF7, position 10826-11284, lenght 153 aa, proposed function: cytochrome C class I 
VNNRLMGALIYGCAWLMATIPVGCGAAPSGTADATNAEQVAAGQKGFQQHCATCHGVNLEGQPNWKQPLPTGGLPAPPHDDTGHTWHHPDQVLFRIT
KYGGQNGGGAGLKSNMPAFEGTLSDTDIWAVLAFIKSNWSPRARAFQEQANTRGQR 
 
>ORF8, position 11172-11816, 215 aa, proposed function: hypothetical protein   
LRVRSVIPTFGRCSPLSKVTGRLEPVRFRSKRIRVGNDKRVAAYDLDCHVPCRRTTNPAASPYLSPKAAESEPRHCRFSAPPPSTGPMCIRTIGPRL
FCWATGNERLGDFLKIFYLSGLSLCPGAALSPQLHSVAMRLRRPLAPEQIADAILVNLFAESALVAICNSLVLALTCIDQMLREPGRQSAHGVRGIL
ITSCREHAAGADVEVRCVVYP 
 
>ORF9, position 13316-11682, length 545 aa, proposed function: FAD dependent oxidoreductase  
MRRYIEEIAADEIIAADICIIGSGPAAFALALPFIKGVPTGTPLKVVMLESAPNVPPIRQALDGAECDVQSAFYKGDQAGVLLYEKRSGSIVSRSVG
YLGTAWPSGEPAFPGRVRAYGGGTHHYHWGGWSWPLEEHDLGGRAFHDGVAWPIPFAELKHWYDQVLTGVVRLNNTEFDNPDYWVRTYPDMGLAVMP
LSEASPLRTRILQFAPFDYAAQYGREIFASDHTDIFYGANAAEFDQVSDGDRKRISRLKVQALNADCTPGRRWYVEANTYVICAGGLESTRLLLLAG
LGDQGSKLGRTFMDHPYMGRMVKFNTTDAVPSGVRKFYMSPDQLLGGPPNHSNFIAGLVPSYKWLNENPKLGDFRILLGSEGFGPSPRTVGINTEPQ
PDHDSRITLTDELGTDPFGQPLMRVDWRTRTIDGDNADTQTLRATIDTLRAVLVDELKYATNFEVIDPAYAETEWTAWRDRSDGSVVGPGLHPMGST
RMSREPGAGVVDQNLRVHNTTNLYVSASSVFPTAGYQNPTNTVCALSARLAQHLIDTSES 
 
>ORF10, position 13881-16613, length 911 aa, tryptophan-5-halogenase  
MHTPSFSLDTIELMALDSQSFVVRTQNDFVHVEGFSRDKITALLQALAHAATDAEIQEVFPEAGRPEGARLLRRLRAGAPSVAKPAVLYRSGASSKD
EAAPLQPRSIVILGNGALAAALQARLREQGIGRIRTVCVRSFVSLNDASFTKRANELYPQPLSSPSESSLDDFACVSDTVMETANEPMLAEVMQGSE
LVVCALENTYYQAFIEVSKATHALGLPILFVTANRQTCMVGPLSIPGVTVTFREAYEAMFHKMAPSVNPEGFLAYVHAQSLDLAHGQAVLQFVEQEL
RTLLSPRPDSVLFGHLVELRAGQVSRMAAVLPVGTAEAYDGEAGWAELRHAAVLRLAVTDGACTSHRSDRQVPHEHTAIKSICVVGGGTAGYLSALT
LRRRMPHLKISLLESSRVPIIGVGEATTPSLPALLHGVLDMDIVDFFTQVKPTFKMGIRFEWGGTTPEHYFNYPFGAHGQLLEAMTYQGHIRDYSLG
SMLMSADKMAIFRTGDGAYESRLHYGAISYAYHIDNQRFVSWLQREAKRAGLHHIDANIQDVVTDDSGQNVVALLTDDGARHEYDFYVDCSGFRSLL
LEKALDSEWVPYDQTLFTDRAVTANVPHGGHIKPYTVAETMDHGWCWNIPMREDDHRGYVFSSAFCDEETAIKEMQAKNPGMSDTKLVTFRSGRHRH
FWKGNVVAIGNSYAFVEPLESTGVHMIAEEILAFIGNFPQSTHDDANRAALNRYMAAYWDELRWFLGLHFRFNTKLDTPFWKACRADVDVSGFDDCL
ATYRKCAPLSYRNHYLTFNRLWGDHGRDVLLMGQQVPANFLPPRESKQQWLRRVELARQAVEMAVDQAEAIRLLESNPDVLRQLVTDDGAWIHTVGE
LFSSETALYSDVYAARLGHMKKPAGFGGAQNVILPSTL 
 
>ORF11, position 17641-16649, length 331 aa, tryptophanyl-tRNA synthetase  
LGIEWHMASAIHPPRLICGSEPRGQLGIGTYAMFVHEQLRLQDQYPGDTFVLIADYAALTHAQPASLVRQTAILGAIYLALGLDVRTSVIYRQSDVP
QLFELFWLVAGLLPPQLAHGSPQAAHLPQNLAEELYPALMAADILGLRASIVNQFTISYERLDYACQIAKEINRRLDQDLFPIPRVVGNFPQPPVTH
TSAQDLFAGPSVFGEASEFAFWLSALDHYGKTHHLVADMAAWFDAIATRLVDMDPLRQLQAACPEGHLLEDRLVRNELAALMVERLKPLHDTYLHLR
SDPHIVEKAMQAGALRVRSELKETVGLLRETLGFSRRGDR 
 
>ORF12, position 18311-17634, lenght  226 aa, proposed function: tryptophan-2,3-dioxygenase 
VSCEHDEYFFMRVLQMSECCFWGALSAVIAAIEATKFGCLEEAMAHMAQALEFLDLLQPITQVLKTIPPEHFWAFRDATDGSSAIQSRWFHLLHIYL
HGLDERKIAIFADIPEISDLIHYGKPGFVSLRSLLRGFAGQPPPELEAFADMASQLDASLYAYRCVHLGIVHRFLPPDAKQGTGGTSGIPYLRKHLT
RRLWPLESEYPQPDLEELNAIDMFQPLVGVGN 
 
>ORF13, position 18424-20013, length 530 aa, IclR family transcriptional regulator 
MGFWAKSLMVFNCFYHDSKPSIRDVAQQTGLSKSSVHRLKQAILRRDQHPESWFWETREGQQWLIRLVVATLYTFGLKRGVGAETLSEFLLRLGLQS
QIGCSPSALRHLMQLLEQAIVETTQEWEREGVTQGQIGPIIGAVDETFLQCMMLVFMDLSSGYLLFEETAQDRTYDTWYARVTARLETLGTRVLYLV
SDRAKPLVKLGKTGLGCLSVPDLFHLIREFVKGYGPAICLRLRQARQALKAARERLEQGQNHDPKSAVGLQTQREVEACQAEVERWEGIRHTYRDHL
MRLSLMVHPWQIEEARPQSSQQVKQRLEAEIEAIETFMETTGLPMKKQMLEKVRKQLADVSALVDLWWQEVHDSAQSQVILTPMWHQWIDTVLLPLM
YWQAQVSRTREPRRKAELVKALQASQGAFEAHALTQYLAPELIEGWKQWAMEHVRAFQRASSAVEGRNGYLSQMQHNHRGLPKRRYQVWSALYNFDC
HAADRSTPASRFFRHNFPDLFEAVLAQIDELPRPRERRQSKVLTV 
 
>ORF14, position 24857- 20745, length 1371 aa, predicted function: a NRPS module (C-A-T-TE) 
MSTTAELLAQLSSLGIKLWDDDGYLGYSAPKGALTPALRAELAAHKADILELLRQSERAAPAPSVGRAPEPRFPLSYGQQALWVLYQQAPESPAFNM
GVSLHIQTPLEVDALRWALQSLAGRHAALRTTFSIQDGLLTQDIQASHDLVLETVDAAALTWDDLMEQVYRASQRPFDLERGPVFRATLFRAAPPSH
ILLLNLHHIAGDAASFGILMADLQALYTQKTRGQAADLPALETTYADYVRWESSLLASSAGARLAEYWTQQLAGELPVLDLPTDRPRPAVRTYQGAS
YTFTLSPALSAQLKTLVQAEQTTLFSLLLAAFQLLLHRYTGQDEVWVGSPSGSGRSQPAFAGIVGYLINPLVFRARFPHEPELTFRQFLQQARQTVF
EALEHQAYPFPLLVQQLQPVRHASYTPLFQTFFVFDSSRLDTASQVEGDLPMTPLGLDQMEGQFDLTLTLTDGERLLGALRYNADLFDTATVARMAG
HFEPLLAGIVTNPDQPLHTLPLLTEAEQHQLLVAWNDTHVPFEPGACVHHWVEQQAQRTPHAMAIEYEGQQLTYDAFNQRANQLAHFLRQRGVGPET
RVGICLERSVEMIVALLGICKSGGAYVPLDPAYPRDRLAFMMQDSQMRLLVTQTSLLEQLPIPDGLPQMVCLDRDWPHIATMPSDNPVVQVAAEQLA
YIIYTSGSSGAPKAVMVPHRGLRNLVSWYHRVFDVNASDHTMQFANLIFDASALDIWPTLCRGATLHIVKPELMSAPQRLQDWLIQLGITIAHTPTV
ITEQLMAMTWPENATLRLLITGGEQLHVPGTASPLPFEVVNNYGPTENSVASTWYVVPPDSPAIPPIGRALDNQSMYVVDGHLQPVPVGVAGELYVG
GVGVSRGYLNQPGLTAEKFVPNPFAQGRLYRTGDLVRYLPDGNLEFLGRIDNQIKLRGFRIELGEIESALRQYPGVWECVVAVREQTAGSSKQLVAY
LVPDAVDPSIKDDQATEIRAHLSHTLPDYMVPTAYVILDALPLTASGKVDMRALPAPERADLQLHIDFAPPRTPTETRLAAMWTQVLGVDRIGIHDH
FFELGGHSLLATRLLAEIETQLGKKLPLSSLFEAPTIAELAPLLIEAPPPQPWSPVVPIQPTGNNPNLFCLPGGAAHVFYFWDLARRLGAEQPFYGL
QPPGYEEDTAPLNRMADFVSLFLENLQQIQPQGPYLLGGHSSGAYIAMALVLALQRQGQAVPAMVILDTIPPGMIPDGGPHVMRNSLADVVRIAKEG
LADRLPIDIETLETLSGDAAWQYVVDGYKQINFLPPQAGVAQLKRMHDMYTGVMQAIVDYRPEDHYEGQLLFFQTHEITIDHPEDMAAGWQGSAPIP
SAFIPFLETIRVC 
>ORF15, position 25457-30154, length 1566 aa, predicted function: a PKS module (KS-AT-KR-ACP) 
VQHRAAMRIVRLEMTENLYHIAIVGLAGRFPGANTIETFWENLRNGRESISFFSGEELEQAGVNPALIHHPDYVKAGAILDHIEQFDAPFFGFYPKE
AAILNPQHRLFLECAWEALERAGYMPEQYRGRIGVYAGAGANNYLSSFHLPRGASGALDPFQVMLGNDRDFLATQVAYKLNLTGPSVAVQTACSTSL
VAVHLACQSLLNHECDMALAGGVNINVPQHQGYLYVEGGIGSHDGHCRAFDAQAQGTVGGNGAGIVVLKRMADVLADGDTVLAVIKGTAINNDGATK
VGFTAPSLEGQAEVIADALAMADVAPETITYIEAHGTGTALGDPIEIGALTYAFQASTGKTGFCKIGAVKTNVGHLNTAAGVTGLIKTTLALQHQML
PPTLHFETPNAQIDFDNSPFAVNTTLTPWETPGYPRRAGVSSFGIGGTNAHVIVEEAPEAPASAPSPRPWQLLVLSARTESALEVMTRHLHDHLRQH
PGLNLADVAYTLQVGRKPFAHSRTLVCQTLDEAVTALEARPPDQVLTTYQEARSRPVVFMFSGQGSQYPNMGRGLYQDEPYFRDIVDQCADALLPHL
GRDLREVIYPSEIAPETAAQQLSQTALTQPALFVIEYALAKLWQHWGIEPHAMIGHSIGEFVAACLAGVFSLQDALFLVATRGRLMQAQASGDMLAV
PLAVEALEPFILDIDGEAHDGSLSLAVINGPVQCVVSGPADAIAHLESRLAEQGVAARRLHTSHAFHSTMMEPALEPFIAAFAGITLNAPRIPYLSN
LTGTWITGEQATDPAYWANQLRQTVNFSAGLEELVKTPDWILLEVGPGTVLRSLALQHPARDAAQTVLASLPHVTDQRSAQQAALQTLGQLWSHRVA
VDWDGYYAAEARRRVLLPTYPFERQRHWIDGAATSARPQADADKRLPLPDWFAIPSWKRSQPVALLPQLDLKAHVFTWLVFTDTCGLGTQLAQALQQ
RGQTVITVMAGEAFSPQDEGGYTLNPTQIADYRALFRALSSAGQLPSRIVHCWHVTQTGDEQAPPLSEPDFDSFYGLLFLAQALGEQNLSEPVNISV
Supplementary 
__________________________________________________________________________________ 
175 
 
IANQLQAVTGDESLVAEKATLLGPSRVISQEYPQMACRSIDIVLPQTTSVPQPLTEQLLGELITDSADAIVAYRGPHRWVQSFEPVTLNPPSVPPIR
PGGVYLITSGLSDTGLVMAYYLAQTAQAKLVLLDPAPFPDQATWPEALASPASSDETRRKIEQLQAIEALGADIFVVQASVTDLDAMQAALQQARQQ
FGPLHGVLHIATSRGSGLMQLKTSEQAQEVLASRVTGTRVLERVLQETPLDFLALFGSNVSIAGGLGQVDECAANAFLDAYAHSRSMAVQAPYPVVA
IDWSGWGWDDHVEQSLTEMPQIQNQVRQLRERYGITPEEAGQAFERILASGQPQIIVSTQSLQAWIDQQNTLTSSSFMDQLDPVPPGPNMPLSDEAY
EAPVNDVKVRIAEVWQEVFGVERIGRHDNFFDLGGHSLLAIQLVSRTREALQLDELPLSALFETPTIAGLAATAGAGEPDEADIEEIEAVLEEIEGL
SEEELRALLAEMSE 
 
>ORF16, position 30163-31380, length 406 aa, predicted function: flavin utilizing monooxygenase (MOX) 
MNELSKRLENLSPEQRELLARRLRAKGVNLPGAEAAADALPQARHVPEARRAQGMQFSLLFFSGDGTTETQGKYDFLLECARFADAHGFRAIWTPER
HFQAFGGLFPNPSVLSAALAMVTERLQIRAGSVVVPLHNPIRLAEEWAVVDNLSNGRVAISLATGWNRGDFTIMPAHFDDRRAIAFDNLATIRRLWR
GECVSFAGVDGEAFEVTILPKPLQPELPVWVTASGSPQTWIDAGAIGANILTAIGRNPDDLVPSITSYREAREKHGHDPQAGIVSVMMHTFLGEDEA
LVKQQVRGPLSGYLKTFIAQDEVLSREETGVEAQQISERDREEMINFAFERYFQQAALFGTPQKCARMVEWMQAVDVDEIACLVDFGADHDAVRASF
QHLSQLREQFSPDHEKQV 
 
>ORF17, position 31386-32639, length 418 aa, predicted function: C domain of NRPS 
MSELSEKIASLSPEQRAVFDLKLKALKAKKQQAPKAEPPKIIRQTVDGPLPLSLDQERLWFINQFAPENAAYNIHTATRLIGNLDMAVLEKSFNAVI
QRHDVLRTSFVAENGQPKQVIAPSLQLSIPIIDLQHLSQAEQDAEAMRHASEEAEAPFDLSQAPLMRVWLLKMSLTEHVLYFNQHHIITDWWSAKLL
FQEMATFYEALLSGQLPVLPEPYQYKDFVLWERERVENQDMARSLAYWRKHLAEGTFQLDLPIAHRRPVEQTFGGRRQWVTIPPGLAHDLKAFSRRE
NVTLFITLTAAFKMLLFRYTGQTDITLGTPLANRSQVELERVLGFLITMLVLHTDLSGALSFKELVHKVRQVILEAYAHQDVPFAKILEIVQLARDW
SRNPIFQFSFIFIDEFYYRTDSLNRFRIDI 
 
>ORF18, position 32700-33794, length 365 aa, predicted function: transposase 
MSDNLRRYRAIHEALRQWYPGDPSGNRARHLTPLAAMISGIVASQSSQVPRIASKVPNGTKPESRVKRFTRWLDNEHVTETVYFLPYAQLLLVGLGL
ETLVLAIDGSTVGRGCVALMVSVVYKGRALPLAWLVREGKKGHFPEQMHIELIEQVQLLVPPGVEVVLVGEGEFDGIDLQRTLHGEEADGDWSYVCR
TALNTIASLDGQDFRLDVMGTLIQPGKWVALEPVYVTSAAYGPVTTICWWAKGYDAPIYLVTNMRDAEQACRYYQKRFRIETFFSDQKSRGFNLHKS
HMSNAERLSPLLMASCLAYIWMVYLGDLCERDGWREVIHRRSRCDLSLFQLGLRLLDYFIDEALPIPVQFHVTI 
 
>ORF19, position 33891-36881, length 997 aa, predicted function: a NRPS module (A-MT-A-T)     
VSRFDMTLIAEDHGEELITYIEYNNELFDAESMDRFASHFQTLLEQMVATPDQPIEQLPMLTEAERQQVLLEWNDTRADYPRNSCLHHLFEEQVQRT
PEATALVFDAPDAASIKLTYRELNERANQLAHYLMQQGVGPETLVGICAERSIEMVVGLYGILKAGGAYVPLDPTYPQERLAVMMADAQVPVLLTQA
HLCEQLPAHEAQTLCLDADWRRVISPMPVENPDSGIQAEHLAYVIYTSGSTGKPKGAMNAHRGVVNRLLWMQDAYGLRADDHILQKTPFSFDVSVWE
FFWPLFTGARLVVAQPEGHQDPSYLVSAIRNHQITTLHFVPPMLSIFLEAPEVETCDTLRRVICSGQALPYELQKRFFSKLSAELHNLYGPTEAAID
VTYWACQPESEQALVPIGRPVANTQIYLLDEHLAPVPIGLPGELHIGGVQVGRGYHHRPELTEAQFIPNPFAEDQERSPTLYKTGDLARWLPDGSID
FIGRLDDQAKLRGFRIELGEIESVLNAHPAVQETLAMVREDEQDQRLVAYLVPDLETAYPIRQQLHLQHDGTVTEDQTSYDLPNGMTLYYQNRSETD
FMYREIFEDHCYLRHGISLPQGSCVFDVGANVGLFSLFVHQACPNAQVYAFEPIPDIFDLLRINTALYGVNANLFAGGLASTNRQDRFTYYPHVSIL
SGRFADAAAEQEVVRTFLLNEDTAHIPEAMLQDMLEERLTSQDITCEFKTLSAVIQENQIDTIDLLKVDVEKSELDILQGIAPHDWPKIKQMVLEVH
DDAAGSFQKVTQLLDTHGFEYVIEQEEMLKDTNLYSIYAKQPASAQPASAQSAATPAVAAWSSVTRLTDDLRTFLQQKLPSYMIPSAFMMLETLPAT
PNGKVDRNALPDPDASFMRQRYEPPGTPTEAQLAVIWQTVLGIEQVGRQDDFFTLGGHSLLAPQVILQVGHAFEIELPLRQLLSNPTLSELAQRIDS
TRETLAGLQDMTSIGDDEADELEELVL 
 
>ORF20, position 36881-40948, length 1356 aa, predicted function: a NRPS module (C-A-OX-T) 
MTPIETFLAELNQRDIKLWAEEENLRIKAPKGALTQELRQQLADRKAEILSFLRPVTRLPVVQPAPDERYEPFHLTDVQYAYWLGRQSAFELGNIST
HVYFELENTDLDLPRLTQAWQRVIERHEMLRAIVLPSGQQQILDIEDLPPYQIDLSGLTAQDEAAVQEGLMSVREEMSHQVLEADQWPLFDIRATRY
AGTTRLHISLDALTVDATSIGMILREWGAWYQHPSTTLKPLDLSYRDYLLTEKALEETDLYRRSERYWRNRLDTLPPAPALPFAQDPATLAEPRFTR
RQAALSPPLWQALQDRAMKENLSPANVILAAFAEILTAWCKTPHFTLNQTLFNRLPLHPQVNDIVGDFTSLMLLEIDNREPGSMLARAATIQEQLWQ
DLEHRYYSGLRVMRDLASQQPSGSALMPIVFTNVLGMKEDANLGGDDSPDAALGKEVYTISQTSQVYLDHAITEWNGHLAYTWDAVEELFPAGMLDE
MFGAYGAFLKRLAADDTAWTETHRQLVPLAQLQQREAINATQAPISSELLHTLFIAQVEAHSSDPAVIATERTLTYGELYQRAAQVGNWLRERGARP
NTLVAVVMEKGWEQVVGVLGILMSGAAYLPVDPALPTERQHYLLEQAQSTLALTQSHLEQSLTWPADPALECLSVDTAPLNVSPSDAPIAFESVQTP
TDLAYVIYTSGSTGLPKGVVIDHRGAVNTVLDINQMFNVTAQDRVLALSALNFDLSVYDIFGLLAVGGTIVMPAEEGRRDPGHWALLMEQHGVTLWD
TVPALMQMLVEYQAGWPLNAPLRLVMMSGDWIPLTLPDRIRTLWPEAQLMSLGGATEASIWSIYYPIGDIDPAWKSVPYGKPMTNQTFHVLNPQLEP
CPTWVPGDLYIGGIGLALGYWRDEEKTNASFITHPHTGERLYKTGDLGCYLPDGNIEFLGREDFQVKVRGHRIELGEIEVNLVRHPAVKEAVVTAVG
KPLEDKQLVAYIVADATENGALSANAQIDQAVYGDANGTLSEPGERAAFKLEQLGLRRLNGNRSVVQFSRPAVDDGQTNAYLRRQSYRQFLSTPMPL
EKLGEWLACLSPHTFAQAVLPKYRYGSAGSLYPVQTYLYIKPDRVAGLAGGPYYYHPADYQLIQLSTTAAIGRDAHGGPNAEIFEHSAFSLFLVGEL
AAIEPMYGAAARDFCLLEAVYMSQLLMEEAPGYEIGLCPIGGLNFDPLRPAFELGDSQVLLHSFVGGAITPEQMRSLPQPEGAPQSLEEDIKAYLGQ
KVPSYMVPNFYVSLEALPLSTNGKVNRQALPVPDLTAFEEDVVAPENETEEQIAAIAREVLSLPQISVTTNFFDLGANSVLMVQMYNQLREALGQ 
Supplementary for Chapter 3.4 
S3.4.1 Protein sequences of the partial NRPS gene cluster identified from genome sequencing of 
candidates “Entotheonella” spp. cell pellet of T. swinhoei chemotype Y  
 
>ORF1, position 26292-22648, lenght 1215 aa, predicted function: AOrn-T, specificity code of OrnA: DVGEIGSIDK (100%) 
YLAWEDAYQLRVAATSHLQMASFSFDVFSGDVVRALCSGGKLVLCPQDLLLAPKELYALMQREQVDCAEFVPAVLRHLLDFLEATEQSLDFMRLLIV
GSDLWHMGEYQKSLDASGPETRHINSYGTTEATIDSSYFERAFEDVLADASSSGLVPIGRPFPNTQLYVLDAHLQPVPVGIPGELYVGGTGLARGYF
NHGELTAERFVPSPFMSHQPGARLYKTGDRARYLPDGNIEYINRTDTQVKLRGFRIELGEIETRLTQHDDVRESVVIAHEVAEGQQVLIAYLVPMGE
PSPAIAELRQHLSEKLPDYMIPSVFVPLQAFPLTPNGKVDRRALPIPEQIRVETVFEPPYTPTEDVLAAVWAEVLRLDRVSRHDNFFELGGHSLLAT
QVVSRVREAFQIEVPVRTVFEAPTIAK 
 
>ORF2, C-APro-T-C-ALeu-T, specificity code of ProA: DVQFIAHVAK (90%), Leu-ArgA: DVYFVGAVIK (60%) 
LGQALETAQQGEHPLPLPPPMQPVPREGDLPLSFAQQRLWFLDQFEGSSATYNTLEAFNLRGRLDIPALEKALHALIRRHEVLRTTFPSQGGQPLQQ
IHPELSLPFSVLDLRHLAEPEQIAEVNRLLAQDAGQPFDLVHGPLLRVALYVRGDTEYVLLVNMHHIISDVWSMGVWWRELDALYQSAVSEPDSPAS
ASLPELPLQYADFAQWQRTWLTGEVLERQLAYWEQHLADAPVRLELPTDHTRSLVQTFRGDMERFELAPPLRADLRALSRRCGASLFMTLYGAFAVL
MSRYTGQDDLVIGTPIANRHYRDIEPLIGFFLNTLALRTDLSGDPGFVDLLAQVRQVTLDAYAHQDIPFEQLVDELAVERNLSHSPLFQVLFVWQDL
PQPVALGEMQMVPLDLTTVTSKFDLTFFLGEAEPEAGGGLRGLVEYNTDLFERATICRMIGHFQQLLHGILDNPDQAVRQLPLLTEAERLQLLVEWN
DTETLDSSDLCLHHMFEQQVARTPDAIAVVFEQHQLTYRELNRRANRLAHHLLALGVGPDVLVGLYVERSLEMVVGLLAILKAGGAYVPLDPAYPEE
RLSYMLADARVQVLLTQEGLCSGLSVPAETITLAPDAMAERLSQQSRENPSSSAGPQNLLYVIYTSGSTGRPKGVAMRHQPLANLVRWQLAQANGAS
PARTLQFTPLSFDVSCQEIFTTWCAGGTLVLITDEIRQDGDALLAYLNAQRIEQLFLPFIALQHLAESVTYQSPPEALRDVITAGEQLHITPALLTG
LANPIAVCTITMAQLRAMWPVPIALHNHYGPTESHVASAYSLTGAVSDWPATPPIGQPVANTQLYILDRVYQPVPVGVTGELYLGGECLARGYLHRP
DLTAERFILNPFEAGRLYKTGDLARYRADGQIEFLGRADDQVKLRGFRIELGEIEAVLAQHPDVRETAVVVREDEGHPKQLVAYVVPHEAPPSFIRD
LRDHLSNTVPDYMVPAAFVLLDTFPLTPSGKVDRRALPAPQQTGLEGGYEAPLNPIEELLAAIWCEVLGLTQIGRHDNFFDLGGHSLLATQVISRIR
DTFEVALPVRTVFESASIAKLALALETARQTEHPVPVPPPIRAVARKGDVPLSFAQQRLWFLDRMIGPSAAYNFTGAFRVHGLLDVKVLEPALNEIV
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RRHEVFRTTFPSVNGEPVQRIAPGTTLPLVVVDLQAPERRAELNHLVSHEMAQPFDLARGPLLRVILYQLDEREQVVLVNMHHIISDGWSMRVWWCE
LDILYRAFVVGDPSPLPELALQYADFSEWQRGWLSGQTLEQQLAYWRQQLADAPTLLELPTDHPRPTVQSFNGAVACFEIEASKVSQLRGLSRSCGV
SLFMTLYGALAVLMSRYSGQEDLVIGSPIANRHYQEIEPLIGFFVNTLPLRVDLSGGPTFTELLVRVRQITLEAHTYQDVPFEQLVVEVEVERNLSH
PPLFQVVLAWQELFPESATLGDLPVTLMEELDLAPAKFDLVLYLDQPQSEDGERLRGQFEYNTDLFERATITRMISHFEQLLDGIIADPEQGVHTLP
LLTQAERHQLLDTRNATQTTYSRTLCAHQLIEAQAQLRPMAQAVLHPPPGPNASLTYGALNQRANQLAHYLRKLGVGPEVIVAVYLDRSLDMIISLL
AILKAGGAYTPIDPGYPPERVKFILDDTQTPVLLTQTNLAEPLVDAQVEVICVDRDWPVVAQESRANPVNVITPDNMAYLIYTSGSTGRPKGVQVTH
GSLLNLIFWLHRLYDMTDADRIPSCSGLSFDVSVYDIWPCLTAGATLCLSVPDVLFSPLQLQDWLITNRITKGFVVTALAERLLSLEWPPDTPLQLM
VTGGEKSHRVPAPHHPFQYYNAYGPAENTVITTCGLVPPNEKTDTIPSIGRPMDNVQVHILDRQLQLVPTGIYGDLCIGGDNLTRGYLRRPGLTAER
FLPNPFSPNPGARMYTTGDLVRYLPNGEIEFAGRMDHQIKIRGFRIELGEIESVLASHAQVQAATVLAWDMGSSQSDKRLVAYLVLDPEQPPTAEAL
RDYLKAHLPEYMVPAVFVPLEAMPLTPNGKVDRRALPSPDDIQPILNEHYVSPQTALEKTIAEVWQEVLSVEKVGIHDNFFDIGGHSLSAIRIQTGL
QTALAEDIPITDLFRYATVASLAEHLSQKQPEPSSWESSQTRSQARRAAMQQRLDRQRGRAHS 
 
>ORF3, position 18537-13849, length 1563 aa, predicted function: a PKS module KS-AT-KR-ACP 
LIVKEGAPIHETEPIHETEEDGMTHSETTENFDSNSNLNFYDIAVVGLSGRFPGATSMAAFWANLCNGVESITHFSDQELEAAGVNPALLKRPDYVK
AGAAPDDIDLFDAGFFGFYPKEAEILNPQNRLFLECAWEVLEIVGYIPETYSGRIGVYAGAGLNGYLTALQATADLDSFQVMIGNEKDFLATQVAYK
LNLTGPGISVQTACSTSLVAVHLACQSLLNRECDMALAGGVTINAAYNQGYLYVEGGIMSPDGHCRTFDAKAQGTVGGSGVGIVALKRLTDAVADGD
TVLAVIKGTAVNNDGAAKVGFTAPGLDGQANVITDALTMAEVEPETISYIEAHGTGTALGDPIEIAALTHAFRATTAKTGFCKIGSVKSNIGHLDAA
AGVTGLIKTVLALHHQVLPPTLHFEQANPKIDFANSPFVVNTALTGWQTHGQPRRAGVSSFGIGGTNAHAILEEAPVVPVASSPSRPWQLLILSART
STALETMTGNLQHHLQHHSELNLADVAYTLQVGRKRFDHSRLLVCQTLDDTIAVLETRPPDRMLTTSQEMRFRPVVFMFSGQGAQYPDMGRELYQRE
PIFRDTVDKYAAYLEPHLGLDIREMIYPDGAQRGEAAQQLSQTSYTQPALFMIEYALAQLWRSWGIEPQAMIGHSIGEYVAACLAGVLSPEDALILV
AARGRLMQEQPRGDMLAVPLTEEAIQPFLDASLSVAAINGPTQCVVSGPADAMTQLESRLSEQGIEGTRLQTSHAFHSEMMTPMLESFRATVASVTL
NPPQIPYLSNLTGTWMTPGQXTDPTYWAQHVRQTVRFADGLDELVKEPEWILLEVGPGTTLRTLAQQYPGRETGQTVLASLPHARDSRPAMQAMLQT
LGQLWCHGAAVDWNGFYAAEARRRVVLPTYPFERQRYWIDSQPMAQAPQLEQKLPLSEWFSIPSWKRSKPLELLPQAGSPQHWLVFVDACGLGTQLV
QRLQQRGQTVITVTAGDEFGQHDAFTYTLNPSEKGDYQALFRALQTGETQPNTIAYLWGVTPAAEVVEGTPDFYSVLFLAQALGERYLTDPIRMAVI
ANQSQAVTGEEPLVPEKSTLIGPCRVIPQEYPHITCRHIDIVLQKAQNHGTEWLVDQLLTELVTDAPDPVIAYRGQHRWAQTFEPVELGQRDSALRP
QGVYLITGGLSDTGLVLAHYLAQTAQAKLVLTDTMPFPDRVEWPGWLETAVAEDETRHKVEQLQAMEALGAEVIVLQADETELTQMQEAVEHARQRF
GPLNGVIHIAASRGGGLMQLKSPEQAHQILAPRVIGTQILTTVLHDTPLDFLALFGSQVSVTGGFGLIDECAANAFLDAYAHSHGPQCPFPVVAIDW
ASWHWDQHFEQLAAGVPQLQEGIKLLRETYGITPDEAGEAFERILSSGQPQIIVSTQDLQTAIEQQNAVTSTNVSGQLDTVQPAAPLDRDFAAPINE
TEQRVAAVWQDTFGIEPIGRDDNFFDLGGHSLLAIQLISRLRDALHLDDLPLSSLFESPTVAELAAITTARQEGSDATDTIAALLEEIEGLSDEEIE
AALAEEMEDDT 
 
>ORF4, position 13821-11965, length 619 aa, predicted function: a NRPS module C-AAla-T, Ala (90%) DIYNNALTYK 
MNDLSDKLAALSPKQRALFELRLKKLNEQQKPPSPQITRRNLTGSCPLSLDQERLWFINRIAPGNAAYNIYFAIRLTGSLDAAILKASINEAIKRHE
ALRTTFGEQNGQPVQHIAPTLTVELPIIERLNLSRAEQDEVAQALATEQAQAPFDLTRGPLVRPVLLKLSDTEHVLIVTQHHIITDWWSSQQLHAEI
VSIYDALVAGHSPDLPDVPFQYSDFVMWEREHLESKDLEDSLAYWRKHLAGGSFKLDLPIANRRPGLQTFQGRRQPLSFPPALAQGLRALSQRENST
MFMTLTAAFYALLFRYTNQTDITLGTPLANRSRVELEQVYGFLITMLVLHIRLSGELSFQELLGRVRTALLEAYTHQDVPFTKILDVVQXERDWSRN
PLFQFSFIFLTETEISLESKALQQSAIEYDPMVSRFDMTLIAWDRGDAIAGCIEYNTDLFTPEAMTRFADHFQTLMESIVAAPDQPIVQLPMLTEAE
RRQLLVEWNETQLDYPTDLCMHHLFEAQAARTPDAVAVVCGSERLTYHELNRQAGQLADHLRALGVGPDVLVGLCVHRSLDMVVGLLGILKAGGAYV
ALDPEYPRERQAFMLRDARLTSCSPNRVWLILCPPVDLLTQQSLVDTLPTSGLTVLCLDTPEAATVPEMASGKPSPAVTPDHLAYILYTSGSTGQPK
GVAIEHRSAVAMLSWSQAEFSPDEVAGMLASTSICFDISVYELFLPLSCGGTVILVDNALALHHQVPTDVRVTLVNTVPSAMRELVRIGGVPPSVKV
VNLAGEPLSNTLVQAVYEQEHVERVYNLYGPSEDTTYSTFLVAEKGAEENPTVGRPIANSQVYIVDEHMQPVPILVPGELYLGGAGLARGYLNQPEM
TQDRFIDNPFGQGRLYKTGDLARYLPDGQIEFLGRMDYQVKLRGFRIELGEIETILSQHEAVRETVVVVREDQPGDPRLVAYVVPNGQAADDEDAEK
LSPALRVHLRQKLPDYMVPSAFVALDSLPLTPNGKIDRLALPAPEGIGLETSYVAPDTPTEETLAAIWAEVLGVPRVGRHDDFFELGGHSLLAIQIM
LRTSAAFEVELPLHYLLHHPNIAEFAQRIDATQQALANLQDTEAATEGEREEVLL 
 
>ORF5, position 10502-6294, length 1403 aa, predicted function: a NRPS module Cy-A-OX-T, Cys(90%) DLYNMSLIWK 
MKPIEALLDELSQLNIKLQAEGENLRLNAPSGVLTPALRQELAERKAEILSFLRPVTTLPQVQPDPAARHQPFPLTDIQQAYWIGRNSAFELGDIST
HVYFELESPNLDVLRLNRAWLKVIERQDMLRAVVLPNGEQQILEQVPAYRIADADLTDQDEAVVAQTLISIRQDMSHQVFAPDQWPLFDIRTSRYDG
RVRLHLSFDSLIVDAWSYGLLLEEWSRFYREPDLVLPPLELSFRDYLIAEKSLEKTDLYERSRQYWLNRMDTIPPAPKLPFAQDPSQIGQPRFIRRE
HQLDRPLWQALKQHAAQVNLLPGNVILAAFAEILSVWCERPHFTLNLTMASRLPLHPQVGDLVGDFTAITLLEIDNSTPGTFMERARRIQDRLWQDL
DHRYFSGLRVLRELMRRQKGGGNALMPIVFTNPLGIEKSDFAQXHEEEGTPADQETPFGENVYTISQTSQVYLDHSLAEWEGSLLFNWDSIADIFPE
GMLDEMFEAYRGFLTRLATDDAAWTEPERQLVPLQQLKQRAAINDTAGSVSEAMLHTLFLSQVEGHADDCAVIAPQRILTYRELYHQAKQVGHWLRQ
EGATPNRLVAVVMEKGWEQIVAVLGVLMSGAAYLPIDPELPTERQHYLLDQGEVDLALTQSRLDRQLTWPADIRRLCVDTAQLNFSGDPEPVQTAND
LAYVLYTSGSTGLPKGVAVPHRGPVNTLLDINRRCEVTAQDRVLALSALNFDLSVYDVFGLLAVGGTIVMPAPEGRRDPAHWADLMVNHGVTLWNSV
PALMQMLVEYQSERPANAPLRTVMMSGDWIPVSLPERIRERWPSVQLMGLGGPTETSIWSNYYPIEQVDPAWKSIPYGKPMTNQTLHVLNGLLEPCP
VWVPGELYIGGRGLALGYWRDEEKTQASFITHPRTGERLYRSGDLGRYLPNGNIEILGREDFQVKIRGYRIELGEIEANLAKHPEVKEALVSAVGDP
KGDKQLVAYVVPAARTDDAVLDQAAYELVAEDGVLTDPLERAAFKLDWPGIRRLEGQRSAVKLSQPSVNEAAYLSRQSYRQFLTDPVPLEKLGAWLA
CLKPQTFAESILPKYRYGSAGGLYPVQLYLYIKPDRVNGLDGGTYYYHPFDHQLIPLSTVTRIGRELHADVNRANFDQSAFSVFLVGELAAIEPMYG
TRAHEFCLLEAGYMSQLLMEEATAYDLGLCPVGGLDFAPLRDDFELGDSHVLLHSLVGGAIAPEQMQTLPQPGAPSRSLEEDIRADLTQKLPTYMVP
GVYVMLEALPLTPNGKVDRQALPMPGTIETFETMVAAENDIEEALASMIQSVLERDQVSVTGNFFDLGASSIQLVQIYNHLREAFDQELSVTDIFRL
PTIRLLARHLSCAEPDAPIAQQQGEQRAQARLAARRPPRPRREGD 
 
>ORF6, position 6394-2206, length 544 aa, proposed function: a PKS module (KS-AT-DH-KR-ACP) 
VPSRTHRSHSSRASNERRPASPPGGHRVRAVKETNMAPIEPEFFEEVAIIGLSGRFPGAVNIEQFWQNLRDGVEALSWFSDDDVAAHHSPHIRQAPN
FVKAGFILDDADVEHFDAAFFDVSPRQAQWTDPQQRLFLECAWEALEHAGLDVTTYAGLIGVFAGASVSTYYLYHLLTAESTSAAYDLQMWMGNEKD
YLATQTAYKLNLQGPCLSVQTACSTGLVAVHLACQSLLNYECDVALAGGVTIKVPQKSGYFYEEGAIFSPDGHCRSFDAKAQGTVFGSGLGLVVLKR
LSQALEDRDHILAVIKGSAINNDGSQKVGYTAPSLNGQANVISQAITMARVEPETITYIEAHGTGTPIGDPIEIAALTQVFRAHTERKGFCALGSVK
TNVGHLESAAGIAGLIKTVLALQHKWLPSSLHFDTPNPEIDFDNSPFYVNTQSAAWQTNGYPRRAGVSSFGIGGTNAHLVLEEAPELHVPETQSTRP
LHVLTLSAKTETALAERARQYQDYLASQTGAHLPDICFTANTGRAHFRHRAAVVTATESLKQFIRNKQFAEPHIKLISNIKGDVASKGVATPAYWVR
HVRQPVRFAAGMRTLEQQGYHLFVELGPQPTLLGMGAQCLPEGHGRWLPSLRQGQADWLPLLTSLAELYVQGVSVDWTGFDRDVPRSKVALPTYPFQ
RQRYWFTASPRSLQPVASDVSSHPLLGQRLRLADAGKTRFQVQIRPESPAYLADHRVFGRAVLPATAYLEMALAAGREVFQHDRLTVEELFIQQALI
LADGWQAFKGSDGSQSRGRRVCLATVQPQLSALQVDCPEEIEMTAFYQPRDGTGGVEYGPYFQALTKLYRGANQALGRVRLPSDLIADAAAYHLHPV
LLDACLQITSALLTGESDAVYLPSGLERLTLFRSDTYTELWAHARASSNIDTTVVIDFDLFDANGERIAELRGSAFRRVGQQTLMRNPAMDWLYDIT
WQPMPYSPSSVGSVQSGSWLVLAGETGLGKTLAARLEARGQRCVLVSASQADQTGLADLLRGSMGAGQPPCQGVVYLWGVDTDSTPAELSLPELTHR
LCVQVLDLVQAIIQAEMTPQLWLVTQGAQAVGKTDRLQVQQAPLWGLGRTIAREHPELQCVCLDLPADATSEDNAHTLFEALSGTDAENQIAYRQGT
RYVARLVRQRESERSGIPLPIHETGGYLITGGLGGLGLRVAQWLVAEGARQLVLCGRQGAATPAARQAVEALQQIGAKVVILQADVAVQNDVVRMLT
AAQELAPLRGIIHAAGVLDDGILLQQSGARFATVMTPKVAGSWHLHQLTEIIPPRFFLCVFPRPHPCWERRGRGIMLRPTRLWMPSRITAAPWDCPG 
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BMBF GenBioCom cluster-meeting, on 21-22 Oct 2010 in Freudenstadt-Lauterbad, 
Schwarzwald, Germany. 
 Insights into the Secondary Metabolism of an Unusual Uncultured Symbiont of Marine 
Sponges.  Die 39. Doktorandenworkshop, Naturstoffe: Chemie, Biologie und Ökologie. 
Held on the 16th April of 2010 in Jena, Germany. 
 Targeting Gene Sequences Encoding the Biosynthesis of Bioactive Metabolites from the 
Metagenomes of Marine Sponges. Symposium of the World Ocean Conference on 11-15 
Mei 2009 in Manado, Indonesia. 
 Alcohol dehydrogenases from marine hyperthermophilic microorganisms and their 
importance to the pharmaceutical industry. International Seminar and Workshop on 
Marine Biodiversity & their Potential for Developing Bio-Pharmaceutical Industry, on the 
17-18
th
 of May 2006 at Jakarta. Full paper was published in the conference proceeding 
(authors: Uria, A.R., R. Machielsen, B.E. Dutilh,
 
M.A. Huynen,
 
and J. van der Oost, 2006). 
 Properties of chitinase from a bacterial strain associated with marine sponge. ASEAN 
Biochemistry Seminar and Workshop on Enzymes: Industrial and Medical Prospects, on 
Feb. 6-7, Airlangga University. Published in the conference proceedings (authors: Uria, 
A.R. and E. Chasanah, 2006). 
 Chitinase and chitosanase from microorganisms associated with marine sponges. The 9
th
 
ASEAN Food Conference entitled: “Emerging Science and Technology in the 
Development of Food Industry in the ASEAN” on the 8-10
th
 of August 2005 in Jakarta. 
Published in the conference proceeding (authors: Uria, A.R. and E. Chasanah, 2005). 
 Bioinformatic Analysis of NADP-dependent Alcohol Dehydrogenase from Marine 
Hyperthermophilic Bacteria. Seminar and Workshop on Bioinformatics held on the 17
th
 
March of 2005 at Research Center for Biotechnology, Indonesian Institute of Sciences 
(LIPI), Cibinong Science Center, Bogor. Uria, A.R., R. Machielsen, and J. van der Oost.  
 
Selected Poster Conference Presentations (and Conference Proceedings): 
 Uria, A. R., C. Rückert, J. Kalinowksi, S. Matsunaga, and J. Piel, 2011. Revealing the 
biosynthetic capacity of uncultured symbiotic bacteria. International VAAM Workshop on 
28-30 September 2011 in Bonn, Germany. 
 Uria, A. R., S. Matsunaga, J. Piel, 2010. Biosynthesis of the antitumor polyketide 
misakinolide A by an uncultivated symbiont of the marine sponge Theonella swinhoei. 
VAAM symposium on symbiotic interaction, on 7-8 Oct 2010 at Würzburg University. 
 Uria, A. R., S. Matsunaga, and J. Piel, 2010. Insight into the Secondary Metabolism of 
Entotheonella sp., an Uncultivated Symbiont of Marine Sponges. Die 22. Irseer 
Naturstofftage, Aktuelle Entwicklungen in der Naturstoff-Forschung, on 22 -24 Februar 
2010 in Irsee, Germany. 
 Dewi, A.S., K. Tarman, A.R. Uria, 2008. Marine Natural Products: Prospects and Impacts 
on the Sustainable Development in Indonesia. The Indonesian Student Scientific Meeting 
(ISSM) on Sustainable development in Indonesia: An interdisciplinary approach. Held on 
13–15 May 2008 at Delft University of Technology, Delft, The Netherlands. Published in 
the conference proceedings. 
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Student Supervision: 
During PhD study, he was given responsibilities by Prof. Piel to supervise the internships of 
the following students: 
 Ms.Samantha Keyser (an undergraduate student in Chemistry at Harvard University), 
2010 (1.5 months). Construction of a fosmid library from the bacterium Serratia ordorifera 
and library screening for isolating a trans-AT gene cluster. 
 Ms. Christina Poppel (a bachelor student in Chemistry at University of Bonn), 2010 (1.5 
months). Generation and screening of a fosmid library from the bacterium Dickeya 
dadantii for isolating a trans-AT gene cluster. 
 Ms. Silke Reiter (a master student in Molecular Biomedicine at University of Bonn), 2010 
(1.5 months). Genetic screening of a metagenomic library for finding the remaining part of 
a Misakinolide A biosynthetic gene cluster. 
 Mr. Birkam Pandey (a master student in Molecular Biotechnology at University of Bonn), 
2011 (1.5 months). Filling in the gaps in the PKS/NRPS gene cluster and scaffolds. 
 Mr. Mark Schultz (a master student in Molecular Biotechnology at University of Bonn), 
2012 (2 weeks). Optimizing the PCR conditions for isolating the remaining parts of a 
partial gene cluster coding for the biosynthesis of keramamide from a sponge 
metagenomic library. 
Before PhD study: 
 In 2001: co-supervising 6 undergraduate students for internships in Microbiology at the 
lab of Dr. I.F.M. Rumengan, Sam Ratulangi University. 
 In 2006: supervising 2 undergraduate students for a 2-month internship in Microbiology at 
Research Center for Marine and Fisheries Product Processing and Biotechnology, 
Jakarta.  
 
Teaching Experience: 
 During 2001-2002: teaching some subjects related to Biotechnology (such as 
Biochemistry, Genetics, and Genetic Engineering) at Faculty of Fisheries and Marine 
Science, Sam Ratulangi University. He worked as a teaching assistant of Dr. I.F.M. 
Rumengan.  
 In 2004: teaching some subjects related to Marine Biotechnology at Faculty of Fisheries 
and Marine Science, Sam Ratulangi University. 
 
Scholarships/award: 
 Deutscher Akademischer Austausch Dienst (DAAD) scholarship from Juni 2007 to 
September 2011 for a doctoral study at University of Bonn, Germany. 
 Netherlands Fellowship Programme (NFP) from Aug 2002 to Feb 2004 for a master study 
at Wageningen University and Research Centre, The Netherlands. 
 National Scientific Event (PIMNAS) award for the category Scientific Writing in Natural 
Sciences. Held at IKIP Negeri Jakarta (Jakarta State University) in January 1999. 
Organized by General Directorate of Higher Education (DIKTI), Ministry of National 
Education of Indonesian Republic.  
 
 
 
Selbständigkeitserklärung 
__________________________________________________________________________________ 
218 
 
Selbständigkeitserklärung 
Hiermit erkläre ich, die eingereichte Arbeit selbstständig verfasst und keine anderen 
Hilfsmittel und Quellen als die angegebenen benutzt zu haben. Diese Arbeit ist 
weder identisch noch teilidentisch mit einer Arbeit, die an der Rheinischen Friedrich-
Wilhelms-Universität Bonn oder einer anderen Hochschule zur Erlangung eines 
akademischen Grades oder als Prüfungsleistung vorgelegt worden ist.  Die 
Promotionsordnung der Mathematisch-Naturwissenschaftlichen Fakultät der 
Rheinischen Friedrich-Wilhelms-Universität Bonn ist mir bekannt. 
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